COTY INC. (Form: 10-K, Received: 08/28/2019 16:33:01)

000.12555.254.54.754.004.250.01250.00250.01250.00250.00750.00750.00250.00250.01P15YP3Y1P3Y62028-12-0121.52.7524.751.542.754.754P4Y0false--06-30FY201900010243052000000000.081800000481000000.0110000000008158000008192000007507000000.0050.010.0200.010.040.04750.0250.010.0200.010.0650.01250.02250.010.0200.010.0800.0420.0060.0230.0360.0840.0350.0040.0170.0320.0580.0150.0580.0100.0380.0780.0800.0330.0020.0140.0750.0760.0040.0190.0800.0420.0060.0230.0600.0160.0820.0180.0840.0200.0580.0150.0600.0150.0570.0150.0740.0720.0850.0740.0800.0711800000800000P28YP26YP30YP30YP25YP17YP10YP29YP28YP34YP30YP5YP2YP4YP10YP11YP11YP7YP3YP2YP5YP2Y0000.2507700000220000014000000251000001500000173000000.010.010.0120000000200000005000000940000050000009400000P3YP40YP10YP8YP5YP40YP5YP15YP1YP3YP3YP3YP2YP20YP3YP2Y0P5Y6500000065000000 0001024305 2018-07-01 2019-06-30 0001024305 2019-08-21 0001024305 2018-12-31 0001024305 2016-07-01 2017-06-30 0001024305 2017-07-01 2018-06-30 0001024305 2019-06-30 0001024305 2018-06-30 0001024305 us-gaap:CommonClassAMember 2019-06-30 0001024305 us-gaap:CommonClassAMember 2018-06-30 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-06-30 0001024305 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2016-07-01 2017-06-30 0001024305 us-gaap:ParentMember 2016-07-01 2017-06-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-06-30 0001024305 2017-06-30 0001024305 us-gaap:TreasuryStockMember 2016-06-30 0001024305 us-gaap:PreferredStockMember 2016-06-30 0001024305 us-gaap:ParentMember 2016-06-30 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-06-30 0001024305 us-gaap:NoncontrollingInterestMember 2016-07-01 2017-06-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2016-07-01 2017-06-30 0001024305 us-gaap:AdditionalPaidInCapitalMember 2016-07-01 2017-06-30 0001024305 us-gaap:RetainedEarningsMember 2016-07-01 2017-06-30 0001024305 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2017-06-30 0001024305 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2016-06-30 0001024305 us-gaap:TreasuryStockMember 2016-07-01 2017-06-30 0001024305 us-gaap:TreasuryStockMember 2017-06-30 0001024305 us-gaap:PreferredStockMember 2017-06-30 0001024305 us-gaap:NoncontrollingInterestMember 2017-06-30 0001024305 us-gaap:AdditionalPaidInCapitalMember 2017-06-30 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-07-01 2017-06-30 0001024305 us-gaap:RetainedEarningsMember 2016-06-30 0001024305 us-gaap:PreferredStockMember 2016-07-01 2017-06-30 0001024305 2016-06-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2016-06-30 0001024305 us-gaap:AdditionalPaidInCapitalMember 2016-06-30 0001024305 us-gaap:NoncontrollingInterestMember 2016-06-30 0001024305 us-gaap:ParentMember 2017-06-30 0001024305 us-gaap:RetainedEarningsMember 2017-06-30 0001024305 us-gaap:PreferredStockMember 2018-06-30 0001024305 us-gaap:ParentMember 2017-07-01 2018-06-30 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001024305 2017-07-01 0001024305 us-gaap:PreferredStockMember 2017-07-01 2018-06-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-06-30 0001024305 us-gaap:ParentMember 2017-07-01 0001024305 us-gaap:RetainedEarningsMember 2018-06-30 0001024305 us-gaap:AdditionalPaidInCapitalMember 2017-07-01 2018-06-30 0001024305 us-gaap:PreferredStockMember 2017-07-01 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-07-01 0001024305 us-gaap:AccountingStandardsUpdate201802Member us-gaap:RetainedEarningsMember 2017-07-01 0001024305 us-gaap:AdditionalPaidInCapitalMember 2017-07-01 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-07-01 2018-06-30 0001024305 us-gaap:TreasuryStockMember 2017-07-01 0001024305 us-gaap:AccountingStandardsUpdate201802Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-07-01 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-07-01 0001024305 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001024305 us-gaap:AccountingStandardsUpdate201609Member us-gaap:ParentMember 2017-07-01 0001024305 us-gaap:RetainedEarningsMember 2017-07-01 2018-06-30 0001024305 us-gaap:TreasuryStockMember 2018-06-30 0001024305 us-gaap:RetainedEarningsMember 2017-07-01 0001024305 us-gaap:ParentMember 2018-06-30 0001024305 us-gaap:NoncontrollingInterestMember 2017-07-01 2018-06-30 0001024305 us-gaap:NoncontrollingInterestMember 2018-06-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2017-07-01 2018-06-30 0001024305 us-gaap:NoncontrollingInterestMember 2017-07-01 0001024305 us-gaap:AccountingStandardsUpdate201609Member us-gaap:RetainedEarningsMember 2017-07-01 0001024305 us-gaap:AccountingStandardsUpdate201609Member 2017-07-01 0001024305 us-gaap:ParentMember 2018-07-01 2019-06-30 0001024305 us-gaap:RetainedEarningsMember 2018-07-01 2019-06-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-07-01 0001024305 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2019-06-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-07-01 2019-06-30 0001024305 us-gaap:TreasuryStockMember 2019-06-30 0001024305 us-gaap:NoncontrollingInterestMember 2018-07-01 2019-06-30 0001024305 us-gaap:ParentMember 2018-07-01 0001024305 us-gaap:CommonClassAMember us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2019-06-30 0001024305 us-gaap:AccountingStandardsUpdate201616Member us-gaap:ParentMember 2018-07-01 0001024305 us-gaap:PreferredStockMember 2018-07-01 2019-06-30 0001024305 us-gaap:NoncontrollingInterestMember 2018-07-01 0001024305 us-gaap:AccountingStandardsUpdate201409Member 2018-07-01 0001024305 us-gaap:NoncontrollingInterestMember 2019-06-30 0001024305 us-gaap:TreasuryStockMember 2018-07-01 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2019-06-30 0001024305 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-06-30 0001024305 us-gaap:CommonClassAMember 2018-07-01 2019-06-30 0001024305 us-gaap:AccountingStandardsUpdate201409Member us-gaap:RetainedEarningsMember 2018-07-01 0001024305 us-gaap:PreferredStockMember 2018-07-01 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 0001024305 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 0001024305 us-gaap:CommonClassAMember us-gaap:ParentMember 2018-07-01 2019-06-30 0001024305 us-gaap:RetainedEarningsMember 2018-07-01 0001024305 us-gaap:ParentMember 2019-06-30 0001024305 us-gaap:AccountingStandardsUpdate201616Member 2018-07-01 0001024305 2018-07-01 0001024305 us-gaap:PreferredStockMember 2019-06-30 0001024305 us-gaap:RetainedEarningsMember 2019-06-30 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001024305 us-gaap:AccountingStandardsUpdate201616Member us-gaap:RetainedEarningsMember 2018-07-01 0001024305 us-gaap:AccountingStandardsUpdate201409Member us-gaap:ParentMember 2018-07-01 0001024305 coty:NonCashAcquisitionofAdditionalRedeemableNoncontrollingInterestMember 2018-07-01 2019-06-30 0001024305 coty:NonCashDebtAssumedForBusinessCombinationMember 2018-07-01 2019-06-30 0001024305 coty:NonCashDebtAssumedForBusinessCombinationMember 2017-07-01 2018-06-30 0001024305 coty:NonCashAcquisitionofAdditionalRedeemableNoncontrollingInterestMember 2017-07-01 2018-06-30 0001024305 coty:NonCashAcquisitionofAdditionalRedeemableNoncontrollingInterestMember 2016-07-01 2017-06-30 0001024305 coty:NonCashDebtAssumedForBusinessCombinationMember 2016-07-01 2017-06-30 0001024305 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-07-01 2019-06-30 0001024305 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-07-01 2019-06-30 0001024305 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-07-01 0001024305 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-06-30 0001024305 srt:ScenarioPreviouslyReportedMember 2016-07-01 2017-06-30 0001024305 srt:RestatementAdjustmentMember 2016-07-01 2017-06-30 0001024305 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201707Member 2017-07-01 2018-06-30 0001024305 srt:ScenarioPreviouslyReportedMember 2017-07-01 2018-06-30 0001024305 srt:RestatementAdjustmentMember 2017-07-01 2018-06-30 0001024305 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201707Member 2016-07-01 2017-06-30 0001024305 us-gaap:OperatingIncomeLossMember 2017-07-01 2018-06-30 0001024305 us-gaap:AccountingStandardsUpdate201606Member 2018-07-01 0001024305 us-gaap:OperatingIncomeLossMember 2016-07-01 2017-06-30 0001024305 coty:InterestExpenseNetandOtherExpenseIncomeNetMember 2017-07-01 2018-06-30 0001024305 us-gaap:OperatingIncomeLossMember 2018-07-01 2019-06-30 0001024305 coty:InterestExpenseNetandOtherExpenseIncomeNetMember 2016-07-01 2017-06-30 0001024305 coty:OtherExpenseNetMember 2016-07-01 2017-06-30 0001024305 us-gaap:FurnitureAndFixturesMember 2017-07-01 2018-06-30 0001024305 us-gaap:FurnitureAndFixturesMember 2016-07-01 2017-06-30 0001024305 coty:InterestExpenseNetandOtherExpenseIncomeNetMember 2018-07-01 2019-06-30 0001024305 us-gaap:FurnitureAndFixturesMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember us-gaap:TrademarksMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember us-gaap:LicensingAgreementsMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember us-gaap:TrademarksMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember coty:ProductFormulationsMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember us-gaap:LicensingAgreementsMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember coty:ProductFormulationsMember 2018-07-01 2019-06-30 0001024305 coty:OtherExpenseNetMember 2017-07-01 2018-06-30 0001024305 coty:OtherExpenseNetMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember us-gaap:BuildingMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember coty:ComputerEquipmentandSoftwareandSoftwareDevelopmentCostsMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember coty:ComputerEquipmentandSoftwareandSoftwareDevelopmentCostsMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember us-gaap:BuildingMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2018-07-01 2019-06-30 0001024305 coty:GalleriaCompanyMember 2016-07-01 2017-06-30 0001024305 coty:BurberryBeautyBusinessMember 2018-07-01 2018-09-30 0001024305 coty:BurberryBeautyBusinessMember 2018-09-30 0001024305 coty:BurberryBeautyBusinessMember 2018-06-30 0001024305 coty:YouniqueLLCMember 2017-06-30 0001024305 coty:YouniqueLLCMember 2017-07-01 2018-03-31 0001024305 coty:YouniqueLLCMember 2018-03-31 0001024305 coty:YouniqueLLCMember us-gaap:CustomerRelationshipsMember 2017-07-01 2018-03-31 0001024305 coty:YouniqueLLCMember coty:ProductFormulationsMember 2017-06-30 0001024305 coty:YouniqueLLCMember coty:ProductFormulationsMember 2017-07-01 2018-03-31 0001024305 coty:YouniqueLLCMember coty:ProductFormulationsMember 2018-07-01 2019-06-30 0001024305 coty:YouniqueLLCMember us-gaap:TrademarksMember 2017-07-01 2018-03-31 0001024305 coty:YouniqueLLCMember us-gaap:TrademarksMember 2018-03-31 0001024305 coty:YouniqueLLCMember us-gaap:CustomerRelationshipsMember 2018-03-31 0001024305 coty:YouniqueLLCMember coty:ProductFormulationsMember 2018-03-31 0001024305 coty:YouniqueLLCMember us-gaap:TrademarksMember 2018-07-01 2019-06-30 0001024305 coty:YouniqueLLCMember us-gaap:TrademarksMember 2017-06-30 0001024305 coty:YouniqueLLCMember us-gaap:CustomerRelationshipsMember 2017-06-30 0001024305 coty:YouniqueLLCMember coty:FoundationLLCMember 2017-02-01 0001024305 coty:BurberryBeautyBusinessMember 2017-10-02 0001024305 coty:GalleriaCompanyMember coty:LuxurySegmentMember 2019-06-30 0001024305 coty:BurberryBeautyBusinessMember 2017-10-02 2017-10-02 0001024305 coty:GhdMember 2016-11-21 2016-11-21 0001024305 coty:BurberryBeautyBusinessMember coty:ConsumerBeautySegmentMember 2016-10-01 0001024305 coty:GalleriaCompanyMember 2016-10-01 2016-10-01 0001024305 coty:BurberryBeautyBusinessMember coty:ProfessionalBeautySegmentMember 2016-10-01 0001024305 coty:YouniqueLLCMember coty:LuxurySegmentMember 2019-06-30 0001024305 coty:PreMergerHoldersofGalleriaCommonStockMember coty:GalleriaCompanyMember us-gaap:MajorityShareholderMember 2016-10-01 2016-10-01 0001024305 coty:GhdMember 2017-07-01 2017-12-31 0001024305 coty:YouniqueLLCMember coty:FoundationLLCMember 2017-02-01 2017-02-01 0001024305 coty:GhdMember us-gaap:TechnologyBasedIntangibleAssetsMember 2017-07-01 2017-12-31 0001024305 coty:GalleriaCompanyMember us-gaap:FairValueAdjustmentToInventoryMember 2016-07-01 2017-06-30 0001024305 coty:GhdMember coty:LuxurySegmentMember 2019-06-30 0001024305 coty:FoundationLLCMember 2017-07-01 2018-06-30 0001024305 coty:BurberryBeautyBusinessMember coty:LuxurySegmentMember 2016-10-01 0001024305 coty:GhdMember us-gaap:CustomerRelationshipsMember 2017-07-01 2017-12-31 0001024305 coty:BurberryBeautyBusinessMember 2017-10-02 2018-06-30 0001024305 coty:GhdMember 2016-11-21 0001024305 coty:BurberryBeautyBusinessMember us-gaap:MeasurementInputExpectedTermMember 2017-10-02 0001024305 coty:FoundationLLCMember 2017-02-01 0001024305 coty:GalleriaCompanyMember coty:CustomerRelationshipsLicenseAgreementsAndProductFormulationsMember 2017-07-01 2017-09-30 0001024305 coty:GhdMember 2019-06-30 0001024305 coty:GalleriaCompanyMember 2017-07-01 2017-09-30 0001024305 coty:YouniqueLLCMember coty:ConsumerBeautySegmentMember 2019-06-30 0001024305 coty:FoundationLLCMember 2017-02-01 2017-02-01 0001024305 coty:GhdMember us-gaap:OtherIntangibleAssetsMember 2017-07-01 2017-12-31 0001024305 coty:YouniqueLLCMember coty:ProfessionalBeautySegmentMember 2019-06-30 0001024305 coty:GalleriaCompanyMember coty:ProfessionalBeautySegmentMember 2019-06-30 0001024305 coty:GhdMember coty:ConsumerBeautySegmentMember 2019-06-30 0001024305 coty:GhdMember coty:ProfessionalBeautySegmentMember 2019-06-30 0001024305 coty:GalleriaCompanyMember us-gaap:AcquisitionRelatedCostsMember 2016-07-01 2017-06-30 0001024305 coty:GalleriaCompanyMember coty:ConsumerBeautySegmentMember 2019-06-30 0001024305 coty:GhdMember us-gaap:TechnologyBasedIntangibleAssetsMember 2017-12-31 0001024305 coty:GhdMember us-gaap:TechnologyBasedIntangibleAssetsMember 2017-06-30 0001024305 coty:GhdMember 2017-06-30 0001024305 coty:GhdMember 2017-12-31 0001024305 coty:GhdMember us-gaap:CustomerRelationshipsMember 2017-06-30 0001024305 coty:GhdMember us-gaap:CustomerRelationshipsMember 2017-12-31 0001024305 coty:GhdMember us-gaap:OtherIntangibleAssetsMember 2017-06-30 0001024305 coty:GhdMember us-gaap:OtherIntangibleAssetsMember 2017-12-31 0001024305 coty:GalleriaCompanyMember us-gaap:CustomerRelationshipsMember 2017-09-30 0001024305 coty:GalleriaCompanyMember 2017-09-30 0001024305 coty:GalleriaCompanyMember 2017-06-30 0001024305 coty:GalleriaCompanyMember us-gaap:CustomerRelationshipsMember 2017-06-30 0001024305 coty:GalleriaCompanyMember us-gaap:TrademarksMember 2017-06-30 0001024305 coty:GalleriaCompanyMember us-gaap:TrademarksMember 2017-07-01 2017-09-30 0001024305 coty:GalleriaCompanyMember us-gaap:TrademarksMember 2017-09-30 0001024305 coty:GalleriaCompanyMember coty:ProductFormulationsMember 2017-07-01 2017-09-30 0001024305 coty:GalleriaCompanyMember coty:ProductFormulationsMember 2017-06-30 0001024305 coty:GalleriaCompanyMember us-gaap:LicensingAgreementsMember 2017-09-30 0001024305 coty:GalleriaCompanyMember us-gaap:LicensingAgreementsMember 2017-06-30 0001024305 coty:GalleriaCompanyMember us-gaap:TrademarksMember 2017-06-30 0001024305 coty:GalleriaCompanyMember us-gaap:TrademarksMember 2017-09-30 0001024305 coty:GalleriaCompanyMember coty:ProductFormulationsMember 2017-09-30 0001024305 coty:GalleriaCompanyMember us-gaap:LicensingAgreementsMember 2017-07-01 2017-09-30 0001024305 coty:GalleriaCompanyMember us-gaap:CustomerRelationshipsMember 2017-07-01 2017-09-30 0001024305 coty:GalleriaCompanyMember us-gaap:TrademarksMember 2017-07-01 2017-09-30 0001024305 srt:MaximumMember coty:GhdMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember coty:GalleriaCompanyMember us-gaap:CustomerRelationshipsMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember coty:BurberryBeautyBusinessMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember coty:YouniqueLLCMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember coty:GhdMember us-gaap:CustomerRelationshipsMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember coty:GhdMember us-gaap:CustomerRelationshipsMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember coty:GhdMember us-gaap:TechnologyBasedIntangibleAssetsMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember coty:GalleriaCompanyMember us-gaap:CustomerRelationshipsMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember coty:GalleriaCompanyMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember coty:GalleriaCompanyMember us-gaap:TrademarksMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember coty:GalleriaCompanyMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember coty:GalleriaCompanyMember us-gaap:LicensingAgreementsMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember coty:GalleriaCompanyMember coty:ProductFormulationsMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember coty:GalleriaCompanyMember us-gaap:TrademarksMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember coty:GhdMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember coty:BurberryBeautyBusinessMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember coty:YouniqueLLCMember us-gaap:CustomerRelationshipsMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember coty:YouniqueLLCMember us-gaap:CustomerRelationshipsMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember coty:YouniqueLLCMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember coty:GalleriaCompanyMember coty:ProductFormulationsMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember coty:GalleriaCompanyMember us-gaap:LicensingAgreementsMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember coty:GhdMember us-gaap:TechnologyBasedIntangibleAssetsMember 2018-07-01 2019-06-30 0001024305 srt:NorthAmericaMember 2017-07-01 2018-06-30 0001024305 srt:NorthAmericaMember 2016-07-01 2017-06-30 0001024305 srt:EuropeMember 2017-07-01 2018-06-30 0001024305 srt:EuropeMember 2016-07-01 2017-06-30 0001024305 coty:AsianLatinAmericaMiddleEastAfricaAustraliaMember 2018-07-01 2019-06-30 0001024305 srt:NorthAmericaMember 2018-07-01 2019-06-30 0001024305 coty:AsianLatinAmericaMiddleEastAfricaAustraliaMember 2016-07-01 2017-06-30 0001024305 srt:EuropeMember 2018-07-01 2019-06-30 0001024305 coty:AsianLatinAmericaMiddleEastAfricaAustraliaMember 2017-07-01 2018-06-30 0001024305 coty:FragrancesMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2016-07-01 2017-06-30 0001024305 coty:HairCareMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2017-07-01 2018-06-30 0001024305 coty:ColorCosmeticsMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2016-07-01 2017-06-30 0001024305 coty:SkinAndBodyCareMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2017-07-01 2018-06-30 0001024305 coty:ColorCosmeticsMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2017-07-01 2018-06-30 0001024305 us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2016-07-01 2017-06-30 0001024305 coty:HairCareMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2016-07-01 2017-06-30 0001024305 us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2019-06-30 0001024305 coty:FragrancesMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2019-06-30 0001024305 coty:ColorCosmeticsMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2019-06-30 0001024305 us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2017-07-01 2018-06-30 0001024305 coty:FragrancesMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2017-07-01 2018-06-30 0001024305 coty:SkinAndBodyCareMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2016-07-01 2017-06-30 0001024305 coty:HairCareMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2019-06-30 0001024305 coty:SkinAndBodyCareMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2019-06-30 0001024305 country:CH 2019-06-30 0001024305 country:BR 2019-06-30 0001024305 country:US 2017-06-30 0001024305 country:CH 2017-06-30 0001024305 coty:AllOtherMember 2019-06-30 0001024305 country:BR 2018-06-30 0001024305 country:US 2019-06-30 0001024305 country:US 2018-06-30 0001024305 country:CH 2018-06-30 0001024305 coty:AllOtherMember 2018-06-30 0001024305 country:BR 2017-06-30 0001024305 coty:AllOtherMember 2017-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:LuxurySegmentMember 2018-07-01 2019-06-30 0001024305 coty:LuxurySegmentMember 2017-07-01 2018-06-30 0001024305 coty:ProfessionalBeautySegmentMember 2016-07-01 2017-06-30 0001024305 us-gaap:CorporateNonSegmentMember 2016-07-01 2017-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:ProfessionalBeautySegmentMember 2018-07-01 2019-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:ProfessionalBeautySegmentMember 2016-07-01 2017-06-30 0001024305 coty:LuxurySegmentMember 2016-07-01 2017-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:ConsumerBeautySegmentMember 2017-07-01 2018-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:LuxurySegmentMember 2017-07-01 2018-06-30 0001024305 coty:ConsumerBeautySegmentMember 2017-07-01 2018-06-30 0001024305 us-gaap:CorporateNonSegmentMember 2018-07-01 2019-06-30 0001024305 coty:ProfessionalBeautySegmentMember 2018-07-01 2019-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:ConsumerBeautySegmentMember 2016-07-01 2017-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:ProfessionalBeautySegmentMember 2017-07-01 2018-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:ConsumerBeautySegmentMember 2018-07-01 2019-06-30 0001024305 coty:ConsumerBeautySegmentMember 2018-07-01 2019-06-30 0001024305 coty:ConsumerBeautySegmentMember 2016-07-01 2017-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:LuxurySegmentMember 2016-07-01 2017-06-30 0001024305 us-gaap:CorporateNonSegmentMember 2017-07-01 2018-06-30 0001024305 coty:ProfessionalBeautySegmentMember 2017-07-01 2018-06-30 0001024305 coty:LuxurySegmentMember 2018-07-01 2019-06-30 0001024305 country:US 2016-07-01 2017-06-30 0001024305 country:US 2017-07-01 2018-06-30 0001024305 country:US 2018-07-01 2019-06-30 0001024305 us-gaap:ContractTerminationMember coty:GlobalIntegrationMember 2019-06-30 0001024305 us-gaap:FacilityClosingMember coty:GlobalIntegrationMember 2019-06-30 0001024305 us-gaap:FacilityClosingMember coty:GlobalIntegrationMember 2016-07-01 2017-06-30 0001024305 us-gaap:OtherRestructuringMember coty:GlobalIntegrationMember 2017-07-01 2018-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:GlobalIntegrationMember 2016-07-01 2017-06-30 0001024305 us-gaap:OtherRestructuringMember coty:GlobalIntegrationMember 2019-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:GlobalIntegrationMember 2018-07-01 2019-06-30 0001024305 coty:GlobalIntegrationMember 2016-07-01 2017-06-30 0001024305 us-gaap:OtherRestructuringMember coty:GlobalIntegrationMember 2018-07-01 2019-06-30 0001024305 us-gaap:ContractTerminationMember coty:GlobalIntegrationMember 2016-07-01 2017-06-30 0001024305 us-gaap:ContractTerminationMember coty:GlobalIntegrationMember 2018-07-01 2019-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:GlobalIntegrationMember 2019-06-30 0001024305 coty:GlobalIntegrationMember 2018-07-01 2019-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:GlobalIntegrationMember 2017-07-01 2018-06-30 0001024305 us-gaap:FacilityClosingMember coty:GlobalIntegrationMember 2018-07-01 2019-06-30 0001024305 us-gaap:OtherRestructuringMember coty:GlobalIntegrationMember 2016-07-01 2017-06-30 0001024305 coty:GlobalIntegrationMember 2017-07-01 2018-06-30 0001024305 us-gaap:ContractTerminationMember coty:GlobalIntegrationMember 2017-07-01 2018-06-30 0001024305 us-gaap:FacilityClosingMember coty:GlobalIntegrationMember 2017-07-01 2018-06-30 0001024305 coty:GlobalIntegrationMember 2019-06-30 0001024305 us-gaap:OtherRestructuringMember coty:A2018RestructuringActionsMember 2019-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:A2018RestructuringActionsMember 2019-06-30 0001024305 us-gaap:ContractTerminationMember coty:A2018RestructuringActionsMember 2018-07-01 2019-06-30 0001024305 us-gaap:FacilityClosingMember coty:A2018RestructuringActionsMember 2017-07-01 2018-06-30 0001024305 coty:A2018RestructuringActionsMember 2017-07-01 2018-06-30 0001024305 us-gaap:FacilityClosingMember coty:A2018RestructuringActionsMember 2019-06-30 0001024305 coty:A2018RestructuringActionsMember 2018-07-01 2019-06-30 0001024305 us-gaap:ContractTerminationMember coty:A2018RestructuringActionsMember 2019-06-30 0001024305 us-gaap:FacilityClosingMember coty:A2018RestructuringActionsMember 2018-07-01 2019-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:A2018RestructuringActionsMember 2017-07-01 2018-06-30 0001024305 us-gaap:OtherRestructuringMember coty:A2018RestructuringActionsMember 2017-07-01 2018-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:A2018RestructuringActionsMember 2018-07-01 2019-06-30 0001024305 us-gaap:ContractTerminationMember coty:A2018RestructuringActionsMember 2017-07-01 2018-06-30 0001024305 us-gaap:OtherRestructuringMember coty:A2018RestructuringActionsMember 2018-07-01 2019-06-30 0001024305 coty:A2018RestructuringActionsMember 2019-06-30 0001024305 us-gaap:OtherRestructuringMember coty:A2018RestructuringActionsMember 2018-06-30 0001024305 coty:A2018RestructuringActionsMember 2018-06-30 0001024305 us-gaap:ContractTerminationMember coty:A2018RestructuringActionsMember 2018-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:A2018RestructuringActionsMember 2018-06-30 0001024305 coty:A2018RestructuringActionsMember 2016-07-01 2017-06-30 0001024305 us-gaap:OtherRestructuringMember 2018-07-01 2019-06-30 0001024305 us-gaap:OtherRestructuringMember 2017-07-01 2018-06-30 0001024305 us-gaap:OtherRestructuringMember 2016-07-01 2017-06-30 0001024305 coty:FixedAssetWriteoffsMember coty:GlobalIntegrationMember 2019-06-30 0001024305 coty:FixedAssetWriteoffsMember coty:GlobalIntegrationMember 2018-07-01 2019-06-30 0001024305 us-gaap:OtherRestructuringMember coty:GlobalIntegrationMember 2018-06-30 0001024305 us-gaap:ContractTerminationMember coty:GlobalIntegrationMember 2018-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:GlobalIntegrationMember 2018-06-30 0001024305 coty:FixedAssetWriteoffsMember coty:GlobalIntegrationMember 2018-06-30 0001024305 coty:GlobalIntegrationMember 2018-06-30 0001024305 srt:ScenarioForecastMember coty:GalleriaCompanyMember us-gaap:OtherRestructuringMember 2019-07-01 2020-06-30 0001024305 us-gaap:AccountingStandardsUpdate201707Member coty:BourjoisMember us-gaap:RestructuringChargesMember us-gaap:PensionPlansDefinedBenefitMember 2016-07-01 2017-06-30 0001024305 us-gaap:AccountingStandardsUpdate201707Member us-gaap:RestructuringChargesMember coty:GlobalIntegrationMember us-gaap:PensionPlansDefinedBenefitMember 2016-07-01 2017-06-30 0001024305 coty:GalleriaCompanyMember us-gaap:OtherRestructuringMember 2018-07-01 2019-06-30 0001024305 coty:BurberryBeautyBusinessMember us-gaap:OtherRestructuringMember 2018-06-30 0001024305 coty:GalleriaCompanyMember us-gaap:OtherRestructuringMember 2019-06-30 0001024305 srt:ScenarioForecastMember coty:GalleriaCompanyMember us-gaap:OtherRestructuringMember 2021-07-01 2022-06-30 0001024305 srt:ScenarioForecastMember coty:GlobalIntegrationMember 2021-07-01 2022-06-30 0001024305 srt:ScenarioForecastMember coty:A2018RestructuringActionsMember 2021-07-01 2022-06-30 0001024305 us-gaap:OtherRestructuringMember 2018-07-01 2019-06-30 0001024305 srt:ScenarioForecastMember us-gaap:OtherRestructuringMember 2020-07-01 2021-06-30 0001024305 srt:ScenarioForecastMember coty:GalleriaCompanyMember us-gaap:OtherRestructuringMember 2020-07-01 2021-06-30 0001024305 srt:ScenarioForecastMember coty:A2018RestructuringActionsMember 2020-07-01 2021-06-30 0001024305 coty:BurberryBeautyBusinessMember us-gaap:OtherRestructuringMember 2018-07-01 2019-06-30 0001024305 coty:GalleriaCompanyMember us-gaap:OtherRestructuringMember 2017-07-01 2018-06-30 0001024305 srt:ScenarioForecastMember coty:A2018RestructuringActionsMember 2019-07-01 2020-06-30 0001024305 coty:BurberryBeautyBusinessMember us-gaap:OtherRestructuringMember 2017-07-01 2018-06-30 0001024305 srt:ScenarioForecastMember coty:BurberryBeautyBusinessMember us-gaap:OtherRestructuringMember 2019-07-01 2020-06-30 0001024305 srt:ScenarioForecastMember coty:GlobalIntegrationMember 2019-07-01 2020-06-30 0001024305 us-gaap:OtherRestructuringMember 2016-07-01 2017-06-30 0001024305 coty:GalleriaCompanyMember us-gaap:OtherRestructuringMember 2016-10-01 0001024305 us-gaap:OtherRestructuringMember 2019-06-30 0001024305 coty:TurnaroundPlanMember us-gaap:SubsequentEventMember 2019-07-01 0001024305 srt:ScenarioForecastMember coty:GlobalIntegrationMember 2020-07-01 2021-06-30 0001024305 srt:ScenarioForecastMember us-gaap:OtherRestructuringMember 2019-07-01 2020-06-30 0001024305 us-gaap:OtherRestructuringMember 2018-06-30 0001024305 coty:BurberryBeautyBusinessMember us-gaap:OtherRestructuringMember 2019-06-30 0001024305 us-gaap:OtherRestructuringMember 2017-07-01 2018-06-30 0001024305 coty:TurnaroundPlanMember us-gaap:SubsequentEventMember 2019-07-01 2019-07-01 0001024305 us-gaap:AccountingStandardsUpdate201707Member us-gaap:OtherNonoperatingIncomeExpenseMember coty:GlobalIntegrationMember us-gaap:PensionPlansDefinedBenefitMember 2016-07-01 2017-06-30 0001024305 coty:GalleriaCompanyMember us-gaap:OtherRestructuringMember 2016-07-01 2017-06-30 0001024305 us-gaap:AccountingStandardsUpdate201707Member coty:BourjoisMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:PensionPlansDefinedBenefitMember 2016-07-01 2017-06-30 0001024305 us-gaap:FinanceReceivablesMember us-gaap:TradeAccountsReceivableMember 2018-06-30 0001024305 us-gaap:FinanceReceivablesMember 2017-07-01 2018-06-30 0001024305 us-gaap:FinanceReceivablesMember 2018-07-01 2019-06-30 0001024305 2019-03-19 0001024305 us-gaap:FinanceReceivablesMember 2018-06-30 0001024305 us-gaap:FinanceReceivablesMember 2016-07-01 2017-06-30 0001024305 us-gaap:FinanceReceivablesMember 2019-06-30 0001024305 us-gaap:FinanceReceivablesMember us-gaap:TradeAccountsReceivableMember 2019-06-30 0001024305 us-gaap:ConstructionInProgressMember 2018-06-30 0001024305 us-gaap:ConstructionInProgressMember 2019-06-30 0001024305 coty:ComputerEquipmentandSoftwareandSoftwareDevelopmentCostsMember 2019-06-30 0001024305 us-gaap:FurnitureAndFixturesMember 2018-06-30 0001024305 us-gaap:LandBuildingsAndImprovementsMember 2018-06-30 0001024305 us-gaap:MachineryAndEquipmentMember 2019-06-30 0001024305 us-gaap:LandBuildingsAndImprovementsMember 2019-06-30 0001024305 us-gaap:MachineryAndEquipmentMember 2018-06-30 0001024305 coty:ComputerEquipmentandSoftwareandSoftwareDevelopmentCostsMember 2018-06-30 0001024305 us-gaap:FurnitureAndFixturesMember 2019-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:FragrancesMember 2018-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:SkinAndBodyCareMember 2018-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:FragrancesMember 2017-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:ColorCosmeticsMember 2019-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:FragrancesMember 2019-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:FragrancesMember 2018-07-01 2019-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:FragrancesMember 2017-07-01 2018-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:SkinAndBodyCareMember 2019-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:ColorCosmeticsMember 2018-07-01 2019-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:ColorCosmeticsMember 2017-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:SkinAndBodyCareMember 2018-07-01 2019-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:SkinAndBodyCareMember 2017-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:ColorCosmeticsMember 2017-07-01 2018-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:ColorCosmeticsMember 2018-06-30 0001024305 us-gaap:OperatingSegmentsMember coty:SkinAndBodyCareMember 2017-07-01 2018-06-30 0001024305 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember coty:PlayboyAndCerrutiMember 2018-06-30 0001024305 us-gaap:TrademarksMember coty:ConsumerBeautySegmentMember 2018-10-01 2018-12-31 0001024305 coty:ConsumerBeautySegmentMember 2018-10-01 2018-12-31 0001024305 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember coty:PlayboyAndCerrutiMember 2017-07-01 2018-06-30 0001024305 us-gaap:TrademarksMember coty:SkinAndBodyCareMember 2018-07-01 2019-06-30 0001024305 us-gaap:TrademarksMember coty:LuxurySegmentMember 2019-04-01 2019-06-30 0001024305 srt:MinimumMember 2018-07-01 2019-06-30 0001024305 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember coty:J.LoMember 2017-06-30 0001024305 us-gaap:LicensingAgreementsMember coty:LuxurySegmentMember 2018-07-01 2019-06-30 0001024305 coty:LuxurySegmentMember 2018-10-01 2018-12-31 0001024305 coty:ConsumerBeautySegmentMember 2019-04-01 2019-06-30 0001024305 srt:MaximumMember 2018-07-01 2019-06-30 0001024305 us-gaap:TrademarksMember 2018-07-01 2019-06-30 0001024305 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2017-07-01 2018-06-30 0001024305 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2016-07-01 2017-06-30 0001024305 us-gaap:TrademarksMember coty:ConsumerBeautySegmentMember 2019-04-01 2019-06-30 0001024305 us-gaap:CustomerRelationshipsMember 2018-07-01 2019-06-30 0001024305 us-gaap:LicensingAgreementsMember 2018-07-01 2019-06-30 0001024305 coty:ProductFormulationsMember 2018-07-01 2019-06-30 0001024305 us-gaap:CustomerRelationshipsMember 2018-06-30 0001024305 us-gaap:TrademarksMember 2018-06-30 0001024305 coty:ProductFormulationsMember 2018-06-30 0001024305 us-gaap:LicensingAgreementsMember 2018-06-30 0001024305 us-gaap:CustomerRelationshipsMember 2019-06-30 0001024305 us-gaap:LicensingAgreementsMember 2019-06-30 0001024305 us-gaap:TrademarksMember 2019-06-30 0001024305 coty:ProductFormulationsMember 2019-06-30 0001024305 us-gaap:TrademarksMember coty:SkinAndBodyCareMember 2019-06-30 0001024305 us-gaap:TrademarksMember coty:ConsumerBeautySegmentMember 2019-06-30 0001024305 us-gaap:TrademarksMember coty:LuxurySegmentMember 2019-06-30 0001024305 us-gaap:TrademarksMember coty:LuxurySegmentMember 2018-12-31 0001024305 us-gaap:TrademarksMember coty:ConsumerBeautySegmentMember 2018-12-31 0001024305 coty:PricingTierOneMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierFiveMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierTwoMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierOneMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierThreeMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierFourMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierFourMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierThreeMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierFiveMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierTwoMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 currency:EUR us-gaap:MediumTermNotesMember coty:A2023EuroNotesMember us-gaap:SeniorNotesMember 2019-06-30 0001024305 currency:USD us-gaap:MediumTermNotesMember coty:A2026DollarNotesMember us-gaap:SeniorNotesMember 2019-06-30 0001024305 currency:EUR us-gaap:MediumTermNotesMember coty:TermLoanBFacilityDueApril2025Member us-gaap:LineOfCreditMember 2019-06-30 0001024305 currency:USD us-gaap:MediumTermNotesMember coty:TermLoanBFacilityDueApril2025Member us-gaap:LineOfCreditMember 2019-06-30 0001024305 currency:USD us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember 2019-06-30 0001024305 currency:EUR us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember 2019-06-30 0001024305 currency:EUR us-gaap:MediumTermNotesMember coty:A2026EuroNotesMember us-gaap:SeniorNotesMember 2019-06-30 0001024305 us-gaap:RevolvingCreditFacilityMember coty:RevolvingCreditFacilityDueApril2023Member us-gaap:LineOfCreditMember 2019-06-30 0001024305 coty:TwoThousandEighteenCotyCreditAgreementMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-06-30 0001024305 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-06-30 0001024305 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-06-30 0001024305 coty:TwoThousandEighteenCotyCreditAgreementMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-06-30 0001024305 coty:TwoThousandEighteenCotyCreditAgreementMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001024305 coty:TwoThousandEighteenCotyCreditAgreementMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-06-30 0001024305 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-06-30 0001024305 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-06-30 0001024305 us-gaap:RevolvingCreditFacilityMember coty:RevolvingCreditFacilityDueApril2023Member us-gaap:LineOfCreditMember 2018-06-30 0001024305 coty:A2023EuroNotesMember us-gaap:SeniorNotesMember 2019-06-30 0001024305 us-gaap:MediumTermNotesMember coty:TermLoanBFacilityDueApril2025Member us-gaap:LineOfCreditMember 2018-06-30 0001024305 us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember 2018-06-30 0001024305 coty:A2026EuroNotesMember us-gaap:SeniorNotesMember 2018-06-30 0001024305 coty:A2023EuroNotesMember us-gaap:SeniorNotesMember 2018-06-30 0001024305 coty:A2026DollarNotesMember us-gaap:SeniorNotesMember 2019-06-30 0001024305 coty:A2026DollarNotesMember us-gaap:SeniorNotesMember 2018-06-30 0001024305 us-gaap:MediumTermNotesMember coty:TermLoanBFacilityDueApril2025Member us-gaap:LineOfCreditMember 2019-06-30 0001024305 coty:A2026EuroNotesMember us-gaap:SeniorNotesMember 2019-06-30 0001024305 us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember 2019-06-30 0001024305 coty:PricingTierSixMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierFiveMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierTwoMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierSixMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierFiveMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierThreeMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierThreeMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierFourMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierOneMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierFourMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierTwoMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierOneMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember 2018-04-05 2018-04-05 0001024305 us-gaap:LetterOfCreditMember 2019-06-30 0001024305 us-gaap:SeniorNotesMember 2018-04-05 2018-04-05 0001024305 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember coty:CotyCreditAgreementMember us-gaap:LineOfCreditMember 2018-07-01 2019-06-30 0001024305 coty:A2023EuroNotesMember us-gaap:SeniorNotesMember 2018-04-05 0001024305 srt:MinimumMember coty:ShorttermLinesofCreditMember 2017-07-01 2018-06-30 0001024305 coty:TermLoanBFacilityDueOctober2022Member us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 us-gaap:LineOfCreditMember 2017-07-01 2018-06-30 0001024305 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember coty:CotyCreditAgreementMember us-gaap:LineOfCreditMember 2018-07-01 2019-06-30 0001024305 us-gaap:LetterOfCreditMember coty:A2018CotyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2018-04-05 0001024305 srt:MaximumMember us-gaap:LineOfCreditMember 2018-07-01 2019-06-30 0001024305 us-gaap:RevolvingCreditFacilityMember coty:CotyCreditAgreementMember us-gaap:LineOfCreditMember 2017-07-01 2018-06-30 0001024305 us-gaap:LineOfCreditMember 2018-07-01 2019-06-30 0001024305 coty:TermLoanBFacilityDueOctober2022Member coty:EuroInterbankOfferedRateEuriborMember 2018-07-01 2019-06-30 0001024305 us-gaap:LineOfCreditMember 2018-06-30 0001024305 srt:MaximumMember coty:ShorttermLinesofCreditMember 2018-07-01 2019-06-30 0001024305 coty:BankGuaranteeMember 2018-06-30 0001024305 coty:ShorttermLinesofCreditMember 2018-06-30 0001024305 srt:MinimumMember us-gaap:LineOfCreditMember 2018-07-01 2019-06-30 0001024305 coty:PeriodEndingDecember312021ThroughMarch312022Member coty:IncurrenceIncrementalFacilitiesMember coty:A2018CotyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-06-26 2019-06-26 0001024305 coty:PeriodEndingDecember312021ThroughMarch312022Member coty:IncurrenceIncrementalFacilitiesMember coty:A2018CotyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-06-27 2019-06-27 0001024305 coty:A2026EuroNotesMember us-gaap:SeniorNotesMember 2018-04-05 2018-04-05 0001024305 us-gaap:LineOfCreditMember 2019-06-30 0001024305 coty:A2026DollarNotesMember us-gaap:SeniorNotesMember 2018-04-05 0001024305 coty:EuroNotesMember us-gaap:SeniorNotesMember 2018-04-05 2018-04-05 0001024305 us-gaap:BridgeLoanMember coty:A2018CotyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2018-04-05 0001024305 coty:A2023EuroNotesMember us-gaap:SeniorNotesMember 2018-04-05 2018-04-05 0001024305 coty:A2026EuroNotesMember us-gaap:SeniorNotesMember 2018-04-05 0001024305 coty:IncurrenceIncrementalFacilitiesMember coty:A2018CotyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2018-04-05 0001024305 us-gaap:RevolvingCreditFacilityMember coty:CotyCreditAgreementMember us-gaap:LineOfCreditMember 2018-07-01 2019-06-30 0001024305 us-gaap:LineOfCreditMember 2017-06-30 0001024305 coty:TermLoanBFacilityDueOctober2022Member us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 coty:A2026DollarNotesMember us-gaap:SeniorNotesMember 2018-04-05 2018-04-05 0001024305 coty:A2018CotyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-06-27 2019-06-27 0001024305 srt:MinimumMember coty:ShorttermLinesofCreditMember 2018-07-01 2019-06-30 0001024305 us-gaap:LineOfCreditMember 2016-07-01 2017-06-30 0001024305 coty:A2018CotyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-06-27 0001024305 coty:ShorttermLinesofCreditMember 2019-06-30 0001024305 coty:BankGuaranteeMember 2019-06-30 0001024305 srt:MaximumMember coty:ShorttermLinesofCreditMember 2017-07-01 2018-06-30 0001024305 coty:IncurrenceIncrementalFacilitiesMember coty:A2018CotyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2018-04-05 2018-04-05 0001024305 us-gaap:LetterOfCreditMember 2018-06-30 0001024305 coty:A2026EuroNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 coty:A2023EuroNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 coty:A2023EuroNotesMember us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 coty:A2026EuroNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 coty:A2026DollarNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 coty:A2023EuroNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 coty:A2026DollarNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 coty:A2026EuroNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 coty:A2026DollarNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 coty:A2023EuroNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 coty:A2026EuroNotesMember us-gaap:DebtInstrumentRedemptionPeriodFiveMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 coty:A2026DollarNotesMember us-gaap:DebtInstrumentRedemptionPeriodFiveMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierTwoMember srt:MaximumMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierThreeMember srt:MaximumMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierFourMember srt:MaximumMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierTwoMember srt:MinimumMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierOneMember srt:MinimumMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierSixMember srt:MaximumMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierFourMember srt:MinimumMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierFiveMember srt:MaximumMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierThreeMember srt:MinimumMember 2018-07-01 2019-06-30 0001024305 coty:PricingTierFiveMember srt:MinimumMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember coty:RevolvingCreditFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 currency:EUR us-gaap:MediumTermNotesMember coty:TermLoanBFacilityDueApril2025Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 currency:EUR us-gaap:MediumTermNotesMember coty:A2023EuroNotesMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 currency:USD us-gaap:MediumTermNotesMember coty:TermLoanBFacilityDueApril2025Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 currency:EUR srt:MaximumMember us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 currency:EUR srt:MinimumMember us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 currency:USD us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 currency:USD srt:MinimumMember us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 currency:USD us-gaap:MediumTermNotesMember coty:A2026DollarNotesMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 currency:EUR srt:MinimumMember us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember coty:RevolvingCreditFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 currency:EUR us-gaap:MediumTermNotesMember coty:A2026EuroNotesMember us-gaap:SeniorNotesMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember coty:RevolvingCreditFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 currency:USD srt:MaximumMember us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 currency:USD srt:MinimumMember us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 currency:USD srt:MaximumMember us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 currency:EUR us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 currency:USD us-gaap:MediumTermNotesMember coty:TermLoanBFacilityDueApril2025Member us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 currency:EUR srt:MaximumMember us-gaap:MediumTermNotesMember coty:TermLoanAFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember coty:RevolvingCreditFacilityDueApril2023Member us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2018-07-01 2019-06-30 0001024305 coty:PeriodEndingDecember312021ThroughMarch312022Member 2018-07-01 2019-06-30 0001024305 coty:PeriodEndingJune302022ThroughSeptember302022Member 2018-07-01 2019-06-30 0001024305 coty:PeriodEndingMarch312023ThroughJune302023Member 2018-07-01 2019-06-30 0001024305 coty:PeriodEndingSeptember302022ThroughDecember312022Member 2018-07-01 2019-06-30 0001024305 coty:PeriodEndingJune302019ThroughDecember312021Member 2018-07-01 2019-06-30 0001024305 coty:PeriodEndingMarch312022ThroughJune302022Member 2018-07-01 2019-06-30 0001024305 coty:RestofWorldMember coty:TaxYear2021Member 2019-06-30 0001024305 coty:TaxYear2020Member 2019-06-30 0001024305 coty:WesternEuropeMember 2019-06-30 0001024305 coty:WesternEuropeMember coty:TaxYear2024andThereafterMember 2019-06-30 0001024305 coty:RestofWorldMember coty:TaxYear2020Member 2019-06-30 0001024305 coty:WesternEuropeMember coty:TaxYear2020Member 2019-06-30 0001024305 coty:TaxYear2021Member 2019-06-30 0001024305 coty:RestofWorldMember 2019-06-30 0001024305 country:US coty:TaxYear2020Member 2019-06-30 0001024305 coty:RestofWorldMember coty:TaxYear2022Member 2019-06-30 0001024305 country:US coty:TaxYear2022Member 2019-06-30 0001024305 coty:RestofWorldMember coty:TaxYear2024andThereafterMember 2019-06-30 0001024305 coty:TaxYear2024andThereafterMember 2019-06-30 0001024305 coty:WesternEuropeMember coty:TaxYear2022Member 2019-06-30 0001024305 country:US coty:TaxYear2024andThereafterMember 2019-06-30 0001024305 coty:WesternEuropeMember coty:TaxYear2023Member 2019-06-30 0001024305 country:US coty:TaxYear2023Member 2019-06-30 0001024305 coty:TaxYear2022Member 2019-06-30 0001024305 coty:TaxYear2023Member 2019-06-30 0001024305 country:US coty:TaxYear2021Member 2019-06-30 0001024305 coty:WesternEuropeMember coty:TaxYear2021Member 2019-06-30 0001024305 coty:RestofWorldMember coty:TaxYear2023Member 2019-06-30 0001024305 us-gaap:OtherNoncurrentLiabilitiesMember 2018-06-30 0001024305 coty:IncomeAndOtherTaxesPayableAndOtherNonCurrentLiabilitiesMember 2019-06-30 0001024305 coty:GalleriaCompanyMember 2016-10-01 2016-12-31 0001024305 coty:IncomeAndOtherTaxesPayableAndOtherNonCurrentLiabilitiesMember 2018-06-30 0001024305 us-gaap:OtherNoncurrentLiabilitiesMember 2019-06-30 0001024305 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-07-01 2019-06-30 0001024305 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2019-06-30 0001024305 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-07-01 2018-06-30 0001024305 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-06-30 0001024305 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 country:US us-gaap:PensionPlansDefinedBenefitMember 2017-07-01 2018-06-30 0001024305 country:US us-gaap:PensionPlansDefinedBenefitMember 2017-06-30 0001024305 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-07-01 2018-06-30 0001024305 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-06-30 0001024305 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-06-30 0001024305 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2019-06-30 0001024305 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-06-30 0001024305 country:US 2017-07-01 2018-06-30 0001024305 us-gaap:ForeignPlanMember 2018-07-01 2019-06-30 0001024305 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-01 2019-06-30 0001024305 coty:BourjoisMember us-gaap:PensionPlansDefinedBenefitMember 2016-07-01 2017-06-30 0001024305 us-gaap:ForeignPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-07-01 2018-06-30 0001024305 coty:GlobalIntegrationMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-07-01 2017-06-30 0001024305 coty:DelLaboratoriesIncMember country:US us-gaap:PensionPlansDefinedBenefitMember 2016-07-01 2017-06-30 0001024305 country:US 2018-07-01 2019-06-30 0001024305 coty:GlobalIntegrationMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2019-06-30 0001024305 us-gaap:ForeignPlanMember 2017-07-01 2018-06-30 0001024305 us-gaap:ForeignPlanMember 2016-07-01 2017-06-30 0001024305 country:US 2016-07-01 2017-06-30 0001024305 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-29 0001024305 us-gaap:EquitySecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:CashAndCashEquivalentsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:CashAndCashEquivalentsMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:FixedIncomeSecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:FixedIncomeSecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:EquitySecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 coty:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 coty:InsuranceContractsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 coty:InsuranceContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 coty:InsuranceContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 coty:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 coty:InsuranceContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 coty:InsuranceContractsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 coty:InsuranceContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 country:US us-gaap:PensionPlansDefinedBenefitMember 2016-07-01 2017-06-30 0001024305 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2016-07-01 2017-06-30 0001024305 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-07-01 2017-06-30 0001024305 coty:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 coty:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2019-06-30 0001024305 coty:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-07-01 2018-06-30 0001024305 coty:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-06-30 0001024305 coty:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 srt:MaximumMember 2017-06-30 0001024305 srt:MaximumMember 2018-06-30 0001024305 srt:MinimumMember 2017-06-30 0001024305 srt:MinimumMember 2018-06-30 0001024305 srt:MinimumMember 2019-06-30 0001024305 srt:MaximumMember 2019-06-30 0001024305 srt:MaximumMember us-gaap:ForeignPlanMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember us-gaap:ForeignPlanMember 2016-07-01 2017-06-30 0001024305 srt:MinimumMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-07-01 2018-06-30 0001024305 srt:MinimumMember us-gaap:ForeignPlanMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember us-gaap:ForeignPlanMember 2017-07-01 2018-06-30 0001024305 srt:MaximumMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-07-01 2018-06-30 0001024305 srt:MaximumMember us-gaap:ForeignPlanMember 2017-07-01 2018-06-30 0001024305 srt:MinimumMember us-gaap:ForeignPlanMember 2016-07-01 2017-06-30 0001024305 srt:MaximumMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2016-07-01 2017-06-30 0001024305 srt:MaximumMember country:US 2016-07-01 2017-06-30 0001024305 srt:MinimumMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2016-07-01 2017-06-30 0001024305 srt:MaximumMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-07-01 2019-06-30 0001024305 srt:MinimumMember country:US 2016-07-01 2017-06-30 0001024305 srt:MinimumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 srt:MaximumMember country:US us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 srt:MaximumMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-06-30 0001024305 srt:MaximumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-06-30 0001024305 srt:MinimumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 srt:MaximumMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-06-30 0001024305 srt:MaximumMember us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-06-30 0001024305 srt:MinimumMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-06-30 0001024305 srt:MinimumMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-06-30 0001024305 us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2017-07-01 2018-06-30 0001024305 us-gaap:NondesignatedMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-07-01 2018-06-30 0001024305 us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2016-07-01 2017-06-30 0001024305 us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-07-01 2019-06-30 0001024305 us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-07-01 2018-06-30 0001024305 us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2018-07-01 2019-06-30 0001024305 us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-01 2017-06-30 0001024305 us-gaap:NondesignatedMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2019-06-30 0001024305 us-gaap:NondesignatedMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-07-01 2017-06-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2017-07-01 2018-06-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2016-07-01 2017-06-30 0001024305 us-gaap:NetInvestmentHedgingMember 2017-07-01 2018-06-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2017-07-01 2018-06-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2018-07-01 2019-06-30 0001024305 us-gaap:NetInvestmentHedgingMember 2016-07-01 2017-06-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2018-07-01 2019-06-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2016-07-01 2017-06-30 0001024305 us-gaap:NetInvestmentHedgingMember 2018-07-01 2019-06-30 0001024305 us-gaap:InterestRateSwapMember 2018-08-01 2018-08-31 0001024305 us-gaap:ForeignExchangeForwardMember 2019-06-30 0001024305 us-gaap:ForeignExchangeForwardMember 2018-06-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedTranslationAdjustmentMember 2018-06-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:InterestRateRiskMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2017-07-01 2018-06-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2016-07-01 2017-06-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2016-07-01 2017-06-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2017-07-01 2018-06-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2018-07-01 2019-06-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2018-07-01 2019-06-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:InterestRateRiskMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-30 0001024305 coty:U.A.E.JVMember us-gaap:OtherNoncurrentLiabilitiesMember 2018-06-30 0001024305 coty:SingaporeSubsidiaryMember 2019-06-30 0001024305 coty:U.A.E.JVMember coty:AccruedExpensesAndOtherCurrentLiabilitiesMember 2018-06-30 0001024305 coty:SingaporeSubsidiaryMember 2017-05-23 2017-05-23 0001024305 coty:SingaporeSubsidiaryMember 2017-05-23 0001024305 coty:U.A.E.JVMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2018-06-30 0001024305 coty:U.A.E.JVMember us-gaap:OtherNoncurrentLiabilitiesMember 2019-06-30 0001024305 coty:SingaporeSubsidiaryMember us-gaap:SubsequentEventMember 2019-07-01 2019-07-31 0001024305 coty:U.A.E.JVMember coty:AccruedExpensesAndOtherCurrentLiabilitiesMember 2019-06-30 0001024305 coty:U.A.E.JVMember 2018-06-30 0001024305 coty:U.A.E.JVMember 2019-06-30 0001024305 coty:U.A.E.JVMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-06-30 0001024305 coty:SingaporeSubsidiaryMember 2018-06-30 0001024305 coty:FoundationLLCMember 2019-06-30 0001024305 coty:UnitedArabEmiratesSubsidiaryMember 2019-06-30 0001024305 coty:FoundationLLCMember 2018-06-30 0001024305 coty:FoundationLLCMember 2018-07-01 2019-06-30 0001024305 coty:UnitedArabEmiratesSubsidiaryMember srt:ScenarioForecastMember 2028-12-31 0001024305 coty:YouniqueLLCMember 2019-06-30 0001024305 coty:UnitedArabEmiratesSubsidiaryMember 2018-06-30 0001024305 coty:YouniqueLLCMember 2018-06-30 0001024305 coty:UnitedArabEmiratesSubsidiaryMember 2018-07-01 2019-06-30 0001024305 coty:PlatinumProgramMember us-gaap:CommonClassAMember 2018-07-01 2019-06-30 0001024305 us-gaap:CommonClassAMember 2019-06-06 0001024305 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2018-07-01 2019-06-30 0001024305 coty:SeriesA1PreferredStockMember 2019-06-14 0001024305 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:SeriesAPreferredStockMember 2018-07-01 2019-06-30 0001024305 us-gaap:StockCompensationPlanMember coty:SeriesA1PreferredStockMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2018-07-01 2019-06-30 0001024305 coty:JABCosmeticsB.V.Member us-gaap:MajorityShareholderMember us-gaap:CommonClassAMember 2016-09-30 2016-09-30 0001024305 us-gaap:StockCompensationPlanMember coty:SeriesA1PreferredStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2018-07-01 2019-06-30 0001024305 coty:ProcterandGambleMember srt:MaximumMember coty:ProcterandGambleBeautyBrandsMember coty:TransactionAgreementwithProctorandGambleMember 2018-07-01 2019-06-30 0001024305 coty:SeriesA1PreferredStockMember coty:SharebasedCompensationAwardTrancheSixMember 2019-06-30 0001024305 coty:SeriesA1PreferredStockMember 2019-02-04 2019-02-04 0001024305 us-gaap:SeriesAPreferredStockMember 2019-06-17 0001024305 us-gaap:SeriesAPreferredStockMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-06-30 0001024305 us-gaap:StockCompensationPlanMember coty:SeriesA1PreferredStockMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2018-07-01 2019-06-30 0001024305 coty:SeriesA1PreferredStockMember coty:SharebasedCompensationAwardTrancheFiveMember 2019-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember us-gaap:OtherNoncurrentLiabilitiesMember 2017-06-30 0001024305 us-gaap:SeriesAPreferredStockMember 2018-05-17 0001024305 us-gaap:SeriesAPreferredStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2019-06-30 0001024305 us-gaap:SeriesAPreferredStockMember 2019-06-30 0001024305 coty:JABCosmeticsB.V.Member us-gaap:CommonClassAMember 2019-04-30 0001024305 us-gaap:SeriesAPreferredStockMember 2019-01-14 0001024305 coty:EmployeeStockOptionsRestrictedStockUnitsRSUsMemberAndEmployeeStockOwnershipProgramMember coty:PlatinumProgramMember 2018-07-01 2019-06-30 0001024305 coty:EmployeeStockOptionsRestrictedStockUnitsRSUsMemberAndEmployeeStockOwnershipProgramMember coty:PlatinumProgramMember 2016-07-01 2017-06-30 0001024305 coty:EmployeeStockOptionsRestrictedStockUnitsRSUsMemberAndEmployeeStockOwnershipProgramMember coty:PlatinumProgramMember 2017-07-01 2018-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember coty:AccruedExpensesAndOtherCurrentLiabilitiesMember 2018-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember us-gaap:OtherNoncurrentLiabilitiesMember 2019-06-30 0001024305 coty:JABCosmeticsB.V.Member us-gaap:MajorityShareholderMember us-gaap:CommonClassAMember 2017-07-01 2018-06-30 0001024305 us-gaap:SeriesAPreferredStockMember 2018-05-18 0001024305 coty:SeriesA1PreferredStockMember 2019-06-30 0001024305 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2017-07-01 2018-06-30 0001024305 us-gaap:CommonClassAMember 2016-09-28 0001024305 us-gaap:RestrictedStockUnitsRSUMember us-gaap:OtherNoncurrentLiabilitiesMember 2018-06-30 0001024305 us-gaap:SeriesAPreferredStockMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2019-06-30 0001024305 coty:PlatinumProgramMember us-gaap:CommonClassAMember 2017-07-01 2018-06-30 0001024305 us-gaap:CommonClassAMember 2016-09-29 0001024305 us-gaap:CommonClassAMember 2019-06-28 2019-06-28 0001024305 coty:SeriesA1PreferredStockMember 2019-06-13 0001024305 coty:IncrementalRepurchaseProgramMember us-gaap:CommonClassAMember 2016-02-03 0001024305 coty:SeriesA1PreferredStockMember 2019-06-14 2019-06-14 0001024305 us-gaap:RestrictedStockUnitsRSUMember coty:AccruedExpensesAndOtherCurrentLiabilitiesMember 2017-06-30 0001024305 2019-04-30 2019-04-30 0001024305 coty:PlatinumProgramMember us-gaap:CommonClassAMember 2016-07-01 2017-06-30 0001024305 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:SeriesAPreferredStockMember 2016-07-01 2017-06-30 0001024305 coty:SeriesA1PreferredStockMember coty:SharebasedCompensationAwardTrancheFourMember 2019-06-30 0001024305 us-gaap:SeriesAPreferredStockMember 2019-01-15 0001024305 us-gaap:SeriesAPreferredStockMember 2019-01-15 2019-01-15 0001024305 us-gaap:RestrictedStockUnitsRSUMember coty:AccruedExpensesAndOtherCurrentLiabilitiesMember 2019-06-30 0001024305 us-gaap:SeriesAPreferredStockMember 2019-06-18 0001024305 coty:SeriesA1PreferredStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2019-06-30 0001024305 coty:SeriesA1PreferredStockMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2019-06-30 0001024305 coty:JABCosmeticsB.V.Member us-gaap:MajorityShareholderMember us-gaap:CommonClassAMember 2016-07-01 2017-06-30 0001024305 us-gaap:SeriesAPreferredStockMember 2019-06-18 2019-06-18 0001024305 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:SeriesAPreferredStockMember 2017-07-01 2018-06-30 0001024305 coty:JABCosmeticsB.V.Member us-gaap:MajorityShareholderMember us-gaap:CommonClassAMember 2018-07-01 2019-06-30 0001024305 coty:JABCosmeticsB.V.Member us-gaap:CommonClassAMember 2019-04-30 2019-04-30 0001024305 coty:SeriesA1PreferredStockMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-06-30 0001024305 us-gaap:SeriesAPreferredStockMember 2017-11-16 0001024305 coty:SeriesA1PreferredStockMember 2019-02-04 0001024305 us-gaap:SeriesAPreferredStockMember 2017-03-27 0001024305 us-gaap:SeriesAPreferredStockMember 2017-02-16 0001024305 srt:MinimumMember us-gaap:CommonClassAMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember us-gaap:CommonClassAMember 2016-07-01 2017-06-30 0001024305 us-gaap:CommonClassAMember 2016-07-01 2017-06-30 0001024305 us-gaap:CommonClassAMember 2017-07-01 2018-06-30 0001024305 srt:MaximumMember us-gaap:CommonClassAMember 2018-07-01 2019-06-30 0001024305 srt:MaximumMember us-gaap:CommonClassAMember 2017-07-01 2018-06-30 0001024305 srt:MinimumMember us-gaap:CommonClassAMember 2016-07-01 2017-06-30 0001024305 srt:MinimumMember us-gaap:CommonClassAMember 2017-07-01 2018-06-30 0001024305 us-gaap:AccountingStandardsUpdate201802Member us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-07-01 0001024305 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-07-01 2018-06-30 0001024305 us-gaap:AccountingStandardsUpdate201802Member us-gaap:AccumulatedTranslationAdjustmentMember 2017-07-01 0001024305 coty:AccumulatedForeignCurrencyAdjustmentGainLossonNetInvestmentHedgeAttributabletoParentMember 2017-07-01 2018-06-30 0001024305 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-07-01 2019-06-30 0001024305 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-07-01 2018-06-30 0001024305 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-06-30 0001024305 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0001024305 coty:AccumulatedForeignCurrencyAdjustmentGainLossonNetInvestmentHedgeAttributabletoParentMember 2018-06-30 0001024305 coty:AccumulatedForeignCurrencyAdjustmentGainLossonNetInvestmentHedgeAttributabletoParentMember 2018-07-01 2019-06-30 0001024305 us-gaap:AccumulatedTranslationAdjustmentMember 2017-07-01 2018-06-30 0001024305 us-gaap:AccountingStandardsUpdate201802Member coty:AccumulatedForeignCurrencyAdjustmentGainLossonNetInvestmentHedgeAttributabletoParentMember 2017-07-01 0001024305 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-06-30 0001024305 us-gaap:AccumulatedTranslationAdjustmentMember 2018-07-01 2019-06-30 0001024305 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-06-30 0001024305 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-06-30 0001024305 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-07-01 2019-06-30 0001024305 coty:AccumulatedForeignCurrencyAdjustmentGainLossonNetInvestmentHedgeAttributabletoParentMember 2017-06-30 0001024305 us-gaap:AccumulatedTranslationAdjustmentMember 2018-06-30 0001024305 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-06-30 0001024305 us-gaap:AccumulatedTranslationAdjustmentMember 2017-06-30 0001024305 coty:AccumulatedForeignCurrencyAdjustmentGainLossonNetInvestmentHedgeAttributabletoParentMember 2019-06-30 0001024305 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-06-30 0001024305 us-gaap:AccountingStandardsUpdate201802Member us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-07-01 0001024305 2017-11-30 0001024305 2018-09-14 2018-09-14 0001024305 2018-08-21 2018-08-21 0001024305 2017-03-10 2017-03-10 0001024305 2017-08-22 2017-08-22 0001024305 2018-05-31 2018-05-31 0001024305 2017-12-14 2017-12-14 0001024305 2019-03-15 2019-03-15 0001024305 2017-05-31 0001024305 2016-08-01 2016-08-01 0001024305 2018-08-31 0001024305 2018-11-30 0001024305 2018-02-28 0001024305 2016-12-19 2016-12-19 0001024305 2017-06-13 2017-06-13 0001024305 2018-03-15 2018-03-15 0001024305 2018-05-31 0001024305 2019-06-28 2019-06-28 0001024305 2016-08-11 2016-08-11 0001024305 2016-12-09 2016-12-09 0001024305 2018-06-14 2018-06-14 0001024305 2017-02-09 2017-02-09 0001024305 2018-02-08 2018-02-08 0001024305 2016-12-19 0001024305 2019-06-06 2019-06-06 0001024305 2018-02-28 2018-02-28 0001024305 2017-11-09 2017-11-09 0001024305 2017-02-28 2017-02-28 0001024305 2017-11-30 2017-11-30 0001024305 2019-02-28 2019-02-28 0001024305 2016-08-11 0001024305 2019-05-08 2019-05-08 0001024305 2017-09-01 2017-09-01 0001024305 2016-08-19 2016-08-19 0001024305 2019-02-08 2019-02-08 0001024305 2018-08-31 2018-08-31 0001024305 2018-11-07 2018-11-07 0001024305 2019-02-28 0001024305 2017-02-28 0001024305 2017-05-31 2017-05-31 0001024305 2018-12-14 2018-12-14 0001024305 2018-05-09 2018-05-09 0001024305 2019-06-06 0001024305 2016-12-28 2016-12-28 0001024305 2017-09-14 2017-09-14 0001024305 2017-05-10 2017-05-10 0001024305 2018-11-30 2018-11-30 0001024305 2017-09-01 0001024305 us-gaap:RestrictedStockUnitsRSUMember 2019-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember 2018-07-01 2019-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember 2018-06-30 0001024305 coty:SeriesAAndSeriesA1PreferredStockMember 2018-07-01 2019-06-30 0001024305 coty:SeriesAAndSeriesA1PreferredStockMember 2016-07-01 2017-06-30 0001024305 coty:SeriesAAndSeriesA1PreferredStockMember 2017-07-01 2018-06-30 0001024305 coty:NonQualifiedOptionsMember 2019-06-30 0001024305 coty:NonQualifiedOptionsMember 2018-06-30 0001024305 coty:NonQualifiedOptionsMember 2018-07-01 2019-06-30 0001024305 coty:SeriesAAndSeriesA1PreferredStockMember 2018-06-30 0001024305 coty:SeriesAAndSeriesA1PreferredStockMember 2019-06-30 0001024305 coty:NonQualifiedOptionsMember 2017-07-01 2018-06-30 0001024305 coty:NonQualifiedOptionsMember 2016-07-01 2017-06-30 0001024305 us-gaap:SeriesAPreferredStockMember 2018-07-01 2019-06-30 0001024305 coty:ExecutiveOwnershipProgramMember 2018-07-01 2019-06-30 0001024305 coty:RestrictedAndOtherShareAwardsMember 2019-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2018-10-01 2018-10-01 0001024305 coty:NonQualifiedOptionsMember coty:SharebasedCompensationAwardTrancheTwoSubtrancheTwoMember 2018-07-01 2019-06-30 0001024305 us-gaap:EmployeeStockOptionMember 2018-07-01 2019-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember 2017-07-01 2018-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember 2016-07-01 2017-06-30 0001024305 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-07-01 2018-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2018-10-01 2018-10-01 0001024305 coty:FormerChiefExecutiveOfficerMember us-gaap:PhantomShareUnitsPSUsMember 2015-07-01 2016-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember coty:OmnibusLongTermIncentivePlanMember 2017-07-01 2018-06-30 0001024305 us-gaap:SeriesAPreferredStockMember 2017-07-01 2018-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember coty:TwoThousandandSevenStockPlanforDirectorsMember 2018-07-01 2019-06-30 0001024305 us-gaap:EmployeeStockOptionMember 2019-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember coty:TwoThousandandSevenStockPlanforDirectorsMember 2017-07-01 2018-06-30 0001024305 us-gaap:SeriesAPreferredStockMember 2016-07-01 2017-06-30 0001024305 coty:NonQualifiedOptionsMember coty:SharebasedCompensationAwardTrancheTwoSubtrancheThreeMember 2018-07-01 2019-06-30 0001024305 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-07-01 2017-06-30 0001024305 coty:NonQualifiedOptionsMember coty:SharebasedCompensationAwardTrancheTwoSubtrancheOneMember 2018-07-01 2019-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2018-10-01 2018-10-01 0001024305 us-gaap:RestrictedStockUnitsRSUMember coty:OmnibusLongTermIncentivePlanMember 2018-07-01 2019-06-30 0001024305 coty:NonQualifiedOptionsMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2018-07-01 2019-06-30 0001024305 coty:FormerChiefExecutiveOfficerMember us-gaap:PhantomShareUnitsPSUsMember us-gaap:CommonClassAMember 2015-07-24 2015-07-24 0001024305 coty:RestrictedAndOtherShareAwardsMember 2018-07-01 2019-06-30 0001024305 coty:ExecutiveOwnershipProgramMember 2017-07-01 2018-06-30 0001024305 2018-10-01 0001024305 coty:NonQualifiedOptionsMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2018-07-01 2019-06-30 0001024305 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2019-06-30 0001024305 coty:FormerChiefExecutiveOfficerMember us-gaap:PhantomShareUnitsPSUsMember 2015-07-21 2015-07-21 0001024305 coty:ExecutiveOwnershipProgramMember 2016-07-01 2017-06-30 0001024305 coty:FormerChiefExecutiveOfficerMember us-gaap:PhantomShareUnitsPSUsMember us-gaap:CommonClassAMember 2015-07-21 0001024305 coty:LiabilityPlanMember 2018-07-01 2019-06-30 0001024305 coty:EquityPlanMember 2018-07-01 2019-06-30 0001024305 coty:EquityPlanMember 2016-07-01 2017-06-30 0001024305 coty:LiabilityPlanMember 2017-07-01 2018-06-30 0001024305 coty:LiabilityPlanMember 2016-07-01 2017-06-30 0001024305 coty:FringeMember 2017-07-01 2018-06-30 0001024305 coty:FringeMember 2016-07-01 2017-06-30 0001024305 coty:FringeMember 2018-07-01 2019-06-30 0001024305 coty:EquityPlanMember 2017-07-01 2018-06-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember 2018-10-01 2018-10-02 0001024305 coty:ShareholderClassActionLawsuitsMember us-gaap:PendingLitigationMember 2019-04-09 0001024305 coty:BrazilianTaxAssessmentsMember 2019-06-30 0001024305 coty:ShareholderClassActionLawsuitsMember us-gaap:PendingLitigationMember 2019-05-06 0001024305 coty:RestructuringAndOtherBusinessRealignmentCostsMember coty:TurnaroundPlanMember us-gaap:SubsequentEventMember 2019-07-01 0001024305 us-gaap:SubsequentEventMember 2019-08-28 0001024305 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2019-08-28 2019-08-28 0001024305 coty:EmployeeTerminationBenefitsAndOtherBusinessRealignmentCostsMember coty:TurnaroundPlanMember us-gaap:SubsequentEventMember 2019-07-01 0001024305 us-gaap:AllowanceForCreditLossMember 2018-07-01 2019-06-30 0001024305 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-06-30 0001024305 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-06-30 0001024305 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-07-01 2018-06-30 0001024305 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2016-07-01 2017-06-30 0001024305 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-06-30 0001024305 us-gaap:AllowanceForCreditLossMember 2018-06-30 0001024305 us-gaap:AllowanceForCreditLossMember 2016-07-01 2017-06-30 0001024305 coty:SECSchedule1209AllowanceCustomerReturnsMember 2017-06-30 0001024305 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-07-01 2019-06-30 0001024305 us-gaap:AllowanceForCreditLossMember 2017-07-01 2018-06-30 0001024305 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2016-06-30 0001024305 coty:SECSchedule1209AllowanceCustomerReturnsMember 2019-06-30 0001024305 coty:SECSchedule1209AllowanceCustomerReturnsMember 2017-07-01 2018-06-30 0001024305 coty:SECSchedule1209AllowanceCustomerReturnsMember 2018-07-01 2019-06-30 0001024305 coty:SECSchedule1209AllowanceCustomerReturnsMember 2016-07-01 2017-06-30 0001024305 us-gaap:AllowanceForCreditLossMember 2017-06-30 0001024305 us-gaap:AllowanceForCreditLossMember 2019-06-30 0001024305 coty:SECSchedule1209AllowanceCustomerReturnsMember 2018-06-30 0001024305 us-gaap:AllowanceForCreditLossMember 2016-06-30 0001024305 coty:SECSchedule1209AllowanceCustomerReturnsMember 2016-06-30 coty:unit xbrli:shares xbrli:pure iso4217:USD xbrli:shares iso4217:USD iso4217:GBP coty:segment coty:jurisdiction iso4217:EUR coty:vote coty:employee coty:lawsuit iso4217:BRL

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 10-K

(Mark One)



☒	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED		JUNE 30, 2019
OR
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM TO
COMMISSION FILE NUMBER		001-35964

COTY INC.

(Exact name of registrant as specified in its charter)



Delaware		13-3823358
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

350 Fifth Avenue,
New York,	NY	10118
(Address of principal executive offices)		(Zip Code)

(212) 389-7300

Registrant’s telephone number, including area code




SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
Title of each class	Trading symbol	Name of each exchange on which registered
Class A Common Stock, $0.01 par value	COTY	The New York Stock Exchange
SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:
	None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ý No o

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ý

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer	ý	Accelerated filer	o
Non-accelerated filer	o
		Smaller reporting company	☐
		Emerging growth company	☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ý

As of December 31, 2018, the aggregate market value of the registrant’s Class A Common Stock held by non-affiliates was $2.9 billion based on the number of shares held by non-affiliates as of December 31, 2018 and the last reported sale price of the registrant’s Class A Common Stock on December 31, 2018.

At August 21, 2019, 754,196,725 shares of the registrant’s Class A Common Stock, $0.01 par value were outstanding.

Table of Contents

COTY INC.

INDEX TO ANNUAL REPORT ON FORM 10-K



		Page
Part I:
Item 1.	Business	1
Item 1A.	Risk Factors	5
Item 1B.	Unresolved Staff Comments	23
Item 2.	Properties	23
Item 3.	Legal Proceedings	23
Part II:
Item 5.	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	24
Item 6.	Selected Financial Data	27
Item 7.	Management's Discussion and Analysis of Financial Condition and Results of Operations	28
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	54
Item 8.	Financial Statements and Supplementary Data	54
Item 9A.	Controls and Procedures	54
Part III:
Item 10.	Directors, Executive Officers and Corporate Governance	55
Item 11.	Executive Compensation	55
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	55
Item 13.	Certain Relationships and Related Transactions, and Director Independence	56
Item 14.	Principal Accounting Fees and Services	56
Part IV:
Item 15.	Exhibits, Financial Statement Schedules	56
Signatures		61

Forward-looking Statements

Certain statements in this Form 10-K are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, the Company’s Turnaround Plan (as defined below), strategic planning, targets, segment reporting and outlook for future reporting periods (including the extent and timing of revenue, expense and profit trends and changes in operating cash flows and cash flows from operating activities and investing activities), its future operations and strategy, ongoing and future cost efficiency and restructuring initiatives and programs, strategic transactions (including their expected timing and impact), investments, licenses and portfolio changes, synergies, savings, performance, cost, timing and integration of acquisitions, future cash flows, liquidity and borrowing capacity, timing and size of cash outflows and debt deleveraging, impact and timing of supply chain disruptions and the resolution thereof, timing and extent of any future impairments, and synergies, savings, impact, cost, timing and implementation of the Company’s Turnaround Plan, including operational and organizational structure changes, operational execution and simplification initiatives, the move of the Company’s headquarters, and the priorities of senior management. These forward-looking statements are generally identified by words or phrases, such as “anticipate”, “are going to”, “estimate”, “plan”, “project”, “expect”, “believe”, “intend”, “foresee”, “forecast”, “will”, “may”, “should”, “outlook”, “continue”, “temporary”, “target”, “aim”, “potential”, “goal” and similar words or phrases. These statements are based on certain assumptions and estimates that we consider reasonable, but are subject to a number of risks and uncertainties, many of which are beyond our control, which could cause actual events or results (including our financial condition, results of operations, cash flows and prospects) to differ materially from such statements, including risks and uncertainties relating to:


•	our ability to successfully implement our multi-year Turnaround Plan, including our management headquarters relocation and management realignment, and to develop and achieve our global business strategies, compete effectively in the beauty industry and achieve the benefits contemplated by our strategic initiatives within the expected time frame or at all;

•

our ability to anticipate, gauge and respond to market trends and consumer preferences, which may change rapidly, and the market acceptance of new products, including any relaunched or rebranded products and the anticipated costs and discounting associated with such relaunches and rebrands, and consumer receptiveness to our current and future marketing philosophy and consumer engagement activities (including digital marketing and media);

•

use of estimates and assumptions in preparing our financial statements, including with regard to revenue recognition, stock compensation expense, income taxes (including the expected timing and amount of the release of any tax valuation allowance), the assessment of goodwill, other intangible and long-lived assets for impairments, the market value of inventory, pension expense, the fair value of redeemable noncontrolling interests and the fair value of acquired assets and liabilities associated with acquisitions;


•	the impact of any future impairments;


•	managerial, transformational, operational, regulatory, legal and financial risks, including diversion of management attention to and management of cash flows, expenses and costs associated with the Turnaround Plan and future strategic initiatives;

•

future acquisitions and the integration thereof with our business, operations, systems, financial data and culture and the ability to realize synergies, avoid future supply chain and other business disruptions, reduce costs (including through our cash efficiency initiatives) and realize other potential efficiencies and benefits (including through our restructuring initiatives) at the levels and at the costs and within the time frames contemplated or at all;

•

increased competition, consolidation among retailers, shifts in consumers’ preferred distribution and marketing channels (including to digital and luxury channels), distribution and shelf-space resets or reductions, compression of go-to-market cycles, changes in product and marketing requirements by retailers, reductions in retailer inventory levels and order lead-times or changes in purchasing patterns, and other changes in the retail, e-commerce and wholesale environment in which we do business and sell our products and our ability to respond to such changes;


•	our and our business partners’ and licensors’ abilities to obtain, maintain and protect the intellectual property used in our and their respective businesses, protect our and their respective reputations (including those of our and their executives or influencers) and public goodwill, and defend claims by third parties for infringement of intellectual property rights;


•	any change to our capital allocation and/or cash management priorities, including any change in our stock dividend reinvestment program (the “Stock Dividend Reinvestment Program”) and policy;


•	any unanticipated problems, liabilities or integration or other challenges associated with a past or future acquired business which could result in increased risk or new, unanticipated or unknown liabilities, including with respect to environmental, competition and other regulatory, compliance or legal matters;


•	our international operations and joint ventures, including enforceability and effectiveness of our joint venture agreements and reputational, compliance, regulatory, economic and foreign political risks, including difficulties and costs associated with maintaining compliance with a broad variety of complex local and international regulations;


•	our dependence on certain licenses (especially in our Luxury division) and our ability to renew expiring licenses on favorable terms or at all;


•	our dependence on entities performing outsourced functions, including outsourcing of distribution functions, and third-party manufacturers, logistics and supply-chain suppliers and other suppliers, including third party software providers;


•	administrative, development and other difficulties in meeting the expected timing of market expansions, product launches and marketing efforts;

•

global political and/or economic uncertainties, disruptions or major regulatory or policy changes, and/or the enforcement thereof that affect our business, financial performance, operations or products, including the impact of Brexit, the current U.S. administration, changes in the U.S. tax code, and recent changes and future changes in tariffs, retaliatory or trade protection measures, trade policies and other international trade regulations in the U.S., the European Union and Asia and in other regions where we operate;


•	currency exchange rate volatility and currency devaluation;


•	the number, type, outcomes (by judgment, order or settlement) and costs of any current or future legal, compliance, tax, regulatory or administrative proceedings, investigations and/or litigation, including litigation relating to the tender offer by Cottage Holdco B.V. (the “Cottage Tender Offer”);


•	our ability to manage seasonal factors and other variability and to anticipate future business trends and needs;

•

disruptions in operations, sales and in other areas, including due to disruptions in our supply chain, restructurings and other business alignment activities, the move of our headquarters to Amsterdam, manufacturing or information technology systems, labor disputes, extreme weather and natural disasters, and the impact of such disruptions on Coty’s ability to generate profits, stabilize or grow revenues or cash flows, comply with its contractual obligations and accurately forecast demand and supply needs and/or future results;


•	restrictions imposed on us through our license agreements, credit facilities and senior unsecured bonds or other material contracts, our ability to generate cash flow to repay, refinance or recapitalize debt and otherwise comply with our debt instruments, and changes in the manner in which we finance our debt and future capital needs;

•

increasing dependency on information technology and our ability to protect against service interruptions, data corruption, cyber-based attacks or network security breaches, costs and timing of implementation and effectiveness of any upgrades or other changes to information technology systems, and the cost of compliance or our failure to comply with any privacy or data security laws (including the European Union General Data Protection Regulation (the “GDPR”) and the California Consumer Privacy Act) or to protect against theft of customer, employee and corporate sensitive information;


•	our ability to attract and retain key personnel and the impact of senior management transitions and organizational structure changes, including the co-location of key business leaders and functions in Amsterdam;


•	the distribution and sale by third parties of counterfeit and/or gray market versions of our products;


•	the impact of the Cottage Tender Offer and of our Turnaround Plan on our relationships with key customers and suppliers and certain material contracts;


•	our relationship with Cottage Holdco B.V., as our majority stockholder, and its affiliates, and any related conflicts of interest or litigation;


•	future sales of a significant number of shares by our majority stockholder or contractually by certain commercial banks on behalf of our majority stockholder, as may be required to satisfy obligations under such majority stockholder's credit agreement, or the perception that such sales could occur; and


•	other factors described elsewhere in this document and in documents that we file with the Securities and Exchange Commission (the “SEC”) from time to time.

When used in this Annual Report on Form 10-K, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation. More information about potential risks and uncertainties that could affect our business and financial results is included under the heading “Risk Factors” and “Management’s Discussion and Analysis of

Financial Condition and Results of Operations” in this Annual Report on Form 10-K and other periodic reports we have filed and may file with the SEC from time to time.

All forward-looking statements made in this document are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this document, and we do not undertake any obligation, other than as may be required by applicable law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise.

Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such, and should only be viewed as historical data.

Industry, Ranking and Market Data

Unless otherwise indicated, information contained in this Annual Report on Form 10-K concerning our industry and the market in which we operate, including our general expectations about our industry, market position and ranking, market opportunity and market size, is based on data from various sources including internal data and estimates as well as third party sources widely available to the public such as independent industry publications, government publications, reports by market research firms or other published independent sources and on our assumptions based on that data and other similar sources. We did not fund and are not otherwise affiliated with the third party sources that we cite. Industry publications and other published sources generally state that the information contained therein has been obtained from third-party sources believed to be reliable. Internal data and estimates are based upon information obtained from trade and business organizations and other contacts in the markets in which we operate and management’s understanding of industry conditions, and such information has not been verified by any independent sources. This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. While we believe the market, industry and other information included in this Annual Report on Form 10-K to be the most recently available and to be generally reliable, such information is inherently imprecise and we have not independently verified any third-party information or verified that more recent information is not available.

Our fiscal year ends on June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2019” refer to the fiscal year ended June 30, 2019. Any reference to a year not preceded by “fiscal” refers to a calendar year.

PART I

Item 1. Business.

Overview

Coty Inc. is one of the world’s largest beauty companies with a rich entrepreneurial heritage and an iconic portfolio of brands. Founded in 1904, Coty has grown into a multi-segment beauty company with market leading positions in both North America and Europe. Today, we are the global leader in fragrance, a strong number two in professional salon hair color & styling, and number three in color cosmetics.

Over the past several years, the transformational acquisition of The Proctor & Gamble Company’s beauty business (the “P&G Beauty Business”) and our other strategic transactions have strengthened and diversified our presence across the countries, product categories and channels in which we compete, building a strong beauty platform. We completed the last steps of the complex integration of the P&G Beauty Business in 2019. Under the direction of our new senior leadership, we undertook a broad review of our business to develop a strategic framework to position us for sustainable performance and long-term success, and in July 2019, we announced a turnaround plan (together with changes to our organizational structure and the co-location of most of our executive team and corporate functions in a centralized management headquarters in Amsterdam, the “Turnaround Plan”) designed to:

•Rediscover growth, by improving execution and fundamentals;

•Regain operational leadership, by reducing complexity and costs; and


•	Build a culture of pride and performance, by creating a culture that balances discipline and creativity, while fostering team spirit and engagement.

As we implement this multi-year Turnaround Plan, we are focused on rejuvenating our core business, by focusing our investments in fewer brands and markets, increasing shelf productivity through improved assortment, improving mix management, and developing a stronger and margin-accretive innovation pipeline. In order to fuel both increased investment in the business as well as improved profitability, we are working to lower our cost of goods sold through improved productivity in our existing manufacturing footprint, reducing product range complexity, and lowering fixed costs through a simplified organizational structure.

Segments

We are organized into three divisions, which are also our operating and reportable segments: Consumer Beauty, Luxury and Professional Beauty. Our organizational structure is product category focused, putting the consumer first, by specifically targeting how and where they shop and what and why they purchase. Each division has end-to-end responsibility to optimize the consumers’ beauty experiences in their relevant categories and channels and to translate this into profitable growth.

Consumer Beauty is primarily focused on color cosmetics, retail hair coloring and styling products, body care and mass fragrances.

Luxury is primarily focused on prestige fragrances, premium skincare and premium cosmetics.

Professional Beauty is primarily focused on hair and nail care products for salon professionals.

For segment and geographic area financial information and information about our long-lived assets, see Note 4, “Segment Reporting” in the notes to our Consolidated Financial Statements, and for information about recent acquisitions or dispositions of any material amount of assets, see Note 3, “Business Combinations” in the notes to our Consolidated Financial Statements.

In connection with our Turnaround Plan, we expect to move from the current organizational structure to a structure based on regional commercial business units in Europe, Middle East & Africa (“EMEA”), Americas and Asia Pacific for the combined Luxury and Consumer Beauty businesses. Such regional business units will be supported by central Luxury and Consumer Beauty marketing teams. Professional Beauty is expected to remain a distinct business unit. We anticipate that our operating and reporting segments would change upon completion of these reporting structure changes and the related changes in the financial information provided to our CEO, which is expected to occur in the third quarter of fiscal 2020.

Brands

The following chart reflects our iconic brand portfolio by segment:



Coty Consumer Beauty	Coty Luxury	Coty Professional Beauty
Adidas	Alexander McQueen	Clairol Professional*
Beckham	Balenciaga	ghd (good hair day)*
Beyonce	Burberry	Kadus Professional*
Biocolor*	Bottega Veneta	Londa Professional*
Bozzano*	Calvin Klein	Nioxin*
Bourjois*	Cavalli	O P I*
Bruno Banani	Chloe	Sassoon Professional
Clairol*	Davidoff	Sebastian*
CoverGirl*	Escada*	System Professional*
Enrique	Gucci	Wella Professionals*
Jovan*	Hugo Boss
Nautica	Jil Sander
Max Factor*	Joop!*
Mexx	Lacoste
Monange*	Lancaster*
Paixao*	Marc Jacobs
Rimmel*	Miu Miu
Risque*	philosophy*
Sally Hansen*	Stella McCartney
Stetson	Tiffany & Co.
Wella*
Younique*
007 James Bond

* Indicates an owned beauty brand.

Marketing

We have a diverse portfolio of over 75 brands, some owned and some licensed, and we employ different models to create a distinct image and personality suited to each brand’s equity, distribution, product focus and consumer. For our licensed brands, we work with licensors to promote brand image. Each of our brands is promoted with logos, packaging and advertising designed to enhance its image and the uniqueness of each brand. We manage our creative marketing work through a combination of our in-house teams and external agencies that design and produce the sales materials, social media strategies, advertisements and packaging for products in each brand.

We promote our brands through various channels to reach and engage beauty consumers, through traditional media, through in-store and in-salon displays, on digital and social media, and through collaborations, product placements and events. In addition, we seek editorial coverage for products and brands in both traditional media and digital and social media to drive influencer amplification and to build brand equity. We also leverage our relationships with celebrities and on-line influencers to endorse certain of our products. Our marketing efforts benefit from cooperative advertising programs with retailers, often in connection with in-store marketing activities designed to engage consumers so that they try, or purchase, our products, including sampling and “gift-with-purchase” programs designed to stimulate product trials.

We have dedicated marketing and sales forces in most of our significant markets. These teams leverage local insights to strategically promote our brands and product offerings and tailor our creative marketing to fit local tastes and resonate with consumers most effectively.

We utilize in-depth brand and market data analytics to develop branding, merchandising and marketing execution strategies to maximize the consumer experience and build a better business. Starting in fiscal 2020, we expect to shift working media resources to a select number of brand/country combinations, which we believe represents a significant opportunity for revenue and gross margin improvement, and to implement a tactical, in-store strategy for the others.

Distribution Channels and Retail Sales

We market, sell and distribute our products in over 150 countries and territories, with dedicated local sales forces in most of our significant markets. We have a balanced multi-channel distribution strategy which complements our product category focused divisions. The Consumer Beauty division primarily sells products through hypermarkets, supermarkets, drug stores and pharmacies, mid-tier department stores, traditional food and drug retailers, and dedicated e-commerce retailers. The Luxury division primarily sells products through prestige retailers, including perfumeries, department stores and e-retailers and duty-free shops, with travel retail sales channels accounting for 14% of the division’s net revenues. The Professional Beauty division primarily sells products to nail and hair salons, nail and hair professionals and professionals’ stores, through both direct sales forces and e-commerce platforms. We also sell our products through third-party distributors. In fiscal 2019, no retailer accounted for more than 10% of our global net revenues; however, certain retailers accounted for more than 10% of net revenues within certain geographic markets and segments. In fiscal 2019, Wal-Mart, our top retailer, accounted for approximately 6% of our net revenues.

Innovation

Innovation is a pillar of our business. We innovate through brand-building and new product lines, as well as through new technology. Our research and development teams work with our marketing and operations teams to identify recent trends and consumer needs and to bring products quickly to market.

We are continuously innovating to increase our sales by elevating our digital presence, including e-commerce and digital, social media and influencer marketing designed to build brand equity and consumer engagement. We have also focused our efforts on meeting evolving consumer shopping preferences and behaviors, both on-line and in-store. We have introduced new ways to customize the consumer experience, including using artificial intelligence-powered tools to provide personalized advice on selecting and using products, and augmented reality tools that invite customers to virtually try products with curated looks, tutorials and product recommendations.

In addition, we continuously seek to improve our products through research and development. Our basic and applied research groups, which conduct longer-term and “blue sky” research, seek to develop proprietary new technologies for first-to-market products and for improving existing products. This research and development is done both internally and through affiliations with various universities, technical centers, supply partners, industry associations and technical associations. As of June 30, 2019, we owned approximately 2,000 utility patents and patent applications globally and approximately 1,800 design patents.

Our principal research and development centers are located in the U.S. and Europe. See “Item 2. Properties.”

We do not perform, nor do we commission any third parties on our behalf to perform, testing of our products or ingredients on animals except where required by law.

Supply Chain

We manufacture and package approximately 77% of our products, primarily in facilities located in the United States, Europe, Brazil, China, Russia, Mexico and Thailand. We recognize the importance of our employees at our manufacturing facilities and have in place programs designed to ensure operating safety. In addition, we implement programs designed to ensure that our manufacturing and distribution facilities comply with applicable environmental rules and regulations. To capitalize on innovation and other supply chain benefits, we continue to utilize a network of third-party manufacturers on a global basis who produce approximately 23% of our finished products.

The principal raw materials used in the manufacture of our products are primarily essential oils, alcohols and specialty chemicals. The essential oils in our fragrance products are generally sourced from fragrance houses. As a result, we realize material cost savings and benefits from the technology, innovation and resources provided by these fragrance houses.

We purchase the raw materials for all our products from various third parties. We also purchase packaging components that are manufactured to our design specifications. We collaborate with our suppliers to meet our stringent design and creative criteria. We believe that we currently have adequate sources of supply for all our products.

Following the acquisition of the P&G Beauty Business, we engaged in a transformation of our supply chain aimed at integrating and optimizing the combined organization. With this footprint transformation now complete, we continue to focus on optimizing our supply chain processes in order to increase efficiency and reduce our order lead times. We have experienced disruptions in our supply chain from time to time, including in connection with our past restructuring efforts, and we work to anticipate and respond to actual and potential disruptions.

Competition

There is significant competition within each market where our products are sold. We compete against manufacturers and marketers of beauty products, hair care, salon professional and personal care products. In addition to the established multinational brands against which we compete, small targeted niche brands continue to enter the beauty market. We also have competition from private label products sold by retailers.

We believe that we compete primarily on the basis of perceived value, including pricing and innovation, product efficacy, service to the consumer, promotional activities, advertising, special events, new product introductions, e-commerce initiatives, direct sales and other activities (including influencers). It is difficult for us to predict the timing, scale and effectiveness of our competitors’ actions in these areas or the timing and impact of new entrants into the marketplace. For additional risks associated with our competitive position, see “Risk Factors—The beauty industry is highly competitive, and if we are unable to compete effectively, our business, prospects, financial condition and results of operation could suffer”.

Intellectual Property

We generally own or license the trademark rights in key sales countries in Trademark International Class 3 (covering cosmetics and perfumery) for use in connection with our brands. When we license trademark rights we generally enter into long-term licenses, and we are generally the exclusive trademark licensee for all Class 3 trademarks as used in connection with our products. We or our licensors, as the case may be, actively protect the trademarks used in our principal products in the U.S. and significant markets worldwide. We consider the protection of our trademarks to be essential to our business.

A number of our products also incorporate patented, patent-pending or proprietary technology in their respective formulations and/or packaging, and in some cases our product packaging is subject to copyright, trade dress or design protection. While we consider our patents and copyrights, and the protection thereof, to be important, no single patent or copyright, or group of related patents or copyrights, is material to the conduct of our business.

Products representing 41% of our fiscal 2019 net revenues are manufactured and marketed under exclusive license agreements granted to us for use on a worldwide and/or regional basis. As of June 30, 2019, we maintained 30 brand licenses.

Our licenses impose obligations and restrictions on us that we believe are common to many licensing relationships in the beauty industry, such as paying annual royalties on net sales of the licensed products, maintaining the quality of the licensed products and the image of the applicable trademarks, achievement of minimum sales levels, promotion of sales and qualifications and behavior of our suppliers, distributors and retailers. We believe that we are currently in material compliance with the terms of our material brand license agreements.

Most brand licenses have renewal options for one or more terms, which can range from two to ten years. Certain brand licenses provide for automatic extensions, so long as minimum annual royalty payments are made, while renewal of others is contingent upon attaining specified sales levels or upon agreement of the licensor. We renewed two key brand licenses in fiscal 2019. While many of our licenses are long term, licenses relating to certain of our brands are up for renewal in the next few years, including seven licenses up for renewal in 2020. These seven licenses together generated approximately 1% of our consolidated net revenues in fiscal 2019. Currently, the average renewal term of the full licensed portfolio is approximately 8 years. For additional risks associated with our licensing arrangements, see “Risk Factors—Our brand licenses may be terminated if specified conditions are not met, and we may not be able to renew expiring licenses on favorable terms or at all” and “Risk Factors—Our failure to protect our reputation, or the failure of our partners or brand licensors to protect their reputations, could have a material adverse effect on our brand images”.

Employees

As of June 30, 2019, we had approximately 19,000 full-time employees in over 46 countries. In addition, we employ a large number of seasonal contractors during our peak manufacturing and promotional season. We expect our overall headcount to decrease as we continue our efforts to restructure and rationalize our business in connection with our Turnaround Plan.

Our employees in the U.S. are not covered by collective bargaining agreements. Our employees in certain countries in Europe are subject to works council arrangements and collective bargaining agreements. We have not experienced a material strike or work stoppage in the U.S. or any other country where we have a significant number of employees.

We recognize the importance of our employees to our business and believe our relationship with our employees is satisfactory.

Government Regulation

We and our products are subject to regulation by various U.S. federal regulatory agencies as well as by various state and local regulatory authorities and by the applicable regulatory authorities in the countries in which our products are produced or sold. Such regulations principally relate to the ingredients, labeling, manufacturing, packaging, advertising and marketing and sales and distribution of our products. Because we have commercial operations overseas, we are also subject to the U.S. Foreign Corrupt Practices Act (the “FCPA”) as well as other countries’ anti-corruption and anti-bribery regimes, such as the U.K. Bribery Act.

We are subject to numerous foreign, federal, provincial, state, municipal and local environmental, health and safety laws and regulations relating to, among other matters, safe working conditions, product stewardship and environmental protection, including those relating to emissions to the air, discharges to land and surface waters, generation, handling, storage, transportation, treatment and disposal of hazardous substances and waste materials, and the registration and evaluation of chemicals. We maintain policies and procedures to monitor and control environmental, health and safety risks, and to monitor compliance with applicable environmental, health and safety requirements. Compliance with such laws and regulations pertaining to the discharge of materials into the environment, or otherwise relating to the protection of the environment, has not had a material effect upon our capital expenditures, earnings or competitive position. However, environmental and social responsibility laws and regulations have tended to become increasingly stringent and, to the extent regulatory changes occur in the future, they could result in, among other things, increased costs and risks of non-compliance for us. For example, certain states in the U.S., such as California, and the U.S. Congress have proposed legislation relating to chemical disclosure and other requirements related to the content of our products. For more information, see “Risk Factors—Changes in laws, regulations and policies that affect our business or products could adversely affect our business, financial condition and results of operations.”

Seasonality

Our sales generally increase during our second fiscal quarter as a result of increased demand by retailers associated with the holiday season. We also experience an increase in sales during our fourth fiscal quarter in our Professional Beauty segment as a result of stronger activity prior to the summer holiday season. Working capital requirements, sales, and cash flows generally experience variability during the three to six months preceding the holiday period due in part to product innovations and new product launches and the size and timing of certain orders from our customers. We generally experience peak inventory levels from July to October and peak receivable balances from September to December. During the months of November, December and January of each year, cash is normally generated as customer payments for holiday season orders are received. For more information, see “Risk Factors—Our business is subject to seasonal variability.”

Availability of Reports

We make available financial information, news releases and other information on our website at www.coty.com. There is a direct link from our website to our SEC filings via the EDGAR database at www.sec.gov, where our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to these reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, are available free of charge as soon as reasonably practicable after we file such reports and amendments with, or furnish them to, the SEC. Stockholders may also contact Investor Relations at 350 Fifth Avenue, New York, New York 10118 or call 212-389-7300 to obtain hard copies of these filings without charge.

Item 1A. Risk Factors.

You should consider the following risks and uncertainties and all of the other information in this Annual Report on Form 10-K and our other filings in connection with evaluating our business and the forward-looking information contained in this Annual Report on Form 10-K. Our business and financial results may also be adversely affected by risks and uncertainties not presently known to us or that we currently believe to be immaterial. If any of the events contemplated by the following discussion of risks should occur or other risks arise or develop, our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities, may be materially and adversely affected. When used in this discussion, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation and the terms “Coty,” the “Company,” “we,” “our,” or “us” mean, unless the context otherwise indicates, Coty Inc. and its majority and wholly-owned subsidiaries.

The beauty industry is highly competitive, and if we are unable to compete effectively, our business, prospects, financial condition and results of operations could suffer.

The beauty industry is highly competitive and can change rapidly due to consumer preferences and industry trends, such as the expansion of digital channels, new “disruptor” trendy brands and advances in technology. Competition in the beauty industry is based on several factors, including pricing, value and quality, product efficacy, packaging and brands, speed or quality of innovation and new product introductions, in-store presence and visibility, promotional activities (including

influencers) and brand recognition, distribution channels, advertising, editorials and adaption to evolving technology and device trends, including via e-commerce initiatives.

Our competitors include large multinational consumer products companies, private label brands and emerging companies, among others, and some have greater resources than we do or may be able to respond more quickly or effectively to changing business and economic conditions than we can. It is difficult for us to predict the timing and scale of our competitors’ actions and their impact on the industry or on our business. For example, the fragrance category is being influenced by new product introductions, niche brands and growing e-commerce distribution. The color cosmetics category has been influenced by entry by new competitors and smaller competitors that are fast to respond to trends and engage with their customers through digital platforms and innovative in-store activations. In addition, the hair color category is being influenced by new product introductions in the premium category and innovations by competitors to meet growing category needs. Furthermore, the Internet and the online retail industry are characterized by rapid technological evolution, changes in consumer requirements and preferences, frequent introductions of new products and services embodying new technologies and the emergence of new industry standards and practices, any of which could render our existing technologies and systems obsolete. Our success will depend, in part, on our ability to identify, develop, acquire or license leading technologies useful in our business, and respond to technological advances and emerging industry standards and practices in a cost-effective and timely way. If we are unable to compete effectively on a global basis or in our key product categories or geographies, it could have an adverse impact on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

Further consolidation in the retail industry and shifting preferences in how and where consumers shop, including to e-commerce, may adversely affect our business, prospects, financial condition and results of operations.

Significant consolidation in the retail industry has occurred during the last several years. The trend toward consolidation, particularly in developed markets such as the U.S. and Western Europe, has resulted in our becoming increasingly dependent on our relationships with, and the overall business health of, fewer key retailers that control an increasing percentage of retail locations, which trend may continue. For example, certain retailers account for over 10% of our net revenues in certain geographies, including the U.S. Our success is dependent on our ability to manage our retailer relationships, including offering trade terms on mutually acceptable terms. Furthermore, increased online competition and declining in-store traffic has resulted, and may continue to result, in brick-and-mortar retailers closing physical stores, which could negatively impact our distribution strategies and/or sales if such retailers decide to significantly reduce their inventory levels for our products (as recently occurred with key customers for OPI in North America) or to designate more shelf space to our competitors. Additionally, these retailers periodically assess the allocation of shelf space and have elected (and could further elect) to reduce the shelf space allocated to our products. Some of our brands, including CoverGirl, have experienced shelf space losses, and such declines may continue. Further consolidation and store closures, or reduction in inventory levels of our products or shelf space devoted to our products, could have a material adverse effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities. We generally do not have long-term sales contracts or other sales assurances with our retail customers.

Consumer shopping preferences have also shifted, and may continue to shift in the future, to distribution channels other than traditional retail in which we have more limited experience, presence and development, such as direct sales and e-commerce. If we are not successful in our efforts to expand distribution channels, including growing our e-commerce activities, we will not be able to compete effectively. In addition, our entry into new categories and geographies has exposed, and may continue to expose, us to new distribution channels or risks about which we have less experience. Any change in our distribution channels, such as direct sales, could also expose us to disputes with distributors. If we are not successful in developing and utilizing these channels or other channels that future consumers may prefer, we may experience lower than expected revenues.

Changes in industry trends and consumer preferences could adversely affect our business, prospects, financial condition and results of operations.

Our success depends on our products’ appeal to a broad range of consumers whose preferences cannot be predicted with certainty and may change rapidly, and on our ability to anticipate and respond in a timely and cost-effective manner to industry trends through product innovations, product line extensions and marketing and promotional activities, among other things. Product life cycles and consumer preferences continue to be affected by the rapidly increasing use and proliferation of social and digital media by consumers, and the speed with which information and opinions are shared. As product life cycles shorten, we must continually work to develop, produce and market new products, maintain and enhance the recognition of our brands and shorten our product development and supply chain cycles.

In addition, net revenues and margins on beauty products tend to decline as they advance in their life cycles, so our net revenues and margins could suffer if we do not successfully and continuously develop new products. This product innovation also can place a strain on our employees and our financial resources, including incurring expenses in connection with product innovation and development, marketing and advertising that are not subsequently supported by a sufficient level of sales.

Furthermore, we cannot predict how consumers will react to any new products that we launch or to repositioning of our brands. Our successful Luxury division product launches may not continue. The amount of positive or negative sales contribution of any of our products may change significantly within a period or from period to period. The above-referenced factors, as well as new product risks, could have an adverse effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

Our success depends on our ability to implement our Turnaround Plan and achieve our global business strategies.

Our future performance and growth depends on the success of our Turnaround Plan and new business strategies, including our management team’s ability to successfully implement them, including a focus on improving gross margin, deleveraging, and standardizing and simplifying our business. The multi-year implementation of the Turnaround Plan, which is still being operationalized, is expected to result in changes to business priorities and operations, capital allocation priorities, operational and organizational structure, and increased demands on management. Such changes could result in short-term and one-time costs without any current revenues, lost customers, reduced sales volume, higher than expected restructuring costs, loss of key personnel, additional supply chain disruptions, higher costs of supply and other negative impacts on our business. Implementation of the Turnaround Plan may take longer than anticipated, and, once implemented, we may not realize, in full or in part, the anticipated benefits or such benefits may be realized more slowly than anticipated. The failure to realize benefits, which may be due to our inability to execute plans, delays in the implementation of the Turnaround Plan, global or local economic conditions, competition, changes in the beauty industry and the other risks described herein, could have a material adverse effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

Our strategy includes simplifying our product range and brand architecture and focusing brand-building efforts behind priority brand/country combinations. In addition, we continue to prioritize our deleveraging objectives. In the future, we may dispose of or discontinue select brands and/or streamline operations, and incur costs or restructuring and/or other charges in doing so. We may face risks of declines in brand performance and license terminations, due to expirations and/or allegations of breach or for other reasons, including with regard to any potentially divested or discontinued brands. If and when we decide to divest or discontinue any brands or lines of business, we cannot be sure that we will be able to locate suitable buyers or that we will be able to complete such divestitures or discontinuances successfully, timely, at appropriate valuations and on commercially advantageous terms, or without significant costs, including relating to any post-closing purchase price adjustments or claims for indemnification. Any future divestitures and discontinuances could have, a dilutive impact on our earnings, create dis-synergies, and divert significant financial, operational and managerial resources from our existing operations and make it more difficult to achieve our operating and strategic objectives. We also cannot be sure of the effect such divestitures or discontinuances would have on the performance of our remaining business or ability to execute our global strategies.

We have incurred significant costs in connection with the integration of acquisitions and simplifying our business, and expect to incur costs in connection with the implementation of our Turnaround Plan, that could affect our period-to-period operating results.

We have incurred significant restructuring costs in the past, and, as we implement our Turnaround Plan (which includes our structure reorganization and the move of our management headquarters), we expect to incur one-time cash costs of approximately $600 million spread over fiscal years 2020 through to 2023, in addition to approximately $160 million connected to previous restructuring programs. As we integrated acquisitions, including the transformational acquisition of the P&G Beauty Business, we experienced challenges, including supply chain disruptions, higher than expected costs and lost customers and related revenue and profits, and we could experience these or other challenges arising from the implementation of the Turnaround Plan. The cash usage associated with such, and similar, expenses has impacted and could continue to impact our ability to execute our business strategies, improve operating results and deleverage our balance sheet.

If our management is not able to effectively manage these initiatives, address fixed and other costs, we incur additional operating expenses or capital expenditures to realize synergies, simplifications and cost savings, or if any significant business activities are interrupted as a result of these initiatives, our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities may be materially adversely affected. The amount and timing of the above-referenced charges and management distraction could further adversely affect our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities. In addition, the implementation of the Turnaround Plan, continuing restructuring initiatives and the integration of acquisitions may impact our ability to anticipate future business trends and accurately forecast future results.

The diversion of resources to the integration of the P&G Beauty Business, together with changes and turnover in our management teams as we reorganized our business, negatively impacted our fiscal 2017, 2018 and 2019 results. The implementation our Turnaround Plan could result in similar challenges. Although our Turnaround Plan is intended to deliver

meaningful, sustainable expense and cost management improvement, events and circumstances such as financial or strategic difficulties, significant employee turnover, business disruption and delays may occur or continue, resulting in new, unexpected or increased costs that could result in us not realizing all of the anticipated benefits of the Turnaround Plan on our expected timetable or at all. In addition, we are executing many initiatives simultaneously, including a change to our organizational structure and global strategy, as well as the move of our management headquarters, which may result in further diversion of our resources, employee attrition and business disruption (including supply chain disruptions), and may adversely impact the execution of such initiatives. Any failure to implement our multi-year Turnaround Plan and other initiatives in accordance with our expectations could adversely affect our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

Our new product introductions may not be as successful as we anticipate, which could have a material adverse effect on our business, prospects, financial condition and results of operations.

We must continually work to develop, produce and market new products and maintain a favorable mix of products in order to respond in an effective manner to changing consumer preferences. We continually develop our approach as to how and where we market and sell our products. In addition, we believe that we must maintain and enhance the recognition of our brands, which may require us to quickly and continuously adapt in a highly competitive industry to deliver desirable products and branding to our consumers. For example, as part of our Turnaround Plan, we are in the process of reevaluating our product assortment and simplifying our product range and brands’ architecture. We are also shifting our focus to supporting our priority brands and brand/country combinations and instituting new objectives for our innovation efforts to support expansion of category coverage. If these or other initiatives are not successful, our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities could be adversely impacted.

We have made changes and may continue to change our process for the continuous development and evaluation of new product concepts. In addition, each new product launch carries risks. For example, we may incur costs exceeding our expectations, our advertising, promotional and marketing strategies may be less effective than planned or customer purchases may not be as high as anticipated. In addition, we may experience a decrease in sales of certain of our existing products as a result of consumer preferences shifting to our newly-launched products or to the products of our competitors as a result of unsuccessful or unpopular product launches harming our brands. Also, initially successful launches may not be sustained. Any of these could have a material adverse effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

As part of our ongoing business strategy we expect that we will need to continue to introduce new products in our traditional product categories and channels, while also expanding our product launches into adjacent categories and channels in which we may have less operating experience. For example, we acquired professional and retail hair brands in connection with the acquisition of the P&G Beauty Business, purchased a premium brand in high-end hair styling and appliances and entered into a joint venture with an online peer-to-peer social selling platform in beauty, all of which were new product categories and channels for us. The peer-to-peer social selling platform business in particular has struggled recently. The success of product launches in adjacent product categories could be hampered by our relative inexperience operating in such categories and channels, the strength of our competitors or any of the other risks referred to herein. Our inability to introduce successful products in our traditional categories and channels or in these or other adjacent categories and channels could limit our future growth and have a material adverse effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

If we are unable to obtain, maintain and protect our intellectual property rights, in particular trademarks, patents and copyrights, or if our brand partners and licensors are unable to maintain and protect their intellectual property rights that we use in connection with our products, our ability to compete could be negatively impacted.

Our intellectual property is a valuable asset of our business. Although certain of the intellectual property we use is registered in the U.S. and in many of the foreign countries in which we operate, there can be no assurances with respect to the continuation of such intellectual property rights, including our ability to further register, use or defend key current or future trademarks. Further, applicable law may provide only limited and uncertain protection, particularly in emerging markets, such as China.

Furthermore, we may not apply for, or be unable to obtain, intellectual property protection for certain aspects of our business. Third parties have in the past, and could in the future, bring infringement, invalidity, co-inventorship, re-examination, opposition or similar claims with respect to our current or future intellectual property. Any such claims, whether or not successful, could be costly to defend, may not be sufficiently covered by any indemnification provisions to which we are party, divert management’s attention and resources, damage our reputation and brands, and substantially harm our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities. Patent expirations may also affect our business. As patents expire (especially with respect to our Professional Beauty hair coloring technology), competitors may be able to legally produce and market products similar to the ones that were patented, which could have a material adverse

effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

In addition, third parties may distribute and sell counterfeit (or grey market) versions of our products, which may be inferior or pose safety risks and could confuse consumers or customers, which could cause them to refrain from purchasing our brands in the future or otherwise damage our reputation. In recent years, there has been an increase in the availability of counterfeit goods, including fragrances, in various markets by street vendors and small retailers, as well as on the Internet. The presence of counterfeit versions of our products in the market and of prestige products in mass distribution channels could also dilute the value of our brands, force us and our distributors to compete with heavily discounted products, cause us to be in breach of contract (including license agreements), impact our compliance with distribution and competition laws in jurisdictions including the E.U. and China, or otherwise have a negative impact on our reputation and business, prospects, financial condition or results of operations. We are rationalizing our wholesale distribution and continue efforts to reduce the amount of product diversion to the value and mass channels, however, stopping such commerce could result in a potential adverse impact to our sales and net revenues, including to those customers who are selling our products to unauthorized retailers, or an increase in returns over historical levels.

In order to protect or enforce our intellectual property and other proprietary rights, we may initiate litigation or other proceedings against third parties, such as infringement suits, opposition proceedings or interference proceedings. Any lawsuits or proceedings that we initiate could be expensive, take significant time and divert management’s attention from other business concerns, adversely impact customer relations and we may not be successful. Litigation and other proceedings may also put our intellectual property at risk of being invalidated or interpreted narrowly. The occurrence of any of these events may have a material adverse effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

In addition, many of our products bear, and the value of our brands is affected by, the trademarks and other intellectual property rights of our brand and joint venture partners and licensors. Our brand and joint venture partners’ and licensors’ ability to maintain and protect their trademark and other intellectual property rights is subject to risks similar to those described above with respect to our intellectual property. We do not control the protection of the trademarks and other intellectual property rights of our brand and joint venture partners and licensors and cannot ensure that our brand and joint venture partners and licensors will be able to secure or protect their trademarks and other intellectual property rights, which could have a material adverse effect on our business, prospects, financial condition, results of operations and cash flows, as well as the trading price of our securities.

Our success depends on our ability to operate our business without infringing, misappropriating or otherwise violating the intellectual property of third parties.

Our commercial success depends in part on our ability to operate without infringing, misappropriating or otherwise violating the trademarks, patents, copyrights and other proprietary rights of third parties. However, we cannot be certain that the conduct of our business does not and will not infringe, misappropriate or otherwise violate such rights. Moreover, our acquisition targets and other businesses in which we make strategic investments are often smaller or younger companies with less robust intellectual property clearance practices, and we may face challenges on the use of their trademarks and other proprietary rights. For example, we have faced oppositions to our use of the “Younique” mark in certain jurisdictions, including the European Economic Area and China. If we are found to be infringing, misappropriating or otherwise violating a third party trademark, patent, copyright or other proprietary rights, we may need to obtain a license, which may not be available in a timely manner on commercially reasonable terms or at all, or redesign or rebrand our products, which may not be possible or result in a significant delay to market or otherwise have an adverse commercial impact. We may also be required to pay substantial damages or be subject to a court order prohibiting us and our customers from selling certain products or engaging in certain activities, which could therefore have a material adverse effect on our business, prospects, financial condition, results of operations and cash flows, as well as the trading price of our securities.

Our goodwill and other assets have been subject to impairment and may continue to be subject to impairment in the future.

We are required, at least annually and sometimes on an interim basis, to test goodwill and indefinite-lived intangible assets to determine if any impairment has occurred. Impairment may result from various factors, including adverse changes in assumptions used for valuation purposes, such as actual or projected revenue growth rates, profitability or discount rates. If the testing indicates that an impairment has occurred, we are required to record a non-cash impairment charge for the difference between the carrying value of the goodwill or indefinite intangible assets and the fair value of the goodwill or of indefinite-lived intangible assets.

We cannot predict the amount and timing of any future impairments, if any. We have experienced impairment charges with respect to goodwill, intangible assets or other items in connection with past acquisitions, and we may experience such charges in connection with such acquisitions or future acquisitions, particularly if business performance declines or expected growth is

not realized or the applicable discount rate changes adversely. For example, in fiscal 2019 we incurred impairment charges of $3,851.9 million, primarily related to goodwill write-downs in our Consumer Beauty business, charges against certain brand trademarks and a Corporate investment. It is possible that material changes in our business, market conditions, or market assumptions could occur over time. Any future impairment of our goodwill or other intangible assets could have an adverse effect on our financial condition and results of operations, as well as the trading price of our securities. For a further discussion of the fiscal 2019 impairment charges and our impairment testing, please refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations-Financial Condition-Liquidity and Capital Resources-Goodwill, Other Intangible Assets and Long-Lived Assets”.

We have taken on significant debt, and the agreements that govern such debt contain various covenants that impose restrictions on us, which may adversely affect our business.

We have a substantial amount of indebtedness. We may not be able to refinance our indebtedness in the future (1) on commercially reasonable terms, (2) on terms, including with respect to interest rates, as favorable as our current debt or (3) at all.

Agreements that govern our indebtedness, including the indenture governing our senior unsecured notes (the “Indenture”) and our credit agreement (as amended, the “2018 Coty Credit Agreement”), impose operating and financial restrictions on our activities. These restrictions may limit or prohibit our ability and the ability of our restricted subsidiaries to, among other things:

•incur indebtedness or grant liens on our property;

•dispose of assets or equity;

•make acquisitions or investments;

•make dividends, distributions or other restricted payments;

•effect affiliate transactions;

•enter into sale and leaseback transactions; and

•enter into mergers, consolidations or sales of substantially all of our assets and the assets of our subsidiaries.

In addition, we are required to maintain certain financial ratios calculated pursuant to a financial maintenance covenant under the 2018 Coty Credit Agreement on a quarterly basis. For a further description of the 2018 Coty Credit Agreement and the covenants thereunder please refer to Note 14, “Debt” in the notes to our Consolidated Financial Statements.

Our debt burden and the restrictions in the agreements that govern our debt could have important consequences, including increasing our vulnerability to general adverse economic and industry conditions; limiting our flexibility in planning for, or reacting to, changes in our business and our industry; requiring the dedication of a substantial portion of any cash flow from operations and capital investments to the payment of principal of, and interest on, our indebtedness, thereby reducing the availability of such cash flow to fund our operations, turnaround strategy, working capital, capital expenditures, future business opportunities and other general corporate purposes; exposing us to the risk of increased interest rates with respect to any borrowings that are at variable rates of interest; restricting us from making strategic acquisitions or causing us to make non-strategic divestitures; limiting our ability to obtain additional financing for working capital, capital expenditures, research and development, debt service requirements, acquisitions and general corporate or other purposes; limiting our ability to adjust to changing market conditions; limiting our ability to take advantage of financing and other corporate opportunities; and placing us at a competitive disadvantage relative to our competitors who are less highly leveraged. Moreover, a material breach of the 2018 Coty Credit Agreement could result in the acceleration of all obligations outstanding under that agreement.

Our ability to service and repay our indebtedness will be dependent on the cash flow generated by our subsidiaries and events beyond our control.

Prevailing economic conditions and financial, business and other factors, many of which are beyond our control, may affect our ability to make payments on our debt and comply with other requirements under the 2018 Coty Credit Agreement and to meet our deleveraging objectives. In particular, due to the seasonal nature of the beauty industry, with the highest levels of consumer demand generally occurring during the holiday buying season in our second fiscal quarter, our subsidiaries’ cash flow in the second half of the fiscal year may be less than in the first half of the fiscal year, which may affect our ability to satisfy our debt service obligations, including to service our senior unsecured notes and the 2018 Coty Credit Agreement, and to meet such deleveraging objectives. If we do not generate sufficient cash flow to satisfy our covenants and debt service obligations, including payments on our senior unsecured notes and under the 2018 Coty Credit Agreement, we may have to undertake additional cost reduction measures or alternative financing plans, such as refinancing or restructuring our debt; selling assets; reducing or delaying capital investments; modifying terms of agreements, including timing of payments, with vendors,

customers, and other third parties; or seeking to raise additional capital. The terms of the Indenture governing our senior unsecured notes, the 2018 Coty Credit Agreement or any existing debt instruments or future debt instruments that we may enter into may restrict us from adopting some of these alternatives. Our ability to restructure or refinance our debt will depend on the capital markets and other macroeconomic conditions and our financial condition at such time. Any refinancing or modification of our debt could result in higher interest rates and may require us to comply with more onerous covenants or reduce our borrowing capacity, which could further restrict our business operations. For example, in connection with the 2019 amendment to the 2018 Credit Agreement, we reduced the borrowing capacity under our revolving credit facility. The inability of our subsidiaries to generate sufficient cash flow to satisfy our covenants and debt service obligations, including the inability to service our senior unsecured notes and the 2018 Coty Credit Agreement, or to refinance our obligations on commercially reasonable terms, could have a material adverse effect on our business, financial condition, results of operations, profitability, cash flows or liquidity, as well as the trading price of our securities, and may impact our ability to satisfy our obligations in respect of our senior unsecured notes and the 2018 Coty Credit Agreement.

Our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase.

Borrowings under the 2018 Coty Credit Agreement are at variable rates of interest and expose us to interest rate risk. If interest rates were to increase, our debt service obligations on the variable rate indebtedness referred to above would increase even if the principal amount borrowed remained the same, and our net income and cash flows will correspondingly decrease. We are currently party to, and in the future, we may enter into additional, interest rate swaps that involve the exchange of floating for fixed rate interest payments, in order to reduce interest rate volatility. However, we may not maintain interest rate swaps with respect to all of our variable rate indebtedness, and any swaps we enter into may not fully mitigate our interest rate risk.

In addition, amounts drawn under the 2018 Coty Credit Agreement may bear interest rates in relation to the London Interbank Offered Rate (“LIBOR”). In 2017, the United Kingdom’s Financial Conduct Authority, which regulates LIBOR, announced that it intends to phase out LIBOR by the end of 2021. It is unclear if LIBOR will cease to exist at that time or if new methods of calculating LIBOR will be established such that it continues to exist after 2021. If LIBOR is no longer available, or if our lenders have increased costs due to changes in LIBOR, we may need to amend our 2018 Coty Credit Agreement and any related interest rate swaps to replace LIBOR with an agreed upon replacement index, which could result in higher rates and adversely impact our interest expense.

We may not be able to identify suitable acquisition targets and our acquisition activities and other strategic transactions may present managerial, integration, operational and financial risks, which may prevent us from realizing the full intended benefit of the acquisitions we undertake.

Our acquisition activities and other strategic transactions expose us to certain risks related to integration, including diversion of management attention from existing core businesses and substantial investment of resources to support integration. During the past several years, we have explored and undertaken opportunities to acquire other companies and assets as part of our growth strategy. For example, we completed five significant acquisitions in fiscal 2016 through fiscal 2018 (including the acquisition of P&G Beauty Business in October 2016) and entered into a joint venture with Younique in February 2017. These assets represent a significant portion of our net assets, particularly the P&G Beauty Business. As we consider growth opportunities, we may continue to seek acquisitions that we believe strengthen our competitive position in our key segments and geographies or accelerate our ability to grow into adjacent product categories and channels and emerging markets or which otherwise fit our strategy. There can be no assurance that we will be able to identify suitable acquisition candidates, be the successful bidder or consummate acquisitions on favorable terms, have the funds to acquire desirable acquisitions or otherwise realize the full intended benefit of such transactions. In addition, acquisitions could adversely impact our deleveraging strategy.

The assumptions we use to evaluate acquisition opportunities may not prove to be accurate, and intended benefits may not be realized. Our due diligence investigations may fail to identify all of the problems, liabilities or other challenges associated with an acquired business which could result in increased risk of unanticipated or unknown issues or liabilities, including with respect to environmental, competition and other regulatory matters, and our mitigation strategies for such risks that are identified may not be effective. As a result, we may not achieve some or any of the benefits, including anticipated synergies or accretion to earnings, that we expect to achieve in connection with our acquisitions, including the acquisition of the P&G Beauty Business, or we may not accurately anticipate the fixed and other costs associated with such acquisitions, or the business may not achieve the performance we anticipated, which may materially adversely affect our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities. Any financing for an acquisition could increase our indebtedness or result in a potential violation of the debt covenants under our existing facilities requiring consent or waiver from our lenders, which could delay or prevent the acquisition, or dilute the interests of our stockholders. For example, in connection with the acquisition of the P&G Beauty Business, Green Acquisition Sub Inc., a wholly-owned subsidiary of the Company, was merged with and into Galleria, with Galleria continuing as the surviving corporation and a direct wholly-owned subsidiary of the Company (the “Green Merger”) and pre-Green Merger holders of our

stock were diluted to 46% of the fully diluted shares of common stock immediately following the Green Merger. In addition, acquisitions of foreign businesses, new entrepreneurial businesses and businesses in new distribution channels, such as our acquisition of the Brazilian personal care and beauty business of Hypermarcas S.A. (the “Hypermarcas Brands”), Younique, Burberry and ghd, entail certain particular risks, including potential difficulties in geographies and channels in which we lack a significant presence, difficulty in seizing business opportunities compared to local or other global competitors, difficulty in complying with new regulatory frameworks, the acquisition of new or unexpected liabilities, the adverse impact of fluctuating exchange rates and entering lines of business where we have limited or no direct experience. See “—Fluctuations in currency exchange rates may negatively impact our financial condition and results of operations” and “—We are subject to risks related to our international operations.”

We face risks associated with our joint ventures.

We are party to several joint ventures in both the U.S. and abroad. Going forward, we may acquire interests in more joint venture enterprises to execute our business strategy by utilizing our partners’ skills, experiences and resources. These joint ventures involve risks that our joint venture partners may:


•	have economic or business interests or goals that are inconsistent with or adverse to ours;


•	take actions contrary to our requests or contrary to our policies or objectives, including actions that may violate applicable law;


•	be unable or unwilling to fulfill their obligations under the relevant joint venture agreements;


•	have financial or business difficulties;


•	take actions that may harm our reputation; or


•	have disputes with us as to the scope of their rights, responsibilities and obligations.

In certain cases, joint ventures may present us with a lack of ability to fully control all aspects of their operations, including due to veto rights, and we may not have full visibility with respect to all operations, customer relations and compliance practices, among others.

Our present or future joint venture projects may not be successful. We have had, and cannot assure you that we will not in the future have, disputes or encounter other problems with respect to our present or future joint venture partners or that our joint venture agreements will be effective or enforceable in resolving these disputes or that we will be able to resolve such disputes and solve such problems in a timely manner or on favorable economic terms, or at all. Any failure by us to address these potential disputes or conflicts of interest effectively could have a material adverse effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

A general economic downturn, credit constriction, uncertainty in global economic or political conditions or other global events or a sudden disruption in business conditions may affect consumer spending, which could adversely affect our financial results.

Global events may impact our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities. We operate in an environment of slow overall growth in the segments and geographies in which we compete with increasing competitive pressure and changing consumer preferences. While luxury fragrances and skin care categories are experiencing strong growth, declines in the retail mass color cosmetics and mass fragrance categories in the U.S. and certain key markets in Western Europe continue to impact our business and financial results. Deterioration of social or economic conditions in Europe or elsewhere could reduce sales and could also impair collections on accounts receivable. For example, the June 23, 2016 referendum in the U.K. in which voters approved an exit from the E.U., commonly referred to as “Brexit,” and subsequent initiation of formal withdrawal procedures by the U.K. government has caused significant volatility in the financial and credit markets and may impact consumer spending and economic conditions generally in Europe. The global markets and currencies have been adversely impacted, including volatility in the value of the British pound as compared to the U.S. dollar. There continues to be a significant lack of clarity over the eventual date and terms of the U.K.’s exit from the E.U. and the terms of the U.K.'s future relationship with the E.U. Although it is unknown what those terms will be, it is possible that there will be greater restrictions on imports and exports between the U.K. and E.U. countries and increased regulatory complexities. These changes may adversely affect our operations and financial results. See “-We are subject to risks related to our international operations.” Further, recent political and economic developments in the U.S. (including public statements by the current administration), the U.K., Europe, Brazil and China have introduced uncertainty in the regulatory and business environment in which we operate (including potential increases in tariffs). These political and economic developments have resulted and could continue to result in changes to legislation or reformation of government policies, rules and regulations pertaining to trade. Such changes could have a significant impact on our business by increasing the cost of doing business, affecting our ability to sell our products and negatively impacting our profitability.

In addition, our sales are affected by the overall level of consumer spending. The general level of consumer spending is affected by a number of factors, including general economic conditions (including potential recessions in one or more significant economies), inflation, interest rates, government policies that affect consumers (such as those relating to medical insurance or income tax), energy costs and consumer confidence, each of which is beyond our control. Consumer purchases of discretionary and other items and services, including beauty products, tend to decline during recessionary periods and otherwise weak economic environments, when disposable income is lower. A decline in consumer spending would likely have a negative impact on our direct sales and could cause financial difficulties at our retailer and other customers. If consumer purchases decrease, we may not be able to generate enough cash flow to meet our debt obligations and other commitments and may need to refinance our debt, dispose of assets or issue equity to raise necessary funds. We cannot predict whether we would be able to undertake any of these actions to raise funds on a timely basis or on satisfactory terms or at all. The financial difficulties of a customer or retailer could also cause us to curtail or eliminate business with that customer or retailer. We may also decide to assume more credit risk relating to the receivables from our customers or retailers, which increases the possibility of late or non-payment of receivables. Our inability to collect receivables from a significant retailer or customer, or from a group of these customers, could have a material adverse effect on our business, prospects, results of operations, financial condition, results of operations, cash flows, as well as the trading price of our securities. If a retailer or customer were to go into liquidation, we could incur additional costs if we choose to purchase the retailer’s or customer’s inventory of our products to protect brand equity.

Volatility in the financial markets could have a material adverse effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

While we currently generate significant cash flows from our ongoing operations and have access to global credit markets through our various financing activities, credit markets may experience significant disruptions. Deterioration in global financial markets could make future financing difficult or more expensive. If any financial institutions that are parties to our credit facilities or other financing arrangements, such as interest rate or foreign currency exchange hedging instruments, were to declare bankruptcy or become insolvent, or experience other financial difficulty, they may be unable to perform under their agreements with us. In addition, the deterioration of the financial condition of any of the financial institutions that hold our short-term investments and cash deposits could negatively impact the value and liquidity of such investments and deposits. This could leave us with reduced borrowing capacity, could leave us unhedged against certain interest rate or foreign currency exposures or could reduce our access to our cash deposits, which could have an adverse impact on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

Fluctuations in currency exchange rates may negatively impact our financial condition and results of operations.

Exchange rate fluctuations have affected and may in the future affect our results of operations, financial condition, reported earnings, the value of our foreign assets, the relative prices at which we and foreign competitors sell products in the same markets and the cost of certain inventory and non-inventory items required by our operations. The currencies to which we are exposed include the euro, the British pound, the Chinese yuan, the Polish zloty, the Russian ruble, the Brazilian real, the Australian dollar and the Canadian dollar. The exchange rates between these currencies and the U.S. dollar in recent years have fluctuated significantly and may continue to do so in the future. A depreciation of these currencies against the U.S. dollar would decrease the U.S. dollar equivalent of the amounts derived from foreign operations reported in our consolidated financial statements and an appreciation of these currencies would result in a corresponding increase in such amounts. The cost of certain items, such as raw materials, transportation and freight, required by our operations may be affected by changes in the value of the various relevant currencies. To the extent that we are required to pay for goods or services in foreign currencies, the appreciation of such currencies against the U.S. dollar would tend to negatively impact our financial condition and results of operations. Our efforts to hedge certain exposures to foreign currency exchange rates arising in the ordinary course of business may not successfully hedge the effect of such fluctuations.

We are subject to risks related to our international operations.

We operate on a global basis, and approximately 69% of our net revenues in fiscal 2019 were generated outside North America. We maintain offices in over 35 countries, and we market, sell and distribute our products in over 150 countries and territories. Our presence in such geographies has expanded as a result of our acquisitions, including the acquisition of the Hypermarcas Brands, the P&G Beauty Business and ghd as well as organic growth, and we are exposed to risks inherent in operating in geographies in which we have not operated in or have been less present in the past.

Non-U.S. operations are subject to many risks and uncertainties, including ongoing instability or changes in a country’s or region’s economic, regulatory or political conditions, including inflation, recession, interest rate fluctuations, sovereign default risk and actual or anticipated military or political conflicts (including any other change resulting from Brexit), labor market disruptions, sanctions, boycotts, new or increased tariffs, quotas, exchange or price controls, trade barriers or other restrictions on foreign businesses, our failure to effectively and timely implement processes and policies across our diverse operations and employee base and difficulties and costs associated with complying with a wide variety of complex and potentially conflicting

regulations across multiple jurisdictions. Non-U.S. operations also increase the risk of non-compliance with U.S. laws and regulations applicable to such non-U.S. operations, such as those relating to sanctions, boycotts and improper payments. In particular, we are monitoring the latest developments regarding Brexit negotiations, including the potential impact on our business if the United Kingdom exits the EU without having a final withdrawal agreement in place (sometimes referred to as a “hard Brexit”). Brexit (and particularly a hard Brexit) could have a number of negative implications for our business, including with respect to the production of our products in the United Kingdom, the transfer or purchase of goods and services into or out of the United Kingdom and our operations in the United Kingdom. We are analyzing various short- and long-term strategies to address Brexit contingencies, but such strategies may not be effective in limiting these negative impacts and Brexit thus could have a material impact on our business and results of operations.

In addition, sudden disruptions in business conditions as a consequence of events such as terrorist attacks, war or other military action or the threat of further attacks, pandemics or other crises or vulnerabilities or as a result of adverse weather conditions or climate changes, may have an impact on consumer spending, which could have a material adverse effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

The U.S. and the other countries in which our products are manufactured or sold have imposed and may impose additional quotas, duties, tariffs, retaliatory or trade protection measures, or other restrictions or regulations, or may adversely adjust prevailing quota, duty or tariff levels, which can affect both the materials that we use to manufacture or package our products and the sale of finished products. For example, in 2018 the E.U. imposed tariffs on certain luxury products imported from the U.S., which impact the sale in the E.U. of certain of our Professional Beauty and Consumer Beauty products that are manufactured in the U.S. Similarly, the tariffs imposed by the U.S. on goods and materials from China are impacting materials we import for use in manufacturing or packaging in the U.S. Measures to reduce the impact of tariff increases or trade restrictions, including shifts of production among countries and manufacturers, geographical diversification of our sources of supply, adjustments in product or packaging design and fabrication, or increased prices, could increase our costs and delay our time to market or decrease sales. Other governmental action related to tariffs or international trade agreements has the potential to adversely impact demand for our products, our costs, customers, suppliers and global economic conditions and cause higher volatility in financial markets. The beauty industry has been impacted by ongoing uncertainty surrounding tariffs and import duties, and international trade relations generally. While we actively review existing and proposed measures to seek to assess the impact of them on our business, changes in tariff rates, import duties and other new or augmented trade restrictions could have a number of negative impacts on our business, including higher consumer prices and reduced demand for our products and higher input costs.

On December 22, 2017, the President of the U.S. signed the Tax Act which made broad and complex changes to the U.S. tax laws that affect businesses operating internationally. In addition, some foreign governments may enact tax laws in response to the Tax Act that could result in further changes to global taxation and that could materially adversely affect our financial results, which could have a material adverse effect on our results of operations, financial condition and cash flows, as well as the trading price of our securities.

We are subject to legal proceedings and legal compliance risks.

We are subject to a variety of legal proceedings and legal compliance risks in the countries in which we do business, including the matters described under the heading “Legal Proceedings” in Part I, Item 3 of this report. We are under the jurisdiction of regulators and other governmental authorities which may, in certain circumstances, lead to enforcement actions, changes in business practices, fines and penalties, the assertion of private litigation claims and damages and adversely impact our customer relationships, particularly to the extent customers were implicated by such proceedings. We are also subject to legal proceedings and legal compliance risks in connection with legacy matters involving the P&G Beauty Business, the Burberry fragrance business, Hypermarcas Brands, ghd and Younique, that were previously outside our control and that we are now independently addressing, which may result in unanticipated or new liabilities. While we believe that we have adopted, and/or will adopt, appropriate risk management and compliance programs, such adoptions take time and, given the global nature of our operations and many laws and regulations to which we are subject, these legal and compliance risks will continue to exist with respect to our business, and additional legal proceedings and other contingencies, the outcome and impact of which cannot be predicted with certainty, will arise from time to time.

As described under “Legal Proceedings” in this report, three putative class action lawsuits have been filed in connection with the Cottage Tender Offer and related Schedule 14D-9.

In addition, we are subject to pending tax assessment matters in Brazil relating to local sales tax credits for the 2016-2017 tax periods. Although we are seeking a favorable administrative decision on the related tax enforcement action, we may not be successful. See Note 25, “Legal Contingencies” for more information regarding our potential tax obligations in Brazil.

Our operations and acquisitions in certain foreign areas expose us to political, regulatory, economic and reputational risks.

We operate on a global basis. Our employees, contractors and agents, business partners, joint venture and joint venture partners and companies to which we outsource certain of our business operations, may take actions in violation of our compliance policies or applicable law. In addition, some of our acquisitions have required us to integrate non-U.S. companies that had not, until our acquisition, been subject to U.S. law or other laws to which we are subject.

In many countries, particularly in those with developing economies, it may be common for persons to engage in business practices prohibited by the laws and regulations applicable to us. In addition, certain countries have laws that differ with those in the US, including relating to competition and product distribution, with which US and other personnel may be unfamiliar, thereby increasing the risk of non-compliance. We are in the process of enhancing our compliance program, including as a result of acquisitions, but we cannot assure you that we will not encounter problems with respect to such programs or that such programs will be effective in ensuring compliance.

Failure by us or our subsidiaries to comply with applicable laws or policies could subject us to civil and criminal penalties, cause us to be in breach of contract or damage to our or our licensors’ reputation, each of which could materially and adversely affect our business, prospects, financial condition, cash flows, results of operations, as well as the trading price of our securities.

In addition, the U.S. may impose additional sanctions at any time on countries where we sell our products. If so, our existing activities may be adversely affected, we may incur costs in order to come into compliance with future sanctions, depending on the nature of any further sanctions that may be imposed, or we may experience reputational harm and increased regulatory scrutiny.

We are subject to the interpretation and enforcement by governmental agencies of other foreign laws, rules, regulations or policies, including any changes thereto, such as restrictions on trade, import and export license requirements, and tariffs and taxes (including assessments and disputes related thereto), which may require us to adjust our operations in certain areas where we do business. We face legal and regulatory risks in the U.S. and abroad and, in particular, cannot predict with certainty the outcome of various contingencies or the impact that pending or future legislative and regulatory changes may have on our business. It is not possible to gauge what any final regulation may provide, its effective date or its impact at this time. These risks could have a material adverse effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

Our failure to protect our reputation, or the failure of our brand partners or licensors to protect their reputations, could have a material adverse effect on our brand images.

Our ability to maintain our reputation is critical to our business and our various brand images. Our reputation could be jeopardized if we fail to maintain high standards for product quality and integrity (including should we be perceived as violating the law) or if we, or the third parties with whom we do business, do not comply with regulations or accepted practices and are subject to a significant product recall, litigation, or allegations of tampering, animal testing, use of certain ingredients (such as certain palm oil) or misconduct by executives or founders. Any negative publicity about these types of concerns or other concerns, whether actual or perceived or directed towards us or our competitors, may reduce demand for our products. Failure to comply with ethical, social, product, labor and environmental standards, or related political considerations, could also jeopardize our reputation and potentially lead to various adverse consumer actions, including boycotts. In addition, the behavior of our employees, including with respect to our employees’ use of social media subjects us to potential negative publicity if such use does not align with our high standards and integrity or fails to comply with regulations or accepted practices. Furthermore, widespread use of digital and social media by consumers has greatly increased the accessibility of information and the speed of its dissemination. Negative or inaccurate publicity, posts or comments on social media, whether accurate or inaccurate, about us, our employees or our brand partners (including influencers) and licensors, our respective brands or our respective products, whether true or untrue, could damage our respective brands and our reputation.

Additionally, our success is also partially dependent on the reputations of our brand partners, influencers and licensors and the goodwill associated with their intellectual property. We often rely on our brand partners, influencers or licensors to manage and maintain their brands, but these licensors’ reputation or goodwill may be harmed due to factors outside our control, which could be attributed to our other brands and have a material adverse effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities. Many of these brand licenses are with fashion houses, whose popularity may decline due to mismanagement, changes in fashion or consumer preferences, allegations against their management or designers or other factors beyond our control. Similarly, certain of our products bear the names and likeness of celebrities, whose brand or image may change without notice and who may not maintain the appropriate celebrity status or positive association among the consumer public to support projected sales levels. In addition, in the event that any of these licensors were to enter bankruptcy proceedings, we could lose our rights to use the intellectual property that the applicable licensors license to us.

Damage to our reputation or the reputations of our brand partners or licensors or loss of consumer confidence for any of these or other reasons could have a material adverse effect on our results of operations, financial condition and cash flows, as well as require additional resources to rebuild our reputation.

Our brand licenses may be terminated if specified conditions are not met, and we may not be able to renew expiring licenses on favorable terms or at all.

We license trademarks for many of our product lines. Our brand licenses typically impose various obligations on us, including the payment of annual royalties, maintenance of the quality of the licensed products, achievement of minimum sales levels, promotion of sales and qualifications and behavior of our suppliers, distributors and retailers. We have breached, and may in the future breach, certain terms of our brand licenses. If we breach our obligations, our rights under the applicable brand license agreements could be terminated by the licensor and we could, among other things, have to pay damages, lose our ability to sell products related to that brand, lose any upfront investments made in connection with such license and sustain reputational damage. In addition, most brand licenses have renewal options for one or more terms, which can range from three to ten years. Certain brand licenses provide for automatic extensions, so long as minimum annual royalty payments are made, while renewal of others is contingent upon attaining of specified sales levels or upon agreement of the licensor. In fiscal 2019, we renewed two key brand licenses. While many of our licenses are long term, licenses relating to certain of our brands are up for renewal in the next few years, including seven licenses up for renewal in 2020. We may not be able to renew expiring licenses on terms that are favorable to us or at all. We may also face difficulties in finding replacements for terminated or expired licenses. Each of the aforementioned risks could have a material adverse effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

Our business is subject to seasonal variability.

Our sales generally increase during our second fiscal quarter as a result of increased demand by retailers associated with the winter holiday season. We also experience an increase in sales during our fourth quarter in our Professional Beauty segment as a result of higher demand prior to the summer holiday season. Accordingly, our financial performance, sales, working capital requirements, cash flow and borrowings generally experience variability during the three to six months preceding and during the holiday period. As a result of this seasonality, our expenses, including working capital expenditures and advertising spend, are typically higher during the period before a high-demand season. Consequently, any substantial decrease in, or inaccurate forecasting with respect to, net revenues during such periods of high demand including as a result of decreased customer purchases, increased product returns, production or distribution disruptions or other events (many of which are outside of our control), would prevent us from being able to recoup our earlier expenses and could have a material adverse effect on our financial condition, results of operations and cash flows, as well as the trading price of our securities.

A disruption in operations could adversely affect our business.

As a company engaged in manufacturing and distribution on a global scale, we are subject to the risks inherent in such activities, including industrial accidents, environmental events, strikes and other labor disputes (including as to works councils), disruptions in supply chain or information systems, loss or impairment of key manufacturing sites or distribution centers, product quality control, safety, licensing requirements and other regulatory issues, as well as natural disasters, pandemics, border disputes, acts of terrorism, possible dawn raids, and other external factors over which we have no control. For example, disruptions in our U.K. planning hub and one of our U.S. distribution centers in the fourth quarter of fiscal 2018 resulted in loss of revenue and increased costs, including penalty payments to retailers for unshipped products, as we were unable to meet consumer demand for certain Consumer Beauty products, which impacted our results of operations in fiscal 2019. As we continue our implementation of our Turnaround Plan and other restructuring activities, any additional or ongoing supply chain disruptions or delay in securing applicable approvals or consultations for such activities may impact our quarterly results. The loss of, or damage or disruption to, any of our manufacturing facilities or distribution centers could have a material adverse effect on our business, prospects, results of operations, financial condition, results of operations, cash flows, as well as the trading price of our securities.

We manufacture and package a majority of our products. Raw materials, consisting chiefly of essential oils, alcohols, chemicals, containers and packaging components, are purchased from various third-party suppliers. The loss of multiple suppliers or a significant disruption or interruption in the supply chain, or our relationships with key suppliers due to our payment terms or otherwise, could have a material adverse effect on the manufacturing and packaging of our products. Increases in the costs of raw materials or other commodities may adversely affect our profit margins if we are unable to pass along any higher costs in the form of price increases or otherwise achieve cost efficiencies in manufacturing and distribution. In addition, failure by our third-party suppliers to comply with ethical, social, product, labor and environmental laws, regulations or standards, or their engagement in politically or socially controversial conduct, such as animal testing, could negatively impact our reputations and lead to various adverse consequences, including decreased sales and consumer boycotts. The Dodd-Frank Wall Street Reform and Consumer Protection Act includes disclosure requirements regarding the use of certain minerals mined from the Democratic Republic of Congo and adjoining countries (each, a “covered country”) and procedures pertaining

to a manufacturer’s efforts regarding the source of such minerals. SEC rules implementing these requirements may have the effect of reducing the pool of suppliers who can supply covered country “conflict free” products, and we may not be able to obtain covered country conflict free products or supplies in sufficient quantities for our operations. For calendar year 2018, we determined that we have no reason to believe that any products we manufactured or contracted to manufacture contained conflict minerals that may have originated in the covered countries. However, since our supply chain is complex, we may face operational obstacles and reputational challenges with our customers and stockholders if we are unable to continue to sufficiently verify the origins for the minerals used in our products.

We have also outsourced and may continue to outsource certain functions, and we are dependent on the entities performing those functions. For example, a short-term transportation workers strike in Brazil impacted the distribution of our products and raw materials in the fourth quarter of fiscal 2018, resulting in increased logistical costs and lost revenues for products that could not be shipped. The failure of one or more such providers to provide the expected services, provide them on a timely basis or provide them at the prices we expect, or the costs incurred in returning these outsourced functions to being performed under our management and direct control, may have a material adverse effect on our results of operations or financial condition.

We are increasingly dependent on information technology, and if we are unable to protect against service interruptions, corruption of our data and privacy protections, cyber-based attacks or network security breaches, our operations could be disrupted.

We rely on information technology networks and systems, including the Internet, to process, transmit and store electronic and financial information, to manage a variety of business processes and activities, and to comply with regulatory, legal and tax requirements. We also increasingly depend on our information technology infrastructure for digital marketing activities, e-commerce and for electronic communications among our locations, personnel, customers and suppliers around the world. These information technology systems, some of which are managed by third parties that we do not control, may be susceptible to damage, disruptions or shutdowns due to failures during the process of upgrading or replacing software, databases or components thereof, cutover activities in our restructuring and simplification initiatives (including in connection with our Turnaround Plan), power outages, hardware failures, computer viruses, attacks by computer hackers, telecommunication failures, user errors, catastrophic events or other problems. For example, in connection with the expected change in our reporting segments in the third quarter of fiscal 2020 in connection with our reorganization, we will need to reconfigure our financial reporting systems. If we experience any delay or problems with such reconfiguration, or if our information technology systems otherwise suffer severe damage, disruption or shutdown and our business continuity plans do not effectively resolve the issues in a timely manner, our product sales, financial condition and results of operations may be materially and adversely affected, and we could experience delays in reporting our financial results. If not managed and mitigated effectively, these risks could increase in the future as we expand our digital capabilities and e-commerce activities, including through the use of new digital applications and technologies. There are further risks associated with the information systems of our joint ventures and of the companies we acquire, both in terms of systems compatibility, process controls, level of security and functionality. It may cost us significant time, money and resources to address these risks and if our systems were to fail or we are unable to successfully expand the capacity of these systems, or we are unable to integrate new technologies into our existing systems, our financial condition, results of operations and cash flows, as well as the trading price of our securities, may be adversely affected.

We are subject to an evolving body of federal, state and non-U.S. laws, regulations, guidelines, and principles regarding data privacy and security. A data breach or inability on our part to comply with such laws, regulations, guidelines, and principles or to quickly adapt our practices to reflect them as they develop, could potentially subject us to significant liabilities and reputational harm. Several governments, including the E.U., have regulations dealing with the collection and use of personal information obtained from their citizens, and regulators globally are also imposing greater monetary fines for privacy violations. For example, in the E.U. a new law governing data practices and privacy called the GDPR became effective in May 2018. The law establishes new requirements regarding the handling of personal data, and non-compliance with the GDPR may result in monetary penalties of up to 4% of worldwide revenue. Regulators, including the U.K.’s Information Commissioner’s Office, have actively enforced the law and imposed substantial fines, and are expected to continue to do so. In addition, the state of California enacted a data privacy law applicable to entities serving or employing California residents (the “California Consumer Privacy Act”) that will require compliance by January 2020. The GDPR, the California Consumer Privacy Act and other changes in laws or regulations associated with the enhanced protection of certain types of sensitive data and other personal information, require us to evaluate our current operations, information technology systems and data handling practices and implement enhancements and adaptations where necessary to comply. Compliance with these laws, could greatly increase our operational costs or require us to adapt certain products, operations, processes or activities in otherwise suboptimal ways, to comply with the stricter regulatory requirements, such as efforts to meet consumer demand for personalized products and services, in jurisdictions where we operate. The regulations are complex and likely require adjustments to our operations. Any failure to comply with all such laws by us, our business partners or third-parties engaged by us could result in significant liabilities and reputational harm.

In addition, if we are unable to prevent or detect security breaches, or properly remedy them, we may suffer financial and reputational damage or penalties because of the unauthorized disclosure of confidential information belonging to us or to our partners, customers or suppliers, including personal employee, consumer or presenter information stored in our or third-party systems or as a result of the dissemination of inaccurate information. In addition, the unauthorized disclosure of nonpublic sensitive information could lead to the loss of intellectual property or damage our reputation and brand image or otherwise adversely affect our ability to compete.

Our information technology systems, operations and security control frameworks require an ongoing commitment of significant resources to maintain, protect, and enhance existing systems to keep pace with continuing changes in technology, legal and regulatory standards, cyber threats and the commercial opportunities that accompany the changing digital and data driven economy. From time to time, we undertake significant information technology systems projects, including enterprise resource planning updates, modifications, integrations and roll-outs. These projects may be subject to cost overruns and delays and may cause disruptions in our daily business operations. These cost overruns and delays and distractions as well as our reliance on certain third parties for certain business and financial information could impact our financial statements and could adversely impact our ability to run our business, correctly forecast future performance and make fully informed decisions.

Our success depends, in part, on our employees, including our key personnel.

Our success depends, in part, on our ability to identify, hire, train and retain our employees, including our key personnel, such as our executive officers and senior management team and our research and development and marketing personnel. We have recently experienced several changes to senior management and the composition of our board of directors, and we are in the process of implementing our Turnaround Plan, including the business structure reorganization and the move of our management headquarters to Amsterdam. Transition periods accompanying changes in leadership and changes due to business reorganization may result in uncertainty, impact business performance and strategies and retention of personnel. The unexpected loss of one or more of our key employees could adversely affect our business. Competition for highly qualified individuals can be intense, and although many of our key personnel have signed non-compete agreements, it is possible that these agreements would be unenforceable, in whole or in part, in some jurisdictions, permitting employees in those jurisdictions to transfer their skills and knowledge to the benefit of our competitors with little or no restriction. We may not be able to attract, assimilate or retain qualified personnel in the future, and our failure to do so could adversely affect our business. Further, other companies may attempt to recruit our key personnel and we may attempt to recruit their key personnel, even if bound by non-competes, which could result in diversion of management attention and our resources to litigation related to such recruitment. These risks may be exacerbated by the stresses associated with changes in our global business strategy, the implementation of our Turnaround Plan and other restructuring activities, including the move of our management headquarters to Amsterdam, any continued changes in our senior management team and other key personnel, and other initiatives.

As we continue to restructure our workforce from time to time (including with respect to the Turnaround Plan and other business restructuring initiatives, as well as acquisitions and our overall growth strategy) and work with more brand partners and licensors, the risk of potential employment-related claims and disputes will also increase. As such, we or our partners may be subject to claims, allegations or legal proceedings related to employment matters including discrimination, harassment (sexual or otherwise), wrongful termination or retaliation, local, state, federal and non-U.S. labor law violations, injury, and wage violations. In addition, our employees in certain countries in Europe are subject to works council arrangements, exposing us to associated delays, works council claims and associated litigation. In the event we or our partners are subject to one or more employment-related claims, allegations or legal proceedings, we or our partners may incur substantial costs, losses or other liabilities in the defense, investigation, settlement, delays associated with, or other disposition of such claims. In addition to the economic impact, we or our partners may also suffer reputational harm as a result of such claims, allegations and legal proceedings and the investigation, defense and prosecution of such claims, allegations and legal proceedings could cause substantial disruption in our or our partners’ business and operations, including delaying and reducing the expected benefits of any associated restructuring activities. We have policies and procedures in place to reduce our exposure to these risks, but such policies and procedures may not be effective and we may be exposed to such claims, allegations or legal proceedings.

Our success depends, in part, on the quality, efficacy and safety of our products.

Product safety or quality failures, actual or perceived, or allegations of product contamination, even when false or unfounded, or inclusion of regulated ingredients could tarnish the image of our brands and could cause consumers to choose other products. Allegations of contamination, allergens or other adverse effects on product safety or suitability for use by a particular consumer, even if untrue, may require us from time to time to recall a product from all of the markets in which the affected production was distributed. Such issues or recalls and any related litigation could negatively affect our profitability and brand image.

In addition, government authorities and self-regulatory bodies regulate advertising and product claims regarding the performance and benefits of our products. These regulatory authorities typically require a reasonable basis to support any marketing claims. What constitutes a reasonable basis for substantiation can vary widely based on geography, and the efforts

that we undertake to support our claims may not be deemed adequate for any particular product or claim. If we are unable to show adequate substantiation for our product claims, or our promotional materials make claims that exceed the scope of allowed claims for the classification of the specific product, regulatory authorities could take enforcement action or impose penalties, such as monetary consumer redress, requiring us to revise our marketing materials, amend our claims or stop selling or recalling certain products, all of which could harm our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities. Any regulatory action or penalty could lead to private party actions, which could further harm our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

If our products are perceived to be defective or unsafe, or if they otherwise fail to meet our consumers’ expectations, our relationships with customers or consumers could suffer, the appeal of one or more of our brands could be diminished, and we could lose sales or become subject to liability claims. In addition, safety or other defects in our competitors’ products could reduce consumer demand for our own products if consumers view them to be similar or view the defects as symptomatic of the product category. Any of these outcomes could result in a material adverse effect on our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

If we underestimate or overestimate demand for our products and do not maintain appropriate inventory levels, our net revenues or working capital could be negatively impacted.

We currently engage in a program seeking to improve control over our product demand and inventories. We have identified, and may continue to identify, inventories that are not saleable in the ordinary course, but our existing program or any future inventory management program may not be successful in improving our inventory control. Our ability to manage our inventory levels to meet demand for our products is important for our business. If we overestimate or underestimate demand for any of our products, we may not maintain appropriate inventory levels, we could have excess inventory that we may need to hold for a long period of time, write down, sell at prices lower than expected or discard, which could negatively impact our reputation, net sales, working capital or cash flows from working capital, or cause us to incur excess and obsolete inventory charges. We also could have inadequate inventories which could hinder our ability to meet demand. We have sought and continue to seek to improve our payable terms, which could adversely affect our relations with our suppliers.

In addition, we have significant working capital needs, as the nature of our business requires us to maintain inventories that enable us to fulfill customer demand. We generally finance our working capital needs through cash flows from operations and borrowings under our credit facilities. If we are unable to finance our working capital needs on the same or more favorable terms going forward, or if our working capital requirements increase and we are unable to finance the increase, we may not be able to produce the inventories required by demand, which could result in a loss of sales. In addition, we are reliant on our cash flows from operations to repay our indebtedness, which may impact the cash flows that are available for working capital needs. Our ability to generate and maintain sufficient cash levels also could impact our ability to reduce our indebtedness.

Changes in laws, regulations and policies that affect our business or products could adversely affect our business, financial condition, results of operations, cash flows, as well as the trading price of our securities.

Our business is subject to numerous laws, regulations and policies. Changes in the laws (both foreign and domestic), regulations and policies, including the interpretation or enforcement thereof, that affect, or will affect, our business or products, including those related to taxes, tariffs, corruption, the environment or climate change, immigration, privacy, restrictions or requirements related to product content, labeling and packaging, trade and customs (including, among others, import and export license requirements, sanctions, boycotts, quotas, trade barriers, and other measures imposed by U.S. and foreign countries), restrictions on foreign investment, the outcome and expense of legal or regulatory proceedings, and any action we may take as a result, and changes in accounting standards, could adversely affect our financial results as well as the trading price of our securities. For example, changes in sanctions against Iran have adversely impacted our net revenues and prohibit us from conducting business in Iran. Also, the Tax Act, enacted in 2017, introduced broad and complex changes to the U.S. tax laws that affect businesses operating internationally, and future regulatory, administrative or legislative guidance could adversely affect our financial results. See “—We are subject to risks related to our international operations”, “—Network marketing is subject to intense government scrutiny, and regulation and changes in the law, or the interpretation and enforcement of the law, might adversely affect our business” and “—We face risks associated with our independent contractors.”

We are also subject to legal proceedings and legal compliance risks in connection with legacy matters related to recently acquired companies that were previously outside our control. Such matters may result in our incurring unanticipated costs that may negatively impact the financial contributions of such acquisitions at least in the periods in which such liability is incurred or require operational adjustments that affect our results of operations with respect to such investments. We may not have adequate or any insurance coverage for some of these legacy matters, including matters assumed in the acquisition of the P&G Beauty Business, Younique, ghd, the Hypermarcas Brands and the Burberry fragrance business. While we believe that we have adopted, and will adopt, appropriate risk management and compliance programs, the global nature of our operations and many laws and regulations to which we are subject mean that legal and compliance risks will continue to exist with respect to our

business, and additional legal proceedings and other contingencies, the outcome of which cannot be predicted with certainty, will arise from time to time, which could adversely affect our business, prospects, financial condition, results of operations and cash flows, as well as the trading price of our securities.

Network marketing is subject to intense government scrutiny, and regulation and changes in the law, or the interpretation and enforcement of the law, might adversely affect our business.

On February 1, 2017, we entered into a joint venture with the founders of Younique, a leading online peer-to-peer social selling platform in beauty. We are now subject to a number of federal and state regulations administered by the Federal Trade Commission (the “FTC”) and various federal and state agencies in the United States related to Younique’s network marketing program, as well as regulations on direct selling in foreign countries administered by foreign agencies. We are subject to the risk that, in one or more countries, Younique’s network marketing program could be found by federal, state or foreign regulators not to be in compliance with applicable law or regulations which could result in significant fines, changes in business practices or a permanent injunction.

Regulations applicable to network marketing organizations generally are directed at preventing fraudulent or deceptive schemes, often referred to as “pyramid” or “chain sales” schemes, by ensuring that product sales ultimately are made to consumers and that advancement within an organization is based on sales of the organization’s products rather than investments in the organization or other non-retail sales-related criteria. The regulatory requirements concerning network marketing programs do not include “bright line” rules and are inherently fact-based and, thus, we are subject to the risk that these laws or regulations or the enforcement or interpretation of these laws and regulations by governmental agencies or courts can change and business practices can evolve. The FTC or other federal, state or foreign courts or agencies may not consider us to be in compliance.

The ambiguity surrounding these laws can also affect the public perception of us. The failure of the network marketing program to comply with current or newly adopted regulations or any allegations or charges to that effect brought by federal, state, or foreign regulators could negatively impact our brands and business in a particular market or in general and may adversely affect our share price.

We are also subject to the risk of private party challenges to the legality of the network marketing program. Some network marketing programs of other companies have been successfully challenged in the past. Adverse judicial determinations with respect to the network marketing program, or in proceedings not involving us directly but that challenge the legality of network marketing systems, in any other market in which we operate, could increase costs to the extent we are obligated to contribute to the cost of defense and could negatively impact our business, prospects, financial condition, results of operations and cash flows, as well as the trading price of our securities.

Our employees or others may engage in misconduct or other improper activities including noncompliance with regulatory standards and regulatory requirements.

We are exposed to the risk of fraud or other misconduct by our personnel or third parties such as independent contractors or agents. Misconduct by employees, independent contractors, or agents could include inadvertent or intentional failures to comply with the laws and regulations to which we are subject or with our policies, provide accurate information to regulatory authorities, comply with ethical, social, product, labor and environmental standards, comply with fraud and abuse laws and regulations, report financial information or data accurately, or disclose unauthorized activities to us. In particular, our business is subject to laws, regulations and policies intended to prevent fraud, kickbacks, self-dealing, resale price maintenance and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs, and other business arrangements. Our current and former employees, influencers or independent contractors may also become subject to allegations of sexual harassment, racial and gender discrimination or other similar misconduct, which, regardless of the ultimate outcome, may result in adverse publicity that could significantly harm our company’s brand, reputation and operations. Employee misconduct could also involve improper use of information obtained in the course of the employee’s prior or current employment, which could result in legal or regulatory action and serious harm to our reputation.

Violations of our prohibition on harassment, sexual or otherwise, could result in liabilities and/or litigation.

We prohibit harassment or discrimination in the workplace, in sexual or in any other form. This policy applies to all aspects of employment. Notwithstanding our conducting training and taking disciplinary action against alleged violations, we may encounter additional costs from claims made and/or legal proceedings brought against us, and we could suffer reputational harm.

We face risks associated with our independent contractors.

We have personnel that we classify as independent contractors for U.S. federal and state and international employment law purposes in certain positions in our business. For example, Younique relies on independent presenters that it classifies as

independent contractors to sell its products through its peer-to-peer social selling platform and we are subject to risks related to Younique presenters’ status as independent contractors.

We are not in a position to directly provide the same direction, motivation and oversight to our independent contractors as we would if such personnel were our own employees. As a result, our independent contractors may not comply with applicable law or our policies and procedures or reflect our culture or values. Violations by our independent contractors of applicable law or of our policies and procedures in dealing with customers and other third parties or failure to meet our standards or reflect our culture could reflect negatively on our products and operations and harm our business reputation and also negatively impact our business, prospects, financial condition, results of operations and cash flows, as well as the trading price of our securities. In addition, it is possible that a court could hold us civilly or criminally accountable based on vicarious liability because of the actions of our independent contractors. In addition, our independent contractors are not subject to employment agreements with us and our ability to retain such personnel or enforce non-competes or other restrictions against them may be limited.

In addition, we are subject to the Internal Revenue Service regulations and applicable state law guidelines regarding independent contractor classification. These regulations and guidelines are subject to changes in judicial and agency interpretation, and it could be determined that the independent contractor classification is inapplicable. If legal standards for classification of independent contractors change, it may be necessary to modify our compensation structure for these personnel, including by paying additional compensation and taxes and/or reimbursing expenses. In addition, if we are determined to have misclassified such personnel as independent contractors, we would incur additional exposure under federal and state law, including workers' compensation, unemployment benefits, labor, employment and tort laws, including for prior periods, as well as potential liability for employee benefits and tax withholdings. Any of these outcomes could result in costs to us, could impair our financial condition and our ability to conduct our business and could damage our reputation and our ability to attract and retain other personnel.

We are subject to risks related to our common stock, our stock repurchase program and our Stock Dividend Reinvestment Program.

Any repurchases pursuant to our stock repurchase program, or a decision to discontinue our stock repurchase program, which may be discontinued at any time, could affect our stock price and increase volatility. In addition, the timing and actual number of any shares repurchased will depend on a variety of factors including the timing of open trading windows, price, corporate and regulatory requirements, an assessment by management and our board of directors of cash availability, capital allocation priorities, including deleveraging, and other market conditions.

Further, we allow pledging by our employees in connection with certain executive ownership programs. A drop in our share price could result in pledged shares being sold pursuant to the terms of the pledge, which could result in a decrease in the trading price of our stock and subject us and our executives to civil and criminal investigations, including with respect to insider trading.

Our Stock Dividend Reinvestment Program allows stockholders to elect to receive 50% of their dividend in cash and reinvest 50% of their dividend in newly issued shares of our common stock. As a result, stockholders who do not elect to participate in the Stock Dividend Reinvestment Program may experience dilution in their ownership percentage over time.

If the Distribution (as defined below) or the acquisition of the P&G Beauty Business does not qualify for its intended tax treatment, in certain circumstances we are required to indemnity P&G for resulting tax-related losses under the tax matters agreement entered into in connection with the acquisition of the P&G Beauty Business dated October 1, 2016 (the “Tax Matters Agreement”).

In connection with the closing of the acquisition of the P&G Beauty Business on October 1, 2016, we and P&G received written opinions from special tax counsel regarding the intended tax treatment of the merger, and The Procter & Gamble Company (“P&G”) received an additional written opinion from special tax counsel regarding the intended tax treatment of the distribution by P&G of its shares of Galleria Co. (“Galleria”) common stock to P&G shareholders by way of an exchange offer (the “Distribution”). The opinions were based on, among other things, certain assumptions and representations as to factual matters and certain covenants made by us, P&G, Galleria and Green Acquisition Sub Inc. The opinions are not binding on the Internal Revenue Service (“IRS”) or a court, and the IRS or a court may not agree with the opinions.

Under the Tax Matters Agreement, in certain circumstances and subject to certain limitations, we are required to indemnify P&G against tax-related losses (e.g., increased taxes, penalties and interest required to be paid by P&G) if the Distribution or the merger fails to qualify for its intended tax treatment, including if the Distribution becomes taxable to P&G as a result of the acquisition of a 50% or greater interest (by vote or value) in us as part of a plan or series of related transactions that included the Distribution or if such failure is attributable to a breach of certain representations and warranties by us or certain actions or omissions by us. If we are required to indemnify P&G in the event of a taxable Distribution, this indemnification obligation would be substantial and could have a material adverse effect on us, including with respect to our financial condition and results of operations.

JAB Cosmetics B.V. (“JABC”) and its affiliates beneficially own approximately 60% of the fully diluted shares of our Class A Common Stock and, as such, have the ability to effect certain decisions requiring stockholder approval, which may be inconsistent with the interests of our other stockholders.

As a result of the completion of the Cottage Tender Offer in May 2019, JABC, through an affiliate, Cottage Holdco B.V., owns approximately 60% of the outstanding shares of our Class A Common Stock. As a result, JABC has the ability to exercise control over certain decisions requiring stockholder approval, including the election of directors, amendments to our certificate of incorporation and approval of significant corporate transactions, such as a merger or other sale of the Company or our assets. In addition, several of the members of our Board of Directors are affiliated with JABC. Accordingly, JAB has significant influence over us and our decisions, including the appointment of management and any other action requiring a vote of our Board of Directors. In addition, this concentration of ownership may have the effect of delaying, preventing or deterring a change in control of us and may negatively affect the market price of our stock.

JABC’s interests may be different from or conflict with our interests or the interests of our other stockholders. JABC and its affiliates are in the business of making investments in companies and may from time to time acquire and hold interests in businesses that compete indirectly with us. JABC or its affiliates may also pursue acquisition opportunities that are complementary to our business, and, as a result, those acquisition opportunities may not be available to us. In addition, JABC’s obligations under its credit facility may cause JABC to take actions which may be inconsistent with your interests. Accordingly, the interests of JABC may not always coincide with our interests or the interests of other stockholders, and JABC may seek to cause us to take courses of action that, in its judgment, could enhance its investment in the Company but which might involve risks to our other stockholders or adversely affect us or our other stockholders.

An affiliate of JABC has pledged all of its beneficially owned Class A Common Stock as a security interest for a credit facility which, in certain circumstances, may result in sales of our shares into the open market, depressing the trading price of our shares of Class A Common Stock.

All shares of Class A Common Stock beneficially owned by JABC are held by its affiliate, Cottage Holdco B.V., whose obligations under its credit facility are secured by a pledge of all such shares for the benefit of its lenders. Cottage Holdco B.V. was newly-created to consummate the Offer and does not have any material assets other than its holdings of our shares of Class A Common Stock and any dividends paid on such shares. It is only Cottage Holdco B.V., and not any of its affiliates, that is an obligor under the credit facility, which is secured by substantially all of the assets of Cottage Holdco B.V. (including the shares of our Class A Common Stock that it owns), subject to customary exceptions. The credit facility contains a maximum loan-to-value ratio which is designed to assure the lenders under the facility that the value of the collateral significantly exceeds the outstanding amount of the loan. If the trading price of our shares of Class A Common Stock drops significantly, Cottage Holdco B.V. may elect to sell its shares of our Class A Common Stock into the open market until such time as it has received proceeds sufficient to prepay the loan and comply with the required loan-to-value ratio. Alternatively, JABC may, but is not required to, contribute additional equity to Cottage Holdco B.V., which would be used to prepay the loan and satisfy the ratio. Any sales by Cottage Holdco B.V. of our shares may themselves have a depressive effect on the trading price of our shares, which may, in turn, require additional selling to maintain the required loan-to-value ratio. Our shares may not trade at a price sufficient to prevent such sales. Any such sales by Cottage Holdco B.V. may have a material adverse effect on the trading price of our shares and the existence of this financing arrangement may itself have an adverse effect on the trading price of our shares.

We are a “controlled company” within the meaning of the New York Stock Exchange rules and, as a result, are entitled to rely on exemptions from certain corporate governance requirements that are designed to provide protection to stockholders of companies that are not “controlled companies”.

Because JABC and its affiliates own more than 50% of the total voting power of our common shares, we are a “controlled company” within the meaning of the New York Stock Exchange (“NYSE”) corporate governance standards. As a controlled company, we are exempt under the NYSE standards from the obligation to comply with certain NYSE corporate governance requirements, including the requirements:


•	that a majority of our board of directors consists of independent directors;


•	that we have a nominating committee that is composed entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and


•	that we have a compensation committee that is composed entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities.

As a result of relying on the controlled company exemptions, the procedures for approving significant corporate decisions could be determined by directors who have a direct or indirect interest in such decisions, and our stockholders do not have the

same protections afforded to stockholders of other companies that are required to comply with all of the independence rules of the NYSE.

Item 1B. Unresolved Staff Comments.

None.

Item 2. Properties.

We occupy numerous offices, manufacturing, distribution and research and development facilities in the U.S. and abroad. Our principal executive offices are located in New York, U.S. and our division corporate headquarters are located in New York for Consumer Beauty, Paris, France for Luxury and Geneva, Switzerland for Professional Beauty.

We consider our properties to be generally in good condition and believe that our facilities are adequate for our operations and provide sufficient capacity to meet anticipated requirements. The following table sets forth our principal owned and leased corporate, manufacturing and research and development facilities as of June 30, 2019. The leases expire at various times subject to certain renewal options at our option.




Location/Facility	Use	Segment
London, England (leased)	Corporate/Commercial	Corporate
New York, New York, U.S. (leased)	Corporate/Commercial	Corporate / Consumer Beauty
Paris, France (3 locations) (leased)	Corporate/Commercial	Corporate / Luxury
Geneva, Switzerland (2 locations) (leased)	Corporate/Commercial/R&D	Corporate / Professional Beauty
Ashford, England (land leased, building owned)	Manufacturing	Consumer Beauty
Bangkok, Thailand (owned)	Manufacturing	Professional Beauty
Capella, Russia (owned)	Manufacturing	Consumer Beauty
Chartres, France (owned)	Manufacturing	Luxury
Cologne, Germany (owned)	Manufacturing	Luxury
Granollers, Spain (owned)	Manufacturing	Luxury
Hunt Valley, U.S. (owned)	Manufacturing	Consumer Beauty
Mariscala, Mexico (owned)	Manufacturing	Professional Beauty
Monaco, Monaco (leased)	Manufacturing	Luxury
Rothenkirchen, Germany (owned)	Manufacturing	Professional Beauty
Sanford, North Carolina, U.S. (owned)	Manufacturing	Luxury
Senador Canedo, Brazil (owned)	Manufacturing	Consumer Beauty
Wujiang, China (owned)	Manufacturing	Consumer Beauty
Morris Plains, New Jersey, U.S. (leased)	R&D	All segments

Item 3. Legal Proceedings.

We are involved, from time to time, in various litigation and administrative and other legal proceedings, including regulatory actions, incidental or related to our business, including consumer class or collective actions, personal injury (including asbestos-related claims), intellectual property, competition, non-compete, compliance and advertising claims litigation and disputes, among others (collectively, “Legal Proceedings”). While we cannot predict any final outcomes relating thereto, management believes that the outcome of current Legal Proceedings will not have a material effect upon our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities. However, management’s assessment of our Legal Proceedings is ongoing, and could change in light of the discovery of additional facts with respect to Legal Proceedings pending against us not presently known to us or determinations by judges, arbitrators, juries or other finders of fact or deciders of law which are not in accord with management’s evaluation of the probable liability or outcome of such Legal Proceedings. From time to time, we are in discussions with regulators, including discussions initiated by us, about actual or potential violations of law in order to remediate or mitigate associated legal or compliance risks. As the outcomes of such proceedings are unpredictable, we can give no assurance that the results of any such proceedings will not materially affect our reputation, our business, prospects, financial condition, results of operations, cash flows or the trading price of our securities.

Certain Litigation. Two purported stockholder class action complaints concerning the Cottage Tender Offer and the Schedule 14D-9 were filed by putative stockholders against the Company and the directors of the Company in the U.S. District Court for the District of Delaware, but have not yet been served. In both complaints, the plaintiffs allege that the Company’s Schedule 14D-9 omits certain information, including, among other things, certain financial data and certain analyses underlying the opinion of Centerview Partners LLC. Plaintiffs assert claims under the federal securities laws and seek, among other things, injunctive and/or monetary relief.

A third consolidated purported stockholder class action and derivative complaint concerning the Cottage Tender Offer and the Schedule 14D-9 is pending against the directors of the Company, JAB Holding Company, S.à.r.l., JAB Cosmetics B.V., and Cottage Holdco B.V. in the Court of Chancery of the State of Delaware. The Company was named as a nominal defendant. The case, which was filed on May 6, 2019, was captioned Massachusetts Laborers’ Pension Fund, on behalf of itself and all similarly situated holders of Coty Inc., v. Peter Harf, Pierre Laubies, Sabine Chalmers, Joachim Faber, Olivier Goudet, Anna-Lena Kamenetzky, Erhard Schoewel, Robert Singer, Paul S. Michaels, JAB Holding Company, S.à.r.l., JAB Cosmetics B.V., and Cottage Holdco B.V., Case No. 2019-0336-CB (“Massachusetts Laborers”). On June 14, 2019, plaintiffs in the consolidated action filed a Verified Amended Class Action and Derivative Complaint (“Amended Complaint”), alleging that the directors and JAB Holding Company, S.à.r.l., JAB Cosmetics B.V., and Cottage Holdco B.V. breached their fiduciary duties to the Company’s stockholders and breached the Stockholders Agreement. The Amended Complaint sought, among other things, monetary relief. The defendants responded to the Amended Complaint on August 22, 2019.

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Common Stock

Our common stock is listed on the New York Stock Exchange under the symbol “COTY.”

Stockholders of Record

As of June 30, 2019 there were 897 stockholders of record of our Class A Common Stock. The actual number of stockholders is greater than this number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.

Dividend Policy

We have paid an annual dividend since fiscal 2011, and we began paying a quarterly dividend in fiscal 2017. Subject to legally available funds, we expect to continue to pay a quarterly cash dividend on our Class A Common Stock, but there can be no assurance that our Board of Directors (“Board”) will continue to declare dividends or that any dividends will be paid in the anticipated amounts and frequency, or at all. On May 8, 2019, the Board approved a stock dividend reinvestment program giving stockholders the option to receive their full dividend in cash or to receive their dividend in 50% cash / 50% common stock. The election was made available to stockholders beginning with the dividend declared on May 8, 2019, and stockholders will be able to make this election on a quarterly basis.

Our controlling shareholder, Cottage Holdco B.V. (“Cottage”), a wholly-owned subsidiary of JAB Cosmetics B.V. (“JABC”) and JAB, owns 60% of Coty and stated its intention to participate in the dividend reinvestment program until Coty reaches its leverage target of 4x.

Furthermore, we are required to comply with certain covenants contained within the agreements that govern our indebtedness, including our credit agreements and the indenture relating to our senior unsecured notes. These agreements contain customary representations and warranties as well as customary affirmative and negative covenants, including but not limited to, restrictions on incurrence of additional debt, liens, dividends and other restricted payments, asset sales, investments, mergers, acquisitions and affiliate transactions. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Financial Condition—Liquidity and Capital Resources—Debt” and Note 14—“Debt” in the notes to our Consolidated Financial Statements.

Market Performance Graph

Comparison of 5 Year Cumulative Total Return ^(a)

Coty Inc., The S&P 500 Index, and Fiscal 2019 Peer Group ^(b)

^(a)Total return assumes reinvestment of dividends at the closing price at the end of each quarter, since June 30, 2014.

^(b)The Peer Group includes L'Oréal S.A., Avon Products, Inc., Estee Lauder Companies, Inc., Revlon, Inc., Shiseido Company, Limited and Inter Parfums Inc.

The Market Performance Graph above assumes a $100.00 investment on June 30, 2014, in Coty Inc.’s common stock, the S&P 500 Index and the Peer Group. The dollar amounts indicated in the graph above are as of the last trading day in the quarter. The returns of each company in the Peer Group have been weighted according to their respective stock market capitalization at the beginning of each measurement period for purposes of arriving at a Peer Group average.

Equity Compensation Plan Information



Plan Category
Plan Category	(1) Number of securities to be issued upon exercise of outstanding options, warrants and rights	Weighted-average exercise price of outstanding options, warrants and rights		Number of securities remaining available for future issuance under equity compensation plans^(f⁾ (excluding securities reflected in column(1))
Equity compensation plans approved by security holders
Options^(a)	27,852,799	$	12.89
Series A and A-1 Preferred Stock ^(b)	8,400,415	10.17
Restricted Stock Units	10,519,148	N/A
Subtotal	46,772,362	—		29,254,407
Equity compensation plans not approved by security holders
Options ^(c)	16,975	$	10.50	—
Series A Preferred Stock ^(b)(d)	1,000,000	22.39
Phantom Units ^(e)	349,432	N/A
Subtotal	1,366,407	—		—
Total	48,138,769			29,254,407

N/A is not applicable

^(a)For information about options, see Note 23, “Share-Based Compensation Plans” in the notes to our Consolidated Financial Statements.

^(b)Upon vesting of the Series A and Series A-1 Preferred Stock, the recipient receives, in cash or shares, at our sole election, the fair market value of our Class A Common Stock on the vest date of the Series A or Series A-1 Preferred Stock less the sum of the fair market value of our Class A Common Stock on the original issue date of the Series A or Series A-1 Preferred Stock and a hurdle price specified in the recipient’s subscription agreement. As such, the benefit provided under the Series A or Series A-1 Preferred Stock will always be based solely on the increase in value of our Class A Common Stock after the date of grant and the Series A or Series A-1 Preferred Stock will not have any value to the participant until the value of our Class A Common Stock exceeds the value of such shares on the date of grant plus the specified hurdle.

^(c)Executive Ownership Plan. From fiscal 2008 until December 2012, we invited certain key executives to participate in our Executive Ownership Plan by purchasing shares of our common stock and receiving stock options to match such purchases. The Executive Ownership Plan was replaced by the Platinum Program in December 2012. All matching stock options have five-year cliff vesting tied to continued employment with us and continued ownership of the restricted shares that the matching stock options match.

^(d) On March 27, 2017, the Board approved an award of 1,000,000 shares of Series A Preferred Stock, par value $0.01 per share, to Lambertus J.H. Becht in his capacity as a non-employee director to compensate him for services performed in connection with closing the P&G Beauty Business transaction, aiding with the transition of the new chief executive officer into his role and integrating the P&G Beauty Business.

^(e) On December 1, 2014, the Board granted Lambertus J.H. Becht an award of 49,432 phantom units (the “December Grant”). On July 21, 2015, the Board granted to Mr. Becht an award of 300,000 phantom units (the “July Grant”). Both the December Grant and July Grant to Mr. Becht were outside of the Company’s Equity and Long-Term Incentive Plan. At the time of December Grant, the phantom units had a value of $1,000,009 based on the closing price of the Company’s Class A Common Stock on December 1, 2014, and at the time of the July Grant, the phantom units had a value of approximately $8,106,000 based on the closing price of the Class A Common Stock on July 21, 2015. Each phantom unit has an economic value equivalent to one share of the Company’s Class A Common Stock. The phantom units vest on the fifth anniversary of the grant date and, in the event of a change in control or Mr. Becht’s death or disability, the phantom units shall vest immediately. Within 30 days of the grant date, Mr. Becht had the ability to elect whether to receive payment in respect of the phantom units in cash or shares of Class A Common Stock. Mr. Becht elected to receive payment in respect of the December Grant and the July Grant in shares of Class A Common Stock.

^(f)Reflects number of securities remaining available for future issuance under equity compensation plans, excluding share reserves related to terminated equity plans.

Issuer Purchases of Equity Securities

No shares of Class A Common Stock were repurchased during the fiscal quarter ended June 30, 2019.

Item 6. Selected Financial Data.



(in millions, except per share data)	Year Ended June 30,
(in millions, except per share data)	2019^(a)			2018^(b)(f)			2017 ^(c)(f)			2016 ^(d)			2015 ^(d)
Consolidated Statements of Operations Data:
Net revenues	$	8,648.5		$	9,398.0		$	7,650.3		$	4,349.1		$	4,395.2
Gross profit	5,342.0			5,790.2			4,622.0			2,603.1			2,638.2
Restructuring costs	44.2			173.2			374.8			86.9			75.4
Acquisition-related costs	—			64.2			355.4			174.0			34.1
Asset impairment charges	3,851.9			—			—			5.5			—
Operating (loss) income	(3,471.5		)	153.3			(420.9		)	254.2			395.1
Interest expense, net	275.7			265.0			218.6			81.9			73.0
Loss on early extinguishment of debt	—			10.7			—			3.1			88.8
Other expense, net	30.9			30.1			18.5			30.4			—
(Loss) income before income taxes	(3,778.1		)	(152.5		)	(658.0		)	138.8			233.3
(Benefit) provision for income taxes	(8.5		)	(24.7		)	(259.5		)	(40.4		)	(26.1		)
Net (loss) income	(3,769.6		)	(127.8		)	(398.5		)	179.2			259.4
Net income attributable to noncontrolling interests	2.5			2.0			15.4			7.6			15.1
Net income attributable to redeemable noncontrolling interests	12.1			39.0			8.3			14.7			11.8
Net (loss) income attributable to Coty Inc.	$	(3,784.2	)	$	(168.8	)	$	(422.2	)	$	156.9		$	232.5
Per Share Data:
Weighted-average common shares
Basic	751.2			749.7			642.8			345.5			353.3
Diluted	751.2			749.7			642.8			354.2			362.9
Dividends declared per common share	$	0.50		$	0.50		$	0.65		$	0.25		$	0.20
Net (loss) income attributable to Coty Inc. per common share:
Basic	$	(5.04	)	$	(0.23	)	$	(0.66	)	$	0.45		$	0.66
Diluted	(5.04		)	(0.23		)	(0.66		)	0.44			0.64



(in millions)	Year Ended June 30,
(in millions)	2019^(a)			2018^(b)			2017 ^(c)			2016 ^(d)			2015 ^(d)
Consolidated Cash Flows Data:
Net cash provided by operating activities	$	639.6		$	413.7		$	757.5		$	501.4		$	526.3
Net cash (used in) investing activities	(454.0		)	(687.6		)	(1,163.6		)	(1,059.2		)	(171.2		)
Net cash (used in) provided by financing activities	(160.3		)	69.3			595.2			592.6			(1,138.2		)



(in millions)	As of June 30,
(in millions)	2019^(a)		2018^(b)		2017 ^(c)		2016 ^(d)		2015 ^(d)
Consolidated Balance Sheet Data:
Cash and cash equivalents	$	340.4	$	331.6	$	535.4	$	372.4	$	341.3
Total assets^(e)	17,665.4		22,630.2		22,548.2		7,035.6		5,998.0
Total debt, net of discount	7,735.0		7,610.5		7,205.0		4,162.8		2,634.7
Total Coty Inc. stockholders’ equity	4,586.9		8,849.7		9,314.7		360.2		969.8


^(a)	In fiscal 2019, we adopted, on a modified retrospective basis as of July 1, 2018, authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for ASC 606, Revenue from Contracts with Customers and ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory.


^(b)	Included in fiscal 2018 are the financial impacts of the acquisition of the Burberry Beauty Business as of October 2, 2017.


^(c)	Included in fiscal 2017 are the financial impacts of the acquisitions of the P&G Beauty Business as of October 1, 2016, ghd as of November 21, 2016 and Younique as of February 1, 2017.


^(d)	Included in fiscal 2016 and 2015 are the financial impacts of the Hypermarcas Brands as of February 1, 2016 and the Bourjois acquisition as of April 1, 2015.

^(e)

In fiscal 2017, we adopted authoritative guidance issued by the FASB requiring that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability, consistent with debt discounts. Prior to the adoption of this guidance, debt issuance costs were presented within total assets in the Consolidated Balance Sheets. Total assets for all periods presented in the table above have been conformed to the current balance sheet presentation.

^(f)

In fiscal 2019, we adopted authoritative guidance issued by the FASB requiring employers to report the service cost component of net periodic benefit cost in the same line item or items as other compensation costs arising from services rendered by the underlying employees during the period. The other components of net periodic benefit cost are required to be reported separately and outside of operating income. In addition, only the service cost component would be eligible for capitalization in assets. The impacts of the adoption of this standard were retrospectively applied to fiscal years 2018 and 2017 presented in the table above.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of the financial condition and results of operations of Coty Inc. and its consolidated subsidiaries, should be read in conjunction with the information contained in the Consolidated Financial Statements and related notes included elsewhere in this document. When used in this discussion, the terms “Coty,” the “Company,” “we,” “our,” or “us” mean, unless the context otherwise indicates, Coty Inc. and its majority and wholly-owned subsidiaries. The following discussion contains forward-looking statements. See “Forward-Looking Statements” and “Risk Factors” for a discussion on the uncertainties, risks and assumptions associated with these statements as well as any updates to such discussion as may be included in subsequent reports we file with the SEC. Actual results may differ materially and adversely from those contained in any forward-looking statements. The following discussion includes certain non-GAAP financial measures. See “Overview—Non-GAAP Financial Measures” for a discussion of non-GAAP financial measures and how they are calculated.

All dollar amounts in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated.

OVERVIEW

We are a global beauty company. We manufacture, market, sell and distribute branded beauty products, including fragrances, color cosmetics, hair care products and skin & body related products throughout the world.

Operating and Reportable Segments

Our business is organized into three divisions: Luxury, Consumer Beauty and Professional Beauty, and our operating and reportable segments reflect this divisional structure. Certain shared costs and the results of corporate initiatives are managed outside of our three segments by Corporate.

Our organizational structure is product category focused, putting the consumer first, by specifically targeting how and where they shop and what and why they purchase. Each division has full end-to-end responsibility to optimize the consumers’ beauty experiences in their relevant categories and channels in this new organizational design and translate this into profitable growth.

The operating and reportable segments are:

Luxury — primarily focused on prestige fragrances, premium skin care and premium cosmetics;

Consumer Beauty — primarily focused on color cosmetics, retail hair coloring and styling products, mass fragrance, mass skin care and body care;

Professional Beauty — primarily focused on hair and nail care products for professionals.

Geographic Structure

We have determined our geographic regions to be North America (Canada and the U.S.), Europe and ALMEA (Asia, Latin America, the Middle East, Africa and Australia).

Overview

We are one of the world’s largest beauty companies, with an iconic portfolio of brands across fragrance, color cosmetics, hair color and styling, and skin and body care. We are the global leader in fragrance, a strong number two in professional hair color & styling, and number three in color cosmetics. The transformational acquisition of the P&G Beauty Business and our other strategic transactions have strengthened and diversified our presence across the countries, categories and channels in which we compete, building a strong beauty platform. Our products are sold in more than 150 countries around the world.

Certain product categories and geographies in which we compete continue to grow moderately. This includes mid single digit growth in the luxury fragrance category and low single digit decline in the mass beauty category driven by declines in North America and Europe. Additionally, in certain categories, our revenues are declining faster than the category which continue to negatively impact our business and financial results.

The economics of developing, producing, launching, supporting and discontinuing products impact the timing of our sales and operating performance each period. In addition, as product life cycles shorten, results are driven primarily by successfully developing, introducing and marketing new, innovative products.

Fiscal 2019 results

Despite strong consumer demand and innovation in the Luxury and Professional Beauty divisions, results in fiscal 2019 reflected the impact of supply chain disruptions on all divisions, arising from our supply chain footprint transformation (the “Supply Chain Disruptions”). The deterioration in Consumer Beauty’s results were further impacted by the continued weakness in U.S. and Europe mass beauty categories, and the continued impact from distribution losses, primarily in the U.S. We have resolved the supply chain issues, and they had minimal impact on our results during the fourth quarter of fiscal 2019.

Fiscal 2019 milestones and Turnaround Plan

Our top priority is taking the necessary steps to stabilize our consumer business and build lasting and sustainable performance at Coty. In fiscal 2019, we completed the last steps of the complex integration of the P&G Beauty Business, including our one order, one invoice, one shipment integration program which enables us to sell, ship and invoice our brands in a more efficient way for our customers. We also completed the transformation of our supply chain footprint.

Under the direction of our new senior leadership, we undertook a broad review of our business to develop a strategic framework to position us for sustainable performance and long-term success, and in July 2019, we announced a multi-year Turnaround Plan that aims to stabilize and gradually accelerate revenue growth, improve our profitability through gross margin growth and cost control, and deleverage our balance sheet. The priorities of the Turnaround Plan are threefold: to rediscover growth, to regain operational leadership and to build a culture of pride and performance.

In connection with the Turnaround Plan, we announced organizational changes intended to align our costs with our revenue realities, simplify decision making and enable our teams in the markets to act with closer guidance and with greater speed. We expect to move from the current organizational structure into regional commercial business units for Luxury and Consumer Beauty, as well as create new regions: Americas, Asia Pacific and EMEA. Such regional business units will be supported by central Luxury and Consumer Beauty marketing teams. Professional Beauty is expected to remain a distinct business unit due to its unique salon channel focus. Our commercial front line – the local sales and marketing teams facing our customers and building our brands locally – will see little impact and will remain specialized in their respective products and sales channels. In order to reduce geographic fragmentation and costs, the reorganization includes the co-location of most of our executive team and corporate functions in a centralized management headquarters in Amsterdam.

The reorganization is accompanied by strategies to drive substantial improvement in our Consumer Beauty business while also further optimizing our Luxury and Professional Beauty businesses. We aim to achieve this by focusing our investments in fewer brands and markets, increasing shelf productivity through improved assortment, improving mix management, and developing a stronger and margin-accretive innovation pipeline. In order to fuel both increased investment in the business (including targeted advertising and consumer promotion spend and disciplined research and development investments) as well as improved profitability, we are working to lower our cost of goods sold through improved productivity in our existing manufacturing footprint, simplifying our product range, and lowering fixed costs through a simplified organizational structure. We are also focused on increasing our cash flow and reducing our indebtedness.

To implement the Turnaround Plan, we expect to incur one-time cash costs of approximately $600 million spread over fiscal years 2020 through to 2023, in addition to approximately $160 million connected to previous programs.

Outlook

For fiscal year 2020, we expect to moderate the decline in our net revenues and target moderate improvements in cash flow and operating income, underpinned by our efforts to lower costs and improve operational execution. By fiscal year 2023, we are targeting moderate net revenue growth, significant expansion in operating income and operating margin and improvements in cash flow.

Non-GAAP Financial Measures

To supplement the financial measures prepared in accordance with GAAP, we use non-GAAP financial measures including Adjusted operating income, Adjusted net income attributable to Coty Inc. and Adjusted net income attributable to Coty Inc. per common share (collectively, the “Adjusted Performance Measures”). The reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in tables below. These non-GAAP financial measures should not be considered in isolation from, or as a substitute for or superior to, financial measures reported in accordance with GAAP. Moreover, these non-GAAP financial measures have limitations in that they do not reflect all the items associated with the operations of the business as determined in accordance with GAAP. Other companies, including companies in the beauty industry, may calculate similarly titled non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.

Despite the limitations of these non-GAAP financial measures, our management uses the Adjusted Performance Measures as key metrics in the evaluation of our performance and annual budgets and to benchmark performance of our business against our competitors. The following are examples of how these Adjusted Performance Measures are utilized by our management:


•	strategic plans and annual budgets are prepared using the Adjusted Performance Measures;


•	senior management receives a monthly analysis comparing budget to actual operating results that is prepared using the Adjusted Performance Measures; and


•	senior management’s annual compensation is calculated, in part, by using the Adjusted Performance Measures.

In addition, our financial covenant compliance calculations under our debt agreements are substantially derived from these Adjusted Performance Measures.

Our management believes that Adjusted Performance Measures are useful to investors in their assessment of our operating performance and the valuation of the Company. In addition, these non-GAAP financial measures address questions we routinely receive from analysts and investors and, in order to ensure that all investors have access to the same data, our management has determined that it is appropriate to make this data available to all investors. The Adjusted Performance Measures exclude the impact of certain items (as further described below) and provide supplemental information regarding our operating performance. By disclosing these non-GAAP financial measures, our management intends to provide investors with a supplemental comparison of our operating results and trends for the periods presented. Our management believes these measures are also useful to investors as such measures allow investors to evaluate our performance using the same metrics that our management uses to evaluate past performance and prospects for future performance. We provide disclosure of the effects of these non-GAAP financial measures by presenting the corresponding measure prepared in conformity with GAAP in our financial statements, and by providing a reconciliation to the corresponding GAAP measure so that investors may understand the adjustments made in arriving at the non-GAAP financial measures and use the information to perform their own analyses.

Adjusted operating income excludes restructuring costs and business structure realignment programs, amortization, acquisition-related costs and acquisition accounting impacts, asset impairment charges and other adjustments as described below. We do not consider these items to be reflective of our core operating performance due to the variability of such items from period-to-period in terms of size, nature and significance. They are primarily incurred to realign our operating structure and integrate new acquisitions, and fluctuate based on specific facts and circumstances. Additionally, Adjusted net income attributable to Coty Inc. and Adjusted net income attributable to Coty Inc. per common share are adjusted for certain interest and other (income) expense as described below and the related tax effects of each of the items used to derive Adjusted net income as such charges are not used by our management in assessing our operating performance period-to-period.

Adjusted Performance Measures reflect adjustments based on the following items:

•

Costs related to acquisition activities: We have excluded acquisition-related costs and acquisition accounting impacts such as those related to transaction costs and costs associated with the revaluation of acquired inventory in connection with business combinations because these costs are unique to each transaction. The nature and amount of such costs vary significantly based on the size and timing of the acquisitions and the maturities of the businesses being acquired. Also, the size, complexity and/or volume of past acquisitions, which often drives the magnitude of such expenses, may not be indicative of the size, complexity and/or volume of any future acquisitions.

•

Restructuring and other business realignment costs: We have excluded costs associated with restructuring and business structure realignment programs to allow for comparable financial results to historical operations and forward-looking guidance. In addition, the nature and amount of such charges vary significantly based on the size and timing of the programs. By excluding the referenced expenses from our non-GAAP financial measures, our management is able to further evaluate our ability to utilize existing assets and estimate their long-term value. Furthermore, our management believes that the adjustment of these items supplement the GAAP information with a measure that can be used to assess the sustainability of our operating performance.

•

Amortization expense: We have excluded the impact of amortization of finite-lived intangible assets, as such non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Our management believes that the adjustment of these items supplement the GAAP information with a measure that can be used to assess the sustainability of our operating performance. Although we exclude amortization of intangible assets from our non-GAAP expenses, our management believes that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in the amortization of additional intangible assets.


•	Asset impairment charges: We have excluded the impact of asset impairments as such non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Our management believes that the adjustment of these items supplement the GAAP information with a measure that can be used to assess the sustainability of our operating performance.

•

Loss/(Gain) on sale of brand assets: We have excluded the impact of Loss/(gain) on sale of brand assets as such amounts are inconsistent in amount and frequency and are significantly impacted by the size of divestitures. Our management believes that the adjustment of these items supplement the GAAP information with a measure that can be used to assess the sustainability of our operating performance.


•	Interest (income) expense: We have excluded foreign currency impacts associated with acquisition-related and debt financing-related forward contracts, as well as debt financing transaction costs as the nature and amount of such charges are not consistent and are significantly impacted by the timing and size of such transactions.

•

Other expense (income): We have excluded the impact of costs incurred for legal and advisory services rendered in connection with the evaluation of the tender offer initiated by certain of our shareholders. Our management believes these costs do not reflect our underlying ongoing business, and the adjustment of such costs helps investors and others compare and analyze performance from period to period. We have also excluded the impact of pension curtailment (gains) and losses and pension settlements as such events are triggered by our restructuring and other business realignment activities and the amount of such charges vary significantly based on the size and timing of the programs.


•	Loss on early extinguishment of debt: We have excluded loss on extinguishment of debt as this represents a non-cash charge, and the amount and frequency of such charges is not consistent and is significantly impacted by the timing and size of debt financing transactions.


•	Noncontrolling interest: This adjustment represents the after-tax impact of the non-GAAP adjustments included in Net income attributable to noncontrolling interests based on the relevant non-controlling interest percentage.


•	Tax: This adjustment represents the impact of the tax effect of the pretax items excluded from Adjusted net income. The tax impact of the non-GAAP adjustments are based on the tax rates related to the jurisdiction in which the adjusted items are received or incurred.

While acquiring brands and licenses comprises a part of our overall growth strategy, along with targeting organic growth opportunities, we have excluded acquisition-related costs and acquisition accounting impacts in connection with business combinations because these costs are unique to each transaction and the amount and frequency are not consistent and are significantly impacted by the timing and size of our acquisitions. Our management assesses the success of an acquisition as a component of performance using a variety of indicators depending on the size and nature of the acquisition, including:


•	the scale of the combined company by evaluating consolidated and segment financial metrics;


•	the expansion of product offerings by evaluating segment, brand, and geographic performance and the respective strength of the brands;


•	the evaluation of market share expansion in categories and geographies;


•	the earnings per share accretion and substantial incremental free cash flow generation providing financial flexibility for us; and


•	the comparison of actual and projected results, including achievement of projected synergies, post integration; provided that timing for any such comparison will depend on the size and complexity of the acquisition.

Constant Currency

We operate on a global basis, with the majority of our net revenues generated outside of the U.S. Accordingly, fluctuations in foreign currency exchange rates can affect our results of operations. Therefore, to supplement financial results presented in accordance with GAAP, certain financial information is presented in “constant currency”, excluding the impact of foreign currency exchange translations to provide a framework for assessing how our underlying businesses performed excluding the impact of foreign currency exchange translations. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. We calculate constant currency information by translating current and prior-period results for entities reporting in currencies other than U.S. dollars into U.S. dollars using prior year foreign currency exchange rates. The constant currency calculations do not adjust for the impact of revaluing specific transactions denominated in a currency that is different to the functional currency of that entity when exchange rates fluctuate. The constant currency information we present may not be comparable to similarly titled measures reported by other companies.

Basis of Presentation of Acquisitions and Divestitures

During the period when we complete an acquisition, divestiture or early license termination, the financial results of the current year period are not comparable to the financial results presented in the prior year period. When explaining such changes from period to period and to maintain a consistent basis between periods, we exclude the financial contribution of: (i) the acquired brands or businesses in the current year period until we have twelve months of comparable financial results and (ii) the divested brands or businesses or early terminated brands in the prior year period, to maintain comparable financial results with the current fiscal year period. Acquisitions, divestitures and early license terminations that would impact the comparability of financial results between periods presented in the Management’s Discussion and Analysis of Financial Condition and Results of Operations are shown in the table below.



Period of acquisition, divestiture, or termination	Acquisition, divestiture, or termination	Impact on basis of 2019/2018 presentation	Impact on basis of 2018/2017 presentation
First quarter fiscal 2017	n/a	n/a	n/a
Second quarter fiscal 2017	Acquisition: P&G Beauty Business (all segments) Ghd (Professional segment)	n/a	First quarter of fiscal 2018 P&G financial contribution excluded and five months of fiscal 2018 ghd financial contribution excluded
Third quarter fiscal 2017	Acquisitions: Younique (Consumer Beauty segment)	n/a	Seven months of fiscal 2018 financial contribution excluded
Fourth quarter fiscal 2017	n/a	n/a	n/a
First quarter fiscal 2018	n/a	n/a	n/a
Second quarter fiscal 2018	Acquisition: Burberry Beauty Business (Luxury segment)	First quarter fiscal 2019 financial contribution excluded	Second, third, and fourth quarter fiscal 2018 financial contribution excluded
Third quarter fiscal 2018	Termination: Guess (Consumer Beauty segment)	First, second and third quarter fiscal 2018 financial contribution excluded	n/a
Fourth quarter fiscal 2018	Divestitures of licenses: Playboy (Consumer Beauty segment) and Cerruti (Luxury segment)	First, second, third and fourth quarter fiscal 2018 financial contribution excluded	n/a

When used herein, the term “Acquisitions” and “Divestitures” refer to the financial contributions of the related acquisitions or divestitures and early license terminations shown above, during the period that is not comparable as a result of such acquisitions or divestitures and early license terminations.

A detailed discussion of the fiscal 2018 year-over-year changes can be found in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations of the Company’s Annual Report on Form 10-K filed on August 21, 2018.

NET REVENUES

In fiscal 2019, net revenues decreased 8%, or $749.5, to $8,648.5 from $9,398.0 in fiscal 2018. The impact of the acquisition of the Burberry Beauty Business had a positive contribution of 1% to the total change in net revenues in fiscal 2019 as compared to fiscal 2018. This was more than offset by the impact of the termination of the Guess license and the divestitures of the licenses of Playboy and Cerruti, which had a negative impact of 2% on the total change in net revenues in fiscal 2019 as compared to fiscal 2018. Excluding the impacts of the Acquisitions and Divestitures, total net revenues in fiscal 2019 decreased 7%, or $657.3, to $8,586.2 from $9,243.5 in fiscal 2018, reflecting a negative foreign currency exchange translation impact of 3% and a decrease in unit volume of 4%. The decrease in net revenues primarily reflects:


(i)	Shelf-space losses primarily impacting CoverGirl, Rimmel and Clairol which have contributed to the negative share trends in the color cosmetics and hair color categories in North America;


(ii)	Performance challenges in our brands across Europe which have contributed to the region’s negative share trends in the color cosmetics category;


(iii)	Moderate weakness in the mass beauty categories in North American and Europe; and


(iv)	The Supply Chain Disruptions, which negatively impacted net revenues primarily in the first half of 2019 and were resolved in the fourth quarter of fiscal 2019.

Net Revenues by Segment



	Year Ended June 30,						Change %
(in millions)	2019		2018		2017		2019/2018		2018/2017
NET REVENUES
Luxury	$	3,294.3	$	3,210.5	$	2,566.6	3	%	25	%
Consumer Beauty	3,539.3		4,268.1		3,688.2		(17	%)	16	%
Professional Beauty	1,814.9		1,919.4		1,395.5		(5	%)	38	%
Total	$	8,648.5	$	9,398.0	$	7,650.3	(8	%)	23	%

Luxury

In fiscal 2019, net revenues from the Luxury segment increased 3%, or $83.8 to $3,294.3 from $3,210.5 in fiscal 2018. The impact of the acquisition of the Burberry Beauty Business had a positive contribution of 2% on the total change in net revenues for the segment in fiscal 2019 as compared to fiscal 2018. This was partially offset by the impact of the divestiture of the license of Cerruti, which had a negative contribution of 1% on the total change in net revenues for the segment in fiscal 2019 as compared to fiscal 2018. Excluding the impacts of the Acquisitions and Divestitures, net revenues from the Luxury segment increased 2%, or $50.8, to $3,232.0 in fiscal 2019 from $3,181.2 in fiscal 2018, reflecting an increase in unit volume of 7%, offset by a negative foreign currency exchange translation impact of 3% and a negative price and mix impact of 2%. This increase in net revenues primarily reflects: (i) increased net revenues from Burberry due to the integration and growth of the brand since the acquisition of the Burberry Beauty Business in the second quarter of fiscal 2018; (ii) increased net revenues from Calvin Klein due to the continued success from the launch of Calvin Klein Women in the first quarter of fiscal 2019; and (iii) increased net revenues from Gucci due to a number of successful launches in fiscal 2019 including Gucci Bloom Nettare di Fiori, Gucci Guilty Pour Femme, Gucci Alchemist Garden and the relaunch of Gucci Make-up. These increases were partially offset by a net revenue decline in (i) Hugo Boss due to the Supply Chain Disruptions primarily during the first half of fiscal 2019; (ii) lower net revenues from philosophy due to reduced promotional activities with a key U.S. customer and due to the timing of shipments; and (iii) the negative impact of foreign currency exchange translation.

Consumer Beauty

In fiscal 2019, net revenues from the Consumer Beauty segment decreased 17%, or $728.8, to $3,539.3 from $4,268.1 in fiscal 2018. The impact of the termination of Guess and the divestiture of the license of Playboy had a negative contribution of 2% on the total change in net revenues for the segment in fiscal 2019 as compared to fiscal 2018. Excluding the impact of the Divestitures, net revenues from the Consumer Beauty segment decreased 15%, or $603.6, to $3,539.3 in fiscal 2019 from $4,142.9 in fiscal 2018, primarily reflecting a negative price and mix impact of 6%, a decrease in unit volume of 5%, and a negative foreign currency exchange translation impact of 4%. The decrease in net revenues primarily reflects:


(i)	Shelf-space losses primarily impacting CoverGirl, Rimmel and Clairol which have contributed to the negative share trends in the color cosmetics and hair color categories in North America;


(ii)	Performance challenges in our brands across Europe which have contributed to the region’s negative share trends in the color cosmetics category;


(iii)	Moderate weakness in the mass beauty categories in North America and Europe;


(iv)	The Supply Chain Disruptions which resulted in lower net revenues primarily in the first half of the year mainly in the color cosmetics category, namely the Rimmel, Max Factor and Bourjois brands;


(v)	Reduced net revenues from Younique due to a decline in presenter sponsorship; and


(vi)	The negative impact of foreign currency exchange translation.

These net revenue declines were partially offset by increased net revenue from Monange supported by continued share gains in Brazil. The negative price and mix impact for the segment primarily reflects this higher volume from Monange and the remainder of the body care category which has relatively lower-priced products.

Professional Beauty

In fiscal 2019, net revenues from the Professional Beauty segment decreased 5%, or $104.5, to $1,814.9 from $1,919.4 in fiscal 2018 primarily reflecting a decrease in unit volume of 6% and a negative foreign currency exchange translation impact of 3%, partially offset by a positive price and mix impact of 4%. The decrease in this segment primarily reflects: (i) decreased volume for hair care brands due to lower shipments to optimize retailer trade inventory levels for certain key U.S. customers; (ii) lower net revenues due to the Supply Chain Disruptions mainly impacting OPI and brands across the hair care category in the first half of fiscal 2019; and (iii) the negative impact of foreign currency exchange translation. These decreases were partially offset by: (i) a net revenue increase in ghd due to the product launch of the ghd Glide in the third quarter and continued innovation and success from the launch of Platinum+; and (ii) favorable price and mix impacts from the Wella Koleston Perfect ME+ product restage in the first quarter of fiscal 2019.

Net Revenues by Geographic Regions

In addition to our reporting segments, net revenues by geographic regions are as follows.



	Year Ended June 30,						Change %
(in millions)	2019		2018		2017		2019/2018		2018/2017
NET REVENUES
North America	$	2,656.5	$	2,966.0	$	2,506.9	(10	%)	18	%
Europe	3,777.8		4,201.6		3,325.7		(10	%)	26	%
ALMEA	2,214.2		2,230.4		1,817.7		(1	%)	23	%
Total	$	8,648.5	$	9,398.0	$	7,650.3	(8	%)	23	%

North America

In fiscal 2019, net revenues in North America decreased 10% or $309.5, to $2,656.5 from $2,966.0 in fiscal 2018. Excluding the impacts of the Acquisition and Divestitures, net revenues in North America decreased 10% or $304.3, to $2,641.9 in fiscal 2019 from $2,946.2 in fiscal 2018, primarily due to: (i) shelf-space losses in the United States primarily impacting CoverGirl, Rimmel and Clairol, which have contributed to the negative share trends in the color cosmetics and hair color categories in North America; (ii) reduced net revenues in the United States from the Supply Chain Disruptions primarily in the first half of fiscal 2019; (iii) reduced net revenues from Younique due to a decline in presenter sponsorship; (iv) decreased volume for Professional hair care brands due to lower shipments to optimize retailer trade inventory levels for certain key U.S. customers; and (v) lower net revenues from philosophy due to distribution losses at a key U.S. customer and due to the timing of shipments. These decreases were partially offset by increased net revenues from Burberry in the United States due to the integration and growth of the Burberry Beauty Business.

Europe

In fiscal 2019, net revenues in Europe decreased 10%, or 423.8, to $3,777.8 from $4,201.6 in fiscal 2018. Excluding the impacts of the Acquisition and Divestitures, net revenues in Europe decreased 9%, or 361.5, to 3,748.8 in fiscal 2019 from 4,110.3 in fiscal 2018, primarily due to: (i) performance challenges in our Consumer Beauty brands across Europe which have contributed to the region’s negative share trends in the color cosmetics category; (ii) declines in Rimmel, Bourjois, and Max Factor across the region due to the Supply Chain Disruptions primarily in the first half of fiscal 2019; (iii) declines in mass fragrances in Western Europe in part due to negative share and category trends in the mass fragrances category; and (iv) negative foreign currency exchange translation impacts. These declines were partially offset by incremental net revenues from Calvin Klein and Burberry across the region. Excluding the impact of the Acquisitions, Divestitures and the negative foreign currency exchange translation impact of 4%, net revenues in Europe decreased 5%.

ALMEA

In fiscal 2019, net revenues in ALMEA decreased 1%, or $16.2, to $2,214.2 from $2,230.4 in fiscal 2018. Excluding the impacts of the Acquisitions and Divestitures, net revenues in ALMEA remained consistent at $2,195.5 in fiscal 2019 compared to $2,187.0 in fiscal 2018, primarily due to (i) unfavorable foreign currency exchange translation impacts of certain currencies in Latin America; and (ii) lower net revenues in China and the Middle East from Max Factor and the retail hair line of Wella hair products due to changes to retailer trade inventory levels. These decreases were offset by (i) higher net revenues from Monange due to category growth and share gains in Brazil; (ii) increased net revenues in China from Gucci and Burberry; and (iii) increased net revenues in South Africa from brands across the color cosmetics and prestige fragrance categories. Excluding the impact of the Acquisitions, Divestitures and the negative foreign currency exchange translation impact of 7%, net revenues in ALMEA increased 7%.

COST OF SALES

In fiscal 2019, cost of sales decreased 8%, or $301.3, to $3,306.5 from $3,607.8 in fiscal 2018. Cost of sales as a percentage of net revenues decreased to 38.2% in fiscal 2019 from 38.4% in fiscal 2018, resulting in a gross margin improvement of approximately 20 basis points, primarily reflecting:


(i)	a favorable mix impact associated with the increased proportion of net revenue contribution from higher-margin Luxury and Professional Beauty products in the twelve months ended June 30, 2019 as compared to the twelve months ended June 30, 2018;


(ii)	lower costs from distributor terminations and accelerated depreciation of buildings and equipment associated with plant closures related to the Global Integration Activities (as defined below) in fiscal 2018; and


(iii)	decreased excess and obsolescence expense on inventory in the Corporate segment for artwork transition activities on acquired inventory in connection with the acquisition of the P&G Beauty Business.

These improvements were partially offset by:


(i)	increased excess and obsolescence expense on inventory within the Consumer Beauty segment;


(ii)	increased freight expenses, primarily reflecting higher import duties and freight rates; and


(iii)	the negative mix impact within the Consumer Beauty segment associated with a higher proportionate net revenue contribution from lower-margin body care products, which has its primary commercial market located in Brazil;

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

In fiscal 2019, selling, general and administrative expenses decreased 9%, or $454.2, to $4,563.9 from $5,018.1 in fiscal 2018. Selling, general and administrative expenses as a percentage of net revenues decreased to 52.8% in fiscal 2019 from 53.4% in fiscal 2018, or approximately 60 basis points. This decrease primarily reflects:

(i)

150 basis points related to lower advertising and consumer promotion costs due to a rationalization of non-strategic spending in non-working media and other consumer promotion activities across all segments, a decrease in media spending within the Consumer Beauty segment due to higher investments in the prior year on the brand relaunches of CoverGirl and Clairol as well as media decreases in the current year in brands across the color cosmetics category; and


(ii)	20 basis points related to lower share-based compensation expense due to significant executive forfeitures of share-based compensation instruments and the impact of actual forfeitures on the change in the estimated forfeiture rates during the period.

These decreases were partially offset by:

(i)

60 basis points related to higher administrative costs due to increased depreciation expense on IT assets placed into service in conjunction with our integration activities as well as the decline in net revenues in the Consumer Beauty segment out-pacing the overall decline in administrative costs from compensation expense savings as a result of restructuring actions and certain other programs and travel & entertainment expense savings from the implementation of more stringent spending policies; and


(ii)	50 basis points related to higher distribution and warehousing expenses due to a strategic shift in certain markets to distribute through subsidiaries as opposed to third-party distributors, which increases storage and handling costs and due to incremental customer penalties stemming from the Supply Chain Disruptions.

OPERATING (LOSS) INCOME

In fiscal 2019, operating (loss) of ($3,471.5) decreased greater than 100%, or ($3,624.8), from income of $153.3 in fiscal 2018 primarily due to the asset impairment charges of $3,851.9 in fiscal 2019. Operating margin, or operating (loss) income as a percentage of net revenues, decreased to (40.1)% of net revenues in fiscal 2019 as compared to 1.6% in fiscal 2018.

Favorable and (unfavorable) basis point changes in operating (loss) income as a percentage of net revenues for the fiscal years ended June 30, 2019 and 2018 as compared to the respective prior year periods, are comprised of the following:



	Year Ended June 30,
(bps rounded to nearest tenth)	2019/2018		2018/2017
Asset impairment charges ^(a)	(4,450	)	—
Amortization Expense	(30	)	(20	)
Cost of sales	20		120
Loss (gain) on sale of brand assets	30		(30	)
Selling, general and administrative expenses	60		(60	)
Acquisition-related costs	70		400
Restructuring costs	130		300
Total basis point favorable (unfavorable) change	(4,170	)	710


^(a)	See Operating (Loss) Income by Segment for the asset impairment charges by division.

Operating (Loss) Income by Segment



	Year Ended June 30,									Change %
(in millions)	2019			2018			2017			2019/2018		2018/2017
OPERATING (LOSS) INCOME
Luxury	$	232.8		$	248.7		$	158.0		(6	%)	57	%
Consumer Beauty	(3,598.7		)	278.9			261.2			<(100%)		7	%
Professional Beauty	122.1			119.4			78.5			2	%	52	%
Corporate	(227.7		)	(493.7		)	(918.6		)	54	%	46	%
Total	$	(3,471.5	)	$	153.3		$	(420.9	)	<(100%)		>100%

Luxury

In fiscal 2019, operating income for Luxury decreased 6%, or $15.9, to $232.8 from $248.7 in fiscal 2018. Operating margin decreased to 7.1% of net revenues in fiscal 2019 as compared to 7.7% in fiscal 2018, primarily driven by the asset impairment charges of $122.2 in fiscal 2019.

Consumer Beauty

In fiscal 2019, operating (loss) income for Consumer Beauty decreased greater than 100%, or ($3,877.6), to a loss of ($3,598.7) from income of $278.9 in fiscal 2018. Operating margin decreased to less than (100%) of net revenues in fiscal 2019 as compared to 6.5% in fiscal 2018, primarily driven by the asset impairment charges of $3,690.7 in fiscal 2019.

Professional Beauty

In fiscal 2019, operating income for Professional Beauty increased 2%, or $2.7 to $122.1 from $119.4 in fiscal 2018. Operating margin increased to 6.7% of net revenues in fiscal 2019 as compared to 6.2% in fiscal 2018, primarily driven by lower selling, general and administrative expenses as a percentage of net revenues and lower cost of goods sold as a percentage of net revenues, partially offset by the asset impairment charges of $27.0 in fiscal 2019.

Corporate

Corporate primarily includes expenses not directly relating to our operating activities. These items are included in Corporate since we consider them to be corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.

Operating loss for Corporate was $227.7, $493.7 and $918.6 in fiscal 2019, 2018 and 2017, respectively, as described under “Adjusted Operating Income” below. The operating loss of $227.7 in fiscal 2019 includes $12.0 million of asset impairment charges related to a Corporate investment.

Adjusted Operating Income by Segment

We believe that adjusted operating income by segment further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” A reconciliation of reported operating income (loss) to adjusted operating income is presented below, by segment:



	Year Ended June 30, 2019
(in millions)	Reported (GAAP)			Adjustments ^(a)			Adjusted (Non-GAAP)
Operating (loss) income
Luxury	$	232.8		$	(278.4	)	$	511.2
Consumer Beauty	(3,598.7		)	(3,817.7		)	219.0
Professional Beauty	122.1			(97.3		)	219.4
Corporate	(227.7		)	(227.8		)	0.1
Total	(3,471.5		)	(4,421.2		)	949.7



	Year Ended June 30, 2018
(in millions)	Reported (GAAP)^(b)			Adjustments ^(a)(b)			Adjusted (Non-GAAP)^(b)
Operating income (loss)
Luxury	$	248.7		$	(145.1	)	$	393.8
Consumer Beauty	278.9			(132.2		)	411.1
Professional Beauty	119.4			(75.5		)	194.9
Corporate	(493.7		)	(496.2		)	2.5
Total	153.3			(849.0		)	1,002.3



	Year Ended June 30, 2017
(in millions)	Reported (GAAP)^(b)			Adjustments ^(a)(b)			Adjusted (Non-GAAP)^(b)
Operating (loss) income
Luxury	$	158.0		$	(125.0	)	$	283.0
Consumer Beauty	261.2			(94.5		)	355.7
Professional Beauty	78.5			(55.6		)	134.1
Corporate	(918.6		)	(920.6		)	2.0
Total	(420.9		)	(1,195.7		)	774.8


^(a)	See a reconciliation of reported operating income to adjusted operating income and a description of the adjustments under “adjusted operating income for Coty Inc.” below. All adjustments are reflected in Corporate, except for amortization expense and the asset impairment charges which are reflected in the Luxury, Consumer Beauty and Professional Beauty divisions.

^(b)

Prior periods have been restated in accordance with the adoption of ASU No. 2017-07 as the curtailment gains and pension settlements are a non-service component of the net periodic benefit cost and have therefore been retrospectively reported outside operating income. See “Reconciliation of Reported Net (Loss) Income Attributable to Coty Inc. to Adjusted Net Income Attributable to Coty Inc.” for the description of transactions that have been retrospectively reported outside operating income.

Adjusted Operating Income for Coty Inc.

Adjusted operating income provides investors with supplementary information relating to our performance. See “Overview—Non-GAAP Financial Measures.” Reconciliation of reported operating (loss) income to adjusted operating income is presented below:



	Year Ended June 30,									Change %
(in millions)	2019			2018^(a)			2017^(a)			2019/2018		2018/2017
Reported operating (loss) income	$	(3,471.5	)	$	153.3		$	(420.9	)	<(100%)		>100%
% of Net revenues	(40.1		)%	1.6		%	(5.5		%)
Asset impairment charges	3,851.9			—			—			N/A		N/A
Amortization expense	353.5			352.8			275.1			—	%	28	%
Restructuring and other business realignment costs	215.8			391.5			428.8			(45	%)	(9	%)
Costs related to acquisition activities	—			76.1			494.9			(100	%)	(85	%)
Loss/(gain) on sale of brand assets	—			28.6			(3.1		)	(100	%)	>100%
Total adjustments to reported operating (loss) income	4,421.2			849.0			1,195.7			>100%		(29	%)
Adjusted operating income	$	949.7		$	1,002.3		$	774.8		(5	%)	29	%
% of Net revenues	11.0		%	10.7		%	10.1		%

^(a)

In fiscal 2019, adjusted operating income decreased 5%, or $52.6, to $949.7 from $1,002.3 in fiscal 2018. Adjusted operating margin increased to 11.0% of net revenues in fiscal 2019 as compared to 10.7% in fiscal 2018, driven by approximately 70 basis points related to lower adjusted selling, general and administrative expenses partially offset by approximately 40 basis points related to higher adjusted costs of sales as a percentage of net revenues. Excluding the impact of foreign currency exchange translations, adjusted operating income decreased 1%.

Restructuring and Other Business Realignment Costs

We have in place a number of restructuring plans to improve our cost structure, including opportunities to simplify and streamline operations. In particular, in connection with the acquisition of the P&G Beauty Business, we have incurred restructuring and related costs aimed at integrating and optimizing the combined organization, which we refer to as the Global Integration Activities. In addition, in 2018, we began evaluating initiatives to reduce fixed costs and enable further investment in the business, which we refer to as the 2018 Restructuring Actions. We have incurred cumulative restructuring charges of $85.2 related to approved initiatives through June 30, 2019.

On July 1, 2019, we announced our Turnaround Plan. To implement the Turnaround Plan, we expect to incur restructuring and other business realignment costs, in addition to costs associated with previously announced programs. The Company expects incremental cash costs related to the Turnaround Plan to be approximately $600.0. In addition, the Company will continue to incur cash costs of $160.0 related to restructuring and other business realignment costs connected to previously announced programs.

In fiscal 2019, we incurred restructuring and other business realignment costs of $215.8, as follows:


•	We incurred restructuring costs of $44.2 primarily related to the Global Integration Activities and 2018 Restructuring Actions, included in the Consolidated Statements of Operations; and


•	We incurred business structure realignment costs of $171.6 primarily related to our Global Integration Activities, and certain other programs. This amount includes $162.2 in Selling, general and administrative expenses and $9.4 in Cost of sales.

In fiscal 2018, we incurred restructuring and other business realignment costs of $391.5, as follows:


•	We incurred restructuring costs of $173.2 primarily related to the Global Integration Activities and 2018 Restructuring Actions, included in the Consolidated Statements of Operations; and


•	We incurred business structure realignment costs of $218.3 primarily related to our Global Integration Activities, and certain other programs. This amount includes $167.2 in Selling, general and administrative expenses and $51.1 in Cost of sales.

In all reported periods, all restructuring and other business realignment costs were reported in Corporate.

Amortization Expense

In fiscal 2019, amortization expense increased to $353.5 from $352.8 in fiscal 2018. In fiscal 2019, amortization expense of $155.3, $127.8, and $70.4 were reported in the Luxury, Consumer Beauty, and Professional Beauty segments, respectively.

In fiscal 2018, amortization expense increased to $352.8 from $275.1 in fiscal 2017, primarily as a result of the Acquisitions. In fiscal 2018, amortization expense of $145.1, $132.2, and $75.5 were reported in the Luxury, Consumer Beauty, and Professional Beauty segments, respectively.

Costs related to acquisition activities

In fiscal 2019, we did not incur any acquisition related costs.

In fiscal 2018, we incurred $76.1 of costs related to acquisition activities. We recognized Acquisition-related costs of $64.2, primarily in connection with the acquisitions of the P&G Beauty Business, the Burberry Beauty Business, ghd and Younique. We also incurred $7.1 of cost related to acquired inventory step-up amortization in connection with the acquisitions of Younique and the Burberry Beauty Business, as well as $4.8 in excess & obsolescence expense on inventory associated with the Burberry Beauty Business acquisition, included in Cost of sales in the Consolidated Statements of Operations.

In all reported periods, all acquisition-related costs were reported in Corporate, except where otherwise noted.

Asset Impairment Charges

In fiscal 2019, we incurred $3,851.9 of asset impairment charges primarily due to:

(i) $3,690.7 related to goodwill and other intangible assets in the Consumer Beauty reporting unit recorded in fiscal 2019;

(ii) $109.6 related to the philosophy trademark that is part of the Luxury reporting unit recorded in fiscal 2019;

(iii) $27.0 related to the professional product line of the Wella trademark that is part of the Professional Beauty reporting unit recorded in fiscal 2019;

(iii) $12.6 charge in the Luxury reporting unit during fiscal 2019 related to an acquired trademark associated with a terminated pre-existing license as a result of the acquisition; and

(iv) $12.0 related to a Corporate investment recorded during fiscal 2019.

For further detail as to the factors in the second and fourth quarters resulting in the asset impairment charges please refer to the Goodwill and Other Intangibles note to the Consolidated Financial Statements.

In fiscal 2018, we did not incur any asset impairment charges.

Loss (Gain) on sale of brand assets

In fiscal 2019, we did not incur a loss (gain) on sale of brand assets.

In fiscal 2018, we sold certain assets relating to our Playboy and Cerruti fragrance brands and recorded a loss of $28.6 which has been reflected in loss (gain) on sale of brand assets in the Consolidated Statements of Operations.

INTEREST EXPENSE, NET

In fiscal 2019, net interest expense was $275.7 as compared with $265.0 in fiscal 2018. This increase is primarily a result of higher average debt balances.

LOSS ON EARLY EXTINGUISHMENT OF DEBT

In fiscal 2019, we did not incur any losses related to the early extinguishment of debt.

In fiscal 2018, we incurred $10.7 in losses related to the write-off of debt discount and deferred financing costs in connection with the refinancing of our credit agreement entered into on October 27, 2017 (the “Coty Credit Agreement”) and the debt facilities available under the Galleria Credit Agreement (the “Galleria Credit Agreement”).

OTHER EXPENSE (INCOME), NET

In fiscal 2019, we incurred $30.9 of net other expense. The other expense in fiscal 2019 primarily includes $16.1 of legal and advisory services rendered in connection with the evaluation of the tender offer initiated by certain of our shareholders, $13.3 due to the change in the Mandatorily Redeemable Financial Instrument (“MRFI”) balance associated with a certain Southeast Asian subsidiary and $3.8 related to the write off of unamortized deferred financing fees associated with the 2019 Amendment to the 2018 Coty Credit Agreement, which was partially offset by pension curtailment gains of $5.1 as a result of the Global Integration Activities, which significantly reduced the expected years of future service for employees participating in our non-U.S. pension plans.

In fiscal 2018, we incurred $30.1 of net other expense. The other expense in fiscal 2018 primarily includes $24.1 in expense related to third-party debt issuance costs incurred in connection with the refinancing of the Coty Credit Agreement and Galleria Credit Agreement and $12.5 related to the change in the MRFI balance primarily associated with a certain Southeast Asian subsidiary. These other expense charges were partially offset by a $10.4 curtailment gain triggered by an amendment to a non-U.S. postretirement healthcare plan during fiscal 2018, which significantly reduced the expected years of future service for employees participating in the plan.

INCOME TAXES

The following table presents our (benefit) provision for income taxes, and effective tax rates for the periods presented:



	2019			2018			2017
(Benefit) for income taxes	$	(8.5	)	$	(24.7	)	$	(259.5	)
Effective income tax rate	0.2		%	16.2		%	39.4		%

The effective income tax rate for fiscal 2019 was 0.2% as compared with 16.2% in fiscal 2018 and 39.4% in fiscal 2017.

The effective income tax rate in fiscal 2019 includes the impact of the goodwill impairment that is not tax-deductible.

The effective income tax rate in fiscal 2018 includes an expense of $41.0 as a result of the Tax Act. This expense is due to the one-time deemed repatriation tax offset by a tax benefit on the revaluation of the Company’s deferred taxes. See Note 16—Income Taxes in the notes to our Consolidated Financial Statements for additional information.

The effective rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, (ii) adjustments to our unrecognized tax benefits and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.

Reconciliation of Reported (Loss) Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:



	Year Ended June 30, 2019								Year Ended June 30, 2018								Year Ended June 30, 2017
(in millions)	(Loss)/ income before income taxes			(Benefit)provision for income taxes			Effective tax rate		(Loss)/ income before income taxes			(Benefit)provision for income taxes			Effective tax rate		(Loss)/income before income taxes			(Benefit)provision for income taxes			Effective tax rate
Reported (loss) income before income taxes	$	(3,778.1	)	(8.5		)	0.2	%	$	(152.5	)	(24.7		)	16.2	%	$	(658.0	)	(259.5		)	39.4	%
Adjustments to reported operating income (loss) ^{(a) (b)}	4,421.2			143.4					849.0			156.0					1,195.7			349.2
Other adjustments ^{(b) (c)}	11.0			2.3					23.0			6.9					16.3			6.2
Adjusted income before income taxes	$	654.1		$	137.2		21.0	%	$	719.5		$	138.2		19.2	%	$	554.0		$	95.9		17.3	%


^(a)	See a description of adjustments under “Adjusted Operating Income for Coty Inc.”

^(b)

The tax effects of each of the items included in adjusted income are calculated in a manner that results in a corresponding income tax benefit/provision for adjusted income. In preparing the calculation, each adjustment to reported income is first analyzed to determine if the adjustment has an income tax consequence. The benefit/provision for taxes is then calculated based on the jurisdiction in which the adjusted items are incurred, multiplied by the respective statutory rates and offset by the increase or reversal of any valuation allowances commensurate with the non-GAAP measure of profitability.


^(c)	See “Reconciliation of Reported Net (Loss) Income Attributable to Coty Inc. to Adjusted Net Income Attributable to Coty Inc.”

The adjusted effective tax rate was 21.0% compared to 19.2% in the prior-year period. The differences were primarily due to the resolution of a foreign uncertain tax position of approximately $43.0 in the prior period. Cash paid during the years ended June 30, 2019, 2018 and 2017, for income taxes of $110.3, $124.6 and $90.1 represents 16.9%, 17.3% and 16.3% of Adjusted income before income taxes for the fiscal year ended, respectively.

NET LOSS ATTRIBUTABLE TO COTY INC.

In fiscal 2019, net loss attributable to Coty Inc. increased $3,615.4 to a loss of $3,784.2 from a loss of $168.8 in fiscal 2018. This net loss increase primarily reflects a higher operating loss in the current year compared to operating income in the prior year.

We believe that adjusted net income attributable to Coty Inc. provides an enhanced understanding of our performance. See “Overview—Non-GAAP Financial Measures.”



	Year Ended June 30,									Change %
(in millions)	2019			2018			2017			2019/2018		2018/2017
Reported net loss attributable to Coty Inc.	$(3,784.2)			$	(168.8	)	$	(422.2	)	<(100%)		60	%
% of Net revenues	(43.8		%)	(1.8		%)	(5.5		%)
Adjustments to reported operating income ^(a)	4,421.2			849.0			1,195.7			>100%		(29	%)
Adjustments to other expense (income) ^(b)	11.0			13.7			14.9			(20	%)	(8	%)
Loss on early extinguishment of debt ^(c)	—			10.7			—			(100	%)	N/A
Adjustments to interest (income) expense ^(d)	—			(1.4		)	1.4			100	%	<(100%)
Adjustments to noncontrolling interest expense ^(e)	(14.7		)	(24.0		)	(25.9		)	39	%	7	%
Change in tax provision due to adjustments to reported net (loss) income attributable to Coty Inc.	(145.7		)	(162.9		)	(355.4		)	11	%	54	%
Adjusted net income attributable to Coty Inc.	$	487.6		$	516.3		$	408.5		(6	%)	26	%
% of Net revenues	5.6		%	5.5		%	5.3		%
Per Share Data
Adjusted weighted-average common shares
Basic	751.2			749.7			642.8
Diluted	754.3			753.1			647.8
Adjusted net income attributable to Coty Inc. per common share
Basic	$	0.65		$	0.69		$	0.64
Diluted	$	0.65		$	0.69		$	0.63

Prior periods have been restated in accordance with the adoption of ASU No. 2017-07. See below for the description of transactions that have been retrospectively reported outside operating income.


^(a)	See a description of adjustments under “Adjusted Operating Income for Coty Inc.”

^(b)

In fiscal 2019, the Company incurred legal and advisory services of $16.1 rendered in connection with the evaluation of the tender offer initiated by certain of our shareholders, partially offset by pension curtailment gains of $5.1 as a result of the Global Integration Activities, which significantly reduced the expected years of future service for employees participating in our non-U.S. pension plans. In fiscal 2018, we incurred losses of $24.1 related to the expensing of third-party debt issuance costs incurred in connection with the refinancing of the Coty Credit Agreement and Galleria Credit Agreement, partially offset by pension curtailment gains of $10.4 triggered by an amendment to a non-U.S. postretirement healthcare plan during fiscal 2018, which significantly reduced the expected years of future service for employees participating in the plan. In accordance with the adoption of ASU No. 2017-07, the curtailment gains and pension settlements are a non-service component of the net periodic benefit cost and have therefore been retrospectively reported outside operating income. In fiscal 2017, we recorded pension expense of $17.5 in connection with the settlement of obligations related to the U.S. Del Laboratories, Inc. Additionally, we recorded pension curtailment gains of $2.6 for pension plans where there was a significant reduction in the expected years of future service for plan participants as a result of the Acquisition Integration Program and Global Integration Activities.


^(c)	In fiscal 2018, the amount represents the write-off of debt discount and deferred financing costs in connection with the refinancing of the Coty Credit Agreement and Galleria Credit Agreement, included in Loss on early extinguishment of debt in the Consolidated Statements of Operations.


^(d)	The amount in fiscal 2018 represents one-time gains of $1.4 on short-term forward contracts to exchange euros for U.S. dollars to repay U.S. dollar debt balances outstanding under the Coty Credit Agreement and Galleria Credit Agreement, in connection with the refinancing

of those respective agreements in April 2018, included in Interest expense, net in the Consolidated Statements of Operations. The amount in fiscal 2017 represents a net loss of $1.4 incurred in connection with the acquisition of the Hypermarcas Brands and subsequent intercompany loans, included in Interest expense, net in the Consolidated Statements of Operations.


^(e)	The amounts represent the after-tax impact of the non-GAAP adjustments included in Net income attributable to noncontrolling interest based on the relevant noncontrolling interest percentage in the Consolidated Statements of Operations.

Quarterly Results of Operations Data

The following tables set forth our unaudited quarterly consolidated statements of operations data for each of the eight quarters in the periods ended June 30, 2019. We have prepared the quarterly consolidated statements of operations data on a basis consistent with the consolidated financial statements included in Part II, Item 8, “Financial Statements and Supplementary Data” in this Annual Report on Form 10-K. In the opinion of management, the financial information reflects all adjustments, consisting only of normal recurring adjustments, which we consider necessary for a fair presentation of this data. This information should be read in conjunction with the consolidated financial statements and related notes included in Part II, Item 8, “Financial Statements and Supplementary Data” in this Annual Report. The results of historical periods are not necessarily indicative of the results of operations for any future period.



	Fiscal 2019^(a)												Fiscal 2018 ^(b)
	Three Months Ended												Three Months Ended
	June 30,			March 31,			December 31,			September 30,			June 30,			March 31,			December 31,			September 30,
(in millions, except per share data)	2019			2019			2018			2018			2018			2018			2017			2017
Consolidated Statements of Operations Data:
Net revenues	$	2,115.4		$	1,990.6		$	2,511.2		$	2,031.3		$	2,299.4		$	2,222.7		$	2,637.6		$	2,238.3
Gross profit	1,315.9			1,249.4			1,554.5			1,222.2			1,403.0			1,410.4			1,612.7			1,364.1
Restructuring costs	0.5			6.7			21.5			15.5			97.6			42.7			21.7			11.2
Acquisition-related costs	—			—			—			—			0.5			2.6			7.0			54.1
Asset impairment charges	2,874.2			—			965.1			12.6			—			—			—			—
Operating (loss) income	(2,731.7		)	85.5			(804.6		)	(20.7		)	(72.1		)	20.7			175.2			29.5
Interest expense, net	71.3			72.0			68.3			64.1			65.7			72.6			60.3			66.4
Loss on early extinguishment of debt	—			—			—			—			10.7			—			—			—
Other expense (income), net	5.9			17.5			4.8			2.7			17.6			3.8			4.2			4.5
(Loss) income before income taxes	(2,808.9		)	(4.0		)	(877.7		)	(87.5		)	(166.1		)	(55.7		)	110.7			(41.4		)
Provision (benefit) for income taxes	(9.4		)	—			78.3			(77.4		)	4.1			4.4			(7.9		)	(25.3		)
Net (loss) income	$	(2,799.5	)	$	(4.0	)	$	(956.0	)	$	(10.1	)	$	(170.2	)	$	(60.1	)	$	118.6		$	(16.1	)
Net income (loss) attributable to noncontrolling interests	$	(1.6	)	$	2.3		$	0.6		$	1.2		$	5.0		$	1.1		$	(1.9	)	$	(2.2	)
Net income attributable to redeemable noncontrolling interests	$	1.5		$	5.8		$	4.0		$	0.8		$	6.1		$	15.8		$	11.3		$	5.8
Net (loss) income attributable to Coty Inc.	$	(2,799.4	)	$	(12.1	)	$	(960.6	)	$	(12.1	)	$	(181.3	)	$	(77.0	)	$	109.2		$	(19.7	)
Per Share Data:
Weighted-average common shares:
Basic	751.6			751.4			751.1			750.8			750.6			750.1			749.6			748.6
Diluted	751.6			751.4			751.1			750.8			750.6			750.1			752.7			748.6
Dividends declared per common share	$	0.125		$	0.125		$	0.125		$	0.125		$	0.125		$	0.125		$	0.125		$	0.125
Net (loss) income attributable to Coty Inc. per common share:
Basic	$	(3.72	)	$	(0.02	)	$	(1.28	)	$	(0.02	)	$	(0.24	)	$	(0.10	)	$	0.15		$	(0.03	)
Diluted	(3.72		)	(0.02		)	(1.28		)	(0.02		)	(0.24		)	(0.10		)	0.15			(0.03		)


^(a)	In fiscal 2019, we adopted authoritative guidance issued by the FASB for ASC 606, Revenue from Contracts with Customers, ASU No. 2016-16 and Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory, the impacts of which were applied as of July 1, 2018 in the financial results presented.

^(b)

Beginning in the second quarter of fiscal 2018, the financial results presented above include the impacts of the Burberry Beauty Business acquisition. Additionally, in fiscal 2019, we adopted authoritative guidance issued by the FASB for ASU No. 2017-07, Compensation—Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, the impacts of which were applied to the financial results of the fiscal 2018 periods presented.

FINANCIAL CONDITION

LIQUIDITY AND CAPITAL RESOURCES

Overview

As of June 30, 2019, we had cash and cash equivalents of $340.4 compared with $331.6 at June 30, 2018. Our cash and cash equivalents balances increased by $8.8 during fiscal 2019 primarily as a result of cash generated from operations and net borrowings from long-term debt, partially offset by cash used for capital expenditures, dividend payments to shareholders and acquisitions. During fiscal 2019, we increased our cash held outside of the U.S. by $28.9.

Our cash flows are subject to seasonal variation throughout the year, including demands on cash made during our first fiscal quarter in anticipation of higher global sales during the second fiscal quarter and strong cash generation in the second fiscal quarter as a result of increased demand by retailers associated with the holiday season. Our principal uses of cash are to fund planned operating expenditures, capital expenditures, interest payments, acquisitions, dividends, share repurchases and any principal payments on debt. The working capital movements are based on the sourcing of materials related to the production of products within each of our segments. The phasing of payments to vendors also impacts our working capital from time-to-time as we seek to efficiently manage our cash and working capital requirements.

As a result of the cash on hand, our ability to generate cash from operations and through access to our revolving credit facility and other lending sources, we believe we have sufficient liquidity to meet our ongoing needs on both a near term and long-term basis.

Debt

On April 5, 2018, we completed an offering of three series of U.S. dollar denominated and euro denominated senior unsecured notes in an aggregate principal amount of $550.0 and €800 million, in a private offering.

On April 5, 2018, we entered into a credit agreement which amended and restated the existing credit agreements. The credit agreement provides for senior secured credit facilities comprised of (i) a five year revolving credit facility in an aggregate principal amount up to $3,250.0, (ii) a five year term loan A facility consisting of (a) $1,000.0 denominated in U.S. dollars and (b) €2.035 billion denominated in Euros and (iii) a seven year term loan B facility consisting of (a) $1,400.0 denominated in U.S. dollars and (b) €850 million denominated in Euros. Future borrowings under the 2018 Coty Credit Agreement could be used for corporate purposes.

On June 27, 2019, we entered into an amendment (“2019 Amendment”) to the 2018 Coty Credit Agreement. The 2019 Amendment modified the 2018 Coty Credit Agreement by amending the financial covenants to (i) delay until March 31, 2022 the total net leverage ratio step down from 5.25 to 5.0, (ii) extend the applicable window for certain cost savings add-backs in the calculation of Adjusted EBITDA for purpose of determining the total net leverage ratio, and (iii) amend the determination of the exchange rate to be used for purposes of calculating “Total Indebtedness” (as defined in the 2018 Coty Credit Agreement) for purposes of the total net leverage ratio, and decreasing the total commitments under the revolving credit facility by $500.0 to $2,750.0.

See Note 14—Debt in the notes to our Consolidated Financial Statements for additional information on our debt arrangements and prior period credit agreements.

Receivables Purchase Agreement

On March 19, 2019, we entered into an Uncommitted Receivables Purchase Agreement (the “Receivables Purchase Agreement”) with a financial institution, with an aggregate facility limit of $150.0. Eligible trade receivables are purchased by the financial institution for cash at net invoice value less a factoring fee. Cash received from the selling of receivables under the Receivables Purchase Agreement are presented as a change in trade receivables within the operating activities section of the Consolidated Statements of Cash Flows.

During the fiscal year ended June 30, 2019, total trade receivables factored under the Receivables Purchase Agreement, was $267.3 and $118.3, on a gross basis and net of collections, respectively. The net factored amount primarily reflects the timing of certain trade receivables factored late in the fourth fiscal quarter.

Business Combinations

We did not enter into any business combinations in fiscal 2019. For additional information on our prior period business combinations from fiscal years 2018 and 2017, see Note 3—Business Combinations in the notes to our Consolidated Financial Statements.

Dispositions

We did not divest of any brands during fiscal 2019.

During fiscal 2018, we divested the Playboy and Cerruti brands and related assets for total proceeds of $33.0. We allocated $12.3 of goodwill to these brands as part of the sale. We recorded a non-cash loss of $28.6 which has been reflected in Loss (gain) on sale of brand assets in the Consolidated Statements of Operations for the fiscal year ended June 30, 2018.

Cash Flows



	Year Ended June 30,
	2019			2018			2017
Consolidated Statements of Cash Flows Data: (in millions)
Net cash provided by operating activities	$	639.6		$	413.7		$	757.5
Net cash used in investing activities	(454.0		)	(687.6		)	(1,163.6		)
Net cash (used in) provided by financing activities	(160.3		)	69.3			595.2

Net cash provided by operating activities

Net cash provided by operating activities was $639.6, $413.7 and $757.5 for fiscal 2019, 2018 and 2017, respectively. The increase in operating cash inflows in fiscal 2019 as compared with fiscal 2018 was $225.9. This increase is primarily driven by an increase of $286.5 in net income after adjusting for non-cash items only partially offset by increased outflows from net changes in working capital accounts of $60.7. The increase in net income after adjusting for non-cash items in fiscal 2019, compared to fiscal 2018, as noted above. Working capital changes included an increase in cash outflows from accounts payable and accrued expenses and other current liabilities of $642.4 which were only partially offset by higher inflows from trade receivables, prepaid expenses and other current assets and inventory of $581.7. The increase in cash outflows from accounts payable and accrued expenses and other current liabilities were mainly the result of decreases in current restructuring accruals for payments of prior year amounts accrued, combined with decreases in trade spend related payables and accruals due to a smaller revenue base decreasing the level of trade spending. Changes in trade receivables contributed to $424.5 of the increase in cash inflows during fiscal 2019 compared to fiscal 2018 mainly due to positive results from stronger collection efforts and the implementation of additional factoring facilities.

Net cash used in investing activities

Net cash used in investing activities was $(454.0), $(687.6) and $(1,163.6) for fiscal 2019, 2018 and 2017, respectively. The decrease in cash used for investing activities of $233.6 in fiscal 2019 as compared to fiscal 2018 primarily relates to higher cash outflows of $237.2 from cash paid in prior year for business combinations including the Burberry Beauty Business for $245.1 and other acquisition related activity of $32.4 compared to cash outflows in the current year of $40.8 for the purchase of a trademark.

Net cash (used in) provided by financing activities

Net cash (used in) provided by financing activities was $(160.3), $69.3 and $595.2 for fiscal 2019, 2018 and 2017, respectively. The decrease in cash inflows of $229.6 in fiscal 2019 as compared to fiscal 2018 was primarily due to lower net borrowings of $294.8. These decreases were partially offset by cash increases from lower payments for debt issuance costs of $37.7 and lower cash dividend payments of $29.6.

Dividends

On May 8, 2019, the Board approved a stock dividend reinvestment program giving shareholders the option to receive their full dividend in cash or to receive their dividend in 50% cash / 50% common stock. Shareholders were able to make this election on a quarterly basis, beginning with the dividend declared on May 8, 2019. The percentage of our total Common Stock for which the shareholders elected to participate in the Stock Dividend Reinvestment Program for the June 28, 2019 dividend was 68%.

As may be declared by the Board of Directors (the “Board”), we anticipate issuing future dividends on a quarterly basis.

For additional information on our dividends, see Note 22—Equity in the notes to our Consolidated Financial Statements.

Treasury Stock - Share Repurchase Program

For additional information on our Share Repurchase Program, see Note 22—Equity in the notes to our Consolidated Financial Statements.

Contractual Obligations and Commitments

Our principal contractual obligations and commitments as of June 30, 2019 are presented below:



(in millions)	Total		Payments Due in Fiscal										Thereafter
(in millions)	Total		2020		2021		2022		2023		2024		Thereafter
Long-term debt obligations	$	7,740.5	$	189.3	$	189.3	$	189.3	$	4,090.9	$	23.6	$	3,058.1
Interest on long-term debt obligations ^(a)	1,913.3		276.1		286.3		306.3		310.9		269.0		464.7
Operating lease obligations	721.5		122.2		111.2		91.3		76.7		67.8		252.3
License agreements: ^(b)
Royalty payments	761.4		157.4		100.2		81.4		65.0		60.3		297.1
Other contractual obligations ^(c)	590.2		371.6		95.2		66.8		33.8		22.3		0.5
Other long-term obligations:
Pension obligations (mandated) ^(d)	90.3		17.5		17.8		18.0		18.4		18.6		—
Total	$	11,817.2	$	1,134.1	$	800.0	$	753.1	$	4,595.7	$	461.6	$	4,072.7

^(a) Interest costs on our debt after consideration of our interest rate swap arrangements are determined based on interest rate forecast and assumptions of the amount of debt outstanding. A 25 basis-point increase in our variable interest rate debt would have increased our interest costs by $88.3 over the term of our long-term debt.

^(b) Obligations under license agreements relate to royalty payments and required advertising and promotional spending levels for our products bearing the licensed trademark. Royalty payments are typically made based on contractually defined net sales. However, certain licenses require minimum guaranteed royalty payments regardless of sales levels. Minimum guaranteed royalty payments and required minimums for advertising and promotional spending have been included in the table above. Actual royalty payments and advertising and promotional spending are expected to be higher. Furthermore, early termination of any of these license agreements could result in potential cash outflows that have not been reflected above.

^(c) Other contractual obligations primarily represent advertising/marketing, manufacturing, logistics and capital improvements commitments. Additionally, we have included the mandatorily redeemable financial instruments arising out of our subsidiaries as discussed in Note 20—Mandatorily Redeemable Financial Interest. We also maintain several distribution agreements for which early termination could result in potential future cash outflows that have not been reflected above.

^(d) Represents future contributions to our pension and other postretirement benefit plans over the next five years mandated by local regulations or statutes. Subsequent funding requirements cannot be reasonably estimated as the return on plan assets in future periods, as well as future assumptions are not known.

The table above excludes obligations for uncertain tax benefits, including interest and penalties, of $179.9 as of June 30, 2019, as we are unable to predict when, or if, any payments would be made. See Note 16—Income Taxes in the notes to our Consolidated Financial Statements for additional information on our uncertain tax benefits.

The table excludes $451.8 of RNCI which is reflected in Redeemable noncontrolling interests in the Consolidated Balance Sheet as of June 30, 2019 related to our 25.0% RNCI in our subsidiary in the Middle East (“Middle East Subsidiary”) and our 40.7% interest in our subsidiary Foundation, LLC (“Foundation”). Given the provisions of the associated Put and Call rights, both RNCI are redeemable outside of our control and are recorded in temporary equity.

See Note 21—Redeemable Noncontrolling Interests in the notes to our Consolidated Financial Statements for further discussion related to the calculation of the redemption value for each of these noncontrolling interests.

Derivative Financial Instruments and Hedging Activities

We are exposed to foreign currency exchange fluctuations and interest rate volatility through our global operations. We utilize natural offsets to the fullest extent possible in order to identify net exposures. In the normal course of business, established policies and procedures are employed to manage these net exposures using a variety of financial instruments. We do not enter into derivative financial instruments for trading or speculative purposes.

Foreign Currency Exchange Risk Management

We operate in multiple functional currencies and are exposed to the impact of foreign currency fluctuations. For foreign currency exposures, which primarily relate to receivables, inventory purchases and sales, payables and intercompany loans, derivatives are used to better manage the earnings and cash flow volatility arising from foreign currency exchange rate fluctuations. We recorded foreign currency losses of $3.5, $3.9 and $1.5 in fiscal 2019, 2018 and 2017, respectively, resulting

from non-financing foreign currency exchange transactions which are included in their associated expense type and are included in the Consolidated Statements of Operations. Net gains (losses) of $7.6, $8.5 and $(12.8) in fiscal 2019, 2018 and 2017, respectively, resulting from financing foreign exchange currency transactions are included in Interest expense, net in the Consolidated Statements of Operations. Net (losses) of nil, nil and $(1.7) in fiscal 2019, 2018 and 2017, respectively, resulting from acquisition-related foreign exchange currency transactions are included in Other expense, net in the Consolidated Statements of Operations.

Exchange gains or losses are also partially offset through the use of qualified derivatives under hedge accounting, for which we record accumulated gains or losses in Accumulated other comprehensive income until the underlying transaction occurs at which time the gain or loss is reclassified into the respective account in the Consolidated Statements of Operations.

We have experienced and will continue to experience fluctuations in our net income as a result of balance sheet transactional exposures. As of June 30, 2019, in the event of a 10.0% unfavorable change in the prevailing market rates of hedged foreign currencies versus the U.S. dollar, the change in fair value of all foreign exchange forward contracts would result in a $7.7 increase in the fair value of the forward contracts. In the view of management, these hypothetical gains resulting from an assumed change in foreign currency exchange rates are not material to our consolidated financial statement position or results of operations. This gain does not include the impact on our underlying foreign currency exposures.

Interest Rate Risk Management

We are exposed to interest rate risk that relates primarily to our indebtedness, which is affected by changes in the general level of the interest rates primarily in the U.S. and Europe. We periodically enter into interest rate swap agreements to facilitate our interest rate management activities. We have designated these agreements as cash flow hedges and, accordingly, applied hedge accounting. The effective changes in fair value of these agreements are recorded in AOCI/(L), net of tax, and ineffective portions are recorded in current- period earnings. Amounts in AOCI/(L) are subsequently reclassified to earnings as interest expense when the hedged transactions are settled.

We expect that both at the inception and on an ongoing basis, the hedging relationship between any designated interest rate hedges and underlying variable rate debt will be highly effective in achieving offsetting cash flows attributable to the hedged risk during the term of the hedge. If it is determined that a derivative is not highly effective, or that it has ceased to be a highly effective hedge, we will be required to discontinue hedge accounting with respect to that derivative prospectively. The corresponding gain or loss position of the ineffective hedge recorded to AOCI/(L) will be reclassified to current-period earnings.

If interest rates had been 10% higher/lower and all other variables were held constant, Loss before income taxes in fiscal 2019 would decrease/increase by $27.1.

During August 2018, we extended the maturity of our interest rate swap portfolio, in order to maintain a 50:50 ratio of fixed to floating rate debt through 2021 to better manage our medium term exposure to interest rate increases. Looking forward, we expect that the fixed to floating rate debt ratio will improve as we reduce the notional value of our floating rate debt. We intend to continue to target a 50:50 euro to U.S. dollar liability split under our long term debt agreements which would match our underlying cash inflows, to manage our exposure to foreign exchange risk in the financial markets.

Credit Risk Management

We attempt to minimize credit exposure to counterparties by generally entering into derivative contracts with counterparties that have an “A” (or equivalent) credit rating. The counterparties to these contracts are major financial institutions. Exposure to credit risk in the event of nonperformance by any of the counterparties is limited to the fair value of contracts in net asset positions, which totaled $1.7 as of June 30, 2019. Accordingly, management believes risk of material loss under these hedging contracts is remote.

Inflation Risk

To date, we do not believe inflation has had a material effect on our business, financial condition or results of operations. However, if our costs were to become subject to significant inflationary pressures in the future, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities.

Off-Balance Sheet Arrangements

We had no material off-balance sheet arrangements as of June 30, 2019 and 2018.

Critical Accounting Policies

We prepare our Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles. The preparation of these Consolidated Financial Statements requires us to make estimates, assumptions and judgments that affect

the reported amounts of assets, liabilities, revenues and expenses and related disclosures. These estimates and assumptions can be subjective and complex and, consequently, actual results may differ from those estimates that would result in material changes to our operating results and financial condition. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our most critical accounting policies relate to revenue recognition, the assessment of goodwill, other intangible and long-lived assets for impairment, business combinations, inventory, pension benefit costs, income taxes and the valuation of redeemable noncontrolling interests.

Our management has discussed the selection of significant accounting policies and the effect of estimates with the Audit and Finance Committee of our Board of Directors.

Revenue Recognition

Net revenues comprise gross revenues less customer discounts and allowances, actual and expected returns (estimated based on an analysis of historical experience and position in product life cycle) and various trade spending activities. Trade spending activities represent variable consideration promised to the customer and primarily relate to advertising, product promotions and demonstrations, some of which involve cooperative relationships with customers. The costs of trade spend activities are estimated considering all reasonably available information, including contract terms with the customer, the Company’s historical experience and its current expectations of the scope of the activities, and is reflected in the transaction price when sales are recorded. For additional information on our revenue accounting policies, see Note 2—Summary of Significant Accounting Policies. Returns represent 2%, 2% and 2% of gross revenue after customer discounts and allowances in fiscal 2019, 2018 and 2017, respectively. Trade spending activities recorded as a reduction to gross revenue after customer discounts and allowances represent 8%, 8%, and 7% in fiscal 2019, 2018 and 2017, respectively.

Our sales return accrual reflects seasonal fluctuations, including those related to the holiday season in the first half of our fiscal year. This accrual is a subjective critical estimate that has a direct impact on reported net revenues, and is calculated based on history of actual returns, estimated future returns and information provided by retailers regarding their inventory levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The types of known or anticipated events that we have considered, and will continue to consider, include the financial condition of our customers, store closings by retailers, changes in the retail environment, and our decision to continue to support new and existing brands. If the historical data we use to calculate these estimates does not approximate future returns, additional allowances may be required.

Goodwill, Other Intangible Assets and Long-Lived Assets

Goodwill

Goodwill is calculated as the excess of the cost of purchased businesses over the fair value of their underlying net assets. Other intangible assets consist of indefinite-lived trademarks. Goodwill and other indefinite-lived intangible assets are not amortized.

We assess goodwill at least annually as of May 1 for impairment, or more frequently, if certain events or circumstances warrant. We test goodwill for impairment at the reporting unit level, which is the same level as our reportable segments. We identify our reporting units by assessing whether the components of our reporting segments constitute businesses for which discrete financial information is available and management of each reporting unit regularly reviews the operating results of those components.

When testing goodwill for impairment, we have the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as the basis to determine if it is necessary to perform a quantitative goodwill impairment test. In performing our qualitative assessment, we consider the extent to which unfavorable events or circumstances identified, such as changes in economic conditions, industry and market conditions or company specific events, could affect the comparison of the reporting unit’s fair value with its carrying amount. If we conclude that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, we are required to perform a quantitative impairment test.

Quantitative impairment testing for goodwill is based upon the fair value of a reporting unit as compared to its carrying value. We make certain judgments and assumptions in allocating assets and liabilities to determine carrying values for our reporting units. The impairment loss recognized would be the difference between a reporting unit’s carrying value and fair value in an amount not to exceed the carrying value of the reporting unit’s goodwill.

Testing goodwill for impairment requires us to estimate fair values of reporting units using significant estimates and assumptions. The assumptions made will impact the outcome and ultimate results of the testing. We use industry accepted valuation models and set criteria that are reviewed and approved by various levels of management and, in certain instances, we engage independent third-party valuation specialists for advice. To determine fair value of the reporting unit, we used a

combination of the income and market approaches. We believe the blended use of both models compensates for the inherent risk associated with either model if used on a stand-alone basis, and this combination is indicative of the factors a market participant would consider when performing a similar valuation.

Under the income approach, we determine fair value using a discounted cash flow method, projecting future cash flows of each reporting unit, as well as a terminal value, and discounting such cash flows at a rate of return that reflects the relative risk of the cash flows. Under the market approach, we utilize information from comparable publicly traded companies with similar operating and investment characteristics as the reporting units, which creates valuation multiples that are applied to the operating performance of the reporting units being tested, to value the reporting unit.

The key estimates and factors used in these approaches include revenue growth rates and profit margins based on our internal forecasts, our specific weighted-average cost of capital used to discount future cash flows, and comparable market multiples for the industry segment as well as our historical operating trends. Certain future events and circumstances, including deterioration of market conditions, higher cost of capital, a decline in actual and expected consumer consumption and demands, could result in changes to these assumptions and judgments. A revision of these assumptions could cause the fair values of the reporting units to fall below their respective carrying values, resulting in a non-cash impairment charge. Such charge could have a material effect on the Consolidated Statements of Operations and Balance Sheets.

There were no impairments of goodwill at our reporting units in fiscal 2018 or 2017.

During fiscal 2019, we recorded total goodwill impairments of $3,391.1, resulting in remaining goodwill balances as of June 30, 2019 of $1,216.4, $2,921.7 and $935.7, in our Consumer Beauty, Luxury and Professional Beauty reporting units, respectively. The goodwill impairment charge was a result of the following impairment tests:

In the course of evaluating the results for the second quarter of fiscal 2019, we noted that since the previous impairment test, the cash flows associated with our Consumer Beauty reporting unit were adversely impacted by negative category trends and market share losses in the color cosmetics, hair color and mass fragrance categories; additional shelf-space losses for CoverGirl, Clairol, and Max Factor; expected increased costs in the short-term to offset the lower service levels caused by supply chain disruptions; and lower than expected net revenues and profitability for Younique. Additionally, we included the impact of a 75 basis point increase in the discount rate on the valuation model, due to changes in the market assumptions, which adversely affected the fair value of the reporting unit. We concluded that these factors represented indicators of impairment that warranted an interim impairment test for goodwill and certain other intangible assets in the Consumer Beauty reporting unit.

To determine the fair value of our Consumer Beauty reporting unit, we used an updated average annual revenue growth rate of (3.3)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.0%. The result of the interim impairment test showed that the fair value of the reporting unit was lower than its carrying value, resulting in an $832.5 goodwill impairment charge. There were no impairments of goodwill at other reporting units during the interim impairment test in the second quarter of fiscal 2019.

Based on the annual impairment test performed at May 1, 2019, we determined that the fair values of our Luxury and Professional Beauty reporting units exceeded their respective carrying values at that date by approximately 70.4% and 22.5%, respectively. For our Consumer Beauty reporting unit, we determined that the fair value did not exceed the carrying value, and as such we recorded an asset impairment charge of $2,558.6 related to goodwill of the Consumer Beauty reporting unit. The cash flows associated with our Consumer Beauty reporting unit were adversely affected by factors that developed during the fourth quarter of fiscal 2019 including fourth quarter net revenue results and market share trends that were below expectations, continued net revenue and profitability declines for Younique in excess of management’s expectations, and the development of our Turnaround Plan to stabilize operations and improve profitability. The Turnaround Plan impacted the projected cash flows associated with the Consumer Beauty reporting unit by lowering revenue growth and, in the near term, margin expectations. Such changes in our estimated forecasts were based on a top down review of the business which resulted in decisions to simplify the product range as well as identify priority brand-country combinations and invest behind such combinations at scale, which will initially lower net revenues and profits. The Turnaround Plan also considered the latest market data including continued negative category trends in the color cosmetics, hair color and mass fragrance categories that were below expectations and indicated a longer required recovery period. Additionally, the forecast was updated to include the costs of the Turnaround Plan. Overall, these factors negatively impacted the cash flows of the Consumer Beauty reporting unit and resulted in a decrease in our assumed terminal growth rate, which also adversely affected the fair values.

To determine the fair value of our Consumer Beauty reporting unit, we used an updated average annual revenue growth rate of (5.9)% for fiscal 2019 to fiscal 2023, a 1.0% decrease in the terminal growth rate since the second quarter of fiscal 2019, and a discount rate of 8.0%. As the Consumer Beauty reporting unit was impaired, it has a 0% excess and as such, further material negative trends in its actual and expected business performance or an increase in the discount rate may result in further impairments. If the average annual revenue growth rate for fiscal 2019 to fiscal 2023 declined by 1% it may cause an additional impairment of $214.0. If the discount rate increased by 0.5%, it may cause an additional impairment of $195.5.

We believe the assumptions used in calculating the estimated fair value of the reporting units are reasonable. However, we can provide no assurances that we will achieve such projected results. Further, we can provide no assurances that we will not have to recognize additional impairment of goodwill in the future due to other market conditions or changes in our discount rates. Recognition of additional impairment of a significant portion of our goodwill would negatively affect our reported results of our operations and total capitalization.

Other Intangible Assets

We assess indefinite-lived other intangible assets (trademarks) at least annually as of May 1 for impairment, or more frequently if certain events occur or circumstances change that would more likely than not reduce the fair value of an indefinite-lived intangible asset below its carrying value. Trademarks are tested for impairment on a brand level basis.

The trademarks’ fair values are based upon the income approach, primarily utilizing the relief from royalty methodology. This methodology assumes that, in lieu of ownership, a third party would be willing to pay a royalty in order to obtain the rights to use the comparable asset. An impairment loss is recognized when the estimated fair value of the intangible asset is less than the carrying value. Fair value calculation requires significant judgments in determining both the assets’ estimated cash flows as well as the appropriate discount and royalty rates applied to those cash flows to determine fair value. Variations in economic conditions or a change in general consumer demands, operating results estimates or the application of alternative assumptions could produce significantly different results.

The carrying value of our indefinite-lived other intangible assets was $2,729.8 as of June 30, 2019, and is comprised of trademarks for the following brands: OPI of $661.8, CoverGirl of $501.0, the professional product line of Wella of $413.0, Max Factor of $247.0, Sally Hansen of $161.9, philosophy of $156.4, ghd related trademarks of $149.6, Bourjois of $67.0, Clairol of $32.7 and other trademarks totaling $339.4.

On May 1, 2018 and 2017, we performed our annual impairment testing of indefinite-lived other intangible assets and determined that no adjustments to carrying values were required.

During fiscal 2019, we recorded total impairments on our indefinite-lived other intangible assets of $429.1, resulting in a balance as of June 30, 2019 of $1,324.7, $177.4 and $1,227.7 in our Consumer Beauty, Luxury and Professional Beauty reporting units, respectively. The impairment charges were a result of the following impairment tests:

As noted above, in the course of evaluating the results for the second quarter of fiscal 2019, the cash flows associated with the Consumer Beauty reporting unit were adversely impacted during the quarter which warranted an interim impairment test for goodwill and certain other intangible assets in the Consumer Beauty reporting unit. Accordingly, we re-evaluated future cash flows of intangible assets and the impact of a 75 basis point increase to the discount rate. This resulted in asset impairment charges of $90.8 related to indefinite-lived other intangible assets for our CoverGirl, Clairol and a regional Brazilian skin care trademark, and $7.0 related to a finite-lived other intangible asset for a regional hair license agreement.

The fair value of the CoverGirl trademark fell below its carrying value using projections that assumed an average annual growth rate of (3.3)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.5%. The fair value of the Clairol trademark fell below its carrying value using projections that assumed an average annual growth rate of (6.1)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.5%. The fair value of the regional Brazilian skin care trademark fell below its carrying value using projections that assumed an annual growth rate of 7.7% for fiscal 2019 to fiscal 2023 and a discount rate of 13.0%. The regional hair license agreement was concluded to be fully impaired due to on-going shelf space losses.

In addition to the Consumer Beauty reporting unit, we also identified indicators of impairment related to the philosophy trademark that is part of the Luxury reporting unit during the second quarter of fiscal 2019. In addition to the impact of a 75 basis point increase in the discount rate, we considered the impact of lower than expected net revenue growth in the U.S. during the quarter, shelf space losses at key retailers and a decrease in the level of expected profitability of the trademark. We concluded that the fair value of the philosophy trademark fell below its carrying value using projections that assumed an average annual growth rate of 1.2% for fiscal 2019 to fiscal 2023 and a discount rate of 8.5%. This resulted in an asset impairment charge of $22.8.

As part of the May 1, 2019 annual impairment test, we considered the impact of the certain factors on the cash flows of the indefinite-lived other intangible assets associated with the Consumer Beauty reporting unit that developed during the fourth quarter of fiscal 2019. This resulted in asset impairment charges of $201.7 related to indefinite-lived other intangible assets for our CoverGirl, Max Factor, Sally Hansen, Bourjois, Clairol and two regional Brazilian trademarks. These factors included fourth quarter net revenue results below expectations, and the development of our Turnaround Plan to stabilize operations and improve profitability. The Turnaround Plan impacted the projected cash flows associated with our indefinite-lived other intangible assets by lowering revenue growth and, in the near term, margin expectations. Such changes in our estimated forecasts were based on a top down review of the business which resulted in decisions to simplify the product range as well as identify priority brand-country combinations and invest behind such combinations at scale, which will initially lower net revenues and profits. The Turnaround Plan also considered the latest market data including continued negative category trends

in the color cosmetics, hair color and mass fragrance categories that were below expectations and indicated a longer required recovery period. Overall, these factors negatively impacted the cash flows of our indefinite-lived other intangible assets and resulted in a decrease in their assumed terminal growth rates, which also adversely affected their fair values. Additionally we noted the fair values of the indefinite-lived other intangible assets were adversely impacted by an additional 25 basis point increase to the discount rate due to changes in market assumptions. Based on results of the test, the fair value of the Max Factor trademark fell below its carrying value using projections that assumed an average annual growth rate of (4.8)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.75%. The fair value of the Bourjois trademark fell below its carrying value using projections that assumed an average annual growth rate of (14.9)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.75%. The fair value of the CoverGirl trademark fell below its carrying value using projections that assumed an average annual growth rate of (2.2)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.75%. The fair value of the Sally Hansen trademark fell below its carrying value using projections that assumed an average annual growth rate of (4.9)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.75%. The fair value of the Clairol trademark fell below its carrying value using projections that assumed an average annual growth rate of (5.7)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.75%.

We also noted during the annual impairment test that the cash flows related to the philosophy trademark decreased since the second quarter of fiscal 2019 mainly due to updated projections as a result of a revised strategy for the business developed as part of the Turnaround Plan in the fourth quarter of fiscal 2019 to simplify the product range. The fair value of the philosophy trademark was also adversely affected by a 25 basis point increase in the discount rate for trademarks, since the second quarter of fiscal 2019. This caused the fair value of the philosophy trademark to fall below its carrying value using projections that assumed an average annual growth rate of (6.1)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.75%. This resulted in an asset impairment charge of $86.8.

Further, we noted during the annual impairment test that the cash flows related to the professional product line of Wella trademark were adversely impacted by lower than expected revenue in the U.S. in the fourth quarter of fiscal 2019 and the impact of a 100 basis point increase in the discount rate for the trademark since the fiscal 2018 annual impairment test. This caused the fair value of the professional product line of Wella trademark to fall below its carrying value using projections that assumed an average annual growth rate of (1.0)% for fiscal 2019 to fiscal 2023 and a discount rate of 8.75%. This resulted in an asset impairment charge of $27.0.

As the impaired indefinite-lived intangible assets have a 0% excess, further material negative trends in the actual and expected business performance or an increase in the discount rate may result in further impairments. For instance, with regards to our CoverGirl trademark, our largest impaired indefinite-lived intangible asset, if the average annual revenue growth rate for fiscal 2019 to fiscal 2023 declined by 1% it may cause an additional impairment of $26.0. If the discount rate increased by 0.5%, it may cause an additional impairment of $31.0. With regards to our professional product line of Wella trademark, our second largest impaired indefinite-lived intangible asset, if the average annual revenue growth rate for fiscal 2019 to fiscal 2023 declined by 1% it may cause an additional impairment of $21.0. If the discount rate increased by 0.5%, it may cause an additional impairment of $24.0.

As of May 1, 2019, we determined that the fair value of our ghd trademark exceeded its carrying value by approximately 5.4% using projections that assumed an average annual revenue growth rate of 5.8% for fiscal 2019 to fiscal 2023 and a discount rate of 10.5%. The fair value of the ghd trademark would fall below its carrying value if the average annual revenue growth rate decreased by approximately 96 basis points or the discount rate increased by 45 basis points.

The fair values of the remaining indefinite-lived trademarks exceeded their carrying values by amounts ranging from 27.1% to more than 100%.

We believe the assumptions used in calculating the estimated fair value of the trademarks are reasonable and attainable. However, we can provide no assurances that we will not have to recognize additional impairment of indefinite-lived intangible assets in the future due to other market conditions or changes in our discount rates. Recognition of additional impairment of a significant portion of our indefinite-lived intangible assets would negatively affect our reported results of operations and total capitalization.

Long-Lived Assets

Long-lived assets, including tangible and intangible assets with finite lives, are amortized over their respective lives to their estimated residual values and are also reviewed for impairment whenever certain triggering events may indicate impairment. When such events or changes in circumstances occur, a recoverability test is performed comparing projected undiscounted cash flows from the use and eventual disposition of an asset or asset group to its carrying value. If the projected undiscounted cash flows are less than the carrying value, an impairment would be recorded for the excess of the carrying value over the fair value, which is determined by discounting future cash flows.

During fiscal 2019 and 2018, we recorded asset impairment charges of $27.8 and $15.6, respectively, primarily relating to the planned disposal of certain manufacturing facilities, and the write-off of machinery and equipment in excess of our needs

due to our Global Integration Activities. The impairment charges are included in Restructuring costs in the Consolidated Statements of Operations. There were no impairments on long-lived assets in fiscal 2017.

Business Combinations

We allocate the cost of an acquired business to the assets acquired and liabilities assumed based on their estimated fair values as of the date of acquisition. The excess value of the cost of an acquired business over the estimated fair value of the assets acquired and liabilities assumed is recognized as goodwill. The valuation of the acquired assets and liabilities will impact our future operating results, as we recognize depreciation and amortization expense on long-lived assets. We use a variety of information sources to determine the value of acquired assets and liabilities including: third-party appraisers for the values and lives of property, identifiable intangibles and inventories; and legal counsel or other experts to assess the obligations and liabilities associated with legal, environmental or other claims.

Significant judgment is required in estimating the fair value of intangible assets and in assigning their respective useful lives. The fair value estimates are based on historical information and on future expectations and assumptions deemed reasonable by management, but are inherently uncertain. Determining the useful life of an intangible asset also requires judgment. Certain brand intangibles are expected to have indefinite lives based on their history and our plans to manage the acquired brands. Other intangible assets are expected to have determinable useful lives. Our assessment of intangible assets that have an indefinite life and those that have a determinable life is based on a number of factors including the competitive environment, market share, brand history, underlying product life cycles, operating plans and the macroeconomic environment. The costs of determinable-lived intangible assets are amortized to expense over the estimated useful life.

We generally use the following methodologies for valuing our significant acquired intangibles assets:


•	Trademarks (indefinite or finite) - We use a relief from royalty method to value trademarks. The key assumptions for the model are forecasted net revenue, the royalty rate, the effective tax rate and the discount rate.


•	Customer relationships and license agreements - We use an excess earnings method to value customer relationships. The key assumptions for the model are forecasted net revenue and earnings before interest, taxes, depreciation and amortization (“EBITDA”), the estimated allocation of earnings between different classes of assets, the attrition rate, the effective tax rate and the discount rate.

Inventory

Inventories include items which are considered salable or usable in future periods, and are stated at the lower of cost or net realizable value, with cost being based on standard cost which approximates actual cost on a first-in, first-out basis. Costs include direct materials, direct labor and overhead (e.g., indirect labor, rent and utilities, depreciation, purchasing, receiving, inspection and quality control) and in-bound freight costs. We classify inventories into various categories based upon their stage in the product life cycle, future marketing sales plans and the disposition process.

We also record an inventory obsolescence reserve, which represents the excess of the cost of the inventory over its estimated net realizable value, based on various product sales projections. This reserve is calculated using an estimated obsolescence percentage applied to the inventory based on age, historical trends, and requirements to support forecasted sales. In addition, and as necessary, we may establish specific reserves for future known or anticipated events. These estimates could vary significantly, either favorably or unfavorably, from the amounts that we may ultimately realize upon the disposition of inventories if future economic conditions, customer inventory levels, product discontinuances, sales return levels, competitive conditions or other factors differ from our estimates and expectations.

Pension Benefit Costs

We sponsor both funded and unfunded pension plans in various forms covering employees who meet the applicable eligibility requirements. We use several statistical and other factors in an attempt to estimate future events in calculating the liability and expense related to these plans. Certain significant variables require us to make assumptions such as anticipated discount rate and expected rate of return on plan assets. We evaluate these assumptions with our actuarial advisors and select assumptions that we believe reflect the economics underlying our pension obligations. While we believe these assumptions are within accepted industry ranges, an increase or decrease in the assumptions or economic events outside our control could have a material impact on reported net income.

The discount rates used to measure the benefit obligations at the measurement date and the net periodic benefit cost for the subsequent fiscal year are reset annually using data available at the measurement date.

The long-term rates of return on our pension plan assets are based on management’s expectations of long-term average rates of return to be achieved by the underlying investment portfolios. In establishing this assumption, management considers historical and expected returns for the assets in which the plan is invested, as well as current economic and market conditions. The difference between actual and expected return on plan assets is reported as a component of accumulated other

comprehensive income (loss). Those gains or losses that are subject to amortization over future periods will be recognized as a component of the net periodic benefit cost in such future periods. In fiscal 2019, our pension plans had actual returns on assets of $3.5 as compared with expected return on assets of $8.2, which resulted in a net deferred gain/(loss) of $(4.7), substantially all of which is currently subject to be amortized over periods ranging from approximately 9 to 28 years. The actual return on assets was primarily related to the performance of equity markets during the past fiscal year.

The weighted-average assumptions used to determine our projected benefit obligation were as follows:



	Pension Plans
	U.S.		International
	2019	2018	2019	2018
Discount rates	3.2%-3.6%	4%	0.4%-8.4%	0.6%-8.0%

The weighted-average assumptions used to determine our net periodic benefit cost during the fiscal year were as follows:



	Pension Plans
	U.S.			International
	2019	2018	2017	2019	2018	2017
Discount rates	4.0%	3.6%	3.3%-3.8%	0.6%-8.0%	0.4%-7.5%	0.2%-7.8%
Expected long-term rates of return on plan assets	N/A	N/A	N/A	2.0%-8.4%	1.8%-8.2%	1.6%-6.0%

The actuarial assumptions used by us may differ materially from actual results due to changing market and economic conditions. Differences from these assumptions could significantly impact the actual amount of net periodic benefit cost and liability recorded by us.

Income Taxes

We are subject to income taxes in the U.S. and various foreign jurisdictions. We account for income taxes under the asset and liability method. Therefore, income tax expense is based on reported income before income taxes, and deferred income taxes reflect the effect of temporary differences between the amounts of assets and liabilities that are recognized for financial reporting purposes and the amounts that are recognized for income tax purposes. Deferred taxes are recorded at currently enacted statutory tax rates and are adjusted as enacted tax rates change.

A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount that is more likely than not to be realized based on currently available evidence. We consider how to recognize, measure, present and disclose in financial statements uncertain tax positions taken or expected to be taken on a tax return.

We are subject to tax audits in various jurisdictions. We regularly assess the likely outcomes of such audits in order to determine the appropriateness of liabilities for unrecognized tax benefits. We classify interest and penalties related to unrecognized tax benefits as a component of the provision for income taxes.

For unrecognized tax benefits, we first determine whether it is more-likely-than-not (defined as a likelihood of more than fifty percent) that a tax position will be sustained based on its technical merits as of the reporting date, assuming that taxing authorities will examine the position and have full knowledge of all relevant information. A tax position that meets this more-likely-than-not threshold is then measured and recognized at the largest amount of benefit that is greater than fifty percent likely to be realized upon effective settlement with a taxing authority. As the determination of liabilities related to unrecognized tax benefits, including associated interest and penalties, requires significant estimates to be made by us, there can be no assurance that we will accurately predict the outcomes of these audits, and thus the eventual outcomes could have a material impact on our operating results or financial condition and cash flows.

Unrecognized tax benefits are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of examinations by tax authorities, developments in case law and closing of statute of limitations. Such adjustments are reflected in the provision for income taxes as appropriate. In addition, we are present in approximately 55 tax jurisdictions and we are subject to the continuous examination of our income tax returns by the Internal Revenue Service (IRS) and other tax authorities. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes.

As a result of the 2017 Tax Act changing the U.S. to a modified territorial tax system, the Company no longer asserts that any of its undistributed foreign earnings are permanently reinvested. We do not expect to incur significant withholding or state taxes on future distributions. To the extent there remains a basis difference between the financial reporting and tax basis of an

investment in a foreign subsidiary after the repatriation of the previously taxed income of $4,600.0, the Company is permanently reinvested.

The Tax Act requires a U.S. shareholder of a foreign corporation to include in income its global intangible low-taxed income (“GILTI”). In general, GILTI is described as the excess of a U.S. shareholder’s total net foreign income over a deemed return on tangible assets. As a result of recently released FASB guidance, an entity may choose to recognize deferred taxes for temporary differences expected to reverse as GILTI in future years or an entity can elect to treat GILTI as a period cost and include it in the tax expense of the year it is incurred. As such, we have elected to treat the tax on GILTI as a tax expense in the year it is incurred rather than recognizing deferred taxes.

Redeemable Noncontrolling Interests

Noncontrolling interests, where we may be required to repurchase the noncontrolling interest under a put option or other contractual redemption requirement, are reported in the Consolidated Balance Sheets between liabilities and equity, as redeemable noncontrolling interests (“RNCI”). We adjust the redeemable noncontrolling interests to the higher of the redemption value or the carrying value (the acquisition date fair value adjusted for the noncontrolling interest’s share of net income (loss) and dividends) on each balance sheet date with changes recognized as an adjustment to additional paid-in capital (“APIC”).

Younique

We use an income approach, a market approach or a combination of these approaches to estimate the fair value of the RNCI related to our subsidiary Foundation, which holds a 100% interest in Younique, LLC. The income approach is used to determine the fair value of the Foundation RNCI using a discounted cash flow method, projecting future cash flows of the business, as well as a terminal value, and discounting such cash flows at a rate of return that reflects the relative risk of the cash flows. For the market approach, we use a selected multiple based on comparable companies multiplied by the forecasted cash flows. The key estimates and factors used in this approach include, but are not limited to, revenue growth rates and profit margins based on our internal forecasts and the entity specific weighted-average cost of capital used to discount future cash flows.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

We have operations both within the U.S. and internationally, and we are exposed to market risks in the ordinary course of our business, including the effect of foreign currency fluctuations, interest rate changes and inflation. Information relating to quantitative and qualitative disclosures about these market risks is set forth in under the captions “Foreign Currency Exchange Risk Management,” “Interest Rate Risk Management,” and “Credit Risk Management” within Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources” and is incorporated in this Item 7A by reference.

Item 8. Financial Statements and Supplementary Data.

The information required by this Item appears beginning on page F-1 of this Annual Report on Form 10-K and is incorporated in this Item 8 by reference.

Item 9A. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

Our management, with the participation of our Chief Executive Officer (“CEO”) and our Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2019. Based on the evaluation of our

disclosure controls and procedures as of June 30, 2019, our CEO and CFO concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

We have included our Management Report over Internal Control over Financial Reporting in “Item 15. Exhibits, Financial Statement Schedules” and is incorporated in this Item 9A by reference.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(f) and 15d-15(f) of the Exchange Act during the fourth fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Our management, including our CEO and CFO, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving our objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

PART III

Item 10. Directors, Executive Officers and Corporate Governance.

Directors

Information regarding directors is incorporated by reference to the “Directors” and “Corporate Governance” sections of our proxy statement on Schedule 14A for the 2019 Annual Meeting of Stockholders (the “2019 Proxy Statement”).

Executive Officers

Information regarding executive officers is incorporated by reference to the “Executive Officers” section of our 2019 Proxy Statement.

Section 16(a) Beneficial Ownership Reporting Compliance

This information is incorporated by reference to the “Section 16(a) Beneficial Ownership Reporting Compliance” section of our 2019 Proxy Statement.

Code of Ethics

This information is incorporated by reference to the “Corporate Governance Guidelines and Code of Business Conduct” section of our 2019 Proxy Statement.

Item 11. Executive Compensation.

This information is incorporated by reference to the “Executive Compensation” and “Director Compensation” sections of our 2019 Proxy Statement.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

This information is incorporated by reference to the “Security Ownership of Certain Beneficial Owners and Management” section of our 2019 Proxy Statement.

Item 13. Certain Relationships and Related Transactions, and Director Independence.

This information is incorporated by reference to the “Certain Relationships and Transactions of Related Persons” and “Corporate Governance” section of our 2019 Proxy Statement.

Item 14. Principal Accounting Fees and Services.

This information is incorporated by reference to the “Audit Fees and Other Fees” section of our 2019 Proxy Statement.

PART IV

Item 15. Exhibits, Financial Statement Schedules.

List of documents filed as part of this Report:


(1)	Consolidated Financial Statements and Reports of Independent Registered Public Accounting Firm included herein: See Index on page F-1.


(2)	Financial Statement Schedule: See S-1.


(3)	All other schedules are omitted as they are inapplicable or the required information is furnished in the Company’s Consolidated Financial Statements or the Notes thereto.


(4)	List of Exhibits:



Exhibit Number		Document
2.1		Transaction Agreement dated as of July 8, 2015 among The Procter & Gamble Company, Coty Inc., Galleria Co. and Green Acquisition Sub Inc. (incorporated by reference to Exhibit 2.2 to the Company’s Annual Report on Form 10-K filed on August 17, 2015).*
2.2		Repurchase Letter Agreement dated August 13, 2015 among The Procter & Gamble Company, Coty Inc., Galleria Co. and Green Acquisition Sub Inc. (incorporated by reference to Exhibit 2.3 to the Company’s Annual Report on Form 10-K filed on August 17, 2015).
2.3		Letter Agreement, dated February 19, 2016, by and among The Procter & Gamble Company, the registrant, Galleria Co. and Green Acquisition Sub Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on February 25, 2016).
2.4		Third Amendment to Transaction Agreement, dated May 25, 2016, by and among The Procter & Gamble Company, Coty Inc., Galleria Co. and Green Acquisition Sub Inc. (incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed on May 27, 2016).
2.5		Fourth Amendment to Transaction Agreement, dated August 25, 2016, by and among The Procter & Gamble Company, Coty Inc., Galleria Co. and Green Acquisition Sub Inc. (incorporated by reference to Exhibit 2.5 to Amendment No. 4 to the Company’s Registration Statement on Form S-4, filed on August 25, 2016).*
2.6		Side Letter, dated September 13, 2016, between Coty Inc. and The Procter & Gamble Company (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on November 9, 2016).
2.7		Assignment and Transfer Agreement, dated as of November 2, 2015, by and between JAB Cosmetics B.V. and Coty Inc., including as an exhibit thereto that certain Shares and Trademarks Sale and Purchase Agreement, dated as of November 2, 2015, by and among JAB Cosmetics B.V., Hypermarcas S.A., Cosmed Indústria de Cosméticos e Medicamentos S.A., and as intervening and consenting parties, Novita Distribuição, Armazenamento e Transportes S.A., and Savoy Indústria de Cosméticos S.A. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on November 3, 2015).
2.8		Sale and Purchase Agreement, dated as of October 17, 2016, by and among Coty Inc., Gloria Coinvest 1 L.P., Lion Capital Fund III L.P., Lion Capital Fund III SBS L.P., Lion Capital Fund III (USD) L.P., Lion Capital Fund III SBS (USD) L.P., Ghd Nominees Limited (“GHD”), the management sellers named therein, and the other individual sellers named therein (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on October 17, 2016).*
2.9		Tax Matters Agreement, effective as of October 1, 2016, by and among Coty Inc., The Procter & Gamble Company, Galleria Co. and Green Acquisition Sub Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 3, 2016).
2.10		Contribution Agreement, dated as of January 10, 2017, by and among Coty Inc., Coty US Holdings Inc., Foundation, LLC, Younique, LLC, UEV Holdings, LLC, Aspen Cove Holdings, Inc., each of the other unit holders of Younique, LLC, and Derek Maxfield (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on February 1, 2017).



3.1		Amended and Restated Certificate of Incorporation of Coty Inc. (incorporated by reference to Exhibit 3.1 to Amendment No. 5 of the Company’s Registration Statement on Form S-1 (File No. 333-182420) filed on May 14, 2013)
3.2		Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Coty Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on October 3, 2016).
3.3		Amended and Restated By-Laws (incorporated by reference to Exhibit 3.2 to Amendment No. 4 to the Company’s Registration Statement on Form S-1 (File No. 333-182420) filed on April 24, 2013).
4.1		Specimen Class A Common Stock Certificate of the registrant (incorporated by reference to Exhibit 4.1 to Amendment No. 6 to the Company’s Registration Statement on Form S-1 (File No. 333-182420) filed on May 28, 2013)
4.2		Certificate of Designations of Preferred Stock, Series A, dated April 17, 2015 (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on April 20, 2015).
4.3		Certificate of Designations of Preferred Stock, Series A-1, dated February 4, 2019 (incorporated by reference to Exhibit 4.3 to the Company’s Quarterly Report on Form 10-Q filed on February 8, 2019).
4.4		Indenture, dated as of April 5, 2018, among Coty Inc., the guarantors named therein, Deutsche Bank Trust Company Americas, as Trustee, Registrar and U.S. Paying Agent with respect to the 2026 Dollar Notes, and Deutsche Bank AG. London Branch, as London Paying Agent with respect to the Euro Notes (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on April 10, 2018).
4.5		Form of 2026 Dollar notes (included in Exhibit 4.4) (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on April 10, 2018).
4.6		Form of 2023 Euro Notes (included in Exhibit 4.4) (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on April 10, 2018).
4.7		Form of 2036 Euro Notes (included in Exhibit 4.4) (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on April 10, 2018).
4.8		Stockholders Agreement, dated as of March 17, 2019, by and among JAB Holdings, Parent, Offeror and the Company (incorporated by reference to Exhibit (e)(17) to the Company’s Solicitation/Recommendation Statement on Schedule 14D-9/A filed on March 18, 2019).
4.9		Description of Securities.
10.1		Credit Agreement, dated as of October 27, 2015, by and among Coty Inc., the other borrowers party thereto from time to time, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, and the other agents from time to time party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 30, 2015).
10.2		Pledge and Security Agreement, dated as of October 27, 2015, by and among Coty Inc., its subsidiaries signatory thereto and any other subsidiary who may become a party thereto and JPMorgan Chase Bank, N.A, as collateral agent (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on October 30, 2015).
10.3		Credit Agreement, dated January 26, 2016, among Galleria Co., as initial borrower, the other borrowers from time to time party thereto, J.P. Morgan Chase Bank, N.A., as administrative agent and collateral agent, and the other agents and lenders party thereto (incorporated by reference to Exhibit 10.4 of Galleria Co.’s Registration Statement on Form S-4 filed on April 22, 2016).
10.4		Guaranty Agreement, dated as of October 27, 2015, by and among Coty Inc., its subsidiaries signatory thereto and any other subsidiary who may become a party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (incorporate by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on October 30, 2015).
10.5		Incremental Assumption Agreement and Amendment No. 1, dated April 8, 2016 to the Credit Agreement, by and among Coty Inc., Coty B.V., certain subsidiaries of Coty Inc. party thereto, the incremental lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 14, 2016).
10.6		Incremental Assumption Agreement and Refinancing Amendment to Credit Agreement, dated as of October 28, 2016, among Coty Inc., Coty B.V., the other loan parties party thereto, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 28, 2016).
10.7		Amended and Restated Credit Agreement, dated as of April 5, 2018, by and among Coty Inc., Coty B.V., the other borrowers party thereto from time to time, the lenders and other parties from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 10, 2018).



10.8		Amendment No. 1, dated June 27, 2019, to the Amended and Restated Credit Agreement, dated April 5, 2018, by and among Coty Inc., Coty B.V., the other borrowers party thereto from time to time, the lenders and other parties from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 1, 2019).
10.9		Registration Rights Agreement, dated April 1, 2015, between Coty Inc. and Mousseluxe S.a.r.l. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 1, 2015).
10.10		Transition Services Agreement, effective as of October 1, 2016, by and between The Procter & Gamble Company and Galleria Co. (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on October 3, 2016).
10.11		Incremental Facility Activation Notice, dated as of October 28, 2016, among Coty Inc., each incremental term A lender and JPMorgan Chase Bank, N.A. as administrative agent (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on October 28, 2016).
10.12		Employment Agreement, dated June 20, 2016, between Coty Services UK Limited and Patrice de Talhouët (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on From 8-K filed on June 24, 2016).†
10.13		Employment Agreement, dated January 2014, between Coty Geneva S.A. Versoix and Mario Reis (incorporated by reference to Exhibit 10.22 to the Company’s Annual Report on Form 10-K filed on August 28, 2014).†
10.14		Employment Agreement, dated July 20, 2016, by and between Camillo Pane and Coty Services UK Limited, as amended October 24, 2016 (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed on October 28, 2016).†
10.15		Open-Ended Employment Agreement, dated August 24, 2015, between Coty S.A.S. and Sebastien Froidefond (incorporated by reference to Exhibit 10.58 to the Company’s Current Report on Form 8-K filed on November 5, 2015).†
10.16		Side Letter, dated as of March 31, 2017, between Coty Services UK Limited and Sébastien Froidefond (incorporated by reference to Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q filed on May 10, 2017).†
10.17		Offer Letter, dated as of April 1, 2016, between Ayesha Zafar and the Company (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 11, 2016).†
10.18		Employment Agreement, dated October 12, 2015, between Coty Geneva SA Versoix and Sylvie Moreau (incorporated by reference to Exhibit 10.30 to the Company’s Quarterly Report on Form 10-Q filed on February 4, 2016).†
10.19		Employment Agreement, dated November 2, 2015, between Coty S.A.S. and Edgar Huber (incorporated by reference to Exhibit 10.31 to the Company’s Quarterly Report on Form 10-Q filed on February 4, 2016).†
10.20		Employment Agreement, dated as of October 11, 2016, between Coty Services UK Limited and Greerson McMullen (incorporated by reference to Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q filed on February 9, 2017).†
10.21		Employment Agreement, dated as of January 16, 2017, between Coty Inc. and Laurent Kleitman (incorporated by reference to Exhibit 10.26 to the Company’s Annual Report on Form 10-K filed on August 23, 2017).†
10.22		Separation Agreement, dated as of February 1, 2019, between Coty Inc. and Laurent Kleitman (incorporated by reference to Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q filed on May 8, 2019).†
10.23		Employment Agreement, dated as of February 12, 2018, between Coty Services U.K. Limited and Esra Erkal-Paler (incorporated by reference to Exhibit 10.21 to the Company’s Annual Report on Form 10-K filed on August 21, 2018).†
10.24		Offer Letter, dated as of September 4, 2017, between Daniel Ramos and the Company (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on November 9, 2017).†
10.25		Employment Agreement, dated November 12, 2018, between Coty Services UK Limited and Pierre Laubies (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K on November 14, 2018).†
10.26		Employment Agreement, dated February 1, 2019, between Coty SAS and Pierre-André Terisse.(incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on May 8, 2019).†
10.27		Offer Letter, dated as of January 7, 2019, between Gianni Pieraccioni and Coty Inc. (incorporated by reference to Exhibit (e)(10) to the Company’s Solicitation/Recommendation Statement on Schedule 14D-9 filed on February 27, 2019).†
10.28		Offer Letter, dated January 10, 2019, between Coty Services UK Limited and Luc Volatier (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q filed on May 8, 2019).†



10.29		Form of Indemnification Agreement between the registrant and its directors and officers (incorporated by reference to Exhibit 10.24 to Amendment No. 4 to the Company’s Registration Statement on Form S-1(File No. 333-182420) filed on April 24, 2013).
10.30		Amended and Restated Annual Performance Plan, as of February 1, 2017 (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q filed on May 10, 2017).†
10.31		Adoption of Amendments to Pre-2008 Stock Options Granted Under the Coty Inc. 2007 Stock Plan for Directors Or the Coty Inc. Stock Plan for Non-Employee Directors (applicable to awards outstanding on September 14, 2010) (incorporated by reference to Exhibit 10.40 to Amendment No. 4 to the Company’s Registration Statement on Form S-1 (File No. 333-182420) filed on April 24, 2013).†
10.32		Form of Restricted Stock Unit Award under Coty Inc. 2007 Stock Plan for Directors, as amended on April 8, 2013 (incorporated by reference to Exhibit 10.41 to Amendment No. 4 to the Company’s Registration Statement on Form S-1 (File No. 333-182420) filed on April 24, 2013).†
10.33		Amended and Restated Coty Inc. Equity and Long-Term Incentive Plan, as amended and restated on February 1, 2017 (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed on May 10, 2017).†
10.34		Restricted Stock Unit Award Terms and Conditions Under Coty Inc. Equity and Long-Term Incentive Plan, as amended and restated on April 8, 2013 (incorporated by reference to Exhibit 10.44 to Amendment No. 4 to the Company’s Registration Statement on Form S-1 (File No. 333-182420) filed on April 24, 2013).†
10.35		Restricted Stock and Restricted Stock Unit Tandem Award Terms and Conditions under the Coty Inc. Equity and Long-Term Incentive Plan, as amended and restated on April 8, 2013 (incorporated by reference to Exhibit 10.45 to Amendment No. 4 to the Company’s Registration Statement on Form S-1 (File No. 333-182420) filed on April 14, 2013).†
10.36		Form of Subscription Agreement for Series A Preferred Stock (incorporated by reference to Exhibit 10.55 to the Company’s Annual Report on Form 10-K filed on August 17, 2015).†
10.37		Subscription Agreement, dated as of November 23, 2016, between Coty Inc. and Camillo Pane (incorporated by reference to Exhibit 10.10 to the Company’s Quarterly Report on Form 10-Q filed on February 9, 2017).†
10.38		Subscription Agreement, dated as of February 16, 2017, between Coty Inc. and Sébastien Froidefond (incorporated by reference to Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q filed on May 10, 2017).†
10.39		Subscription Agreement, dated as of March 27, 2017, between Coty Inc. and Lambertus J.H. Becht (incorporated by reference to Exhibit 10.8 to the Company’s Quarterly Report on Form 10-Q filed on May 10, 2017).†
10.40		Amended Form of Elite Subscription and Stock Option Agreement (incorporated by reference to Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q filed on May 10, 2017).†
10.41		Form of Phantom Unit Award Terms and Conditions (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 5, 2014).†
10.42		Terms and Conditions Performance Stock Options under Coty Inc. Equity and Long-Term Incentive Plan, as amended and restated on October 28, 2015 (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on February 8, 2018).†
10.43		Side Letter, dated as of November 29, 2017, between Coty Services UK Limited and Camillo Pane (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed on February 8, 2018).†
10.44		Side Letter, dated November 29, 2017, between Coty Services UK Limited and Patrice de Talhouët (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q filed on February 8, 2018).†
10.45		Form of Subscription Agreement for Series A-1 Preferred Stock†
10.46		Terms and Conditions of 2019 Incentive Stock Options under Coty Inc. Equity and Long-Term Incentive plan.†
21.1		List of significant subsidiaries.
23.1		Consent of Deloitte & Touche LLP.
24.1		Power of Attorney (included in signature page).
31.1		Certification of Chief Executive Officer, pursuant to Rules 13a-14a and 15d-14(a)
31.2		Certification of Chief Financial Officer, pursuant to Rules 13a-14(d) and 15d-14(d)
32.1		Certification of Chief Executive Officer, pursuant to 18 U.S. C. Section 1350
32.2		Certification of Chief Financial Officer, pursuant to 18 U.S. C. Section 1350



101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		XBRL Taxonomy Extension Labels Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document
*	Schedules and similar attachments have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementary to the Securities and Exchange Commission a copy of any omitted schedule or similar attachment upon request.
†	Exhibit is a management contract or compensatory plan or arrangement.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of New York, New York on August 28, 2019.



		COTY INC.
		By:	/s/Pierre-André Terisse
			Name: Pierre-André Terisse
			Title: Chief Financial Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Greerson G. McMullen, as his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that all said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated:



Signature	Title	Date

/s/Pierre Laubies	Chief Executive Officer and Director (Principal Executive Officer)	August 28, 2019
(Pierre Laubies)		August 28, 2019
/s/Pierre-André Terisse	Chief Financial Officer (Principal Financial Officer)	August 28, 2019
(Pierre-André Terisse)	Chief Financial Officer (Principal Financial Officer)	August 28, 2019
/s/Ayesha Zafar	Senior Vice President, Group Controller (Principal Accounting Officer)	August 28, 2019
(Ayesha Zafar)		August 28, 2019
/s/Peter Harf	Chairman of the Board of Directors	August 28, 2019
(Peter Harf)	Chairman of the Board of Directors	August 28, 2019
/s/Sabine Chalmers	Director	August 28, 2019
(Sabine Chalmers)	Director	August 28, 2019
/s/Joachim Faber	Director	August 28, 2019
(Joachim Faber)	Director	August 28, 2019
/s/Olivier Goudet	Director	August 28, 2019
(Olivier Goudet)	Director	August 28, 2019
/s/Anna-Lena Kamenetzky	Director	August 28, 2019
(Anna-Lena Kamenetzky)	Director	August 28, 2019
/s/Paul Michaels	Director	August 28, 2019
(Paul Michaels)	Director	August 28, 2019
/s/Erhard Schoewel	Director	August 28, 2019
(Erhard Schoewel)	Director	August 28, 2019
/s/Robert Singer	Director	August 28, 2019
(Robert Singer)	Director	August 28, 2019

Table of Contents

MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

Coty’s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) of the Securities Exchange Act of 1934) to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America ("GAAP"). Coty’s internal control over financial reporting includes those policies and procedures that:

(i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets;

(ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors; and

(iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.

Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Coty’s management evaluated the effectiveness of internal control over financial reporting as of June 30, 2019 based on the criteria established in “Internal Control - Integrated Framework (2013)” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on the evaluation, management has concluded that Coty maintained effective internal control over financial reporting as of June 30, 2019.

The Company's internal control over financial reporting as of June 30, 2019 has been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their attestation report which appears herein.



/s/Pierre Laubies		/s/Pierre-André Terisse
Pierre Laubies		Pierre-André Terisse
Chief Executive Officer and Director		Chief Financial Officer

August 28, 2019

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and the Board of Directors of Coty Inc.

Opinion on Internal Control over Financial Reporting

We have audited the internal control over financial reporting of Coty Inc. and subsidiaries (the “Company”) as of June 30, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of June 30, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by COSO.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements, and financial statement schedule as of and for the year ended June 30, 2019 of the Company and our report dated August 28, 2019 expressed an unqualified opinion on those financial statements and financial statement schedule.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Deloitte & Touche LLP

New York, New York

August 28, 2019

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and the Board of Directors of Coty Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Coty Inc. and subsidiaries (the "Company") as of June 30, 2019 and 2018, the related consolidated statements of operations, comprehensive income (loss), equity, and redeemable noncontrolling interests, and cash flows, for each of the three years in the period ended June 30, 2019, and the related notes and the financial statement schedule listed in the Index at Item 15 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2019 and 2018, and the results of its operations and its cash flows for each of the three years in the period ended June 30, 2019, in conformity with accounting principles generally accepted in the United States of America.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of June 30, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated August 28, 2019, expressed an unqualified opinion on the Company's internal control over financial reporting.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Goodwill and Other Indefinite-lived Intangible Assets - Impairment of Consumer Beauty Reporting Unit Goodwill and certain Trademarks - Refer to Notes 2 and 11 to the financial statements

Critical Audit Matter Description

The Company’s evaluation of goodwill for impairment involves the comparison of the fair value of each reporting unit to its carrying value. The Company determines the fair value of its reporting units using a discounted cash flow model and the market approach. The determination of the fair value using the discounted cash flow model requires management to make significant estimates and assumptions related to expected revenue growth rates, expected profit margins, and discount rates. The determination of the fair value using the market approach requires management to make significant assumptions related to comparable market multiples for each reporting unit. Changes in these assumptions could have a significant impact on either the fair value, the amount of any goodwill impairment charge, or both. Management assesses goodwill at least annually as of May 1 for impairment, or more frequently, if certain events or circumstances warrant. The goodwill balance was $5,073.8 million as of June 30, 2019, of which $1,216.4 million was allocated to the Consumer Beauty reporting unit (“Consumer

Beauty”). During fiscal 2019, the Company recognized a $3,391.1 million goodwill impairment charge, as the fair value of Consumer Beauty was lower than its carrying value.

The Company has trademarks that are indefinite-lived intangible assets. The Company’s evaluation of the trademarks for impairment involves the comparison of the fair value of each trademark to its carrying value. Management estimates the fair value of these trademarks annually on its elected assessment date of May 1, 2019, based upon the income approach, using the relief from royalty methodology, which is a specific discounted cash flow method. The determination of the fair values requires management to make significant estimates and assumptions related to the trademarks’ estimated cash flows, royalty rates and discount rates, especially those related to the CoverGirl, Max Factor, Sally Hansen, philosophy, Wella professional and ghd trademarks (“the trademarks”). Changes in these assumptions could have a significant impact on the fair value of the trademarks, the amount of any impairment charge, or both. As of June 30, 2019, the carrying value of the trademarks was $2,729.8 million, of which $501.0 million, $247.0 million, $161.9 million, $156.4 million, $413.0 million and $149.6 million related to the CoverGirl, Max Factor, Sally Hansen, philosophy, Wella professional and ghd trademarks, respectively. During fiscal 2019, the Company recognized trademark impairment charges of $429.1 million (mainly related to CoverGirl, Max Factor, Sally Hansen, philosophy and Wella professional), as the fair values of the trademarks were lower than their carrying values. In addition, the fair value of the ghd trademark exceeded its carrying value by approximately 5.4%.

Given the significant judgments made by management to estimate the fair value of Consumer Beauty’s operations and the impairment charge recorded during the year, performing auditing procedures to evaluate the reasonableness of management’s judgments regarding the business and valuation assumptions utilized in the valuation model, particularly the forecasts of future revenue growth rates and profit margins and the selection of the discount rate, required a high degree of auditor judgment and an increased extent of effort, including the need to involve our fair value specialists. In addition, given the determination of fair values of the trademarks required management to make significant estimates and assumptions relating to the estimated cash flows and the selection of the royalty and discount rates, the impairment charges recorded during the year for the CoverGirl, Max Factor, Sally Hansen, philosophy and Wella professional trademarks, and the difference between fair value and carrying value for the ghd trademark, performing audit procedures to evaluate the reasonableness of such estimates and assumptions required a high degree of auditor judgment and an increased extent of effort, including the need to involve our fair value specialists.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to the forecasts of future revenues and profit margins for Consumer Beauty and estimated cash flows for the trademarks, the selection of the royalty rates for the trademarks, and the selection of the discount rates for Consumer Beauty and the trademarks included the following, among others:


•	We tested the effectiveness of controls over goodwill and indefinite-lived intangible assets, including those over the forecasts of future revenues and profit margins and the selection of the respective discount and royalty rates.


•	We evaluated management’s ability to accurately forecast by comparing actual results in previous years to management’s historical forecasts and by comparing the May and June 2019 forecasts with actual results for those months, for Consumer Beauty and the trademarks, respectively.


•	We evaluated the reasonableness of management’s forecasts of future revenues for Consumer Beauty and forecasts of estimated cash flows for the trademarks, by comparing management’s forecasts with:


◦	Historical cash flows and trends.


◦	Internal communications to management and the Board of Directors.


◦	Forecasted information included in Company press releases, as well as analyst and industry reports of the Company and selected companies in its peer group.


•	We considered the impact of industry and market conditions on management’s forecasts for Consumer Beauty and the trademarks.


•	We evaluated the impact of changes in management’s forecasts from the May 1, 2019 annual measurement date to June 30, 2019.

•

With the assistance of our fair value specialists, we evaluated the discount rates for Consumer Beauty and the trademarks, and royalty rates for the trademarks, including testing the underlying source information and the mathematical accuracy of the calculations, and developing a range of independent estimates and comparing those to the respective discount rates and royalty rates selected by management.


•	With the assistance of our fair value specialists, we evaluated the market approach for Consumer Beauty, including evaluating the reasonableness of the selected guideline public companies and the resulting market multiples calculation, as well as benchmarking the selected multiple for Consumer Beauty against these guideline public companies.

/s/ Deloitte & Touche LLP

New York, New York

August 28, 2019

We have served as the Company’s auditor since 1995.

COTY INC. & SUBSIDIARIES

INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS




Consolidated Statements of Operations		F-1
Consolidated Statements of Comprehensive Income (Loss)		F-2
Consolidated Balance Sheets		F-3
Consolidated Statements of Equity and Redeemable Noncontrolling Interests		F-6
Consolidated Statements of Cash Flows		F-7
Notes to Consolidated Financial Statements		F-9
Financial Statement Schedule:
Schedule II—Valuation and Qualifying Accounts		S-1

COTY INC. & SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except per share data)



	Year Ended June 30,
	2019			2018			2017
Net revenues	$	8,648.5		$	9,398.0		$	7,650.3
Cost of sales	3,306.5			3,607.8			3,028.3
Gross profit	5,342.0			5,790.2			4,622.0
Selling, general and administrative expenses	4,563.9			5,018.1			4,040.7
Amortization expense	353.5			352.8			275.1
Restructuring costs	44.2			173.2			374.8
Acquisition-related costs	—			64.2			355.4
Asset impairment charges	3,851.9			—			—
Loss (gain) on sale of brand assets	—			28.6			(3.1		)
Operating (loss) income	(3,471.5		)	153.3			(420.9		)
Interest expense, net	275.7			265.0			218.6
Loss on early extinguishment of debt	—			10.7			—
Other expense, net	30.9			30.1			18.5
Loss before income taxes	(3,778.1		)	(152.5		)	(658.0		)
Benefit for income taxes	(8.5		)	(24.7		)	(259.5		)
Net loss	(3,769.6		)	(127.8		)	(398.5		)
Net income attributable to noncontrolling interests	2.5			2.0			15.4
Net income attributable to redeemable noncontrolling interests	12.1			39.0			8.3
Net loss attributable to Coty Inc.	$	(3,784.2	)	$	(168.8	)	$	(422.2	)
Net loss attributable to Coty Inc. per common share:
Basic	$	(5.04	)	$	(0.23	)	$	(0.66	)
Diluted	(5.04		)	(0.23		)	(0.66		)
Weighted-average common shares outstanding:
Basic	751.2			749.7			642.8
Diluted	751.2			749.7			642.8

See notes to Consolidated Financial Statements.

F-1

COTY INC. & SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In millions)



	Year Ended June 30,
	2019			2018			2017
Net loss	$	(3,769.6	)	$	(127.8	)	$	(398.5	)
Other comprehensive income (loss):
Foreign currency translation adjustment	(113.2		)	115.7			121.9
Net unrealized derivative gain (loss) on cash flow hedges, net of taxes of $14.0, $(2.2) and $(7.7), respectively	(45.0		)	15.2			41.5
Pension and other post-employment benefits, net of tax of $17.3, $1.5 and $(25.1), respectively	(59.3		)	17.5			80.6
Total other comprehensive (loss) income, net of tax	(217.5		)	148.4			244.0
Comprehensive (loss) income	(3,987.1		)	20.6			(154.5		)
Comprehensive income attributable to noncontrolling interests:
Net income	2.5			2.0			15.4
Foreign currency translation adjustment	0.1			0.5			(0.1		)
Total comprehensive income attributable to noncontrolling interests	2.6			2.5			15.3
Comprehensive income attributable to redeemable noncontrolling interests:
Net income	12.1			39.0			8.3
Comprehensive loss attributable to Coty Inc.	$	(4,001.8	)	$	(20.9	)	$	(178.1	)

See notes to Consolidated Financial Statements.

F-2

COTY INC. & SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In millions, except per share data)



	June 30, 2019			June 30, 2018
ASSETS
Current assets:
Cash and cash equivalents	$	340.4		$	331.6
Restricted cash	40.0			30.6
Trade receivables—less allowances of $48.1 and $81.8, respectively	1,161.2			1,536.0
Inventories	1,153.3			1,148.9
Prepaid expenses and other current assets	577.8			603.9
Total current assets	3,272.7			3,651.0
Property and equipment, net	1,600.6			1,680.8
Goodwill	5,073.8			8,607.1
Other intangible assets, net	7,422.3			8,284.4
Deferred income taxes	146.3			107.4
Other noncurrent assets	149.7			299.5
TOTAL ASSETS	$	17,665.4		$	22,630.2
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	1,732.7		$	1,928.6
Accrued expenses and other current liabilities	1,483.7			1,844.4
Short-term debt and current portion of long-term debt	193.8			218.9
Income and other taxes payable	66.9			52.1
Total current liabilities	3,477.1			4,044.0
Long-term debt, net	7,469.9			7,305.4
Pension and other post-employment benefits	593.5			533.3
Deferred income taxes	652.5			842.5
Other noncurrent liabilities	427.2			388.5
Total liabilities	12,620.2			13,113.7
COMMITMENTS AND CONTINGENCIES (Note 25)
REDEEMABLE NONCONTROLLING INTERESTS	451.8			661.3
EQUITY:
Preferred stock, $0.01 par value; 20.0 shares authorized; 9.4 and 5.0 issued and outstanding, at June 30, 2019 and 2018, respectively	0.1			—
Class A Common Stock, $0.01 par value; 1,000.0 shares authorized, 819.2 and 815.8 issued and 754.2 and 750.7 outstanding at June 30, 2019 and 2018, respectively	8.1			8.1
Additional paid-in capital	10,620.5			10,750.8
Accumulated deficit	(4,541.2		)	(626.2		)
Accumulated other comprehensive (loss) income	(58.8		)	158.8
Treasury stock—at cost, shares: 65.0 at June 30, 2019 and 2018, respectively	(1,441.8		)	(1,441.8		)
Total Coty Inc. stockholders’ equity	4,586.9			8,849.7
Noncontrolling interests	6.5			5.5
Total equity	4,593.4			8,855.2
TOTAL LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY	$	17,665.4		$	22,630.2

See notes to Consolidated Financial Statements.

F-3

COTY INC. & SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EQUITY

AND REDEEMABLE NONCONTROLLING INTERESTS

(In millions)



	Preferred Stock			Class A Common Stock			Class B Common Stock					Additional Paid-in			(Accumulated			Accumulated Other Comprehensive			Treasury Stock				Total Coty Inc. Stockholders’			Noncontrolling			Total			Redeemable Noncontrolling
	Shares	Amount		Shares	Amount		Shares		Amount			Capital			Deficit)			Income (Loss)			Shares	Amount			Equity			Interests			Equity			Interests
BALANCE—July 1, 2016	1.7	$	—	138.7	$	1.4	262.0		$	2.6		$	2,038.4		$	(37.0	)	$	(239.7	)	63.6	$	(1,405.5	)	$	360.2		$	6.9		$	367.1		$	73.3
Issuance of Class A Common Stock for acquisition				409.7	$	4.1						$	9,624.5												$	9,628.6					$	9,628.6
Issuance of Preferred Stock	2.5	$	—																						$	—					$	—
Conversion of Class B to Class A Common Stock				262.0	$	2.6	(262.0	)	$	(2.6	)	$	—												$	—					$	—
Purchase of Class A Common Stock																					1.4	$	(36.3	)	$	(36.3	)				$	(36.3	)
Exercise of employee stock options and restricted stock units and related tax benefits				2.5	$	—						$	22.8												$	22.8					$	22.8
Share-based compensation expense												$	20.0												$	20.0					$	20.0
Dividends ($0.650 per common share)												$	(375.0	)											$	(375.0	)				$	(375.0	)
Net (loss) income															$	(422.2	)								$	(422.2	)	$	15.4		$	(406.8	)	$	8.3
Other comprehensive income (loss)																		$	244.1						$	244.1		$	(0.1	)	$	244.0
Distribution to noncontrolling interests, net												$	—												$	—		$	(10.0	)	$	(10.0	)	$	(32.3	)
Redeemable noncontrolling interest due to business combination (See Note 3)																									$	—					$	—		$	415.9
Reclassification of noncontrolling interest to mandatory redeemable financial interest												$	(40.7	)											$	(40.7	)	$	(9.2	)	$	(49.9	)	$	—
Adjustment of redeemable noncontrolling interests to redemption value												$	(86.8	)											$	(86.8	)				$	(86.8	)	$	86.8
Adjustment to repurchase of redeemable noncontrolling interests																									$	—					$	—		$	(0.9	)
BALANCE—June 30, 2017	4.2	$	—	812.9	$	8.1	—		$	—		$	11,203.2		$	(459.2	)	$	4.4		65.0	$	(1,441.8	)	$	9,314.7		$	3.0		$	9,317.7		$	551.1

See notes to Consolidated Financial Statements.

F-4

COTY INC. & SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EQUITY

AND REDEEMABLE NONCONTROLLING INTERESTS

(In millions)



	Preferred Stock				Class A Common Stock			Additional Paid-in			(Accumulated			Accumulated Other Comprehensive		Treasury Stock				Total Coty Inc. Stockholders’			Noncontrolling		Total			Redeemable Noncontrolling
	Shares		Amount		Shares	Amount		Capital			Deficit)			Income		Shares	Amount			Equity			Interests		Equity			Interests
BALANCE as previously reported—July 1, 2017	4.2		$	—	812.9	$	8.1	$	11,203.2		$	(459.2	)	$	4.4	65.0	$	(1,441.8	)	$	9,314.7		$	3.0	$	9,317.7		$	551.1
Adjustment due to the adoption of ASU 2016-09											8.3									8.3					8.3
BALANCE as adjusted—July 1, 2017	4.2		$	—	812.9	$	8.1	$	11,203.2		$	(450.9	)	$	4.4	65.0	$	(1,441.8	)	$	9,323.0		$	3.0	$	9,326.0		$	551.1
Issuance of Preferred Stock	1.0		—																	—					—
Cancellation of Preferred Stock	(0.2	)	—																	—					—
Exercise of employee stock options and restricted stock units and related tax benefits					2.9	—		22.6												22.6					22.6
Shares withheld for employee taxes								(3.6		)										(3.6		)			(3.6		)
Share-based compensation expense								31.5												31.5					31.5
Dividends ($0.500 per common share)								(377.6		)										(377.6		)			(377.6		)
Net income (loss)											(168.8		)							(168.8		)	2.0		(166.8		)	39.0
Other comprehensive income														147.9						147.9			0.5		148.4
Adjustment due to the adoption of ASU 2018-02											(6.5		)	6.5						—					—
Distribution to noncontrolling interests, net																				—					—			(54.3		)
Dilution of redeemable noncontrolling interest due to additional contribution (See Note 20)								17.0												17.0					17.0			(17.0		)
Additional redeemable noncontrolling interests due to employee grants (See Note 21)								(7.4		)										(7.4		)			(7.4		)	7.4
Proceeds from redeemable noncontrolling interests																				—					—			0.2
Adjustment of redeemable noncontrolling interests to redemption value								(134.9		)										(134.9		)			(134.9		)	134.9
BALANCE—June 30, 2018	5.0		$	—	815.8	$	8.1	$	10,750.8		$	(626.2	)	$	158.8	65.0	$	(1,441.8	)	$	8,849.7		$	5.5	$	8,855.2		$	661.3

See notes to Consolidated Financial Statements.

F-5

COTY INC. & SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EQUITY

AND REDEEMABLE NONCONTROLLING INTERESTS

(In millions)



	Preferred Stock				Class A Common Stock			Additional Paid-in			(Accumulated			Accumulated Other Comprehensive			Treasury Stock				Total Coty Inc. Stockholders’			Noncontrolling			Total			Redeemable Noncontrolling
	Shares		Amount		Shares	Amount		Capital			Deficit)			Income (Loss)			Shares	Amount			Equity			Interests			Equity			Interests
BALANCE as previously reported—July 1, 2018	5.0		$	—	815.8	$	8.1	$	10,750.8		$	(626.2	)	$	158.8		65.0	$	(1,441.8	)	$	8,849.7		$	5.5		$	8,855.2		$	661.3
Revised Adjustment due to the adoption of ASU No. 2016-16 (See Note 2)											(112.6		)								(112.6		)				(112.6		)
Adjustment due to the adoption of ASC 606 (See Note 2)											(18.2		)								(18.2		)				(18.2		)
BALANCE as adjusted—July 1, 2018	5.0		$	—	815.8	$	8.1	$	10,750.8		$	(757.0	)	$	158.8		65.0	$	(1,441.8	)	$	8,718.9		$	5.5		$	8,724.4		$	661.3
Issuance of Preferred Stock	7.9		0.1					0.7													0.8						0.8
Cancellation of Preferred Stock	(3.5	)	—		—	—		—													—						—
Exercise of employee stock options and restricted stock units					1.0	—		5.2													5.2						5.2
Shares withheld for employee taxes								(1.4		)											(1.4		)				(1.4		)
Share-based compensation expense								16.9													16.9						16.9
Dividends declared - Cash and Other ($0.500 per common share)								(347.5		)											(347.5		)				(347.5		)
Dividends settled in Shares of Class A Common Stock					2.4	—		30.6													30.6						30.6
Dividends declared - Stock ($0.125 per Common Share)								(30.6		)											(30.6		)				(30.6		)
Net income (loss)											(3,784.2		)								(3,784.2		)	2.5			(3,781.7		)	12.1
Other comprehensive loss														(217.6		)					(217.6		)	0.1			(217.5		)
Distribution to noncontrolling interests, net								—													—			(1.6		)	(1.6		)	(26.8		)
Additional redeemable noncontrolling interests due to employee grants and other adjustments								(0.6		)											(0.6		)				(0.6		)	1.6
Adjustment of redeemable noncontrolling interests to redemption value								196.4													196.4						196.4			(196.4		)
BALANCE—June 30, 2019	9.4		$	0.1	819.2	$	8.1	$	10,620.5		$	(4,541.2	)	$	(58.8	)	65.0	$	(1,441.8	)	$	4,586.9		$	6.5		$	4,593.4		$	451.8

See notes to Consolidated Financial Statements.

F-6

COTY INC. & SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)



	Year Ended June 30,
	2019			2018			2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(3,769.6	)	$	(127.8	)	$	(398.5	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	736.0			737.0			555.1
Asset impairment charges	3,851.9			—			—
Deferred income taxes	(175.7		)	(101.7		)	(390.0		)
Provision for bad debts	11.6			24.0			23.4
Provision for pension and other post-employment benefits	29.5			32.4			53.6
Share-based compensation	14.8			30.6			24.6
Loss on assets under restructuring programs	27.8			15.6			6.7
Loss (gain) on sale of brand assets	—			28.6			(3.1		)
Loss on early extinguishment of debt	—			10.7			—
Other	43.1			(16.9		)	19.2
Change in operating assets and liabilities, net of effects from purchase of acquired companies:
Trade receivables	344.9			(79.6		)	(279.8		)
Inventories	(21.9		)	(60.0		)	162.3
Prepaid expenses and other current assets	11.5			(107.6		)	(105.7		)
Accounts payable	(127.3		)	159.5			540.9
Accrued expenses and other current liabilities	(378.1		)	(22.5		)	479.2
Income and other taxes payable	66.4			(83.2		)	85.0
Other noncurrent assets	24.5			(17.9		)	23.4
Other noncurrent liabilities	(49.8		)	(7.5		)	(38.8		)
Net cash provided by operating activities	639.6			413.7			757.5
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(426.6		)	(446.4		)	(432.3		)
Payments for business combinations, net of cash acquired	(40.8		)	(278.0		)	(742.6		)
Proceeds from sale of long term assets, including assets under restructuring programs	13.4			36.8			11.3
Net cash used in investing activities	(454.0		)	(687.6		)	(1,163.6		)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from short-term debt, original maturity more than three months	—			—			9.5
Repayments of short-term debt, original maturity more than three months	—			—			(10.2		)
Net proceeds from (repayments of) short-term debt, original maturity less than three months	(21.3		)	21.0			(49.2		)
Proceeds from revolving loan facilities	2,183.3			3,185.5			2,244.4
Repayments of revolving loan facilities	(1,729.1		)	(3,643.2		)	(2,074.4		)
Proceeds from term loans and other long term debt	—			7,467.2			1,075.0
Repayments of term loans and other long term debt	(189.8		)	(6,492.6		)	(136.1		)
Dividend payments	(346.2		)	(375.8		)	(372.6		)
Net proceeds from issuance of Class A Common Stock and Series A Preferred Stock	5.9			22.6			22.8
Payments for purchases of Class A Common Stock held as Treasury Stock	—			—			(36.3		)
Net (payments) proceeds for foreign currency contracts	(0.4		)	12.4			(1.2		)
Distributions to mandatorily redeemable financial interests, redeemable noncontrolling interests and noncontrolling interests	(38.1		)	(66.4		)	(42.3		)
Purchase of additional mandatorily redeemable financial interests, redeemable noncontrolling interests and noncontrolling interests	—			—			(9.8		)
Payment of debt issuance costs	(17.4		)	(55.1		)	(24.4		)
All other	(7.2		)	(6.3		)	—

F-7



Net cash (used in) provided by financing activities	(160.3		)	69.3			595.2
EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH	(7.1		)	(3.9		)	9.2
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	18.2			(208.5		)	198.3
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period	362.2			570.7			372.4
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—End of period	$	380.4		$	362.2		$	570.7
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Cash paid during the year for interest	$	290.7		$	242.8		$	190.2
Cash received during the period for settlement of interest rate swaps (See Note 19)	43.2			—			—
Cash paid during the year for income taxes, net of refunds received	110.3			124.6			90.1
SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING AND INVESTING ACTIVITIES:
Accrued capital expenditure additions	$	109.2		$	158.8		$	106.7
Non-cash stock issued for business combination	—			—			9,628.6
Non-cash debt assumed for business combination	—			—			1,943.0
Non-cash acquisition of additional redeemable noncontrolling interests	—			—			415.9
Non-cash reclassification from noncontrolling interest to mandatorily redeemable financial interest	—			—			49.9
Non-cash contingent consideration for business combination (See Note 3)	—			8.3			—
Non-cash Common Stock dividend	30.6			—			—

See notes to Consolidated Financial Statements.

F-8

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

1. DESCRIPTION OF BUSINESS

Coty Inc. and its subsidiaries (collectively, the “Company” or “Coty”) manufacture, market, sell and distribute branded beauty products, including fragrances, color cosmetics, hair care products and skin & body related products throughout the world. Coty is a global beauty company with a rich entrepreneurial history and an iconic portfolio of brands.

The Company operates on a fiscal year basis with a year-end of June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2019” refer to the fiscal year ending June 30, 2019. When used in this Annual Report on Form 10-K, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation.

The Company’s sales generally increase during the second fiscal quarter as a result of increased demand associated with the winter holiday season. Financial performance, working capital requirements, sales, cash flows and borrowings generally experience variability during the three to six months preceding the holiday season. Product innovations, new product launches and the size and timing of orders from the Company’s customers may also result in variability. The Company also generally experiences an increase in sales during its fourth fiscal quarter in its Professional Beauty segment as a result of higher demand prior to the summer holiday season.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Principles of Consolidation

The accompanying financial statements of the Company are presented on a consolidated basis in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany accounts and transactions have been eliminated in consolidation.

The Company also consolidates majority-owned entities in the United States of America, United Arab Emirates, Kingdom of Saudi Arabia, Malaysia, Indonesia, Philippines, Singapore, Hong Kong, China, South Korea, Thailand and Taiwan where the Company has the ability to exercise controlling influence. Ownership interests of noncontrolling parties are presented as mandatorily redeemable financial interests, noncontrolling interests or redeemable noncontrolling interests, as applicable.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the period reported. Significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, the market value of inventory, the fair value of acquired assets and liabilities associated with acquisitions, pension benefit costs, the assessment of goodwill, other intangible assets and long-lived assets for impairment, income taxes, and the valuation of redeemable noncontrolling interests. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment will be reflected in the Consolidated Financial Statements in future periods.

Cash Equivalents

Cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase.

Restricted Cash

Restricted cash represents funds that are not readily available for general purpose cash needs due to contractual limitations. Restricted cash is classified as a current or long-term asset based on the timing and nature of when or how the cash is expected to be used or when the restrictions are expected to lapse. As of June 30, 2019 and June 30, 2018, the Company had restricted cash of $40.0 and $30.6, respectively, included in Restricted cash in the Consolidated Balance Sheets. The restricted cash balance as of June 30, 2019 primarily provides collateral for certain bank guarantees on rent, customs and duty accounts and also consists of collections on factored receivables that remain unremitted to the factor as of June 30, 2019. Restricted cash is included as a component of Cash, cash equivalents, and restricted cash in the Consolidated Statement of Cash Flows.

F-9

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

Trade Receivables

Trade receivables are stated net of the allowance for doubtful accounts and cash discounts, which is based on the evaluation of the accounts receivable aging, specific exposures, and historical trends. The Company reviews its allowances by assessing factors such as an individual trade receivable aging and customers’ liquidity. Trade receivables are written off on a case-by-case basis, net of any amounts that may be collected.

Inventories

Inventories include items which are considered salable or usable in future periods, and are stated at the lower of cost or net realizable value, with cost being based on standard cost which approximates actual cost on a first-in, first-out basis. Costs include direct materials, direct labor and overhead (e.g., indirect labor, rent and utilities, depreciation, purchasing, receiving, inspection and quality control) and in-bound freight costs. The Company classifies inventories into various categories based upon their stage in the product life cycle, future marketing sales plans and the disposition process.

The Company also records an inventory obsolescence reserve, which represents the excess of the cost of the inventory over its net realizable value, based on various product sales projections. This reserve is calculated using an estimated obsolescence percentage applied to the inventory based on age, historical trends, and requirements to support forecasted sales. In addition, and as necessary, the Company may establish specific reserves for future known or anticipated events.

Property and Equipment and Other Long-lived Assets

Property and equipment is stated at cost less accumulated depreciation or amortization. The cost of renewals and betterments is capitalized and depreciated. Expenditures for maintenance and repairs are expensed as incurred. Property and equipment that is disposed of through sale, trade-in, donation, or scrapping is written off, and any gain or loss on the transaction, net of costs to dispose, is recorded in Gain (loss) on sale of assets. Depreciation and amortization are computed principally using the straight-line method over the following estimated useful lives:



Description	Estimated Useful Lives
Buildings	20-40 years
Marketing furniture and fixtures	3-5 years
Machinery and equipment	2-15 years
Computer equipment and software	2-5 years
Property and equipment under capital leases and leasehold improvements	Lesser of lease term or economic life

Intangible assets with finite lives are amortized principally using the straight-line method over the following estimated useful lives:



Description	Estimated Useful Lives
License agreements	5-34 years
Customer relationships	2-28 years
Trademarks	2-30 years
Product formulations and technology	3-29 years

Long-lived assets, including tangible and intangible assets with finite lives, are tested for recoverability whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. When such events or changes in circumstances occur, a recoverability test is performed comparing projected undiscounted cash flows from the use and eventual disposition of an asset or asset group to its carrying value. If the projected undiscounted cash flows are less than the carrying value, an impairment charge would be recorded for the excess of the carrying value over the fair value. The Company estimates fair value based on the best information available, including discounted cash flows and/or the use of third-party valuations.

Goodwill and Other Indefinite-lived Intangible Assets

Goodwill is calculated as the excess of the cost of purchased businesses over the fair value of their underlying net assets. Goodwill is allocated and evaluated at the reporting unit level, which are the Company’s operating segments. The Company identifies its operating segments by assessing whether the components of the Company’s reportable segments constitute businesses for which discrete financial information is available and management of each operating segment regularly reviews the operating results of those components. The Company has identified three reporting units. Luxury, Consumer Beauty and

F-10

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

Professional Beauty are considered operating segments and each a reporting unit. The Company allocates goodwill to one or more reporting units that are expected to benefit from synergies of the business combination.

Goodwill and other intangible assets with indefinite lives are not amortized, but are evaluated for impairment annually as of May 1 or whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. When testing goodwill for impairment, the Company has the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as the basis to determine if it is necessary to perform a quantitative goodwill impairment test. In performing its qualitative assessment, the Company considers the extent to which unfavorable events or circumstances identified, such as changes in economic conditions, industry and market conditions or company specific events, could affect the comparison of the reporting unit’s fair value with its carrying amount. If the Company concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company is required to perform a quantitative impairment test.

Quantitative impairment testing for goodwill is based upon the fair value of a reporting unit as compared to its carrying value. The Company makes certain judgments and assumptions in allocating assets and liabilities to determine carrying values for its reporting units. To determine fair value of the reporting unit, the Company uses a combination of the income and market approaches. Under the income approach, fair value is determined using a discounted cash flow method, projecting future cash flows of each reporting unit, as well as a terminal value, and discounting such cash flows at a rate of return that reflects the relative risk of the cash flows. Under the market approach, information from comparable publicly traded companies with similar operating and investment characteristics as the reporting units is utilized to create valuation multiples that are applied to the operating performance of the reporting units being tested, to value the reporting unit. The impairment loss recognized would be the difference between a reporting unit’s carrying value and fair value in an amount not to exceed the carrying value of the reporting unit’s goodwill.

Indefinite-lived other intangible assets principally consist of trademarks. The fair values of indefinite-lived other intangible assets are estimated and compared to their respective carrying values. The trademarks’ fair values are based upon the income approach, utilizing the relief from royalty or excess earnings methodology. This methodology assumes that, in lieu of ownership, a third party would be willing to pay a royalty in order to obtain the rights to use the comparable asset. An impairment loss is recognized when the estimated fair value of the intangible asset is less than its carrying value.

Deferred Financing Fees

The Company capitalizes costs related to the issuance of debt instruments, as applicable. Such costs are amortized over the contractual term of the related debt instrument in Interest expense, net using the straight-line method, which approximates the effective interest method, in the Consolidated Statements of Operations.

Noncontrolling Interests and Redeemable Noncontrolling Interests

Interests held by third parties in consolidated majority-owned subsidiaries are presented as noncontrolling interests, which represents the noncontrolling stockholders’ interests in the underlying net assets of the Company’s consolidated majority-owned subsidiaries. Noncontrolling interests that are not redeemable are reported in the equity section of the Consolidated Balance Sheets.

Noncontrolling interests, where the Company may be required to repurchase the noncontrolling interest under a put option or other contractual redemption requirement, are reported in the Consolidated Balance Sheets between liabilities and equity, as redeemable noncontrolling interests. The Company adjusts the redeemable noncontrolling interests to the higher of the redemption value or the carrying value (the acquisition date fair value adjusted for the noncontrolling interest’s share of net income (loss) and dividends) on each balance sheet date with changes recognized as an adjustment to retained earnings, or in the absence of retained earnings, as an adjustment to additional paid-in capital.

Revenue Recognition

On July 1, 2018, the Company adopted ASC 606, Revenue from Contracts with Customers and all related amendments (the “New Revenue Standard”) using the modified retrospective method applied to those contracts which were not completed as of July 1, 2018. Results for reporting periods beginning after July 1, 2018 are presented under the New Revenue Standard, while prior period amounts are not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 605, Revenue Recognition. See section below regarding Recently Adopted Accounting Pronouncements for more information on the impact of the adoption of this standard.

For periods after July 1, 2018, revenue is recognized at a point in time and/or over time when control of the promised goods or services is transferred to the Company’s customers, which usually occurs upon delivery. Revenue is recognized in an amount that reflects the consideration we expect to be entitled to in exchange for transferring those goods or services. At contract inception, the Company assesses the goods and services promised in its contracts with customers and identifies a

F-11

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

performance obligation for each promise to transfer to the customer a good or service (or bundle of goods or services) that is distinct. To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. The Company’s revenue contracts principally represent a performance obligation to sell its beauty products to trade customers and are satisfied when control of promised goods and services is transferred to the customers.

The Company’s payment terms vary by the type and location of its customers and the products offered. The term between invoicing and when payment is due is not significant.

The Company’s sales return accrual reflects seasonal fluctuations, including those related to revenues for the holiday season in the first half of the fiscal year. This accrual is a subjective critical estimate that has a direct impact on reported net revenues, and is calculated based on history of actual returns, estimated future returns and information provided by retailers regarding their inventory levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The types of known or anticipated events that the Company has considered, and will continue to consider, include the financial condition of our customers, store closings by retailers, changes in the retail environment, and our decision to continue to support new and existing brands. Returns represented 2%, 2% and 2% of gross revenue after customer discounts and allowances in fiscal 2019, 2018 and 2017, respectively. Trade spending activities recorded as a reduction to gross revenue after customer discounts and allowances represented 8%, 8%, and 7% in fiscal 2019, 2018 and 2017, respectively.

The Company accounts for certain customer store fixtures as other assets. Such fixtures are amortized using the straight-line method over the period of 3 to 5 years as a reduction of revenue.

For the presentation of the Company’s revenues disaggregated by segment and product category see Note 4—Segment Reporting.

Cost of Sales

Cost of sales includes all of the costs to manufacture the Company’s products. For products manufactured in the Company’s own facilities, such costs include raw materials and supplies, direct labor and factory overhead. For products manufactured for the Company by third-party contractors, such costs represent the amounts invoiced by the contractors. Cost of sales also includes royalty expense associated with license agreements. Additionally, shipping costs, freight-in and depreciation and amortization expenses related to manufacturing equipment and facilities are included in Cost of sales in the Consolidated Statements of Operations.

Selling, General and Administrative Expenses

Selling, general and administrative expenses include advertising and promotional costs and research and development costs. Also included in Selling, general and administrative expenses are share-based compensation, certain warehousing fees, non-manufacturing overhead, personnel and related expenses, rent on operating leases, and professional fees.

Advertising and promotional costs are expensed as incurred and totaled $1,899.5, $2,206.3 and $1,883.3 in fiscal 2019, 2018 and 2017, respectively. Included in advertising and promotional costs are $127.6, $120.9, and $107.4 of depreciation of marketing furniture and fixtures, such as product displays, in fiscal 2019, 2018 and 2017, respectively. Research and development costs are expensed as incurred and totaled $162.8, $174.6 and $139.2 in fiscal 2019, 2018 and 2017, respectively.

Share-Based Compensation

Common Stock

Common shares are available to be awarded for the exercise of phantom units, vested stock options, the settlement of restricted stock units (“RSUs”), and the conversion of Series A and Series A-1 Preferred Stock.

Share-based compensation expense is measured and fixed at the grant date, based on the estimated fair value of the award and is recognized on a straight-line basis, net of estimated forfeitures, over the employee’s requisite service period.

F-12

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

The fair value of stock options is determined using the Black-Scholes valuation model using the assumptions discussed in Note 23—Share-Based Compensation Plans. The fair value of RSUs is determined on the date of grant based on the Company’s stock price.

Preferred Stock

The Company has issued Series A and Series A-1 Preferred Stock that can be converted into Class A Common Stock or settled in cash. Series A and Series A-1 Preferred Stock are accounted for using liability plan accounting to the extent the award is expected to be settled in cash. Accordingly, share-based compensation expense for the portion that is liability accounted is measured based on the fair value of the award on each reporting date and recognized as an expense to the extent earned. Share-based compensation expense for the portion of the grants that the Company is not required to settle in cash is measured based on the estimated fair value of the award at the time it is known that they are going to be settled in shares and is recognized on a straight-line basis, net of estimated forfeitures, over the employee’s requisite service period.

The fair value of Series A and Series A-1 Preferred Stock is determined using the binomial valuation model and the weighted-average assumptions discussed in Note 23—Share-Based Compensation Plans.

Treasury Stock

The Company accounts for treasury stock under the cost method. When shares are reissued or retired from treasury stock they are accounted for at an average price. When treasury stock is re-issued at a price higher than its cost, the difference is recorded as a component of Additional paid-in-capital in the Company’s Consolidated Balance Sheets. When treasury stock is re-issued at a price lower than its cost, the difference is recorded as a reduction of Additional paid-in-capital to the extent that there are treasury stock gains to offset the losses. If there are no treasury stock gains in Additional paid-in-capital, the losses upon re-issuance of treasury stock are recorded as a reduction of Retained earnings in the Company’s Consolidated Balance Sheets.

Income Taxes

The Company is subject to income taxes in the U.S. and various foreign jurisdictions. The Company accounts for income taxes under the asset and liability method. Therefore, income tax expense is based on reported (Loss) income before income taxes, and deferred income taxes reflect the effect of temporary differences between the carrying amounts of assets and liabilities that are recognized for financial reporting purposes and the carrying amounts that are recognized for income tax purposes. A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount that is more likely than not to be realized based on currently available evidence. The Company considers how to recognize, measure, present and disclose in financial statements uncertain tax positions taken or expected to be taken on a tax return.

The Company is subject to tax audits in various jurisdictions. The Company regularly assesses the likely outcomes of such audits in order to determine the appropriateness of liabilities for unrecognized tax benefits (“UTBs”). The Company classifies interest and penalties related to UTBs as a component of the provision for income taxes.

For UTBs, the Company first determines whether it is more-likely-than-not (defined as a likelihood of more than fifty percent) that a tax position will be sustained based on its technical merits as of the reporting date, assuming that taxing authorities will examine the position and have full knowledge of all relevant information. A tax position that meets this more-likely-than-not threshold is then measured and recognized at the largest amount of benefit that is greater than fifty percent likely to be realized upon effective settlement with a taxing authority. As the determination of liabilities related to UTBs and associated interest and penalties requires significant estimates to be made by the Company, there can be no assurance that the Company will accurately predict the outcomes of these audits, and thus the eventual outcomes could have a material impact on the Company’s operating results or financial condition and cash flows.

The Tax Act requires a U.S. shareholder of a foreign corporation to include in income its global intangible low-taxed income (“GILTI”). In general, GILTI is described as the excess of a U.S. shareholder’s total net foreign income over a deemed return on tangible assets. As a result of recently released Financial Accounting Standards Board (“FASB”) guidance, an entity may choose to recognize deferred taxes for temporary differences expected to reverse as GILTI in future years or an entity can elect to treat GILTI as a period cost and include it in the tax expense of the year it is incurred. As such, the Company has elected to treat the tax on GILTI as a tax expense in the year it is incurred rather than recognizing deferred taxes.

F-13

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

Restructuring Costs

Charges incurred in connection with plans to restructure and integrate acquired businesses or in connection with cost-reduction initiatives that are initiated from time to time are included in Restructuring costs in the Consolidated Statements of Operations if such costs are directly associated with an exit or disposal activity, a reorganization, or with integrating an acquired business. These costs can include employee separations, contract and lease terminations, and other direct exit costs. Employee severance and other termination benefits are primarily determined based on established benefit arrangements, local statutory requirements or historical practices. The Company recognizes these benefits when payment is probable and estimable. Additional elements of severance and termination benefits associated with non-recurring benefits are recognized ratably over each employee’s required future service period.

Costs to terminate a contract before the end of its term are recognized and measured at their fair value when the Company gives written notice to the counterparty. For lease terminations, a liability based on the remaining lease rentals, reduced by estimated sublease rentals is measured at the cease-use date. All other costs are recognized as incurred.

Other business realignment costs represent the incremental cost directly related to the restructuring activities which can include accelerated depreciation, professional or consulting fees and other internal costs including compensation related costs for dedicated internal resources. Other business realignment costs are generally recorded in Selling, general and administrative expenses in the Consolidated Statements of Operations.

Charges for accelerated depreciation are recognized on long-lived assets that will be taken out of service before the end of their normal service, in which case depreciation estimates are revised to reflect the use of the asset over its shortened useful life. All other costs are recognized as incurred.

Business Combinations

The Company accounts for business combinations using the acquisition method of accounting. The acquisition method of accounting requires that purchase price, including the fair value of contingent consideration, of the acquisition be allocated to the assets acquired and liabilities assumed using the fair values determined by management as of the acquisition date.

The Company remeasures the fair value of contingent consideration at each reporting period using a probability-adjusted discounted cash flow method based on significant inputs not observable in the market and any change in the fair value from either the passage of time or events occurring after the acquisition date, is recorded in earnings. Contingent consideration payments that exceed the acquisition date fair value of the contingent consideration are reflected as an operating activity in the Consolidated Statements of Cash Flows. Payments made for contingent consideration recorded as part of an acquisition’s purchase price are reflected as financing activities in the Company’s Consolidated Statements of Cash Flows, if paid more than three months after the acquisition date. If paid within three months of the acquisition date, these payments are reflected as investing activities in the Company’s Consolidated Statements of Cash Flows.

The Company generally uses the following methodologies for valuing our significant acquired intangibles assets:


•	Trademarks (indefinite or finite) - The Company uses a relief from royalty method to value trademarks. The key assumptions for the model are forecasted net revenue, the royalty rate, the effective tax rate and the discount rate.

•

Customer relationships and license agreements - The Company uses an excess earnings method to value customer relationships and license agreements. The key assumptions for the model are forecasted net revenue, earnings before interest, taxes, depreciation and amortization (“EBITDA”), the estimated allocation of earnings between different classes of assets, the attrition rate, the effective tax rate and the discount rate.

Fair Value Measurements

The following fair value hierarchy is used in selecting inputs for those assets and liabilities measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company’s assumptions (unobservable inputs). The Company evaluates these inputs and recognizes transfers between levels, if any, at the end of each reporting period. The hierarchy consists of three levels:

Level 1 - Valuation based on quoted market prices in active markets for identical assets or liabilities;

Level 2 - Valuation based on inputs other than Level 1 inputs that are observable for the assets or liabilities either directly or indirectly;

Level 3 - Valuation based on prices or valuation techniques that require inputs that are both significant to the fair value measurement and supported by little or no observable market activity.

F-14

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

The Company has not elected the fair value measurement option for any financial instruments or other assets not required to be measured at fair value on a recurring basis.

Derivative Instruments and Hedging Activities

Refer to Note 19—Derivative Instruments for the Company’s policies for Derivative Instruments and Hedging Activities.

Foreign Currency

Exchange gains or losses incurred on non-financing foreign exchange currency transactions conducted by one of the Company’s operations in a currency other than the operation’s functional currency are reflected in Cost of sales or operating expenses. Net losses of $3.5, $3.9 and $1.5 in fiscal 2019, 2018 and 2017, respectively resulting from non-financing foreign exchange currency transactions are included in the Consolidated Statements of Operations.

Assets and liabilities of foreign operations are translated into U.S. dollars at the rates of exchange in effect at the end of the reporting period. Income and expense items are translated at the average exchange rates prevailing during each reporting period presented. Translation gains or losses are reported as cumulative adjustments in Accumulated other comprehensive income (loss) (“AOCI/(L)”).

Net gains (losses) of $7.6, $8.5 and $(12.8) in fiscal 2019, 2018 and 2017, respectively, resulting from financing foreign exchange currency transactions are included in Interest expense, net in the Consolidated Statements of Operations. Net (losses) of nil, nil and $(1.7) in fiscal 2019, 2018 and 2017, respectively, resulting from acquisition-related foreign exchange currency transactions are included in Other expense, net in the Consolidated Statements of Operations.

Recently Adopted Accounting Pronouncements

On July 1, 2018, the Company adopted ASC 606, Revenue from Contracts with Customers, and all related amendments (the “New Revenue Standard”) using the modified retrospective method applied to those contracts which were not completed as of July 1, 2018. Results for reporting periods beginning after July 1, 2018 are presented under the New Revenue Standard, while prior period amounts are not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 605, Revenue Recognition.

The Company recorded a net increase to its accumulated deficit as of July 1, 2018 (as presented below) due to the cumulative impact of adopting the New Revenue Standard, with the impact primarily related to the timing of accrual for certain customer incentives and markdowns at the time of sell-in and reclassification of certain marketing fixtures expense as a reduction of gross revenue.

The cumulative effects of the revenue accounting changes on the Company's Consolidated Balance Sheet as of July 1, 2018 were as follows:



	June 30, 2018			Adjustments			July 1, 2018
ASSETS
Property and equipment, net	$	1,680.8		$	(6.2	)	$	1,674.6
Deferred income taxes	107.4			0.6			108.0
Other noncurrent assets	299.5			6.9			306.4

LIABILITIES AND EQUITY
Current liabilities:
Accrued expenses and other current liabilities	$	1,844.4		$	20.7		$	1,865.1
Deferred income taxes	842.5			(1.2		)	841.3
Accumulated deficit	(626.2		)	(18.2		)	(644.4		)

The following table summarizes the impacts of adopting the New Revenue Standard on the Consolidated Statements of Operations for fiscal 2019:

F-15

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)



	As reported (New Revenue Standard)			Current period adjustments			As adjusted (previous revenue standard)
Net revenues	$	8,648.5		$	1.8		$	8,650.3
Selling, general and administrative expenses	4,563.9			3.4			4,567.3
Net (loss) income	(3,769.6		)	(1.3		)	(3,770.9		)
Net (loss) income attributable to Coty Inc.	(3,784.2		)	(0.9		)	(3,785.1		)

Net (loss) income attributable to Coty Inc. per common share:
Basic	$	(5.04	)	$	—		$	(5.04	)
Diluted	(5.04		)	—			(5.04		)

In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory, which requires entities to recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. The Company adopted the standard in the first quarter of fiscal 2019 using the modified retrospective transition method and recognized tax expense, as an adjustment to the July 1, 2018 accumulated deficit balance of $7.6 and $120.8 that were previously deferred in Prepaid expenses and other current assets and Other noncurrent assets, respectively. The recognition of this tax expense was partially offset by a previously unrecognized deferred tax asset of $15.8, resulting in a cumulative-effect adjustment of $112.6 as an increase to the July 1, 2018 accumulated deficit balance.

In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, which provides an updated model for determining if acquired assets and liabilities constitute a business. In a business combination, the acquired assets and liabilities are recognized at fair value and goodwill could be recognized. In an asset acquisition, the assets are allocated value based on relative fair value and no goodwill is recognized. The ASU narrows the definition of a business. The Company adopted the standard in the first quarter of fiscal 2019 on a prospective basis. The adoption of this guidance did not have an impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, which simplifies the subsequent measurement of goodwill by eliminating step two from the goodwill impairment test. The Company early adopted the ASU during the first quarter of fiscal 2019. As of July 1, 2018, the adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In March 2017, the FASB issued ASU No. 2017-07, Compensation—Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (“ASU No. 2017-07”), which requires employers to report the service cost component of net periodic benefit cost in the same line item or items as other compensation costs arising from services rendered by the underlying employees during the period. The other components of net periodic benefit cost are required to be reported separately and outside of operating income. In addition, only the service cost component would be eligible for capitalization in assets. The new guidance also allows a practical expedient that permits employers to use the amounts disclosed in its pension and other postretirement benefit plan note for the prior comparative periods as the estimation basis for applying the retrospective presentation requirements. The Company adopted this standard during the first quarter of fiscal 2019 and retrospectively applied it to each prior period presented. In doing so, as a practical expedient, the Company used the prior comparative period Employee Benefit Plans footnote (see Note 18).

The following table presents our results under our historical method of accounting and as adjusted to reflect our adoption of ASU No. 2017-07:

F-16

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)



	Year Ended June 30,
	2018									2017
	As Previously Reported			Effect of Adoption of ASU No. 2017-07			As Adjusted			As Previously Reported			Effect of Adoption of ASU No. 2017-07			As Adjusted
Cost of sales	$	3,608.4		$	(0.6	)	$	3,607.8		$	3,028.5		$	(0.2	)	$	3,028.3
Selling, general and administrative expenses	5,009.6			8.5			5,018.1			4,060.0			(19.3		)	4,040.7
Restructuring costs	173.2			—			173.2			372.2			2.6			374.8
Operating income	161.2			(7.9		)	153.3			(437.8		)	16.9			(420.9		)
Other expense, net	38.0			(7.9		)	30.1			1.6			16.9			18.5
Net income	(127.8		)	—			(127.8		)	(398.5		)	—			(398.5		)

In May 2017, the FASB issued ASU No. 2017-09, Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting, which narrows the scope of changes in grant terms that would require modification accounting. The Company adopted this standard during the first quarter of fiscal 2019 on a prospective basis. The adoption of this standard did not have an effect on the Company’s Consolidated Financial Statements.

In June 2018, the FASB issued ASU No. 2018-07, Compensation—Stock Compensation (Topic 718): Scope of Nonemployee Share-Based Payment Activities, which expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted this standard during the fourth quarter of fiscal 2019 on a modified retrospective basis. The adoption of this standard did not have a material impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40), which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted the standard in the first quarter of fiscal 2019 on a prospective basis. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.

F-17

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

Recently Issued and Not Yet Adopted Accounting Pronouncements



Accounting Standard Update(s)	Topic	Effective Period	Summary
2018-13	Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement	Fiscal 2021 with early adoption permitted.	The FASB issued authoritative guidance that modifies the disclosure requirements by removing, modifying and adding disclosures related to fair value measurements. The Company is evaluating the impact this guidance will have on the Company’s Consolidated Financial Statements and related disclosures.
2018-14	Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans	Fiscal 2021 with early adoption permitted.	The FASB issued authoritative guidance that modifies the disclosure requirements by removing, modifying and clarifying disclosures related to defined benefit plans. The Company is evaluating the impact this guidance will have on the Company’s Consolidated Financial Statements and related disclosures.
2016-13 2018-19	Measurement of Credit Losses on Financial Instruments	Fiscal 2021 with early adoption permitted.	The FASB issued authoritative guidance, which requires that a financial asset (or a group of financial assets) measured at an amortized cost basis be presented at the net amount expected to be collected. This approach to estimating credit losses applies to most financial assets measured at amortized cost and certain other instruments, including but not limited to, trade and other receivables. The Company is evaluating the impact this guidance will have on the Company’s Consolidated Financial Statements and related disclosures.
2016-02 2018-10 2018-11 2018-20	Leases	Fiscal 2020.	In February 2016, the FASB issued ASU No. 2016-02, Leases, which requires lessees to recognize assets and liabilities for most leases. Under the new standard, a lessee should recognize in the Consolidated Balance Sheets a liability to make future lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term. The recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee have not significantly changed from current U.S. GAAP standards. Additional ASUs have since been issued which provide amended and additional guidance for the implementation of ASU No. 2016-02. All related guidance has been codified into, and is now known as, ASC 842, Leases. The new leasing guidance will be effective for the Company in fiscal 2020 with early adoption permitted. The Company has provisionally determined the following: The Company will adopt the standard using the modified retrospective approach whereby it will recognize a transition adjustment at the effective date of ASC 842, July 1, 2019, rather than at the beginning of the earliest comparative period presented. Prior period information will not be restated. In addition, the Company will apply the package of practical expedients permitted under the transition guidance within the new standard, which allows a lessee to carryforward their population of existing leases, the classification of each lease, as well as the treatment of initial direct costs as of the period of adoption. The Company has identified the population of leases to which the guidance applies and has implemented changes in its systems, procedures and controls relating to how lease information is obtained, processed and analyzed. Based on its preliminary assessment, the Company expects that the adoption of this standard will result in a material increase in the lease-related assets and liabilities on its balance sheet, but expects minimal impact to its statement of operations and cash flows.

3. BUSINESS COMBINATIONS

P&G Beauty Business Acquisition

On October 1, 2016, the Company acquired the P&G Beauty Business in order to further strengthen the Company’s position in the global beauty industry. The purchase price was $11,570.4 and consisted of $9,628.6 of total equity consideration and $1,941.8 of assumed debt.

The Company issued 409.7 million shares of common stock to the former holders of Galleria Co. (“Galleria”) (which held the assets of the P&G Beauty Business) common stock, together with cash in lieu of fractional shares. Coty Inc. is considered to be the acquiring company for accounting purposes.

F-18

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

The Company has finalized the valuation of assets acquired and liabilities assumed for the P&G Beauty Business acquisition. The Company recognized certain measurement period adjustments as disclosed below during the quarter ended September 30, 2017. The measurement period for the P&G Beauty Business acquisition closed at the end of the first quarter of fiscal 2018.

The following table summarizes the allocation of the purchase price to the net assets of the P&G Beauty Business as of the October 1, 2016 acquisition date:



	Estimated fair value as previously reported^(a)			Measurement period adjustments^(b)			Final fair value as adjusted			Estimated useful life (in years)
Cash and cash equivalents	$	387.6		$	—		$	387.6
Inventories	465.5			—			465.5
Property, plant and equipment	742.9			(16.9		)	726.0			3 - 40
Goodwill	5,528.4			35.5			5,563.9			Indefinite
Trademarks — indefinite	1,575.0			—			1,575.0			Indefinite
Trademarks — finite	747.7			—			747.7			10 - 30
Customer relationships	1,074.2			18.8			1,093.0			2 - 26
License agreements	2,299.0			12.0			2,311.0			4 - 30
Product formulations	183.8			(10.0		)	173.8			5 - 28
Other net working capital	(23.2		)	—			(23.2		)
Net other assets	64.6			(33.7		)	30.9
Unfavorable contract liabilities	(130.0		)	—			(130.0		)
Pension liabilities	(404.1		)	—			(404.1		)
Deferred tax liability, net	(941.0		)	(5.7		)	(946.7		)
Total purchase price	$	11,570.4		$	—		$	11,570.4

^(a)As previously reported in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2017. The business combination was completed in fiscal 2017.

^(b)The Company recorded measurement period adjustments in the first quarter of fiscal 2018. The measurement period adjustments related to Customer relationships, License agreements and Product formulations, collectively, of $20.8, were a result of changes in assumptions that were used at the date of acquisition for valuation purposes including allocation of costs and synergies. The measurement period adjustments related to Property, plant and equipment and Net other assets of ($16.9) and ($33.7), respectively, primarily related to obtaining new facts and circumstances about acquired assets and liabilities that existed at the acquisition date. The increase to Deferred tax liability, net was primarily a result of the change of the jurisdictional allocation of the tangible and intangible assets. All measurement period adjustments were offset against Goodwill.

Goodwill is primarily attributable to the anticipated company-specific synergies and economies of scale expected from the operations of the combined company. The synergies include certain cost savings, operating efficiencies, and leverage of the acquired brand recognition to be achieved as a result of the P&G Beauty Business acquisition. Goodwill is not expected to be deductible for tax purposes. Goodwill of $1,889.8, $3,188.1 and $486.0 is allocated to the Luxury, Consumer Beauty and Professional Beauty segments, respectively. The allocation of goodwill to segments was based on the relative fair values of expected future cash flows.

ghd Acquisition

On November 21, 2016, the Company completed the acquisition of 100% of the equity interest of Lion/Gloria Topco Limited which held the net assets of ghd (“ghd”) which stands for “Good Hair Day,” a premium brand in high-end hair styling appliances. The ghd acquisition further strengthens the Company’s professional hair category and is included in the Professional Beauty segment’s results after the acquisition date. The total cash consideration paid net of acquired cash and cash equivalents was £430.2 million, the equivalent of $531.5, at the time of closing.

The Company has finalized the valuation of assets acquired and liabilities assumed for the ghd acquisition. The Company recognized certain measurement period adjustments as disclosed below during the six months ended December 31, 2017. The measurement period for the ghd acquisition closed on November 21, 2017.

F-19

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

The following table summarizes the allocation of the purchase price to the net assets of ghd as of the November 21, 2016 acquisition date:



	Estimated fair value as previously reported^(a)			Measurement period adjustments^(b)			Final fair value as adjusted			Estimated useful life (in years)
Cash and cash equivalents	$	7.1		$	—		$	7.1
Inventories	79.6			—			79.6
Property, plant and equipment	10.0			—			10.0			3 - 10
Goodwill	174.4			24.6			199.0			Indefinite
Indefinite-lived other intangible assets	163.8			(14.8		)	149.0			Indefinite
Customer relationships	36.6			(2.3		)	34.3			11 - 25
Technology	146.6			(17.2		)	129.4			11 - 17
Other net working capital	(16.6		)	4.7			(11.9		)
Net other assets	0.9			(0.9		)	—
Deferred tax liability, net	(63.9		)	5.9			(58.0		)
Total purchase price	$	538.5		$	—		$	538.5

^(a)As previously reported in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2017. The business combination was completed in fiscal 2017.

^(b) The Company recorded measurement period adjustments in the first half of fiscal 2018. The measurement period adjustments related to decreases to Technology, Indefinite-lived other intangible assets and Customer relationships of $17.2, $14.8 and $2.3, respectively, and a decrease to the deferred tax liability of $5.9 were a result of changes in assumptions that were used at the date of acquisition for valuation purposes. The measurement period adjustments related to Other net working capital of $4.7 were a result of obtaining new facts and circumstances about acquired accrued expenses that existed as of the acquisition date. All measurement period adjustments were offset against Goodwill.

Goodwill is not expected to be deductible for tax purposes. The goodwill is attributable to expected synergies resulting from integrating ghd’s products into the Company’s existing sales channels. Goodwill of $49.0, $42.0, and $108.0 is allocated to the Luxury, Consumer Beauty and Professional Beauty segments, respectively. The allocation of goodwill to the segments was due to the reduction in corporate and regional overhead allocated to these segments due to the addition of the ghd acquisition.

Younique Acquisition

On February 1, 2017, the Company completed its acquisition of 60% of the membership interest in Foundation, LLC (“Foundation”), which held the net assets of Younique, LLC, a Utah limited liability company (“Younique”), for cash consideration of $600.0, net of acquired cash and assumed debt, and an additional payment of $7.5 for working capital adjustments paid in fiscal 2018. The existing Younique membership holders contributed their 100% membership interest in Younique to Foundation in exchange for a 40% membership interest in Foundation and $607.5 of cash consideration. Younique strengthens the Consumer Beauty segment’s product offerings. The Company accounts for the noncontrolling interest portion of the acquisition as a redeemable noncontrolling interest.

The Company has finalized the valuation of assets acquired and liabilities assumed for the Younique acquisition. The Company recognized certain measurement period adjustments as disclosed below during the nine months ended March 31, 2018. The measurement period for the Younique acquisition closed on February 1, 2018.

F-20

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

The following table summarizes the allocation of the purchase price to the net assets of Younique as of the February 1, 2017 acquisition date:



	Estimated fair value as previously reported^(a)			Measurement period adjustments^(b)			Final fair value as adjusted			Estimated useful life (in years)
Cash and cash equivalents	$	17.5		$	—		$	17.5
Inventories	88.1			—			88.1
Property, plant and equipment	67.1			—			67.1			3 - 8
Goodwill	575.3			(0.3		)	575.0			Indefinite
Trademark — finite	123.0			—			123.0			20
Product formulations	0.6			—			0.6			5
Customer relationships	197.0			—			197.0			7 - 10
Other net working capital	(27.7		)	0.3			(27.4		)
Short-term and long-term debt	(1.2		)	—			(1.2		)
Total equity value	1,039.7			—			1,039.7

Redeemable noncontrolling interest	415.9			—			415.9
Net cash and debt acquired	16.3			—			16.3
Total purchase price	$	607.5		$	—		$	607.5

^(a)As previously reported in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2017. The business combination was completed in fiscal 2017.

^(b)The Company recorded measurement period adjustments in the nine months ended March 31, 2018 to account for an increase in the estimated other net working capital of $0.3 as of the February 1, 2017 acquisition date. This adjustment is offset against Goodwill.

Goodwill is expected to be deductible for tax purposes. The goodwill is attributable to expected synergies resulting from certain manufacturing and supply chain cost savings. Goodwill of $95.0, $420.0 and $60.0 is allocated to the Luxury, Consumer Beauty and Professional Beauty segments, respectively. The allocation of goodwill to the segments was due to the reduction in corporate and regional overhead allocated to these segments due to the addition of the Younique acquisition.

Burberry Beauty Business Acquisition

On October 2, 2017, the Company acquired the exclusive global license rights and other related assets for the Burberry Limited (“Burberry”) luxury fragrances, cosmetics and skincare business (the “Burberry Beauty Business”). The Burberry Beauty Business acquisition further strengthens the Company’s position in the global luxury beauty industry. Total purchase consideration, after post-closing adjustments, was £191.7 million, the equivalent of $256.3, at the time of closing. Included in the purchase price was cash consideration of £183.3 million, the equivalent of $245.1, at the time of closing, in addition to £8.4 million, the equivalent of $11.2, of estimated contingent consideration, at the time of closing.

The aggregate future contingent consideration payments will range from zero to £16.7 million and will be payable on a quarterly basis to Burberry as certain items of inventory transferred to the Company at the acquisition date are subsequently used or sold. The amount of the contingent consideration recorded was estimated as of the acquisition date and is subject to change based on the related inventory usage. The fair value of the contingent consideration was determined by estimating the future inventory usage and corresponding payments over a four-year period, with the contingent payments being made in each of the respective years. The estimate of the portion of contingent consideration payable within twelve months from the June 30, 2019 balance sheet date is recorded in Accrued expenses and other current liabilities and the remainder is recorded in Other noncurrent liabilities in the Consolidated Balance Sheet. From the date of acquisition through the end of fiscal 2019, the Company made £4.8 million in contingent payments.

The Company has finalized the valuation of assets acquired and liabilities assumed for the Burberry Beauty Business acquisition. The Company recognized certain measurement period adjustments as disclosed below during the three months ended September 30, 2018. The measurement period for the Burberry Beauty Business acquisition closed on October 1, 2018.

F-21

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

The following table summarizes the estimated allocation of the purchase price to the net assets of the Burberry Beauty Business as of the October 2, 2017 acquisition date:



	Estimated fair value as previously reported^(a)			Measurement period adjustments^(b)			Estimated fair value as adjusted			Estimated useful life (in years)
Inventories	$	47.9		$	—		$	47.9
Property, plant and equipment	5.8			—			5.8			1 - 3
License and distribution rights	177.8			6.7			184.5			3 - 15
Goodwill	34.9			(9.4		)	25.5			Indefinite
Net other liabilities	(10.1		)	2.7			(7.4		)
Total purchase price	$	256.3		$	—		$	256.3

^(a)As previously reported in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2018.

^(b)The Company recorded measurement period adjustments in the first quarter of fiscal 2019. The measurement period adjustments related to an increase in the value of the License and distribution rights due to changes in assumptions that were used at the date of acquisition for valuation purposes. The measurement period adjustment related to the decrease in net other liabilities acquired was a result of obtaining new facts and circumstances about acquired accrued expenses that existed as of the acquisition date. All measurement period adjustments were offset against Goodwill.

Goodwill is expected to be deductible for tax purposes. The goodwill is attributable to expected synergies resulting from integrating the Burberry Beauty Business products into the Company’s existing sales channels. Goodwill of $12.9, $6.8, and $5.8 is allocated to the Luxury, Consumer Beauty and Professional Beauty segments, respectively. The allocation of goodwill to the segments were due to the reduction in corporate and regional overhead allocated to these segments due to the addition of the Burberry Beauty Business acquisition.

Unaudited Pro Forma Information

The unaudited pro forma financial information in the table below summarizes the combined results of the Company and the P&G Beauty Business and Younique (the “Pro Forma Acquisitions”). The information in the table below is presented to reflect the pro forma results as if the combination of the P&G Beauty Business and Younique occurred on July 1, 2015. The fiscal year ended June 30, 2017 includes pro forma adjustments for the Pro Forma Acquisitions.

The pro forma adjustments include incremental amortization of intangible assets and depreciation adjustment of property, plant and equipment, based on the values of each asset as well as costs related to financing the Pro Forma Acquisitions. The unaudited pro forma information also includes non-recurring acquisition-related costs as well as amortization of the inventory step-up. Pro forma adjustments were tax-effected at the Company’s statutory rates. For the pro forma basic and diluted earnings per share calculation, 409.7 million shares issued in connection with the P&G Beauty Business acquisition were considered as if issued on July 1, 2015. The pro forma information is presented for informational purposes only and may not be indicative of the results of operations that would have been achieved if the acquisitions of the P&G Beauty Business and Younique had taken place on July 1, 2015 or that may occur in the future, and does not reflect future synergies, integration costs, or other such costs or savings. The pro forma information for the fiscal year ended 2017 is as follows:



	Year Ended June 30, 2017 ^(a)
Pro forma Net revenues	$	8,889.2
Pro forma Net (loss) income	(101.2		)
Pro forma Net (loss) income attributable to Coty Inc.	(142.7		)
Pro forma Net (loss) income attributable to Coty Inc. per common share
Basic	$	(0.19	)
Diluted	$	(0.19	)

^(a) For the twelve months ended June 30, 2017, the pro forma information excluded $476.3 of non-recurring acquisition-related costs and $89.6 of amortization of inventory step up, respectively.

F-22

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

4. SEGMENT REPORTING

The Company’s organizational structure is category focused, putting the consumer first, by specifically targeting how and where they shop and what and why they purchase. Operating and reportable segments (referred to as “segments”) reflect the way the Company is managed and for which separate financial information is available and evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. The Company has designated its Chief Executive Officer as the CODM.

The Company has determined that its three divisions are its operating segments and reportable segments. Each division has full end-to-end responsibility to optimize consumers’ beauty experience in the relevant categories and channels. The operating and reportable segments are:

Luxury — primarily focused on prestige fragrances, premium skin care and premium cosmetics;

Consumer Beauty — primarily focused on color cosmetics, retail hair coloring and styling products, mass fragrance, mass skin care and body care;

Professional Beauty — primarily focused on hair and nail care products for professionals.

On July 1, 2019, the Company announced its turnaround plan, which includes planned changes to the reporting structure to the CODM. As part of these reporting structure changes, management expects to move from the current organizational structure into regional commercial business units in Europe, Middle East & Africa (“EMEA”), Americas and Asia Pacific for the combined Luxury and Consumer Beauty businesses. Such regional business units will be supported by central Luxury and Consumer Beauty marketing teams. Professional Beauty is expected to remain a distinct business unit. The Company anticipates that its operating and reporting segments would change upon completion of such reporting structure changes and the related changes in the financial information provided to the CODM, which is expected to occur in the third quarter of fiscal 2020.

Certain revenues and shared costs and the results of corporate initiatives are being managed outside of the three segments by Corporate. The items within Corporate relate to corporate-based responsibilities and decisions and are not used by the CODM to measure the underlying performance of the segments. Corporate primarily includes restructuring costs, costs related to acquisition activities and certain other expense items not attributable to ongoing operating activities of the segments.

With the exception of goodwill and acquired intangible assets, the Company does not identify or monitor assets by segment. The Company does not present assets by reportable segment since various assets are shared between reportable segments. The allocation of goodwill and acquired intangible assets by segment is presented in Note 11—Goodwill and Other Intangible Assets, net.

F-23

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)



	Year Ended June 30,
SEGMENT DATA	2019			2018			2017
Net revenues:
Luxury	$	3,294.3		$	3,210.5		$	2,566.6
Consumer Beauty	3,539.3			4,268.1			3,688.2
Professional Beauty	1,814.9			1,919.4			1,395.5
Total	$	8,648.5		$	9,398.0		$	7,650.3
Depreciation and amortization:
Luxury	$	271.0		$	253.3		$	203.5
Consumer Beauty	329.8			340.4			256.2
Professional Beauty	135.2			143.3			95.4
Corporate	—			—			—
Total	$	736.0		$	737.0		$	555.1
Operating (loss) income:
Luxury	$	232.8		$	248.7		$	158.0
Consumer Beauty	(3,598.7		)	278.9			261.2
Professional Beauty	122.1			119.4			78.5
Corporate	(227.7		)	(493.7		)	(918.6		)
Total	$	(3,471.5	)	$	153.3		$	(420.9	)
Reconciliation:
Operating (loss) income	$	(3,471.5	)	$	153.3		$	(420.9	)
Interest expense, net	275.7			265.0			218.6
Loss on early extinguishment of debt	—			10.7			—
Other expense, net	30.9			30.1			18.5
Loss before income taxes	$	(3,778.1	)	$	(152.5	)	$	(658.0	)

The Company has determined its geographical structure to be North America (Canada and the United States), Europe and ALMEA (Asia, Latin America, the Middle East, Africa and Australia).



	Year Ended June 30,
GEOGRAPHIC DATA	2019		2018		2017
Net revenues:
North America	$	2,656.5	$	2,966.0	$	2,506.9
Europe	3,777.8		4,201.6		3,325.7
ALMEA	2,214.2		2,230.4		1,817.7
Total	$	8,648.5	$	9,398.0	$	7,650.3



	Year Ended June 30,
Long-lived assets:	2019		2018		2017
U.S.	$	5,613.2	$	7,408.5	$	7,662.4
Switzerland	5,444.4		8,000.2		6,899.8
Brazil	712.5		718.2		863.3
All other	2,326.6		2,441.1		3,187.3
Total	$	14,096.7	$	18,568.0	$	18,612.8

For Net revenues, a major country is defined as a group of subsidiaries in a country with combined revenues greater than 10% of consolidated net revenues or as otherwise deemed significant. The United States is the only country that accounts for more than 10% of total net revenues for fiscal years 2019, 2018 and 2017. The United States had net revenues of $2,418.7, $2,704.6 and $2,220.4 in fiscal 2019, 2018 and 2017, respectively.

F-24

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

For Long-lived assets, a major country is defined as a group of subsidiaries within a country with combined long-lived assets greater than 10% of consolidated long-lived assets or as otherwise deemed significant. Long-lived assets include property and equipment, goodwill and other intangible assets.

No customer or group of affiliated customers accounted for more than 10% of the Company’s Net revenues in fiscal 2019, 2018 and 2017 or are otherwise deemed significant.

Presented below are the net revenues associated with Company’s product categories:



	Year Ended June 30,
PRODUCT CATEGORY	2019		2018		2017
Fragrances	39.5	%	36.8	%	36.1	%
Color Cosmetics	26.0	%	28.2	%	29.6	%
Skin & Body Care	9.5	%	10.1	%	12.4	%
Hair Care	25.0	%	24.9	%	21.9	%
Total	100.0	%	100.0	%	100.0	%

5. ACQUISITION-RELATED COSTS

Acquisition-related costs, which are expensed as incurred, represent non-restructuring costs directly related to acquiring and integrating an entity, for both completed and contemplated acquisitions and can include finder’s fees, legal, accounting, valuation, other professional or consulting fees, and other internal costs which can include compensation related expenses for dedicated internal resources. The Company recognized acquisition-related costs of $0.0, $64.2 and $355.4 for the fiscal years ended 2019, 2018 and 2017, respectively, which have been recorded in Acquisition-related costs in the Consolidated Statements of Operations. Acquisition-related costs incurred during the fiscal years ended 2018 and 2017 were primarily related to the P&G Beauty Business acquisition.

6. RESTRUCTURING COSTS

Restructuring costs for the fiscal years ended June 30, 2019, 2018 and 2017 are presented below:



	Year Ended June 30,
	2019			2018			2017
Global Integration Activities	$	28.5		$	106.5		$	365.0
2018 Restructuring Actions	16.8			68.4			—
Other Restructuring	(1.1		)	(1.7		)	9.8
Total	$	44.2		$	173.2		$	374.8

Turnaround Plan

On July 1, 2019, the Company announced a four-year plan to drive substantial improvement in Consumer Beauty while further optimizing Luxury and Professional Beauty (the “Turnaround Plan”). The Company expects to incur additional restructuring charges of approximately $35.0 related to employee termination benefits, contract terminations, and other related exits costs pertaining to the previously approved actions. The Company intends to utilize accruals established related to previously announced programs, as discussed below.

Global Integration Activities

In connection with the acquisition of the P&G Beauty Business, the Company has, and anticipates, that it will continue to incur restructuring and related costs aimed at integrating and optimizing the combined organization (“Global Integration Activities”).

Of the expected costs, the Company has incurred cumulative restructuring charges of $500.0 related to approved initiatives through the fiscal year ended June 30, 2019, which have been recorded in Corporate. The following table presents aggregate restructuring charges for the program:

F-25

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)



	Severance and Employee Benefits			Third-Party Contract Terminations		Fixed Asset Write-offs		Other Exit Costs ^(a)		Total ^(a)
Fiscal 2017	$	333.9		$	22.4	$	4.6	$	4.1	$	365.0
Fiscal 2018	67.5			19.3		14.3		5.4		106.5
Fiscal 2019	(6.0		)	4.5		27.8		2.2		28.5
Cumulative through June 30, 2019	$	395.4		$	46.2	$	46.7	$	11.7	$	500.0

^(a) The fiscal 2017 balance reflects the impact of the ASU 2017-07 adoption which resulted in the reclassification of $0.8 of pension settlement and curtailment credits incurred in connection with Global Integration Activities, from Restructuring costs to Other expense, net. Refer to Note 2—Summary of Significant Accounting Policies for further information on the adoption of ASU 2017-07.

The related liability balance and activity for the Global Integration Activities restructuring costs are presented below:



	Severance and Employee Benefits			Third-Party Contract Terminations			Fixed Asset Write-offs			Other Exit Costs			Total Program Costs
Balance—July 1, 2018	$	203.0		$	17.0		$	—		$	3.1		$	223.1
Restructuring charges	10.8			4.6			27.8			2.4			45.6
Payments	(141.0		)	(9.6		)	—			(3.7		)	(154.3		)
Change in estimates	(16.8		)	(0.1		)	—			(0.2		)	(17.1		)
Non-cash impact	0.9			—			(27.8		)	—			(26.9		)
Effect of exchange rates	(3.2		)	(0.2		)	—			—			(3.4		)
Balance—June 30, 2019	$	53.7		$	11.7		$	—		$	1.6		$	67.0

The Company currently estimates that the total remaining accrual of $67.0 will result in cash expenditures of approximately $44.7, $18.1 and $4.2 in fiscal 2020, 2021 and thereafter, respectively.

2018 Restructuring Actions

During fiscal 2018, the Company began evaluating initiatives to reduce fixed costs and enable further investment in the business (“the 2018 Restructuring Actions”).

Of the expected costs, the Company incurred cumulative restructuring charges of $85.2 related to approved initiatives through the fiscal year ended June 30, 2019, primarily related to role eliminations in Europe and North America, which have been recorded in Corporate. The following table presents aggregate restructuring charges for the program:

F-26

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)



	Severance and Employee Benefits		Third-Party Contract Terminations			Fixed Asset Write-offs		Other Exit Costs		Total
Fiscal 2018	$	63.5	$	0.2		$	1.3	$	3.4	$	68.4
Fiscal 2019	15.4		(0.1		)	—		1.5		16.8
Cumulative through June 30, 2019	$	78.9	$	0.1		$	1.3	$	4.9	$	85.2

The related liability balance and activity of restructuring costs for the 2018 Restructuring Actions are presented below:



	Severance and Employee Benefits			Third-Party Contract Terminations			Other Exit Costs^(a)			Total Program Costs
Balance—July 1, 2018	$	48.0		$	0.2		$	3.3		$	51.5
Restructuring charges	17.2			—			1.5			18.7
Payments	(47.1		)	—			(3.2		)	(50.3		)
Changes in estimates	(1.8		)	(0.1		)	—			(1.9		)
Effect of exchange rates	(0.8		)	—			(0.1		)	(0.9		)
Balance—June 30, 2019	$	15.5		$	0.1		$	1.5		$	17.1

The Company currently estimates that the total remaining accrual of $17.1 will result in cash expenditures of approximately $16.0, $0.7 and $0.4 in fiscal 2020, 2021 and thereafter, respectively.

Other Restructuring

In connection with the acquisition of the Burberry Beauty Business, the Company recorded (income) expenses of $(0.1) and $3.9 of restructuring costs relating to third party contract terminations during the fiscal years ended June 30, 2019 and June 30, 2018, respectively, which have been recorded in Corporate. The related liability balances were $0.7 and $3.9 at June 30, 2019 and June 30, 2018, respectively. The Company currently estimates that the total accrual of $0.7 will result in cash expenditures in fiscal 2020.

The Company executed a number of other restructuring activities in prior years, which are substantially completed. The Company recognized (income) expenses of $(0.8), $(6.5) and $9.8^(a) in fiscal 2019, 2018 and 2017, respectively, which have been recorded in Corporate. The related liability balances were $5.4 and $9.4 at June 30, 2019 and June 30, 2018, respectively. The Company currently estimates that the remaining accrual of $5.4 will result in cash expenditures of $3.2 and $2.2 in fiscal 2020 and 2021, respectively.

In connection with the acquisition of the P&G Beauty Business, the Company assumed restructuring liabilities of approximately $21.7 at October 1, 2016. The Company recognized (income) expenses, net of $(0.2), $0.9 and nil during the fiscal years ended 2019, 2018 and 2017, respectively, which have been recorded in Corporate. The Company currently estimates that the remaining accrual of $2.9 at June 30, 2019 will result in cash expenditures of $2.4, $0.3 and $0.2 in fiscal 2020, 2021 and thereafter, respectively.


^(a)	The fiscal 2017 balance reflects the impact of the ASU 2017-07 adoption which resulted in the reclassification of a $1.8 pension curtailment credit related to the Bourjois acquisition restructuring program, from Restructuring costs to Other expense, net. Refer to Note 2—Summary of Significant Accounting Policies for further information on the adoption of ASU 2017-07.

7. TRADE RECEIVABLES—FACTORING

The Company factors a portion of its trade receivables with unrelated third-party factoring companies on both a recourse and non-recourse basis. Trade receivables factored throughout the fiscal year on a worldwide basis amounted to $547.9 and $300.1 in fiscal 2019 and 2018, respectively. Remaining balances due from factors amounted to $8.6 and $9.9 as of June 30, 2019 and 2018, respectively, and are included in Trade receivables, net in the Consolidated Balance Sheets. Factoring fees paid under these arrangements were $2.4, $0.6 and $0.7 in fiscal 2019, 2018 and 2017, respectively, which were recorded in Selling, general and administrative expenses in the Consolidated Statements of Operations.

F-27

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

New 2019 Factoring Arrangement

On March 19, 2019, the Company entered into an Uncommitted Receivables Purchase Agreement (the “Receivables Purchase Agreement”) with a financial institution, with an aggregate facility limit of $150.0. Eligible trade receivables are purchased by the financial institution for cash at net invoice value less a factoring fee. Pursuant to Receivables Purchase Agreement, the Company acts as collections agent for the financial institution and is responsible for the collection, and remittance to the financial institution, of all customer payments related to trade receivables factored under this arrangement. For certain customer receivables factored, the Company will retain a recourse obligation of up to 10 percent of the respective invoice’s net invoice value, payable to the financial institution if the customer’s payment is not received by the contractual due date. The Company accounts for trade receivable transfers under the Receivables Purchase Agreement as sales and derecognizes the sold receivables from the Consolidated Balance Sheets. The fair value of sold receivables approximated their book value due to their short-term nature. The Company estimated that the fair value of its servicing responsibilities was not material. Cash received from the selling of receivables under the Receivables Purchase Agreement are presented as a change in trade receivables within the operating activities section of the Consolidated Statements of Cash Flows.

8. INVENTORIES

Inventories as of June 30, 2019 and 2018 are presented below:



	June 30, 2019		June 30, 2018
Raw materials	$	259.5	$	278.6
Work-in-process	20.4		21.8
Finished goods	873.4		848.5
Total inventories	$	1,153.3	$	1,148.9

9. PREPAID EXPENSES AND OTHER CURRENT ASSETS

Prepaid expenses and other current assets as of June 30, 2019 and 2018 are presented below:



	June 30, 2019		June 30, 2018
Value added tax, sales and other non-income tax assets	$	209.3	$	235.4
Expected income tax refunds, credits and prepaid income taxes	135.3		101.3
Prepaid marketing, copyright and agency fees	118.9		119.6
Non-trade receivables	22.8		29.9
Prepaid rent, leases and insurance	14.8		17.3
Interest rate swap assets	—		17.1
Other	76.7		83.3
Total prepaid expenses and other current assets	$	577.8	$	603.9

10. PROPERTY AND EQUIPMENT, NET

Property and equipment, net as of June 30, 2019 and 2018 are presented below:

F-28

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)



	June 30, 2019			June 30, 2018
Land, buildings and leasehold improvements	$	679.0		$	671.2
Machinery and equipment	904.4			866.3
Marketing furniture and fixtures	578.0			514.2
Computer equipment and software	819.5			699.1
Construction in progress	134.2			230.8
Property and equipment, gross	3,115.1			2,981.6
Accumulated depreciation and amortization	(1,514.5		)	(1,300.8		)
Property and equipment, net	$	1,600.6		$	1,680.8

Depreciation and amortization expense of property and equipment totaled $382.5, $384.2 and $280.0 in fiscal 2019, 2018 and 2017, respectively, and is recorded in Cost of sales and Selling, general and administrative expenses in the Consolidated Statements of Operations.

During fiscal 2019 and 2018, the Company recorded asset impairment charges of $27.8 and $15.6, respectively, primarily related to the planned disposal of certain manufacturing facilities, and the write-off of machinery and equipment in excess of the Company’s needs due to the Global Integration Activities (refer to Note 6—Restructuring Costs for further information about Global Integration Activities). The impairment charges are included in Restructuring costs in the Consolidated Statements of Operations.

11. GOODWILL AND OTHER INTANGIBLE ASSETS, NET

Assessment for Impairments

The Company tests goodwill and indefinite-lived other intangible assets for impairment at least annually as of May 1, or more frequently, if certain events or circumstances warrant. There were no impairments of goodwill at the Company’s reporting units or of indefinite-lived other intangible assets in fiscal 2018 and 2017.

During fiscal 2019, the Company recorded total goodwill impairments of $3,391.1 and total impairments on indefinite-lived other intangible assets of $429.1. Additionally, the Company recorded impairments of $19.7 on finite-lived other intangible assets during fiscal 2019. The asset impairment charges were a result of the following impairment tests:

In the course of evaluating the results for the second quarter of fiscal 2019, the Company noted the cash flows associated with its Consumer Beauty reporting unit were adversely impacted by negative category trends and market share losses in the color cosmetics, hair color and mass fragrance categories mainly impacting the CoverGirl, Rimmel, Max Factor, Bourjois and Clairol trademarks; additional shelf-spaces losses for CoverGirl, Clairol, and Max Factor; expected increased costs in the short-term to offset the lower service levels caused by supply chain disruptions; and lower than expected net revenues and profitability for Younique. Additionally, the Company included the impact of a 75 basis point increase in the discount rate in the valuation model, due to changes in the market assumptions, which adversely affected the fair values of the reporting unit and trademarks. As a result, in the second quarter of fiscal 2019, the Company recognized asset impairment charges of $930.3, of which $832.5 related to goodwill, $90.8 related to indefinite-lived other intangible assets (mainly related to the CoverGirl and Clairol trademarks) and $7.0 related to finite-lived other intangible assets, as described below and recorded in Asset impairment charges in the Consolidated Statements of Operations.

Also, in the second quarter of fiscal 2019, the Company identified indicators of impairment related to the philosophy trademark that is part of the Luxury reporting unit and recorded an asset impairment charge of $22.8 for the second quarter of fiscal 2019. In addition to the impact of a 75 basis point increase in the discount rate for the trademark, the Company considered the impact of the business indicators of lower than expected net revenue growth in the U.S. and a decrease in the level of expected profitability of the trademark.

In the fourth quarter of fiscal 2019, as a result of the annual impairment test, the Company recorded asset impairment charges of $2,558.6 related to goodwill of the Consumer Beauty reporting unit and $201.7 related to indefinite-lived other intangible assets (mainly CoverGirl, Max Factor, Bourjois, Sally Hansen and Clairol trademarks) that are part of the Consumer Beauty reporting unit. The charges are recorded in Asset impairment charges in the Consolidated Statements of Operations. The Company considered several factors that developed during the fourth quarter of fiscal 2019 that led to the conclusion that the fair values of the Consumer Beauty reporting unit and certain indefinite-lived other intangible assets were below their carrying amounts. These factors included fourth quarter net revenue results and market share trends that were below expectations, continued net revenue and profitability declines for Younique in excess of management’s expectations, and the development of

F-29

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

the Company’s Turnaround Plan to stabilize operations and improve profitability. The Turnaround Plan impacted the projected cash flows associated with the Consumer Beauty reporting unit by lowering revenue growth and, in the near term, margin expectations. Such changes in the Company’s estimated forecasts were based on a top down review of the business which resulted in decisions to simplify the product range as well as identify priority brand-country combinations and invest behind such combinations at scale, which will initially lower net revenues and profits. The Turnaround Plan also considered the latest market data including continued negative category trends in the color cosmetics, hair color and mass fragrance categories that were below expectations and indicated a longer required recovery period. Overall, these factors negatively impacted the cash flows of the Consumer Beauty reporting unit and indefinite-lived other intangible assets and resulted in a decrease in management’s assumed terminal growth rates, which also adversely affected their fair values. Additionally, the Company included the impact of an additional 25 basis point increase in the discount rate in the valuation model for its trademarks, which adversely affected the fair values of the trademarks.

Based on the results of the annual impairment test, the Company also recorded an asset impairment charge of $86.8 in Asset impairment charges in the Consolidated Statements of Operations related to the philosophy trademark that is part of the Luxury reporting unit. The cash flows related to the philosophy trademark decreased mainly due to updated projections as a result of a revised strategy for the business developed as part of the Turnaround Plan in the fourth quarter of fiscal 2019 to simplify the product range. The fair value of the philosophy trademark was also adversely affected by a 25 basis point increase in the discount rate for trademarks since the second quarter of fiscal 2019.

Further, the Company recorded an asset impairment charge of $27.0 in Asset impairment charges in the Consolidated Statements of Operations for fiscal 2019 related to the professional product line of Wella trademark that is part of the Professional Beauty reporting unit. In addition to the impact of a 100 basis point increase in the discount rate for the trademark since the fiscal 2018 annual impairment test, the Company considered the adverse impact of lower than expected revenue in the U.S. on the cash flows associated with the professional product line of Wella trademark due to additional customer destocking activities as well as the impact of the strategy change to simplify the product range.

F-30

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

Goodwill

Goodwill as of June 30, 2019, 2018 and 2017 is presented below:



	Luxury			Consumer Beauty			Professional Beauty			Total
Gross balance at June 30, 2017	$	3,496.8		$	4,732.0		$	967.5		$	9,196.3
Accumulated impairments	(403.7		)	(237.1		)	—			(640.8		)
Net balance at June 30, 2017	$	3,093.1		$	4,494.9		$	967.5		$	8,555.5

Changes during the year ended June 30, 2018
Acquisitions	68.2			—			2.6			70.8
Measurement period adjustments	(185.0		)	228.8			(17.3		)	26.5
Foreign currency translation	(10.3		)	(24.1		)	1.0			(33.4		)
Dispositions	(3.1		)	(9.2		)	—			(12.3		)

Gross balance at June 30, 2018	$	3,366.6		$	4,927.5		$	953.8		$	9,247.9
Accumulated impairments	(403.7		)	(237.1		)	—			(640.8		)
Net balance at June 30, 2018	$	2,962.9		$	4,690.4		$	953.8		$	8,607.1

Changes during the year ended June 30, 2019
Impairment charges	—			(3,391.1		)	—			(3,391.1		)
Measurement period adjustments ^(a)	(10.5		)	0.6			0.5			(9.4		)
Foreign currency translation	(30.7		)	(83.5		)	(18.6		)	(132.8		)

Gross balance at June 30, 2019	$	3,325.4		$	4,844.6		$	935.7		$	9,105.7
Accumulated impairments	(403.7		)	(3,628.2		)	—			(4,031.9		)
Net balance at June 30, 2019	$	2,921.7		$	1,216.4		$	935.7		$	5,073.8

^(a) Includes measurement period adjustments during the twelve month period ended June 30, 2019 in connection with the Burberry Beauty Business acquisition (Refer to Note 3—Business Combinations).

Other Intangible Assets, net

Other intangible assets, net as of June 30, 2019 and 2018 are presented below:



	June 30, 2019		June 30, 2018
Indefinite-lived other intangible assets	$	2,729.8	$	3,186.2
Finite-lived other intangible assets, net	4,692.5		5,098.2
Total Other intangible assets, net	$	7,422.3	$	8,284.4

F-31

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

The changes in the carrying amount of indefinite-lived other intangible assets are presented below:



	Luxury			Consumer Beauty			Professional Beauty			Total
Gross balance at June 30, 2017	409.8			1,696.4			1,278.5			3,384.7
Accumulated impairments	(118.8		)	(75.9		)	(3.1		)	(197.8		)
Net balance at June 30, 2017	291.0			1,620.5			1,275.4			3,186.9

Changes during the year ended June 30, 2018
Measurement period adjustments	—			—			(14.8		)	(14.8		)
Foreign currency translation	4.8			6.7			2.6			14.1

Gross balance at June 30, 2018	$	414.6		$	1,703.1		$	1,266.3		$	3,384.0
Accumulated impairments	(118.8		)	(75.9		)	(3.1		)	(197.8		)
Net balance at June 30, 2018	295.8			1,627.2			1,263.2			3,186.2

Changes during the year ended June 30, 2019
Impairment charges	(109.6		)	(292.5		)	(27.0		)	(429.1		)
Foreign currency translation	(8.8		)	(10.0		)	(8.5		)	(27.3		)

Gross balance at June 30, 2019	405.8			1,693.1			1,257.8			3,356.7
Accumulated impairments	(228.4		)	(368.4		)	(30.1		)	(626.9		)
Net balance at June 30, 2019	$	177.4		$	1,324.7		$	1,227.7		$	2,729.8

Intangible assets subject to amortization are presented below:



	Cost		Accumulated Amortization			Accumulated Impairment			Net
June 30, 2018
License agreements	$	3,362.7	$	(792.9	)	$	—		$	2,569.8
Customer relationships	1,960.5		(508.7		)	(5.5		)	1,446.3
Trademarks	1,002.1		(185.5		)	(0.4		)	816.2
Product formulations and technology	361.2		(95.3		)	—			265.9
Total	$	6,686.5	$	(1,582.4	)	$	(5.9	)	$	5,098.2
June 30, 2019
License agreements ^(a)	$	3,245.3	$	(874.5	)	$	(19.6	)	$	2,351.2
Customer relationships ^(a)	1,951.6		(642.0		)	(5.5		)	1,304.1
Trademarks^(b)	1,039.5		(229.4		)	(0.5		)	809.6
Product formulations and technology	354.1		(126.5		)	—			227.6
Total	$	6,590.5	$	(1,872.4	)	$	(25.6	)	$	4,692.5

^(a) Includes measurement period adjustments during the twelve month period ended June 30, 2019 in connection with the Burberry Beauty Business acquisition (Refer to Note 3—Business Combinations).

^(b)Includes acquired trademark of $40.8.

During fiscal 2019, the Company acquired a trademark associated with a preexisting license. As a result of the acquisition, the preexisting license was effectively terminated, and accordingly the Company recorded $12.6 of Asset impairment charges in the Consolidated Statement of Operations related to the license agreement that is part of the Luxury reporting unit.

During fiscal 2018, the Company sold assets related to the Playboy and Cerruti brands (including related licenses of $26.2 and goodwill of $12.3) for proceeds of $33.0, resulting in a noncash loss of $28.6. During fiscal 2017, the Company sold assets related to the J.Lo brand for a total disposal price of $10.5. The Company allocated $2.4 of goodwill to the brand as part of the

F-32

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

sale. The Company recorded losses (gains) of $28.6 and $(3.1), which are reflected in Loss (gain) on sale of assets in the Consolidated Statements of Operations for the fiscal years ended June 30, 2018 and 2017, respectively.

Amortization expense totaled $353.5, $352.8 and $275.1 for the fiscal years ended June 30, 2019, 2018 and 2017, respectively.

Intangible assets subject to amortization are amortized principally using the straight-line method and have the following weighted-average remaining lives:



Description
License agreements	24.0 years
Customer relationships	15.4 years
Trademarks	21.1 years
Product formulations and technology	9.8 years

As of June 30, 2019, the remaining weighted-average life of all intangible assets subject to amortization is 20.4 years.

The estimated aggregate amortization expense for each of the following fiscal years ending June 30 is presented below:



2020	$	345.8
2021	340.3
2022	322.8
2023	314.4
2024	274.3

License Agreements

The Company records assets for license agreements (“licenses”) acquired in transactions accounted for as business combinations. These licenses provide the Company with the exclusive right to manufacture and market on a worldwide and/or regional basis, certain of the Company’s products which comprise a significant portion of the Company’s revenues. These licenses have initial terms covering various periods. Certain brand licenses provide for automatic extensions ranging from 2 to 10 year terms, at the Company’s discretion.

12. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities as of June 30, 2019 and 2018 are presented below:



	June 30, 2019		June 30, 2018
Advertising, marketing and licensing	$	404.1	$	435.5
Compensation and other compensation related benefits	304.0		333.1
Customer returns, discounts, allowances and bonuses	262.0		328.2
Value added tax, sales and other non-income taxes	128.0		134.5
Restructuring costs	67.0		263.8
Mandatorily redeemable financial instrument liability (See Note 20)	51.8		46.6
Auditing, consulting, legal and litigation accruals	45.0		34.1
Interest	29.7		31.5
Interest rate swap liability	17.9		—
Deferred income	13.8		25.5
Unfavorable contract liability	11.0		11.3
Tax indemnity liability	—		21.1
Other	149.4		179.2
Total accrued expenses and other current liabilities	$	1,483.7	$	1,844.4

F-33

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

13. OTHER NONCURRENT LIABILITIES

Other noncurrent liabilities as of June 30, 2019 and 2018 are presented below:



	June 30, 2019		June 30, 2018
Noncurrent income tax liabilities	$	179.9	$	137.7
Unfavorable contract liabilities	90.5		104.1
Deferred rent	57.4		54.2
Restructuring costs	26.1		31.1
Interest rate swap liability	24.1		—
Mandatorily redeemable financial instrument liability (See Note 20)	6.1		6.7
Burberry contingent consideration	2.3		8.3
Other	40.8		46.4
Total other noncurrent liabilities	$	427.2	$	388.5

14. DEBT



	June 30, 2019			June 30, 2018
Short-term debt	$	4.2		$	9.2
2018 Coty Credit Agreement
2018 Coty Revolving Credit Facility due April 2023	792.1			368.1
2018 Coty Term A Facility due April 2023	3,147.0			3,371.5
2018 Coty Term B Facility due April 2025	2,342.3			2,390.5
Senior Unsecured Notes
2026 Dollar Notes due April 2026	550.0			550.0
2023 Euro Notes due April 2023	625.0			640.9
2026 Euro Notes due April 2026	284.1			291.4
Other long-term debt and capital lease obligations	1.1			1.6
Total debt	7,745.8			7,623.2
Less: Short-term debt and current portion of long-term debt	(193.8		)	(218.9		)
Total Long-term debt	7,552.0			7,404.3
Less: Unamortized debt issuance costs	(71.3		)	(86.2		)
Less: Discount on Long-term debt	(10.8		)	(12.7		)
Total Long-term debt, net	$	7,469.9		$	7,305.4

Short-Term Debt

The Company maintains short-term lines of credit with financial institutions around the world. Total available lines of credit were $113.5 and $129.2, of which $2.3 and $4.7 were outstanding at June 30, 2019 and 2018, respectively. Interest rates on these short-term lines of credit vary depending on market rates for borrowings within the respective geographic locations plus applicable spreads. Interest rates plus applicable spreads on these lines ranged from 0.4% to 7.3% and from 0.2% to 10.7% as of June 30, 2019 and 2018, respectively. The weighted-average interest rate on short-term debt outstanding was 3.3% and 2.2% as of June 30, 2019 and 2018, respectively. In addition, the Company had undrawn letters of credit of $6.3 and $5.4 and bank guarantees of $97.1 and $59.8 as of June 30, 2019 and 2018, respectively.

F-34

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

Long-Term Debt

The Company’s long-term debt facilities consisted of the following as of June 30, 2019 and 2018:

Facility

Maturity Date

Borrowing Capacity (in millions)

Interest Rate Terms

Applicable Interest Rate Spread as of
June 30, 2018

Debt Discount

Repayment Schedule

2018 Coty Revolving Credit Facility

April 2023

(a)

LIBOR^(b) plus a margin ranging from 1.00% to 2.00% per annum or a base rate plus a margin ranging from 0.00% to 1.00% per annum, based on the Company’s total net leverage ratio^{(d) (e) (f)}

1.75%

N/A^(c)

Payable in full at maturity date

2018 Coty Term A Facility - USD Portion

April 2023

$1,000.0

1.75%

N/A^(c)

Quarterly repayments beginning September 30, 2018 at 1.25% of original principal amount

2018 Coty Term A Facility - EUR Portion

April 2023

€2,035.0

1.75%

N/A^(c)

2018 Coty Term B Facility - USD Portion

April 2025

$1,400.0

LIBOR^(b) plus a margin of 2.25% per annum or a base rate plus a margin of 1.25% per annum ^(e)

2.25%

0.25%

Quarterly repayments beginning September 30, 2018 at 0.25% of original principal amount

2018 Coty Term B Facility - EUR Portion

April 2025

€850.0

LIBOR^(b) plus a margin of 2.50% per annum^(e)

2.50%

0.25%

2026 Dollar Notes

April 2026

$550.0

6.5% per annum, payable semi-annually in arrears on April 15 and October 15 of each year, beginning on October 15, 2018

N/A^(c)

Payable in full at maturity date

2023 Euro Notes

April 2023

€550.0

4.0% per annum, payable semi-annually in arrears on April 15 and October 15 of each year, beginning on October 15, 2018

N/A^(c)

2026 Euro Notes

April 2026

€250.0

4.75% per annum, payable semi-annually in arrears on April 15 and October 15 of each year, beginning on October 15, 2018

N/A^(c)


^(a)	As of June 30, 2018, the 2018 Coty Revolving Credit Facility borrowing capacity was $3,250.0. As a result of the June 27, 2019 credit agreement amendment (as described below), the borrowing capacity was reduced to $2,750.0 as of June 30, 2019.


^(b)	As defined in the Interest section below.


^(c)	N/A - Not Applicable.


^(d)	As defined per the 2018 Coty Credit Agreement.


^(e)	The selection of the applicable one, two, three, six or twelve month interest rate for the period is at the discretion of the Company.


^(f)	The Company will pay to the Revolving Credit Facility lenders an unused commitment fee calculated at a rate ranging from 0.10% to 0.35% per annum, based on the Company’s total net leverage ratio^(d). As of June 30, 2019 and 2018, the applicable rate on the unused commitment fee was 0.35% and 0.30%, respectively.

Prior Coty Inc. Credit Facilities

On October 27, 2015, the Company entered into a Credit Agreement (the “2015 Coty Credit Agreement”). The 2015 Coty Credit Agreement was subsequently amended on April 8, 2016 and October 28, 2016. On October 1, 2016, at the closing of the P&G Beauty Business acquisition, the Company assumed the debt facilities available under the Galleria Credit Agreement (the “Galleria Credit Agreement”). These credit agreements were settled on April 5, 2018 as noted below.

Offering of Senior Unsecured Notes

On April 5, 2018 the Company issued, at par, $550.0 of 6.50% senior unsecured notes due 2026 (the “2026 Dollar Notes”), €550.0 million of 4.00% senior unsecured notes due 2023 (the “2023 Euro Notes”) and €250.0 million of 4.75% senior unsecured notes due 2026 (the “2026 Euro Notes” and, together with the 2023 Euro Notes, the “Euro Notes,” and the Euro Notes together with the 2026 Dollar Notes, the “Senior Unsecured Notes”) in a private offering. The net proceeds of this offering, together with borrowings under the Company’s 2018 Credit Agreement were used to repay in full and refinance the indebtedness outstanding under the 2015 Coty Credit Agreement and Galleria Credit Agreement and to pay accrued interest, related premiums, fees and expenses in connection therewith.

The Senior Unsecured Notes are senior unsecured debt obligations of the Company and will be pari passu in right of payment with all of the Company’s existing and future senior indebtedness (including the 2018 Coty Credit Facilities described

F-35

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

below). The Senior Unsecured Notes are guaranteed, jointly and severally, on a senior basis by the Guarantors (as later defined under “2018 Coty Credit Agreement”). The Senior Unsecured Notes are senior unsecured obligations of the Company and are effectively junior to all existing and future secured indebtedness of the Company to the extent of the value of the collateral securing such secured indebtedness. The related guarantees are senior unsecured obligations of each Guarantor and are effectively junior to all existing and future secured indebtedness of such Guarantor to the extent of the value of the collateral securing such indebtedness.

In addition to the optional redemption outlined below, the Company may, at its option, redeem either series of the Euro Notes, in whole but not in part, at a redemption price equal to 100% of the principal amount of the Euro Notes to be redeemed, together with any accrued and unpaid interest thereon to, but excluding, the redemption date, at any time, upon the occurrence of certain tax events.

Upon the occurrence of certain change of control triggering events with respect to a series of Senior Unsecured Notes, the Company will be required to offer to repurchase all or part of the Senior Unsecured Notes of such series at 101% of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the purchase date applicable to such Senior Unsecured Notes.

The Notes contain customary covenants that place restrictions in certain circumstances on, among other things, incurrence of liens, entry into sale or leaseback transactions, sales of all or substantially all of the Company’s assets and certain merger or consolidation transactions. The Notes also provide for customary events of default.

Optional Redemption

Applicable Premium

The indenture governing the Senior Unsecured Notes (the “Indenture”) specifies the Applicable Premium (as defined in the Indenture) to be paid upon early redemption of some or all of the 2026 Dollar Notes, 2023 Euro Notes or 2026 Euro Notes.

The Applicable Premium related to the 2026 Dollar Notes, 2023 Euro Notes and 2026 Euro Notes on any redemption date and as calculated by the Company is the greater of:


(1)	1.0% of the then outstanding principal amount of the respective 2026 Dollar Notes, 2023 Euro Notes and 2026 Euro Notes; and

(2)

the excess, if any, of (a) the present value at such redemption date of (i) the redemption price of such 2026 Dollar Notes, 2023 Euro Notes or 2026 Euro Notes that would apply if such 2026 Dollar Notes, 2023 Euro Notes or 2026 Euro Notes were redeemed on April 15, 2021, April 15, 2020 or April 15, 2021, respectively (such redemption price is expressed as a percentage of the principal amount being set forth in the table appearing in the Redemption Pricing section below), plus (ii) all remaining scheduled payments of interest due on the 2026 Dollar Notes, 2023 Euro Notes or 2026 Euro Notes to and including April 15, 2021, April 15, 2020 and April 15, 2021, respectively (excluding accrued but unpaid interest, if any, to, but excluding, the redemption date), with respect to each of subclause (i) and (ii), computed using a discount rate equal to the Treasury Rate in the case of the 2026 Dollar Notes or Bund Rate in the case of both the 2020 Euro Notes or 2026 Euro Notes (both Treasury Rate and Bund Rate as defined in the Indenture) as of such redemption date plus 50 basis points; over (b) the principal amount of the respective 2026 Dollar Notes, 2023 Euro Notes or 2026 Euro Notes.

Redemption Pricing

At any time and from time to time prior to April 15, 2021, April 15, 2020 and April 15, 2021, the Company may redeem some or all of the 2026 Dollar Notes, 2023 Euro Notes and 2026 Euro Notes, respectively, at redemption prices equal to 100% of the respective principal amounts being redeemed plus the Applicable Premium, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates.

At any time on or after April 15, 2021, April 15, 2020 and April 15, 2021, the Company may redeem some or all of the 2026 Dollar Notes, 2023 Euro Notes and 2026 Euro Notes, respectively, at the redemption prices (expressed in percentage of principal amount) set forth below, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates, if redeemed during the twelve-month period beginning on April 15 of each of the years indicated below:

F-36

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)



	Price
Year	2026 Dollar Notes	2023 Euro Notes	2026 Euro Notes
2020	N/A	102.0000%	N/A
2021	104.8750%	101.0000%	103.5625%
2022	103.2500%	100.0000%	102.3750%
2023	101.6250%	100.0000%	101.1875%
2024 and thereafter	100.0000%	N/A	100.0000%

In addition, at any time prior to April 15, 2021, April 15, 2020 and April 15, 2021, the Company may redeem up to 35% of the aggregate principal amounts of the outstanding 2026 Dollar Notes, 2023 Euro Notes and 2026 Euro Notes, respectively, using the net cash proceeds from certain equity offerings at redemption prices (expressed as a percentage of the principal amount) of 106.50%, 104.00% and 104.75%, respectively, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates; provided that (i) at least 65% of the aggregate principal amount of 2026 Dollar Notes, 2023 Euro Notes and 2026 Euro Notes, respectively, originally issued on the date of the Indenture remain outstanding after each such redemption, and (ii) notice of any such redemption is delivered to the Trustee within 90 days of the closing of each such equity offering.

2018 Coty Credit Agreement

On April 5, 2018, the Company entered into a new credit agreement (the “2018 Coty Credit Agreement”), which amended and restated the previously existing 2015 Coty Credit Agreement. The 2018 Coty Credit Agreement provides for (a) (1) a senior secured term A facility (as described in the table above, the “2018 Coty Term A Facility”) and (2) a senior secured term B facility (as described in the table above, the “2018 Coty Term B Facility”) and (b) the incurrence by the Company and Coty B.V., a Dutch subsidiary of the Company (the “Dutch Borrower” and, together with the Company, the “Borrowers”), of a senior secured revolving facility (as described in the table above, the “2018 Coty Revolving Credit Facility”) (the 2018 Coty Term A Facility, together with the 2018 Coty Term B Facility and the 2018 Coty Revolving Credit Facility, the “2018 Coty Credit Facilities”).

The 2018 Coty Credit Agreement provides that with respect to the 2018 Coty Revolving Credit Facility, up to $150.0 is available for letters of credit and up to $150.0 is available for swing line loans. The 2018 Coty Credit Agreement also permits, subject to certain terms and conditions, the incurrence of incremental facilities thereunder in an aggregate amount of (i) $1,700.0 plus (ii) an unlimited amount if the First Lien Net Leverage Ratio (as defined in the 2018 Coty Credit Agreement), at the time of incurrence of such incremental facilities and after giving effect thereto on a pro forma basis, is less than or equal to 3.00 to 1.00.

The obligations of the Company under the 2018 Coty Credit Agreement are guaranteed by the material wholly-owned subsidiaries of the Company organized in the U.S., subject to certain exceptions (the “Guarantors”) and the obligations of the Company and the Guarantors under the 2018 Coty Credit Agreement are secured by a perfected first priority lien (subject to permitted liens) on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions. The Dutch Borrower does not guarantee the obligations of the Company under the 2018 Coty Credit Agreement or grant any liens on its assets to secure any obligations under the 2018 Coty Credit Agreement.

On June 27, 2019, the Company entered into an amendment (“2019 Amendment”) to the 2018 Coty Credit Agreement. The 2019 Amendment modified the 2018 Coty Credit Agreement by amending the financial covenants to (i) delay until March 31, 2022 the total net leverage ratio step down from 5.25 to 5.0 (as further described in the Covenants section below), (ii) extend the applicable window for certain cost savings add-backs in the calculation of Adjusted EBITDA for purpose of determining the total net leverage ratio, and (iii) amend the determination of the exchange rate to be used for purposes of calculating “Total Indebtedness” (as defined in the 2018 Coty Credit Agreement) for purposes of the total net leverage ratio, and decreasing the total commitments under the revolving credit facility by $500.0 to $2,750.0. In connection with the 2019 Amendment, the Company wrote off $3.8 of unamortized deferred financing fees, which were recorded as Other expense, net in the Consolidated Statement of Operations.

Deferred Issuance Costs

For the fiscal years ended June 30, 2019, 2018 and 2017, the Company capitalized deferred financing fees of $5.9, $37.8, and $24.4, respectively. The Company incurred $0.8 and $24.1 in third-party debt issuance costs during the fiscal years ended June 30, 2019 and 2018, respectively, which were recorded as Other expense, net in the Consolidated Statement of Operations.

F-37

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

Loss on Early Extinguishment of Debt

During the fiscal years ended June 30, 2019, 2018 and 2017, the Company wrote off $0.0, $8.7 and $0.0 of unamortized deferred financing fees related to extinguishments of substantially different debt. Also during the fiscal years ended June 30, 2019, 2018 and 2017, the Company wrote-off $0.0, $2.0 and $0.0 of unamortized original issue debt discounts. The write-offs of these unamortized deferred financing fees and unamortized original issue debt discounts are included in Loss on early extinguishment of debt in the Consolidated Statements of Operations.

Interest

The 2018 Coty Credit Agreement facilities will bear interest at rates equal to, at the Company’s option, either:


•	LIBOR of the applicable qualified currency, of which the Company can elect the applicable one, two, three, six or twelve month rate, plus the applicable margin; or

•ABR plus the applicable margin.

In the case of the 2018 Coty Revolving Credit Facility and the 2018 Coty Term A Facility, the applicable margin means the lesser of a percentage per annum to be determined in accordance with the leverage-based pricing grid and the debt rating-based grid below:



Pricing Tier	Total Net Leverage Ratio:	LIBOR plus:	Alternative Base Rate Margin:
1.0	Greater than or equal to 4.75:1	2.000%	1.000%
2.0	Less than 4.75:1 but greater than or equal to 4.00:1	1.750%	0.750%
3.0	Less than 4.00:1 but greater than or equal to 2.75:1	1.500%	0.500%
4.0	Less than 2.75:1 but greater than or equal to 2.00:1	1.250%	0.250%
5.0	Less than 2.00:1 but greater than or equal to 1.50:1	1.125%	0.125%
6.0	Less than 1.50:1	1.000%	—%



Pricing Tier	Debt Ratings S&P/Moody’s:	LIBOR plus:	Alternative Base Rate Margin:
5.0	Less than BB+/Ba1	2.000%	1.000%
4.0	BB+/Ba1	1.750%	0.750%
3.0	BBB-/Baa3	1.500%	0.500%
2.0	BBB/Baa2	1.250%	0.250%
1.0	BBB+/Baa1 or higher	1.125%	0.125%

In the case of the USD portion of the 2018 Coty Term B Facility, the applicable margin means 2.25% per annum, in the case of LIBOR loans, and 1.25% per annum, in the case of ABR loans. In the case of the Euro portion of the 2018 Coty Term B Facility, the applicable margin means 2.50% per annum, in the case of EURIBOR loans. In no event will LIBOR be deemed to be less than 0.00% per annum.

F-38

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

Fair Value of Debt



	June 30, 2019				June 30, 2018
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
2018 Coty Credit Agreement	$	6,281.4	$	6,058.9	$	6,130.1	$	6,070.8
Senior Unsecured Notes	1,459.1		1,439.6		1,482.3		1,449.9

The Company uses the market approach to value the 2018 Coty Credit Agreement and the Senior Unsecured Notes. The Company obtains fair values from independent pricing services to determine the fair value of these debt instruments. Based on the assumptions used to value these liabilities at fair value, these debt instruments are categorized a Level 2 in the fair value hierarchy.

Debt Maturities Schedule

Aggregate maturities of all long-term debt, including current portion of long-term debt and excluding capital lease obligations as of June 30, 2019, are presented below:



Fiscal Year Ending June 30,
2020	$	189.3
2021	189.3
2022	189.3
2023	4,090.9
2024	23.6
Thereafter	3,058.1
Total	$	7,740.5

Covenants

The 2018 Coty Credit Agreement contains affirmative and negative covenants. The negative covenants include, among other things, limitations on debt, liens, dispositions, investments, fundamental changes, restricted payments and affiliate transactions. With certain exceptions as described below, the 2018 Coty Credit Agreement, as amended, includes a financial covenant that requires us to maintain a Total Net Leverage Ratio (as defined below), equal to or less than the ratios shown below for each respective test period.



Quarterly Test Period Ending	Total Net Leverage Ratio^(a)
June 30, 2019 through December 31, 2021	5.25 to 1.00
March 31, 2022	5.00 to 1.00
June 30, 2022	4.75 to 1.00
September 30, 2022	4.50 to 1.00
December 31, 2022	4.25 to 1.00
March 31, 2023 through June 30, 2023	4.00 to 1.00

^(a) Total Net Leverage Ratio means, as of any date of determination, the ratio of: (a) (i) Total Indebtedness minus (ii) unrestricted cash and Cash Equivalents of the Parent Borrower and its Restricted Subsidiaries as determined in accordance with GAAP to (b) Adjusted EBITDA for the most recently ended Test Period (each of the defined terms used within the definition of Total Net Leverage Ratio have the meanings ascribed to them within the 2018 Coty Credit Agreement, as amended).

In the four fiscal quarters following the closing of any Material Acquisition (as defined in the 2018 Coty Credit Agreement, as amended), including the fiscal quarter in which such Material Acquisition occurs, the maximum Total Net Leverage Ratio shall be the lesser of (i) 5.95 to 1.00 and (ii) 1.00 higher than the otherwise applicable maximum Total Net Leverage Ratio for such quarter (as set forth in the table above). Immediately after any such four fiscal quarter period, there shall be at least two consecutive fiscal quarters during which our Total Net Leverage Ratio is no greater than the maximum Total Net Leverage

F-39

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

Ratio that would otherwise have been required in the absence of such Material Acquisition, regardless of whether any additional Material Acquisitions are consummated during such period.

As of June 30, 2019, the Company was in compliance with all covenants contained within the Debt Agreements.

15. LEASE AND OTHER COMMITMENTS

The Company leases office facilities, equipment and vehicles under non-cancellable operating leases. These leases expire on varying dates, in some instances contain renewal and expansion options, do not restrict the payment of dividends or the incurrence of debt or additional lease obligations, and contain no significant purchase options. In addition to the base rental costs, occupancy lease agreements generally provide for rent escalations resulting from increased assessments for real estate taxes and other charges.

The Company incurred rent expense of $197.7, $208.2 and $166.1 relating to operating leases in fiscal 2019, 2018 and 2017, respectively. The Company collected payments from sub-lessors relating to facilities no longer in use by the Company of $9.4, $6.2 and $6.0 for fiscal 2019, 2018 and 2017, respectively.

Minimum rental commitments under non-cancellable operating leases at June 30, 2019 are included in the following table under Leases. Purchase obligations include commitments to purchase inventory and other services.



Fiscal Year Ending June 30,	Leases			Purchase Obligations
2020	$	122.2		$	317.9
2021	111.2			89.1
2022	91.3			66.8
2023	76.7			33.8
2024	67.8			22.3
Thereafter	252.3			0.5
	721.5			530.4
Less: sublease income	(20.1		)	N/A
Total minimum payments required	$	701.4		$	530.4

16. INCOME TAXES

(Loss) income before income taxes in fiscal 2019, 2018 and 2017 is presented below:



	Year Ended June 30,
	2019			2018			2017
United States	$	(1,994.3	)	$	(324.2	)	$	(524.8	)
Foreign	(1,783.8		)	171.7			(133.2		)
Total	$	(3,778.1	)	$	(152.5	)	$	(658.0	)

F-40

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

The components of the Company’s total (benefit) provision for income taxes during fiscal 2019, 2018 and 2017 are presented below:



	Year Ended June 30,
	2019			2018			2017
(Benefit) provision for income taxes:
Current:
Federal	$	0.8		$	0.2		$	0.4
State and local	11.1			9.8			1.1
Foreign	155.3			67.0			129.0
Total	167.2			77.0			130.5
Deferred:
Federal	(116.6		)	25.2			(256.9		)
State and local	(49.9		)	(0.7		)	(24.2		)
Foreign	(9.2		)	(126.2		)	(108.9		)
Total	(175.7		)	(101.7		)	(390.0		)
Benefit for income taxes	$	(8.5	)	$	(24.7	)	$	(259.5	)

During fiscal 2019, the Company recorded goodwill impairment that is not tax-deductible.

During fiscal 2018, the Company incurred an expense of $41.0 as a result of the Tax Act.

During the second quarter of fiscal 2017, the Company released a valuation allowance in the U.S. as a result of the P&G Beauty Business acquisition of $111.2.

The reconciliation of the U.S. Federal statutory tax rate to the Company’s effective income tax rate during fiscal 2019, 2018 and 2017 is presented below:



	Year Ended June 30,
	2019			2018			2017
Income (loss) before income taxes	$	(3,778.1	)	$	(152.5	)	$	(658.0	)
Benefit for income taxes at statutory rate	$	(793.4	)	$	(42.8	)	$	(230.3	)
State and local taxes—net of federal benefit	(30.7		)	9.9			(15.0		)
Foreign tax differentials	58.8			(21.9		)	53.3
Change in valuation allowances	(6.7		)	8.6			(108.2		)
Change in unrecognized tax benefit	43.4			(24.8		)	25.6
Tax Act	—			41.0			—
Permanent differences—net	1.8			(8.5		)	1.2
Amortization on intercompany sale	—			5.4			5.7
Goodwill impairment	693.0			—			—
Other	25.3			8.4			8.2
(Benefit) provision for income taxes	$	(8.5	)	$	(24.7	)	$	(259.5	)
Effective income tax rate	0.2		%	16.2		%	39.4		%

Significant components of deferred income tax assets and liabilities as of June 30, 2019 and 2018 are presented below:

F-41

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)



	June 30, 2019			June 30, 2018
Deferred income tax assets:
Inventories	$	21.6		$	9.0
Accruals and allowances	63.1			84.2
Sales returns	18.4			13.1
Share-based compensation	14.8			13.4
Employee benefits	133.8			115.7
Net operating loss carry forwards and tax credits	294.3			285.1
Interest expense limitation carry forward	52.3			—
Other	37.1			48.3
Less: valuation allowances	(67.7		)	(104.6		)
Net deferred income tax assets	567.7			464.2
Deferred income tax liabilities:
Intangible assets	986.6			1,115.7
Property, plant and equipment	13.4			18.9
Unrealized gain	0.5			5.4
Licensing rights	23.7			21.5
Other	49.7			37.8
Deferred income tax liabilities	1,073.9			1,199.3
Net deferred income tax liabilities	$	(506.2	)	$	(735.1	)

The expirations of tax loss carry forwards, amounting to $1,272.7 as of June 30, 2019, in each of the fiscal years ending June 30, are presented below:



Fiscal Year Ending June 30,	United States		Western Europe		Rest of World		Total
2020	$	—	$	—	$	68.1	$	68.1
2021	—		—		13.3		13.3
2022	—		1.2		18.5		19.7
2023	—		1.7		8.3		10.0
2024 and thereafter	149.8		835.4		176.4		1,161.6
Total	$	149.8	$	838.3	$	284.6	$	1,272.7

The total valuation allowances recorded are $67.7 and $104.6 as of June 30, 2019 and 2018, respectively. In fiscal 2019, the change in the valuation allowance was due primarily to valuation allowances released on net operating losses and due to less foreign tax credit carryforwards being available after the one-time deemed repatriation tax under the Tax Act.

F-42

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

A reconciliation of the beginning and ending amount of UTBs is presented below:



	Year Ended June 30,
	2019			2018			2017
UTBs—July 1	$	303.6		$	257.9		$	228.9
Additions based on tax positions related to the current year	49.1			44.1			43.6
Additions for tax positions of prior years	8.3			97.4			0.4
Reductions for tax positions of prior years	(9.6		)	(39.9		)	—
Settlements	(2.7		)	(42.3		)	(1.5		)
Lapses in statutes of limitations	(9.0		)	(11.0		)	(13.2		)
Foreign currency translation	(3.6		)	(2.6		)	(0.3		)
UTBs—June 30	$	336.1		$	303.6		$	257.9

As of June 30, 2019, the Company had $336.1 of UTBs of which $162.2 represents the amount that, if recognized, would impact the effective income tax rate in future periods. As of June 30, 2019 and 2018, the liability associated with UTBs, including accrued interest and penalties, is $179.9 and $135.4, respectively, which is recorded in Income and other taxes payable and Other non-current liabilities in the Consolidated Balance Sheets.

During fiscal 2019, the Company accrued interest of $4.5, while in fiscal 2018 and 2017 the Company accrued interest of $0.8 and $1.4, respectively. During fiscal 2019, the Company accrued penalties of $0.0, while in fiscal 2018 and 2017 the Company accrued penalties of $0.4 and $0.1, respectively. The total gross accrued interest and penalties recorded in the Other noncurrent liabilities in the Consolidated Balance Sheets related to UTBs as of June 30, 2019 and 2018 is $17.3 and $13.1, respectively.

The Company is present in approximately 55 tax jurisdictions, and at any point in time is subject to several audits at various stages of completion. As a result, the Company evaluates tax positions and establishes liabilities for UTBs that may be challenged by local authorities and may not be fully sustained, despite a belief that the underlying tax positions are fully supportable. UTBs are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law, and closing of statute of limitations. Such adjustments are reflected in the provision for income taxes as appropriate. In fiscal 2019 and 2018, the Company recognized a tax benefit of $11.7 and $53.3 respectively associated with the settlement of tax audits in multiple jurisdictions and the expiration of foreign and state statutes of limitation. The Company has open tax years ranging from 2009 and forward.

On the basis of information available at June 30, 2019, it is reasonably possible that a decrease of up to $23.1 in UTBs related to U.S. and foreign exposures may be necessary within the coming year. It is also possible the ongoing audits by tax authorities may result in increases or decreases to the balance of UTBs. Since it is common practice to extend audits beyond the Statute of Limitations, the Company is unable to predict the timing or conclusion of these audits and, accordingly, the Company is unable to estimate the amount of changes to the balance of UTBs that are reasonably possible at this time. However, the Company believes it has adequately provided for its UTBs for all open tax years in each tax jurisdiction.

On December 22, 2017, “H.R.1”, formerly known as the “Tax Cuts and Jobs Act” (“Tax Act”) was enacted. The Tax Act significantly revises the U.S. corporate income tax system by, amongst other things, reducing the federal tax rate on U.S. earnings to 21%, implementing a modified territorial tax system and imposing a one-time deemed repatriation tax on historical earnings generated by foreign subsidiaries that have not been repatriated to the U.S.

On December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”) which provides guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the enactment date of the Tax Act for companies to complete the accounting under ASC 740. The Company recorded its initial estimate of the impact of the Tax Act in fiscal 2018. This estimate was a charge of approximately $41.0 as a result of utilizing tax attributes (e.g., net operating losses and foreign tax credits) to fully offset the cash impact of the one-time deemed repatriation tax. During fiscal 2019, the Company finalized its estimate of the impact of the Tax Act and no additional adjustments were required.

F-43

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

17. INTEREST EXPENSE, NET

Interest expense, net for the years ended June 30, 2019, 2018 and 2017 is presented below:



	Year Ended June 30,
	2019			2018			2017
Interest expense	$	302.5		$	287.1		$	219.6
Foreign exchange (gain) losses, net of derivative contracts ^(a)	(7.6		)	(8.5		)	3.4
Interest income	(19.2		)	(13.6		)	(4.4		)
Total interest expense, net	$	275.7		$	265.0		$	218.6

^(a) In the year ended June 30, 2018, the Company recorded gains of $1.4 related to short-term forward contracts to exchange euros for U.S. dollars to facilitate the repayment of U.S. dollar denominated debt. Fluctuations in exchange rates between the dates the short-term forward contracts were entered into and the settlement date resulted in a gain upon settlement of $1.4 included within total Interest expense, net for the fiscal year ended June 30, 2018 in the Company’s Consolidated Statements of Operations.

18. EMPLOYEE BENEFIT PLANS

Savings and Retirement Plans - The Company’s Savings and Retirement Plans include a U.S. defined contribution plan for employees primarily in the U.S. and international savings plans for employees in certain other countries. In the U.S., hourly and salary based employees are eligible to participate in the plan after 90 days of service and the Company matches 100% of employee contributions up to 6.0% of employee compensation. In addition, the Company makes contributions to the plan on behalf of employees determined by their age and compensation.

During fiscal 2019, 2018 and 2017, the defined contribution expense for the U.S. defined contribution plan was $20.4, $22.0 and $20.6, respectively, and the defined contribution expense for the international savings plans was $12.9, $18.3 and $13.3, respectively.

Pension Plans - The Company sponsors contributory and noncontributory defined benefit pension plans covering certain U.S. and international employees primarily in France, Germany and Switzerland. Participants in the U.S. defined benefit pension plan no longer accrue benefits. The Company measures defined benefit plan assets and obligations as of the date of the Company’s fiscal year-end. The Company’s defined benefit pension plans are funded primarily through contributions from the Company after consideration of recommendations from the pension plans’ independent actuaries and are funded at levels sufficient to comply with local requirements.

Settlements and Curtailments for Pension Plans

As part of Global Integration Activities, the Company concluded that restructuring actions resulted in a significant reduction of future services of active employees in certain of our non-U.S. pension plans. As a result, the Company recognized curtailment gains of $5.1 during the year ended June 30, 2019, and net settlement gains of $0.4 and net curtailment gains of $0.4 during the year ended June 30, 2017. The impact of settlement and curtailment activity on the current and prior comparative periods is included in Other expense, net in the Consolidated Statements of Operations, after the adoption of ASU 2017-07.

During fiscal 2017, the Company recognized a curtailment gain of $1.8 in connection with involuntary employee terminations as part of an integration and restructuring program in connection with the Bourjois acquisition, which significantly reduced the expected years of future service of employees within one of the Company’s non-U.S. pension plans. This curtailment gain is included in Other expense, net in the Consolidated Statements of Operations.

The Company settled obligations to U.S. Del Laboratories, Inc. pension plan (the “Del Plan”) participants during fiscal 2017 resulting in the recognition of pre-tax settlement losses of $15.9, included in Other expense, net in the Consolidated Statement of Operations for the year ended June 30, 2017. The Del Plan was fully terminated as a result of these actions.

Plan Amendments for Pension Plans - In June of fiscal 2019, an international pension plan in Switzerland was amended to reduce the interest rate used to calculated future payments to 2.00% from 2.25%. In addition, the annuity conversion rate related to this pension plan was reduced to 5.10% from 6.21%. The impact of these changes resulted in a reduction to the benefit obligation associated with this plan of $10.3.

Other Post-Employment Benefit Plans (“OPEB”) - The Company provides certain post-employment health and life insurance benefits for certain employees and spouses principally in the U.S. and France if certain age and service requirements are met. Estimated benefits to be paid by the Company are expensed over the service period of each employee based on

F-44

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

calculations performed by an independent actuary. In addition, the Company has a supplemental retirement plan and a termination benefit plan for selected salaried employees.

Settlements and Curtailments for OPEB Plans

The Company amended a non-U.S. postretirement healthcare plan during fiscal 2018, which significantly reduced the expected years of future service for employees participating in the plan. The amendment triggered a curtailment gain of $10.4, which is included in Other expense, net in the Consolidated Statement of Operations for the year ended June 30, 2018.

The aggregate reconciliation of the projected benefit obligations, plan assets, funded status and amounts recognized in the Company’s Consolidated Financial Statements related to the Company’s pension plans and other post-employment benefit plans is presented below:



	Pension Plans												Other Post-Employment Benefits						Total
	U.S.						International						Other Post-Employment Benefits						Total
	2019			2018			2019			2018			2019			2018			2019			2018
Change in benefit obligation
Benefit obligation—July 1	$	17.5		$	18.8		$	732.6		$	708.8		$	53.2		$	63.8		$	803.3		$	791.4
Service cost	—			—			33.3			38.8			1.2			1.4			34.5			40.2
Interest cost	0.7			0.7			12.8			12.6			2.1			2.0			15.6			15.3
Plan participants’ contributions	—			—			7.0			7.1			0.2			0.2			7.2			7.3
Plan amendments	—			—			(10.3		)	—			—			—			(10.3		)	—
Benefits paid	(1.3		)	(1.3		)	(16.9		)	(53.1		)	(1.8		)	(1.6		)	(20.0		)	(56.0		)
New employees transfers in	—			—			16.2			23.5			—			—			16.2			23.5
Premiums paid	—			—			(2.5		)	(2.7		)	—			—			(2.5		)	(2.7		)
Pension curtailment	—			—			(5.4		)	0.3			—			(10.4		)	(5.4		)	(10.1		)
Pension settlement	—			—			(37.4		)	(1.0		)	—			—			(37.4		)	(1.0		)
Actuarial loss (gain)	0.8			(0.7		)	69.9			(6.3		)	4.1			(2.5		)	74.8			(9.5		)
Effect of exchange rates	—			—			(10.8		)	4.6			(0.1		)	0.3			(10.9		)	4.9
Other	—			—			1.6			—			(1.1		)	—			0.5			—
Benefit obligation—June 30	$	17.7		$	17.5		$	790.1		$	732.6		$	57.8		$	53.2		$	865.6		$	803.3

Change in plan assets
Fair value of plan assets—July 1	$	—		$	—		$	261.8		$	234.2		$	0.4		$	0.4		$	262.2		$	234.6
Actual return on plan assets	—			—			3.5			18.8			—			—			3.5			18.8
Employer contributions	1.3			1.3			36.4			37.1			1.6			1.4			39.3			39.8
Plan participants’ contributions	—			—			7.0			7.1			0.2			0.2			7.2			7.3
Benefits paid	(1.3		)	(1.3		)	(16.9		)	(52.7		)	(1.8		)	(1.6		)	(20.0		)	(55.6		)
New employees transfers in	—			—			16.2			23.5			—			—			16.2			23.5
Premiums paid	—			—			(2.5		)	(2.7		)	—			—			(2.5		)	(2.7		)
Plan settlements	—			—			(37.4		)	(1.0		)	—			—			(37.4		)	(1.0		)
Effect of exchange rates	—			—			(0.1		)	(2.5		)	—			—			(0.1		)	(2.5		)
Other	—			—			0.5			—			—			—			0.5			—
Fair value of plan assets—June 30	—			—			268.5			261.8			0.4			0.4			268.9			262.2
Funded status—June 30	$	(17.7	)	$	(17.5	)	$	(521.6	)	$	(470.8	)	$	(57.4	)	$	(52.8	)	$	(596.7	)	$	(541.1	)

With respect to the Company’s pension plans and other post-employment benefit plans, amounts recognized in the Company’s Consolidated Balance Sheets as of June 30, 2019 and 2018, are presented below:

F-45

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)



	Pension Plans												Other Post-Employment Benefits						Total
	U.S.						International						Other Post-Employment Benefits						Total
	2019			2018			2019			2018			2019			2018			2019			2018
Noncurrent assets	$	—		$	—		$	1.5		$	1.1		$	—		$	—		$	1.5		$	1.1
Current liabilities	(1.4		)	(1.3		)	(0.8		)	(5.5		)	(2.5		)	(2.1		)	(4.7		)	(8.9		)
Noncurrent liabilities	(16.3		)	(16.2		)	(522.3		)	(466.4		)	(54.9		)	(50.7		)	(593.5		)	(533.3		)
Funded status	(17.7		)	(17.5		)	(521.6		)	(470.8		)	(57.4		)	(52.8		)	(596.7		)	(541.1		)
AOC(L)/I	0.2			1.7			(20.3		)	44.7			10.0			20.1			(10.1		)	66.5
Net amount recognized	$	(17.5	)	$	(15.8	)	$	(541.9	)	$	(426.1	)	$	(47.4	)	$	(32.7	)	$	(606.8	)	$	(474.6	)

The accumulated benefit obligation for the U.S. defined benefit pension plans was $17.7 and $17.5 as of June 30, 2019 and 2018, respectively. The accumulated benefit obligation for international defined benefit pension plans was $733.7 and $669.1 as of June 30, 2019 and 2018, respectively.

Pension plans with accumulated benefit obligations in excess of plan assets and projected benefit obligations in excess of plan assets are presented below:



	Pension plans with accumulated benefit obligations in excess of plan assets								Pension plans with projected benefit obligations in excess of plan assets
	U.S.				International				U.S.				International
	2019		2018		2019		2018		2019		2018		2019		2018
Projected benefit obligation	$	17.7	$	17.5	$	767.5	$	713.9	$	17.7	$	17.5	$	775.9	$	725.0
Accumulated benefit obligation	17.7		17.5		716.3		657.8		17.7		17.5		733.7		669.1
Fair value of plan assets	—		—		248.2		247.0		—		—		254.9		254.2

Net Periodic Benefit Cost

The components of net periodic benefit cost for pension plans and other post-employment benefit plans recognized in the Consolidated Statements of Operations are presented below:



	Year Ended June 30,
	Pension Plans																		Other Post- Employment Benefits
	U.S.									International									Other Post- Employment Benefits									Total
	2019			2018			2017			2019			2018			2017			2019			2018			2017			2019			2018			2017
Service cost	$	—		$	—		$	—		$	33.3		$	38.8		$	34.8		$	1.2		$	1.4		$	1.9		$	34.5		$	40.2		$	36.7
Interest cost	0.7			0.7			1.6			12.8			12.6			6.6			2.1			2.0			1.8			15.6			15.3			10.0
Expected return on plan assets	—			—			(0.9		)	(8.2		)	(7.5		)	(6.3		)	—			—			—			(8.2		)	(7.5		)	(7.2		)
Amortization of prior service (credit) cost	—			—			—			0.2			0.2			0.2			(5.9		)	(5.9		)	(5.9		)	(5.7		)	(5.7		)	(5.7		)
Amortization of net (gain) loss	(0.7		)	(0.7		)	2.3			0.3			1.2			4.2			(0.1		)	(0.1		)	0.1			(0.5		)	0.4			6.6
Settlements (gain) loss recognized	—			—			15.9			(0.8		)	—			(0.5		)	—			—			—			(0.8		)	—			15.4
Curtailment (gain) loss recognized	—			—			—			(5.4		)	0.1			(2.2		)	—			(10.4		)	—			(5.4		)	(10.3		)	(2.2		)
Net periodic benefit cost	$	—		$	—		$	18.9		$	32.2		$	45.4		$	36.8		$	(2.7	)	$	(13.0	)	$	(2.1	)	$	29.5		$	32.4		$	53.6

Pre-tax amounts recognized in AOC(L)/I, which have not yet been recognized as a component of net periodic benefit cost are presented below:



	Pension Plans										Other Post-Employment Benefits
	U.S.				International						Other Post-Employment Benefits					Total
	2019		2018		2019			2018			2019			2018		2019			2018
Net actuarial (loss) gain	$	0.2	$	1.7	$	(29.0	)	$	46.7		$	(0.4	)	$	3.8	$	(29.2	)	$	52.2
Prior service credit (cost)	—		—		8.7			(2.0		)	10.4			16.3		19.1			14.3
Total recognized in AOC(L)/I	$	0.2	$	1.7	$	(20.3	)	$	44.7		$	10.0		$	20.1	$	(10.1	)	$	66.5

F-46

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

Changes in plan assets and benefit obligations recognized in OCI/(L) during the fiscal year are presented below:



	Pension Plans											Other Post-Employment Benefits
	U.S.						International					Other Post-Employment Benefits						Total
	2019			2018			2019			2018		2019			2018			2019			2018
Net actuarial (loss) gain	$	(0.8	)	$	0.7		$	(74.6	)	$	17.8	$	(4.1	)	$	2.3		$	(79.5	)	$	20.8
Amortization of prior service (credit) cost	—			—			0.2			0.2		(5.9		)	(5.9		)	(5.7		)	(5.7		)
Recognized net actuarial (gain) loss	(0.7		)	(0.6		)	(0.5		)	1.2		(0.1		)	(0.1		)	(1.3		)	0.5
Prior service credit (cost)	—			—			10.3			—		—			—			10.3			—
Effect of exchange rates	—			—			(0.4		)	0.3		—			0.1			(0.4		)	0.4
Total recognized in OCI/(L)	$	(1.5	)	$	0.1		$	(65.0	)	$	19.5	$	(10.1	)	$	(3.6	)	$	(76.6	)	$	16.0

Amounts in AOCI/(L) expected to be amortized as components of net periodic benefit cost during fiscal 2020 are presented below:



	Pension Plans					Other Post-Employment Benefits		Total
	U.S.			International		Other Post-Employment Benefits		Total
Prior service credit (cost)	$	—		$	0.8	$	5.9	$	6.7
Net gain (loss)	(0.7		)	0.1		0.1		(0.5		)
Total	$	(0.7	)	$	0.9	$	6.0	$	6.2

Pension and Other Post-Employment Benefit Assumptions

The weighted-average assumptions used to determine the Company’s projected benefit obligation above are presented below:



	Pension Plans				Other Post-Employment Benefits
	U.S.		International		Other Post-Employment Benefits
	2019	2018	2019	2018	2019	2018
Discount rates	3.2%-3.6%	4%	0.4%-8.4%	0.6%-8.0%	1.7%-3.5%	2.3%-4.2%
Future compensation growth rates	N/A	N/A	1.0%-5.8%	1.5%-5.8%	N/A	N/A

The weighted-average assumptions used to determine the Company’s net periodic benefit cost in fiscal 2019, 2018 and 2017 are presented below:



	Pension Plans						Other Post- Employment Benefits
	U.S.			International			Other Post- Employment Benefits
	2019	2018	2017	2019	2018	2017	2019	2018	2017
Discount rates	4%	3.6%	3.3%-3.8%	0.6%-8.0%	0.4%-7.5%	0.2%-7.8%	2.3%-4.2%	1.9%-7.6%	1.4%-8.0%
Future compensation growth rates	N/A	N/A	N/A	1.5%-5.7%	1.5%-6.0%	1.5%-5.8%	N/A	N/A	N/A
Expected long-term rates of return on plan assets	N/A	N/A	N/A	2.0%-8.4%	1.8%-8.2%	1.6%-6.0%	N/A	N/A	N/A

F-47

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

The health care cost trend rate assumptions have a significant effect on the amounts reported.



	Year Ended June 30,
	2019	2018	2017
Health care cost trend rate assumed for next year	7.1%-8.0%	7.4%-8.5%	7.2%-7.4%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)	5%	5%	5%
Year that the rate reaches the ultimate trend rate	2026	2026	2025

A one-percentage point change in assumed health care cost trend rates would have the following effects:



	One Percentage Point Increase		One Percentage Point Decrease
Effect on total service cost and interest cost	$	6.6	$	(5.8	)
Effect on post-employment benefit obligation	0.4		(0.3		)

Pension Plan Investment Policy

The Company’s investment policies and strategies for plan assets are to achieve the greatest return consistent with the fiduciary character of the plan and to maintain a level of liquidity that is sufficient to meet the need for timely payment of benefits. The goals of the investment managers include minimizing risk and achieving growth in principal value so that the purchasing power of such value is maintained with respect to the rate of inflation.

The pension plan’s return on assets is based on management’s expectations of long-term average rates of return to be achieved by the underlying investment portfolios. In establishing this assumption, management considers historical and expected returns for the assets in which the plan is invested, as well as current economic and market conditions.

The asset allocation decision includes consideration of future retirements, lump-sum elections, growth in the number of participants, the Company’s contributions and cash flow. These actual characteristics of the plan place certain demands upon the level, risk and required growth of trust assets. Actual asset allocation is regularly reviewed and periodically rebalanced to the strategic allocation when considered appropriate.

The target asset allocations for the Company’s pension plans as of June 30, 2019 and 2018, by asset category are presented below:



		% of Plan Assets at Year Ended
	Target	2019	2018
Equity securities	40%	41%	41%
Fixed income securities	50%	42%	42%
Cash and other investments	10%	17%	17%

Fair Value of Plan Assets

The international pension plan assets that the Company measures at fair value on a recurring basis, based on the fair value hierarchy as described in Note 2—Summary of Significant Accounting Policies, as of June 30, 2019 and 2018 are presented below:

F-48

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)



	Level 1				Level 2				Level 3				Total
	2019		2018		2019		2018		2019		2018		2019		2018
Equity securities	$	66.8	$	63.0	$	—	$	—	$	—	$	—	$	66.8	$	63.0
Fixed income securities:
Corporate securities	57.9		54.6		—		—		—		—		57.9		54.6
Other:
Cash and cash equivalents	1.0		0.9		—		—		—		—		1.0		0.9
Insurance contracts and other	—		—		—		—		143.2		143.7		143.2		143.7
Total pension plan assets	$	125.7	$	118.5	$	—	$	—	$	143.2	$	143.7	$	268.9	$	262.2

The following is a description of the valuation methodologies used for plan assets measured at fair value:

Equity securities-The fair values reflect the closing price reported on a major market where the individual securities are traded. These investments are classified within Level 1 of the valuation hierarchy.

Corporate securities-The fair values are based on a compilation of primarily observable market information or a broker quote in a non-active market. These investments are classified within Level 1 of the valuation hierarchy.

Cash and cash equivalents-The carrying amount approximates fair value, primarily because of the short maturity of cash equivalent instruments. These investments are classified within Level 1 of the valuation hierarchy.

Insurance contracts and other- Includes contracts issued by insurance companies and other investments that are not publicly traded. These investments are generally classified as Level 3 as there are neither quoted prices nor other observable inputs for pricing. Insurance contracts are valued at cash surrender value, which approximates the contract fair value. Other Level 3 plan assets include real estate and other alternative investment funds requiring inputs that cannot be readily derived from observable market data due to the infrequency with which the underlying assets trade.

The Company sponsors a qualified defined benefit pension plan for all eligible Swiss employees. Retirement benefits are provided based on employees’ years of service and earnings, or in accordance with applicable employee regulations. Consistent with typical Swiss practice, the pension plan is funded through a guaranteed insurance contract with an insurance company (“IC”). The IC is responsible for the investment strategy of the insurance premiums that the Company submits and does not hold individual assets per participating employer. Assets are invested in accordance with the IC’s own strategies and risk assessments. Under the terms of the contract, the interest rate as well as the capital value is guaranteed for each participant, with the IC assuming any risk to the value of the underlying assets. The IC is a member of a security fund, whose purpose is to cover any shortfall in the event they are not able to fulfill its contractual agreements. The plan assets of the Swiss plan are included in the Level 3 valuation.

The Company also sponsors qualified defined benefit pension plans for certain eligible German employees. The Company’s German pension plans are partially funded with plan assets held in a Contractual Trust Arrangement, under which Company assets have been irrevocably transferred to a registered association for the exclusive purpose of securing and funding pension obligations in Germany. The association invests primarily in publicly tradable equity and fixed income securities, using a funding strategy that is reviewed on a regular basis.

Plan assets are also held in the Company’s other non-U.S. defined benefit pension plans. The other non-U.S. defined benefit pension plans provide benefits primarily based on earnings and years of service and are funded in compliance with local laws and practices. The plan assets are invested in various asset classes that are expected to produce a sufficient level of diversification and investment return over the long term at an acceptable level of risk.

The reconciliations of Level 3 plan assets measured at fair value in fiscal 2019 and 2018 are presented below:

F-49

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)



	June 30, 2019			June 30, 2018
Insurance contracts:
Fair value—July 1	$	143.7		$	130.2
Plan assets from acquisitions	—			—
Return on plan assets	(0.2		)	14.0
Purchases, sales and settlements, net	(2.5		)	3.9
Effect of exchange rates	2.2			(4.4		)
Fair value—June 30	$	143.2		$	143.7

Contributions

The Company plans to contribute approximately $1.3 to its remaining U.S. pension plan and expects to contribute approximately $35.5 and $2.4 to its international pension and other post-employment benefit plans, respectively, during fiscal 2020.

Estimated Future Benefit Payments

Expected benefit payments, which reflect expected future service, as appropriate, are presented below:



	Pension Plans				Other Post-Employment Benefits		Total
Fiscal Year Ending June 30,	U.S.		International		Other Post-Employment Benefits		Total
2020	$	1.3	$	36.9	$	2.4	$	40.6
2021	1.3		25.2		2.8		29.3
2022	1.3		25.1		3.1		29.5
2023	1.3		25.8		3.4		30.5
2024	1.2		25.8		3.5		30.5
2025 - 2027	5.8		152.2		18.9		176.9

19. DERIVATIVE INSTRUMENTS

Foreign Exchange Risk

The Company is exposed to foreign currency exchange fluctuations through its global operations. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in foreign exchange rates by creating offsetting positions through the use of derivative instruments and also by designating foreign currency denominated borrowings as hedges of net investments in foreign subsidiaries. The Company expects that through hedging, any gain or loss on the derivative instruments would generally offset the expected increase or decrease in the value of the underlying forecasted transactions. The Company entered into derivatives for which hedge accounting treatment has been applied which the Company anticipates realizing in the Consolidated Statements of Operations through fiscal 2020.

The Company enters into foreign exchange forward contracts to hedge anticipated transactions for periods consistent with the Company’s identified exposures to minimize the effect of foreign exchange rate movements on revenues, costs and on the cash flows that the Company receives from foreign subsidiaries and third parties where there is a high probability that anticipated exposures will materialize. The foreign exchange forward contracts used to hedge anticipated transactions have been designated as foreign exchange cash-flow hedges. Hedge effectiveness of foreign exchange forward contracts is based on the forward-to-forward hypothetical derivative methodology and includes all changes in value.

The Company also continued to use certain derivatives as economic hedges of foreign currency exposure on firm commitments and forecasted transactions, which do not qualify for hedge accounting. Although these derivatives were not designated for hedge accounting, the overall objective of mitigating foreign currency exposure is the same for all derivative instruments. The Company does not enter into derivative financial instruments for trading or speculative purposes, nor is the Company a party to leveraged derivatives. For derivatives not designated as hedging instruments, changes in fair value are recorded in the line item in the Consolidated Statements of Operations to which the derivative relates.

F-50

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

Interest Rate Risk

The Company is exposed to interest rate fluctuations related to its variable rate debt instruments. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in the variable interest rates by entering into offsetting positions through the use of derivative instruments, such as interest rate swap contracts. The interest rate swap contracts result in recognizing a fixed interest rate for the portion of the Company’s variable rate debt that was hedged. This will reduce the negative impact of increases in the variable rates over the term of the contracts. Hedge effectiveness of interest rate swap contracts is based on a long-haul hypothetical derivative methodology and includes all changes in value.

During August 2018, the Company extended the maturity of the interest rate swap portfolio through fiscal 2021 by replacing its original swap contracts with swap contracts having longer maturities to manage the medium term exposure to interest rate increases. The Company received $43.2 for settlement of the original swap contracts. As the forecasted interest expense under the original swap agreements is still probable, the related AOCI/(L) will be amortized in line with the timing of the forecasted transactions. As of June 30, 2019 and 2018, the Company had interest rate swap contracts designated as effective hedges in the notional amount of $2,000.0.

Hedge Accounting

Derivative financial instruments are recorded as either assets or liabilities on the Consolidated Balance Sheets and are measured at fair value.

For derivatives accounted for as hedging instruments, the Company formally designates and documents, at inception, the financial instrument as a hedge of specific underlying forecasted transactions, the risk management objective and the strategy for undertaking the hedge transaction. In addition, the Company formally assesses both at inception and at least quarterly thereafter, whether the financial instruments used in hedging transactions are effective at offsetting changes in either the fair values or cash flows of the related underlying exposures. Additionally, all of the master agreements governing the Company’s derivative contracts contain standard provisions that could trigger early termination of the contracts in certain circumstances which would require the Company to discontinue hedge accounting, including if the Company were to merge with another entity and the creditworthiness of the surviving entity were to be “materially weaker” than that of the Company prior to the merger.

For derivatives designated as cash flow hedges, changes in the fair value are recorded in AOCI/(L). Gains and losses deferred in AOCI/(L) are then recognized in Net income (loss) in a manner that matches the timing of the actual income or expense related to the hedging instruments with the hedged transaction. The gains and losses related to designated hedging instruments are also recorded in the line item in the Consolidated Statements of Operations to which the derivative relates. Cash flows from derivative instruments designated as cash flow hedges are recorded in the same category as the cash flows from the items being hedged in the Consolidated Statements of Cash Flows.

The ineffective portion of foreign exchange forward and interest rate swap contracts are recorded in current-period earnings. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued and gains and losses accumulated in Other comprehensive income (loss) (“OCI”) are reclassified to earnings when the underlying forecasted transaction occurs. If it is no longer probable that the forecasted transaction will occur, then any gains or losses in AOCI/(L) are reclassified to current-period earnings. For fiscal 2019, all of the Company’s foreign exchange forward and interest rate swap contracts designated as hedges were highly effective.

The Company also attempts to minimize credit exposure to counterparties by entering into derivative contracts with counterparties that are major financial institutions and utilizing master netting arrangements. Exposure to credit risk in the event of nonperformance by any of the counterparties with respect to the Company’s foreign exchange forward contracts is limited to the fair value of contracts in net asset positions under master netting arrangements. Exposure to credit risk in the event of nonperformance by any of the counterparties with respect to the Company’s interest rate swap contracts is limited to the fair value of contracts in net asset positions. Accordingly, management of the Company believes risk of material loss under these hedging contracts is remote.

Net Investment Hedge

Foreign currency gains and losses on borrowings designated as a net investment hedge, except ineffective portions, are reported in the cumulative translation adjustment (“CTA”) component of AOCI/(L), along with the foreign currency translation adjustments on those investments. Foreign currency denominated borrowings designated as net investment hedges had nominal exposures of €3,699.3 million and €3,204.1 million as of June 30, 2019 and 2018, respectively.

Net investment hedge effectiveness is assessed based on the change in the spot rate of the foreign currency denominated loans payable. The critical terms (underlying notional and currency) of the loans payable match the portion of the net investments designated as being hedged. The net investment hedges were equal to the designated portions of the international

F-51

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

subsidiaries’ investment balances as of June 30, 2019. As such, the net investment hedges were considered to be effective, and, as a result, the changes in the fair value were recorded within CTA on the Company’s Consolidated Balance Sheets.

Derivative and non-derivative financial instruments which are designated as hedging instruments:

The accumulated gain (loss) on foreign currency borrowings classified as net investment hedges in the foreign currency translation adjustment component of AOCI/(L) was $214.8 and $115.0 as of June 30, 2019 and 2018, respectively.

The amount of gains and losses recognized in OCI in the Consolidated Balance Sheets related to the Company’s derivative and non-derivative financial instruments which are designated as hedging instruments is presented below:



Gain (Loss) Recognized in OCI	Fiscal Year Ended June 30,
	2019			2018			2017
Foreign exchange forward contracts	$	0.9		$	(0.3	)	$	(0.8	)
Interest rate swap contracts	(47.4		)	27.0			40.8
Net investment hedges	99.8			138.7			(21.2		)

The accumulated (loss) gain on derivative instruments classified as cash flow hedges in AOCI/(L), net of tax, was $(13.3) and $31.7 as of June 30, 2019 and 2018, respectively. The estimated net loss related to these effective hedges that is expected to be reclassified from AOCI/(L) into earnings, net of tax, within the next twelve months is $(1.7).

The amount of gains and losses reclassified from AOCI/(L) to the Consolidated Statements of Operations related to the Company’s derivative financial instruments which are designated as hedging instruments is presented below:



Consolidated Statements of Operations Classification of Gain (Loss) Reclassified from AOCI/(L)	Fiscal Year Ended June 30,
	2019		2018			2017
Foreign exchange forward contract:
Net revenues	$	—	$	(0.8	)	$	2.4
Cost of sales	0.2		(0.7		)	(2.2		)
Interest rate swap contracts:
Interest income (expense), net	12.4		6.9			(9.3		)

Derivatives not designated as hedging instruments:

The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments is presented below:



Consolidated Statements of Operations Classification of Gain (Loss) Recognized in Operations	Fiscal Year Ended June 30,
	2019		2018			2017
Selling, general and administrative	$	0.1	$	(0.8	)	$	(0.1	)
Interest income (expense), net	0.1		17.5			(6.5		)
Other income (expense), net	—		0.2			(1.1		)

20. MANDATORILY REDEEMABLE FINANCIAL INTEREST

United Arab Emirates subsidiary

The Company is required under a shareholders agreement to purchase all of the shares held by the noncontrolling interest holder equal to 25% of the outstanding shares of a certain subsidiary in the United Arab Emirates (the “U.A.E. subsidiary”) at the termination of the agreement. The Company has determined such shares to be a mandatorily redeemable financial instrument (“MRFI”) that is recorded as a liability. The liability is calculated based upon a pre-determined formula in accordance with the related U.A.E. Shareholders Agreement. As of June 30, 2019 and 2018, the liability amounted to $7.5 and $8.2, respectively, of which $6.1 and $6.7, respectively, was recorded in Other noncurrent liabilities and $1.4 and $1.5, respectively, was recorded in Accrued expenses and other current liabilities.

F-52

The assets of the U.A.E. subsidiary are restricted in that they are not available for general business use outside the context of the U.A.E. subsidiary and creditors (or beneficial interest holders) do not have recourse to the Company or to its other assets. The U.A.E. subsidiary has total assets and total liabilities of $37.2 and $26.7 as of June 30, 2019, and $33.2 and $20.2 as of June 30, 2018, respectively.

Southeast Asian subsidiary

On May 23, 2017, the Company entered into the Sale of Shares and Termination Deed, as amended (the “Termination Agreement”) to purchase the remaining 49% noncontrolling interest from the noncontrolling interest holder of a certain Southeast Asian subsidiary for a purchase price of $45.0. Additionally, all remaining retained earnings will be paid out as dividends by December 31, 2019. As a result of the Termination Agreement, the noncontrolling interest balance is recorded as an MRFI. The MRFI balance was accreted to the redemption value through the effective date of the purchase with changes in the balance being reflected in Other income (expense) in the Consolidated Statements of Operations. The termination was effective on June 30, 2019 and the Company remitted purchase consideration of $45.0 in July of fiscal 2020 to the noncontrolling interest holder.

As of June 30, 2019 and 2018, the MRFI liability, which includes the termination payment and dividends payable to the noncontrolling interest holder, amounted to $50.4 and $45.1, respectively, which was recorded in Accrued expenses and other current liabilities in the Consolidated Balance Sheet.

21. REDEEMABLE NONCONTROLLING INTERESTS

As of June 30, 2019, the redeemable noncontrolling interests (“RNCI”) consist of interests in a consolidated subsidiary in the Middle East and in the consolidated subsidiaries related to the Younique acquisition. See Note 3—Business Combinations.

Younique

As of June 30, 2018, the Younique membership holders had a 40.6% membership interest in Foundation, which holds 100% of the units of Younique. During the year ended June 30, 2019, additional shares of Foundation were issued to employees of Younique under a stock ownership program and incentive stock grants were granted, resulting in a 0.1% increase to the noncontrolling interest ownership percentage. The cumulative impact of the additional shares for the year ended June 30, 2019 was recorded as an increase to RNCI of $1.6 and a decrease in additional paid-in capital (“APIC”) of $1.6.

The Company accounts for the 40.7% noncontrolling interest portion of Foundation as RNCI due to the noncontrolling interest holder’s ability to put their shares to the Company in certain circumstances. While Foundation is a majority-owned consolidated subsidiary, the Company records income tax expense based on the Company’s 59.3% membership interest in Foundation due to its treatment as a partnership for U.S. income tax purposes. Accordingly, Foundation’s net income attributable to RNCI is equal to the 40.7% noncontrolling interest of Foundation’s net income excluding a provision for income taxes. The Company recognized $365.3 and $597.7 as the redeemable noncontrolling interest balances as of June 30, 2019 and 2018, respectively.

The Company has the right to purchase the RNCI in Foundation from the RNCI holders (each such right, a “Foundation Call right”) upon the occurrence of certain events that are not in the Company’s control. In addition to the Foundation Call right features, the noncontrolling interest holders of Foundation have the right to sell the noncontrolling interests to the Company upon the occurrence of certain events (each such right, a “Foundation Put right”).

The amount at which the Foundation Put right and Foundation Call right can be exercised is based on a fair value at the exercise date, multiplied by the noncontrolling interest holder’s percentage interest in Foundation. In certain circumstances the Foundation Put right or the Foundation Call right may be exercised at a discount or a premium. Currently management views the possibility of these circumstances occurring as remote. The noncontrolling interests are redeemable outside of the Company’s control and are recorded in the Consolidated Balance Sheets at the higher of the redemption value (fair value) or the carrying value (the acquisition date fair value adjusted for the noncontrolling interest’s share of net income (loss) and dividends). The Company adjusts Foundation’s RNCI at the end of each reporting period with changes recognized as adjustments to APIC.

The Company uses an income approach, a market approach or a combination of these approaches to estimate the fair value of the Foundation RNCI. The income approach is used to determine the fair value of the Foundation RNCI using a discounted cash flow method, projecting future cash flows of the business, as well as a terminal value, and discounting such cash flows at a rate of return that reflects the relative risk of the cash flows. For the market approach the Company uses a selected multiple based on comparable companies multiplied by the forecasted cash flows. The key estimates and factors used in this approach

F-53

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

include, but are not limited to, revenue growth rates and profit margins based on our internal forecasts and the entity specific weighted-average cost of capital used to discount future cash flows.

Subsidiary in the Middle East

As of June 30, 2019, the noncontrolling interest holder in the Company’s subsidiary in the Middle East (“Middle East Subsidiary”) had a 25% ownership share. The Company has the ability to exercise the Call right for the remaining noncontrolling interest of 25% on December 31, 2028, with such transaction to close on December 31, 2029. In addition to the Call right feature, the noncontrolling interest holder has the right to sell the noncontrolling interest to the Company on December 31, 2028, with such transaction to close on December 31, 2029 (a “Put right”). The amount at which the Put right and Call right can be exercised is based on a formula prescribed by the amended shareholders’ agreement as summarized in the table below, multiplied by the noncontrolling interest holder’s percentage interest in the Middle East Subsidiary. Given the provision of the Put right, the entire noncontrolling interest is redeemable outside of the Company’s control and is recorded in the Consolidated Balance Sheets at the estimated redemption value. The Company adjusts the redeemable noncontrolling interest to the redemption values at the end of each reporting period with changes recognized as adjustments to APIC. The Company recognized $86.5 and $63.6 as the redeemable noncontrolling interest balances as of June 30, 2019 and 2018, respectively.



	Middle East
Percentage of redeemable noncontrolling interest	25.0%^(a)
Earliest exercise date(s)	December 2028 ^(b)
Formula of redemption value	3-year average of EBIT ^(c) * 6

^(a)The parties are entitled to call or put the remaining interest in July 2028. The Put right and Call right will be exercised in respect of the noncontrolling interest holder’s percentage of shares of the Middle East subsidiary at the time of the exercise.

^(b) The parties are entitled to call or put the noncontrolling interest holder’s percentage of shares of the subsidiary in December 2028.

^(c) EBIT is defined in the amended shareholders’ agreement as the consolidated net earnings before interest and income tax.

22. EQUITY

Common Stock

As of June 30, 2019, the Company’s common stock consisted of Class A Common Stock with a par value of $0.01 per share. The holders of Class A Common Stock are entitled to one vote per share. Prior to September 30, 2016, the Company had Class B Common Stock outstanding. As of June 30, 2019, total authorized shares of Class A Common Stock was 1,000.0 million and total outstanding shares of Class A Common Stock was 754.2 million.

In the fiscal years ended June 30, 2019, 2018, and 2017, the Company issued 1.0 million, 2.9 million, and 2.5 million shares of its Class A Common Stock, respectively, and received $5.2, $22.6, and $21.3, in cash, respectively, in connection with the exercise of employee stock options and settlement of RSUs and special incentive awards.

During the fiscal years ended June 30, 2019, 2018 and 2017, Cottage Holdco B.V. (“Cottage”), a wholly-owned subsidiary of JAB Cosmetics B.V. (“JABC”), and JABC acquired 10.8 million, 14.9 million and 2.6 million shares, respectively, of Class A Common Stock in the open market. The Company did not receive any proceeds from these stock purchases conducted by Cottage or JABC.

On April 30, 2019, Cottage completed a tender offer transaction (the “Offer”), acquiring 150.0 million of outstanding Class A shares of the Company at a price of $11.65 per share and as a result, became the Company’s majority stockholder. Immediately after completion of this tender offer transaction, Cottage indirectly controlled approximately 60% of Coty’s Class A shares and the Company became a majority-owned subsidiary of Cottage. Both Cottage and the shares of the Company held by JABC are indirectly controlled by Lucresca SE, Agnaten SE and JAB Holdings B.V. (“JAB”). The Company did not receive any proceeds from these stock purchases conducted by Cottage.

On October 1, 2016, the Company issued 409.7 million shares of Class A Common Stock in connection with the closing of the P&G Beauty Business acquisition as described in Note 3—Business Combinations.

On September 30, 2016, JABC converted all of its shares of Class B Common Stock of the Company into shares of Class A Common Stock of the Company. The Company issued approximately 262.0 million shares of Class A Common Stock to JABC upon the conversion of JABC’s shares of Class B Common Stock. Prior to October 1, 2016, the Company was a majority-owned subsidiary of JABC.

F-54

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

On September 29, 2016, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation amending the Amended and Restated Certificate of Incorporation of the Company to increase the number of authorized shares of Class A Common Stock from 800.0 million shares to 1,000.0 million shares.

Preferred Stock

As of June 30, 2019, the Company’s preferred stock consisted of Series A and Series A-1 Preferred Stock with a par value of $0.01. The Series A and Series A-1 Preferred Stock are not entitled to receive any dividends and have no voting rights except as required by law. As of June 30, 2019, total authorized shares of preferred stock are 20.0 million.

On May 18, 2018, the Company reduced the total authorized number of shares of Series A Preferred Stock from 6.5 million to 6.3 million.

On January 15, 2019, the Company cancelled 3.0 million shares of its Series A Preferred Stock that were forfeited during the six months ended December 31, 2018, reducing the total authorized number of shares of Series A Preferred Stock from 6.3 million to 3.3 million.

On February 4, 2019, the Company authorized, designated and issued 6.9 million shares of Series A-1 Preferred Stock.

On June 14, 2019, the Company authorized, designated and issued 1.0 million shares of Series A-1 Preferred Stock, increasing the total authorized number of shares of Series A-1 Preferred Stock from 6.9 million to 7.9 million.

On June 18, 2019, the Company cancelled 0.4 million shares of its Series A Preferred Stock that were forfeited during the three months ended March 31, 2019, reducing the total authorized number of shares of Series A Preferred Stock from 3.3 million to 2.9 million.

The Series A and Series A-1 Preferred Stock are issued to executive officers and directors under subscription agreements. Generally, the subscription agreements entitle the holder of the vested Series A or Series A-1 Preferred Stock to exchange the Series A or Series A-1 Preferred Stock into either cash or shares of Class A Common Stock, at the election of the Company, at the exchange value. The exchange value is generally equal to the difference between the 10-day trailing average closing price of a share of Class A Common Stock on the date of exchange and a predetermined hurdle price. The Series A Preferred Stock generally vests on the fifth anniversary of issuance, subject to continued employment with the Company and investment by the holder in shares of Class A Common Stock throughout the vesting period. The Series A-1 Preferred Stock generally vests on graded vesting terms where 60% of the award granted vests after three years, 20% of the award granted vests after four years and 20% of the award granted vests after five years, subject to continued employment with the Company and investment by the holder in shares of Class A Common Stock throughout the vesting period. To the extent the Company controls whether such shares will be settled in cash or equity and intends to settle the grant in equity, the grant is treated as an equity grant, otherwise the grant is treated as a liability grant.

The following table summarizes the key terms of each outstanding issuance of Series A and Series A-1 Preferred Stock:



Issuance Date	Type	Number of Shares Awarded at Grant Date (millions of shares)	Number of Shares Outstanding (millions of shares)	Hurdle Price per Share
February 16, 2017 ^(a)	Series A	0.5	0.3	$	22.66
March 27, 2017 ^{(a) (b)}	Series A	1.0	1.0	$	22.39
November 16, 2017^(a)	Series A	1.0	0.2	$	19.85
February 4, 2019^(a)	Series A-1	6.9	6.9	$	8.75
June 14, 2019^(a)	Series A-1	1.0	1.0	$	14.48


^(a)	If the holder does not exchange the vested Series A or Series A-1 Preferred Stock by a specified expiration date, the Company must automatically exchange the Series A or Series A-1 Preferred Stock into cash or shares, at election of the Company.

^(b)

This grant was sold to Lambertus J.H. Becht (“Mr. Becht”), the Company’s former Chairman of the Board. Under the terms provided in the subscription agreement, the Series A Preferred Stock immediately vested on the grant date and the holder may exchange the vested shares after the fifth anniversary of the date of issuance. The Company requires shareholder approval in order to settle the exchange in shares of Class A Common Stock. Therefore, the award is classified as a liability as of June 30, 2019. An expense (income) of $(0.1) and $(1.7) and $3.8 was recorded during fiscal 2019, 2018 and 2017, respectively, and has been included in Selling, general and administrative expense on the Consolidated Statements of Operations.

F-55

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

As of June 30, 2019, total authorized shares of Series A and Series A-1 Preferred Stock are 2.9 million and 7.9 million, respectively, and total outstanding shares of Series A and Series A-1 Preferred Stock are 1.5 million and 7.9 million, respectively. Of the 1.5 million outstanding shares of Series A Preferred Stock, 1.0 million shares vested on March 27, 2017, 0.3 million shares vest on February 16, 2022 and 0.2 million shares vest on November 16, 2022. Of the 7.9 million outstanding shares of Series A-1 Preferred Stock, 4.1 million shares vest on November 12, 2021, 1.4 million shares vest on November 12, 2022, 1.4 million shares vest on November 12, 2023, 0.6 million shares vest on May 10, 2022, 0.2 million shares vest on May 10, 2023 and 0.2 million shares vest on May 10, 2024. As of June 30, 2019, the Company classified $0.7 Series A and Series A-1 Preferred Stock as equity and $2.0 as a liability, inclusive of the related cash bonuses, recorded in Other noncurrent liabilities in the Consolidated Balance Sheet.

Dividends

On June 6, 2019, the Company registered 9.3 million shares of Class A Common Stock for purchase under the Stock Dividend Reinvestment Program. All holders of records of Class A Common Stock have the opportunity to participate in the program. If a holder elects to participate in the program, fifty percent (50%) of their cash dividends will be reinvested in additional shares of Class A Common Stock.

Prior to October 2016, the Company declared annual cash dividends in the first quarter of the fiscal year. Beginning after October 2016, the Company began declaring cash dividends on a quarterly basis.

The P&G Beauty Business Acquisition dated July 8, 2015 (the “Transaction Agreement”) restricted the Company’s ability to declare, make or pay any dividends, other than in the ordinary course and for an amount not to exceed $0.25 per share prior to the closing of the P&G Beauty Business transaction, without P&G consent. In July 2016, P&G provided consent to the Company’s dividend declared on August 1, 2016.

The following dividends were declared during fiscal years 2019, 2018 and 2017:

F-56

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)



Declaration Date	Dividend Type	Dividend Per Share		Holders of Record Date	Dividend Value		Dividend Payment Date	Dividends Settled in Cash		Dividends Settled in Stock^(a)		Dividends Payable ^(b)
Fiscal 2019
August 21, 2018	Quarterly	$	0.125	August 31, 2018	$	94.6	September 14, 2018	$	93.8	N/A		$	0.8
November 7, 2018	Quarterly	$	0.125	November 30, 2018	$	95.1	December 14, 2018	$	93.9	N/A		$	1.2
February 8, 2019	Quarterly	$	0.125	February 28, 2019	$	95.1	March 15, 2019	$	93.9	N/A		$	1.2
May 8, 2019	Quarterly	$	0.125	June 6, 2019	$	95.1	June 28, 2019	$	63.4	$	30.6	$	1.1
Fiscal 2019		$	0.500		$	379.9		$	345.0	$	30.6	$	4.3

Fiscal 2018
August 22, 2017	Quarterly	$	0.125	September 1, 2017	$	94.4	September 14, 2017	$	93.6	N/A		$	0.8
November 9, 2017	Quarterly	$	0.125	November 30, 2017	$	94.6	December 14, 2017	$	93.7	N/A		$	0.9
February 8, 2018	Quarterly	$	0.125	February 28, 2018	$	94.6	March 15, 2018	$	93.8	N/A		$	0.8
May 9, 2018	Quarterly	$	0.125	May 31, 2018	$	94.6	June 14, 2018	$	93.8	N/A		$	0.8
Fiscal 2018		$	0.500		$	378.2		$	374.9	N/A		$	3.3

Fiscal 2017
August 1, 2016	Annual	$	0.275	August 11, 2016	$	93.4	August 19, 2016	$	92.4	N/A		$	1.0
December 9, 2016	Quarterly	$	0.125	December 19, 2016	$	94.0	December 28, 2016	$	93.4	N/A		$	0.6
February 9, 2017	Quarterly	$	0.125	February 28, 2017	$	94.0	March 10, 2017	$	93.4	N/A		$	0.6
May 10, 2017	Quarterly	$	0.125	May 31, 2017	$	94.0	June 13, 2017	$	93.4	N/A		$	0.6
Fiscal 2017		$	0.650		$	375.4		$	372.6	N/A		$	2.8


^(a)	The June 28, 2019 stock dividend payment of $30.6 resulted in the issuance of 2.4 million shares of Class A Common Stock.


^(b)	The dividend payable is the value of the remaining dividends payable upon settlement of the RSUs and phantom units outstanding as of the Holders of Record Date. Dividends payable are recorded as Accrued expense and other current liabilities and Other noncurrent liabilities in the Consolidated Balance Sheet.

Total dividends in cash and other recorded to additional paid-in capital (“APIC”) in the Condensed Consolidated Balance Sheet as of June 30, 2019 was $(347.5), consisting of $345.0 dividends settled in cash, $4.3 dividends payable, offset by $1.8 of dividends no longer expected to vest as a result of forfeitures of outstanding RSUs.

In addition to the activity noted above, the Company made a payment of $1.2 for the previously accrued dividends on RSUs that vested during the twelve months ended June 30, 2019. Thus, total dividends settled in cash during the twelve months ended June 30, 2019 was $346.2.

Total accrued dividends on unvested RSUs and phantom units of $2.2 and $5.2, $0.8 and $5.2 and $1.0 and $3.2 are included in Accrued expense and other current liabilities and Other noncurrent liabilities, respectively, in the Consolidated Balance Sheet as of June 30, 2019, 2018 and 2017, respectively.

F-57

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

Accumulated Other Comprehensive Income (Loss)



				Foreign Currency Translation Adjustments
	(Losses) Gains on Cash Flow Hedges			(Losses) Gains on Net Investment Hedge			Foreign Currency Translation Adjustments			Pension and Other Post-Employment Benefit Plans			Total
Beginning balance at July 1, 2017	$	12.6		$	(23.7	)	$	(20.8	)	$	36.3		$	4.4
Other comprehensive income before reclassifications	19.2			138.7			(23.5		)	20.8			155.2
Net amounts reclassified from AOCI/(L)^(a)	(4.0		)	—			—			(3.3		)	(7.3		)
Net current-period other comprehensive income	15.2			138.7			(23.5		)	17.5			147.9
Adjustment due to the adoption of ASU 2018-02 (Note 2)	$	3.9		$	—		$	—		$	2.6		$	6.5
Ending balance at June 30, 2018	$	31.7		$	115.0		$	(44.3	)	$	56.4		$	158.8
Other comprehensive income before reclassifications	(35.5		)	99.8			(213.1		)	(53.8		)	(202.6		)
Net amounts reclassified from AOCI/(L) ^(a)	(9.5		)	—			—			(5.5		)	(15.0		)
Net current-period other comprehensive income	(45.0		)	99.8			(213.1		)	(59.3		)	(217.6		)
Ending balance at June 30, 2019	$	(13.3	)	$	214.8		$	(257.4	)	$	(2.9	)	$	(58.8	)

^(a) Amortization of actuarial gains (losses) of $7.0 and $5.2, net of taxes of $1.5 and $1.9, were reclassified out of AOCI/(L) and included in the computation of net period pension costs for the fiscal years ended June 30, 2019 and 2018, respectively (see Note 18—Employee Benefit Plans).

Treasury Stock - Share Repurchase Program

Since February 2014, the Board has authorized the Company to repurchase its Class A Common Stock under approved repurchase programs. On February 3, 2016, the Board authorized the Company to repurchase up to $500.0 of its Class A Common Stock (the “Incremental Repurchase Program”). Subject to certain restrictions on repurchases of shares through September 30, 2018 imposed by the tax matters agreement, dated October 1, 2016, between the Company and P&G entered into in connection with the P&G Beauty Business acquisition, repurchases may be made from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its Class A Common Stock, and general market conditions. As of June 30, 2019, the Company has $396.8 remaining under the Incremental Repurchase Program. The following table summarizes the share repurchase activities during the years ended June 30, 2019, 2018 and 2017:



Period	Number of shares repurchased (in millions)	Cost of shares repurchased (in millions)		Lowest fair value of shares repurchased per share		Highest fair value of shares repurchased per share
Fiscal Year Ended June 30, 2019	—	$	—	$	—	$	—
Fiscal Year Ended June 30, 2018	—	$	—	$	—	$	—
Fiscal Year Ended June 30, 2017	1.4	$	36.3	$	25.35	$	27.40

23. SHARE-BASED COMPENSATION PLANS

The Company has various share-based compensation programs (the “the Compensation Plans”) under which awards, including non-qualified stock options, Series A and Series A-1 Preferred Stock, RSUs and other share-based awards, may be granted or shares of Class A Common Stock may be purchased. As of June 30, 2019, up to 75.0 million shares of the Company's Class A Common Stock were authorized to be granted pursuant to these Plans, of which 55.2 million shares were available. The Company may satisfy the obligation of its stock-based compensation awards with new shares.

The Company accounts for its share-based compensation plans for common stock as equity plans. The share-based compensation for equity plans is estimated and fixed at the grant date, based on the estimated fair value of the award. Series A Preferred Stock is accounted for partially as equity and partially using liability plan accounting to the extent the award is

F-58

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

expected to be settled in cash. Accordingly, share-based compensation expense for the liability plan awards are measured at the end of each reporting period based on the fair value of the award on each reporting date and recognized as an expense to the extent earned.

Total share-based compensation is shown in the table below:



	2019			2018			2017
Equity plan expense	$	16.9		$	31.6		$	20.0
Liability plan (income) expense	(2.1		)	(1.0		)	4.6
Fringe expense	0.4			2.8			4.4
Total share-based compensation expense	$	15.2		$	33.4		$	29.0

The share-based compensation expense for fiscal 2019, 2018 and 2017 of $15.2, $33.4 and $29.0, respectively, includes $33.5, $33.4, and $29.0 expense for the respective period offset by $(18.3), nil and nil income for the respective periods primarily due to significant executive forfeitures of share-based compensation instruments and the impact of actual forfeitures on the change in estimated forfeiture rates during the period.

As of June 30, 2019, the total unrecognized share-based compensation expense related to unvested stock options, Series A and Series A-1 Preferred Stock and restricted stock units and other share awards is $50.5, $9.1 and $80.9, respectively. The unrecognized share-based compensation expense related to unvested stock options, Series A and A-1 Preferred Stock, restricted stock units and other share awards is expected to be recognized over a weighted-average period of 4.26, 4.44 and 3.52 years, respectively.

Nonqualified Stock Options

During fiscal 2019, 2018 and 2017, the Company granted 19.4 million, 5.9 million and 9.3 million nonqualified stock option awards, respectively. These options are accounted for using equity accounting whereby the share-based compensation expense is estimated and fixed at the grant date based on the estimated value of the options using the Black-Scholes valuation model.

During fiscal 2019, 2018 and 2017, the share-based compensation expense recognized on nonqualified stock options is based upon the fair value on the grant date estimated using the Black-Scholes valuation model with the following weighted-average assumptions:



	2019	2018	2017
Expected life	6.50 years	7.50 years	7.50 years
Risk-free interest rate	2.56%	2.19%	1.60%
Expected volatility	40.73%	36.03%	36.74%
Expected dividend yield	4.64%	2.98%	1.62%

Expected life—The expected life represents the period of time (years) that options granted are expected to be outstanding, which the Company calculates using a formula based on the vesting term and the contractual life of the respective option.

Risk-free interest rate—The Company bases the risk-free interest rate on the implied yield available on a U.S. Treasury note with a term equal to the expected term of the underlying options.

Expected volatility—The Company calculates expected volatility based on median volatility for peer companies using expected life daily stock price history equal to the expected life.

Expected dividend yield—The weighted-average expected dividend yield is based upon the Company’s expectation to pay dividends over the contractual term of the options.

Nonqualified stock options generally become exercisable 5 years from the date of the grant or on a graded vesting schedule where 60% of each award granted vests after three years, 20% of each award granted vests after four years and 20% of each award granted vests after five years. All grants expire 10 years from the date of the grant.

F-59

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

The Company’s outstanding nonqualified stock options as of June 30, 2019 and activity during the fiscal year then ended are presented below:



	Shares (in millions)		Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Term (in years)
Outstanding at July 1, 2018	13.4		$	16.75
Granted	19.4		10.89
Exercised	(0.6	)	9.14
Forfeited	(4.3	)	16.42
Outstanding at June 30, 2019	27.9		$	12.89
Vested and expected to vest at June 30, 2019	18.9		$	12.85	$	10.4	8.67
Exercisable at June 30, 2019	1.1		$	10.04	$	3.50	1.63

Of the 27.9 million stock options outstanding, 14.5 million vest on the fifth anniversary of the grant date and 13.4 million vest on a graded vesting schedule where 60% of each award granted vests after three years, 20% of each award granted vests after four years and 20% of each award granted vests after five years.

The grant prices of the outstanding options as of June 30, 2019 ranged from $8.25 to $20.42. The grant prices for exercisable options ranged from $8.25 to $10.50.

A summary of the aggregated weighted-average grant date fair value of stock options granted and total intrinsic value of stock options exercised for fiscal 2019, 2018 and 2017 is presented below:



	2019		2018		2017
Weighted-average grant date fair value of stock options	$	2.87	$	4.87	$	6.34
Intrinsic value of options exercised	11.5		32.2		26.3

The Company’s non-vested nonqualified stock options as of June 30, 2019 and activity during the fiscal year then ended are presented below:



	Shares (in millions)		Weighted Average Grant Date Fair Value
Non-vested at July 1, 2018	11.7		$	5.60
Granted	19.4		2.87
Forfeited	(4.3	)	5.03
Non-vested at June 30, 2019	26.8		$	3.72

The share-based compensation expense recognized on the nonqualified stock options is $5.2, $11.9 and $9.1 during fiscal 2019, 2018 and 2017, respectively.

Executive Ownership Programs

The Company encourages executive stock ownership through various programs. These programs govern shares of Class A Common Stock purchased by employees (“Purchased Shares”). Employees purchased 1.4 million, 2.0 million and 0.8 million shares in fiscal 2019, 2018 and 2017, respectively, and received matching nonqualified stock options or RSUs in accordance with the terms of the Compensation Plans under the Omnibus LTIP. There was no share-based compensation expense recorded in connection with Purchased Shares for fiscal 2019, 2018 and 2017. Additionally, share-based compensation expense recorded in connection with matching stock awards granted in accordance with the Compensation Plans are noted in their respective section of this footnote.

Series A and Series A-1 Preferred Stock

In addition to the Executive Ownership Programs discussed above, the Series A Preferred Stock are accounted for partially as equity and partially as a liability as of June 30, 2019, 2018 and 2017 and the Company recognized an (income) expense of $(4.4), $0.1 and $4.4 in fiscal 2019, 2018 and 2017, respectively. See Note 22—Equity for additional information.

F-60

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

In fiscal 2017, the Company granted Series A Preferred Stock that included cash bonus payments tied to the exercisability of the awards. Due to the addition of cash bonus payments in connection with the grant of Series A Preferred Stock to certain executives in fiscal 2017, the Company began estimating the fair value of the Series A Preferred Stock using a binomial lattice model to value the equity and cash bonus components of the combined instrument. The lattice structure the Company uses to value the awards consists of (i) a common stock lattice that models the possible stock price movements from the valuation date to the maturity date consistent with the stock price and estimated volatility on the valuation date; (ii) a share exchange lattice that calculates the value of the common stock received on conversion; (iii) a cash exchange lattice that calculates the value of the cash bonus; and (iv) a continuation value lattice that tracks the holding value of the combined instrument. In Fiscal 2019, the Company granted Series A-1 Preferred Stock with similar terms as previously granted Series A Preferred Stock and used the binomial lattice model to value the equity and cash bonus components of the combined instrument. As of June 30, 2019, the fair value of the Company’s outstanding Series A and Series A-1 Preferred Stock that are liability accounted were estimated with the following weighted-average assumptions.



	2019	2018	2017
Expected life, in years	4.97 years	4.52 years	5.86 years
Expected volatility	42.53%	35.00%	30.00%
Risk-free rate of return	2.45%	2.70%	1.99%
Dividend yield on Class A Common Stock	6.19%	3.55%	2.67%
Yield on cash	N/A	N/A	4.70%

Expected life, in years - The expected life represents the period of time (years) that Series A or Series A-1 Preferred Stock granted are expected to be outstanding, which the Company calculates using a formula based on the vesting term and the contractual life of the respective Series A or Series A-1 Preferred Stock.

Expected volatility - The Company calculates expected volatility based on the average of historical and implied volatilities.

Risk-free rate of return - The Company bases the risk-free rate of return on the US Constant Maturity Treasury Rate.

Dividend yield on Class A Common Stock - The Company calculated the weighted-average dividend yield on shares using the annualized dividend rate calculated on the per share dividend paid quarterly and the stock price as of the valuation date.

Yield on cash - The Company calculated the weighted-average yield of comparable securities with a similar credit rating to the Company as of June 30, 2019, 2018 and 2017, respectively.

Series A and Series A-1 Preferred Shares generally expire seven years from the date of the grant.

The Company’s outstanding Series A and Series A-1 Preferred Shares as of June 30, 2019 and activity during the fiscal year then ended are presented below:



	Shares (in millions)		Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Term (in years)
Outstanding at July 1, 2018	5.0		$	23.62
Granted	7.9		9.46
Forfeited	(3.5	)	$	24.28
Outstanding at June 30, 2019	9.4		$	11.47
Vested and expected to vest at June 30, 2019	8.9		$	10.91	$	22.20	6.25

The Company’s non-vested shares of Series A and Series A-1 Preferred Stock as of June 30, 2019 and activity during the fiscal year then ended are presented below:

F-61

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)



	Shares (in millions)		Weighted Average Grant Date Fair Value
Non-vested at July 1, 2018	4.0		$	4.99
Granted	7.9		1.24
Forfeited	(3.5	)	5.16
Non-vested at June 30, 2019	8.4		$	1.39

Restricted Share Units

On October 1, 2018, the Company’s Board of Directors approved a modification of the vesting schedules for certain RSUs granted during fiscal 2017, 2018 and 2019 to improve the Company’s ability to retain the affected employees, from five year cliff vesting to graded vesting where 60% of each award granted vests after three years, 20% of each award granted vests after four years and 20% of each award granted vests after five years. Five hundred sixty employees held outstanding awards subject to the October 1, 2018 modification. During the fiscal year ended June 30, 2019, the incremental stock based compensation expense resulting from the modification was offset by income from actual and expected forfeitures in the modified awards.

During fiscal 2019, 6.9 million RSUs were granted under the Omnibus LTIP and 0.1 million RSUs were granted under the 2007 Stock Plan for Directors. During fiscal 2018, 3.7 million RSUs were granted under the Omnibus LTIP and 0.1 million RSUs were granted under the 2007 Stock Plan for Directors.

The Company’s outstanding RSUs as of June 30, 2019 and activity during the fiscal year then ended are presented below:



	Shares (in millions)		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Term
Outstanding at July 1, 2018	7.5
Granted	7.0
Settled	(0.6	)
Cancelled	(3.4	)
Outstanding at June 30, 2019	10.5
Vested and expected to vest at June 30, 2019	8.6		$	114.4	2.16

The share-based compensation expense recorded in connection with the RSUs was $14.4, $21.4 and $15.4 during fiscal 2019, 2018 and 2017, respectively.

The Company’s outstanding and non-vested RSUs as of June 30, 2019 and activity during the fiscal year then ended are presented below:



	Shares (in millions)		Weighted Average Grant Date Fair Value
Outstanding and nonvested at July 1, 2018	7.2		$	19.57
Granted	7.0		11.38
Vested	(0.6	)	17.49
Cancelled	(3.4	)	17.46
Outstanding and nonvested at June 30, 2019	10.2		$	14.79

The total intrinsic value of RSUs vested and settled during fiscal 2019, 2018 and 2017 is $11.1, $12.5 and $3.5, respectively.

Phantom Units

On July 21, 2015, the Board granted Mr. Becht, the Company’s former Chairman of the Board and interim CEO, an award of 300,000 phantom units, in consideration of Mr. Becht’s increased and continuing responsibilities as interim CEO of the Company. At the time of grant, the phantom units had a value of $8.1 based on the closing price of the Company’s Class A

F-62

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

Common Stock on July 21, 2015. Each phantom unit has an economic value equivalent to one share of the Company’s Class A Common Stock settleable in cash or shares at the election of Mr. Becht. The award to Mr. Becht was made outside of the Company’s Omnibus LTIP. On July 24, 2015, Mr. Becht elected to receive payment of the phantom units in the form of shares of Class A Common Stock and the phantom units were valued at $8.0. The phantom units will be settled in shares of Class A Common Stock on the fifth anniversary of the grant date or, in the event of a change of control or Mr. Becht’s death or disability, immediately. The Company recognized $8.0 of share-based compensation expense during the fiscal year ended June 30, 2016 as there are no service or performance conditions with respect to the phantom units.

24. NET LOSS ATTRIBUTABLE TO COTY INC. PER COMMON SHARE

Net loss attributable to Coty Inc. per common share (“basic EPS”) is computed by dividing net loss attributable to Coty Inc. by the weighted-average number of common shares outstanding during the period. Net loss attributable to Coty Inc. per common share assuming dilution (“diluted EPS”) is computed by using the basic EPS weighted-average number of common shares and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities consist of nonqualified stock options, Series A and Series A-1 Preferred Stock and RSUs as of June 30, 2019 and 2018. The dilutive effect of these outstanding instruments is reflected in diluted EPS by application of the treasury stock method.

Net loss attributable to Coty Inc. is adjusted through the application of the two-class method of income per share to reflect a portion of the periodic adjustment of the redemption value in excess of fair value of the redeemable noncontrolling interests. There is no excess of redemption value over fair value of the redeemable noncontrolling interests in fiscal 2019, 2018 and 2017. In addition, there are no participating securities requiring the application of the two-class method of income per share.

Reconciliation between the numerators and denominators of the basic and diluted EPS computations is presented below:



	Year Ended June 30,
	2019			2018			2017
Net loss attributable to Coty Inc.	$	(3,784.2	)	$	(168.8	)	$	(422.2	)
Weighted-average common shares outstanding—Basic	751.2			749.7			642.8
Effect of dilutive stock options and Series A/A-1 Preferred Stock^(a)	—			—			—
Effect of restricted stock and RSUs^(b)	—			—			—
Weighted-average common shares outstanding—Diluted	751.2			749.7			642.8
Net loss attributable to Coty Inc. per common share:
Basic	$	(5.04	)	$	(0.23	)	$	(0.66	)
Diluted	(5.04		)	(0.23		)	(0.66		)


^(a)	As of June 30, 2019, 2018 and 2017, outstanding stock options and Series A/A-1 Preferred Stock with purchase or conversion rights to purchase shares of common stock were excluded in the computation of diluted loss per share due to the net loss incurred during the period.


^(b)	As of June 30, 2019, 2018 and 2017, RSUs were excluded in the computation of diluted loss per share due to the net loss incurred during the period.

25. LEGAL CONTINGENCIES

Legal Matters

The Company is involved, from time to time, in various litigation, administrative and other legal proceedings, including regulatory actions, incidental or related to its business, including consumer class or collective actions, personal injury (including asbestos related claims), intellectual property, competition, compliance and advertising claims litigation and disputes, among others (collectively, “Legal Proceedings”). While the Company cannot predict any final outcomes relating thereto, management believes that the outcome of current Legal Proceedings will not have a material effect upon its business, prospects, financial condition, results of operations, cash flows or the trading price of the Company’s securities. However, management’s assessment of the Company’s current Legal Proceedings is ongoing, and could change in light of the discovery of additional facts with respect to Legal Proceedings not presently known to the Company, further legal analysis, or determinations by judges, arbitrators, juries or other finders of fact or deciders of law which are not in accord with management’s evaluation of the probable liability or outcome of such Legal Proceedings. From time to time, the Company is in discussions with regulators, including discussions initiated by the Company, about actual or potential violations of law in order to remediate or mitigate associated legal or compliance risks and liabilities or penalties. As the outcomes of such proceedings

F-63

COTY INC. & SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

($ in millions, except per share data)

are unpredictable, the Company can give no assurance that the results of any such proceedings will not materially affect its reputation, business, prospects, financial condition, results of operations, cash flows or the trading price of its securities.

Brazilian Tax Assessments

In connection with a local tax audit of one of the Company’s subsidiaries in Brazil, the Company was notified of tax assessments issued in March of 2018. The assessments relate to local sales tax credits, which the Treasury Office of the State of Goiás considers improperly registered for 2016-2017 tax periods. The Company is currently seeking a favorable administrative decision on the tax enforcement action filed by the Treasury Office of the State of Goiás. These tax assessments, including estimated interest and penalties, through June 30, 2019 amount to a total R$249.0 million (approximately $65.2 as of June 30, 2019). The Company believes it has meritorious defenses and it has not recognized a loss for these assessments as the Company does not believe a loss is probable.

26. SUBSEQUENT EVENTS

Quarterly Dividend

On August 28, 2019, the Company announced a quarterly cash dividend of $0.125 per share on its Common Stock, restricted stock units (the “RSUs”) and phantom units. The dividend will be payable on September 30, 2019 to holders of record of Common Stock on September 9, 2019. The shareholders will have an option to elect to receive their dividend 50% in cash and 50% in Common Stock.

Turnaround Plan

As described in Note 6—Restructuring Costs, the Company announced the Turnaround Plan on July 1, 2019. As part of this initiative, the Company intends to incur cash costs of $600.0, beginning in fiscal 2020 through fiscal 2023. The estimate includes cash costs associated with restructuring, primarily related to employee termination benefits, as well as other business realignment costs, including costs associated with the consolidation of management headquarters and systems redesign to support changes in the Company’s reporting structure. In addition, the Company will continue to incur cash costs of $160.0 related to restructuring and other business realignment costs connected to previously announced programs.

Divestiture

On August 27, 2019, the Company entered into a Contribution and Redemption Agreement to transfer all of its membership interest in Foundation, which holds the net assets of Younique, to an existing noncontrolling interest holder. The closing of the transaction is subject to certain regulatory clearances and is expected to occur by the end of calendar year 2019.

F-64

COTY INC. & SUBSIDIARIES

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

Years Ended June 30, 2019, 2018, and 2017

($ in millions, except per share data)

Valuation and Qualifying Accounts



Description	Three Years Ended June 30,
Description	Balance at Beginning of Period		Balance Received through Acquisition		Charged to Costs and Expenses			Deductions				Balance at End of Period
Allowance for doubtful accounts:
2019	$	81.8	$	—	$	11.6		$	(45.3	)	^(a)(b)	$	48.1
2018	58.5		—		16.3			7.0			^(a)(b)	81.8
2017	35.2		—		32.8			(9.5		)	^(b)	58.5
Allowance for customer returns:
2019	$	81.1	$	—	161.2			(186.0		)		$	56.3
2018	67.3		10.1		169.8			(166.1		)		81.1
2017	57.3		11.4		165.7			(167.1		)		67.3
Deferred tax valuation allowances:
2019	$	104.6	$	—	$	4.6	^(c)	$	(41.5	)		$	67.7
2018	60.3		—		54.7		^(c)	(10.4		)		104.6
2017	179.2		—		9.2		^(c)	(128.1		)		60.3


^(a)	Includes reclassification between the allowance for doubtful accounts and gross trade receivables for presentation purposes.


^(b)	Includes amounts written-off, net of recoveries and cash discounts.


^(c)	Includes foreign currency translation adjustments unless otherwise noted.

S-1

Exhibit 4.9

Coty Inc.

Description of Securities

The rights of our stockholders are governed by Delaware General Corporation Law (“DGCL”), our amended and restated certificate of incorporation, as amended (our “Certificate of Incorporation”), and our amended and restated by-laws (our “By-laws”).

The following is a summary of the material terms and provisions of our capital stock and is qualified in its entirety by reference to our Certificate of Incorporation and the amendment thereto and our By-laws , which are incorporated by reference herein and attached as an exhibit to our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, and to the applicable provisions of the DGCL. This summary does not purport to be complete and may not contain all the information that is important to you.

Authorized Capital Stock

Under our Certificate of Incorporation, our authorized capital stock consists of 1,000,000,000 shares of Class A Common Stock, par value $0.01 per share, and 20,000,000 shares of Preferred Stock, par value $0.01 per share.

Registered Securities

Our Class A Common Stock is registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, and is listed on the New York Stock Exchange under the symbol “COTY”.

Class A Common Stock

Dividend Rights

Holders of our Class A Common Stock are entitled to receive dividends, as and when declared by our board of directors (the “Board”), out of our legally available assets, in cash, property, shares of our Class A Common Stock or other securities, after payments of dividends required to be paid on outstanding Preferred Stock, if any.

Voting Rights

Holders of our Class A Common Stock are entitled to one vote per share on all matters submitted to a vote of our stockholders, unless otherwise required by our Certificate of Incorporation or By-laws. At all meetings of the stockholders at which a quorum is present, except as otherwise required by law, the Certificate of Incorporation or the By-laws, any question brought before any meeting of stockholders other than the election of directors, shall be decided by the affirmative vote of the holders of a majority of the votes cast. Elections of directors shall be decided by a plurality of the votes cast.

Stockholder Action by Written Consent

Any action that can be taken at a meeting of the stockholders may be taken by written consent in lieu of the meeting if we receive consents signed by stockholders having the minimum number of votes that would be necessary to approve the action at a meeting at which all shares entitled to vote on the matter were present.

Right to Receive Liquidation Distributions

Upon our liquidation, dissolution or winding up, the assets legally available for distribution to our stockholders will be distributable ratably among the holders of Class A Common Stock, subject to prior satisfaction of all outstanding debts and other liabilities and the preferential rights and payment of liquidation preferences, if any, on any outstanding Preferred Stock.

Amendment of Certificate of Incorporation and By-laws

Our Board and our stockholders are authorized to adopt, amend or repeal our By-laws. The approval of our Board is required to amend our Certificate of Incorporation. In addition, Section 242(b)(2) of the DGCL requires that holders of our Class A Common Stock vote as a class upon the proposed amendment, if the amendment would increase or decrease the par value of the shares of Class A Common Stock, or alter or change the powers, preferences or special rights of the Class A Common Stock so as to affect them adversely.

No Preemptive or Similar Rights

Shares of our Class A Common Stock are not entitled to preemptive rights and are not convertible into any other shares of our capital stock.

Preferred Stock

We are authorized, subject to the limits imposed by the DGCL, to issue Preferred Stock in one or more series, to establish from time to time the number of shares to be included in each series and to fix the designation, powers, rights, preferences and privileges of the shares of each such series and any of the qualifications, limitations or restrictions thereof. Our Board can also increase or decrease the number of shares of any series, but not below the number of shares of a given series then outstanding, plus the number of shares reserved for issuance upon the exercise or vesting of outstanding securities convertible into the applicable series of Preferred Stock, by the affirmative vote of the holders of a majority of the shares of Coty stock entitled to vote, unless a vote of any other holders is required pursuant to a certificate or certificates of designation establishing a series of Preferred Stock, without any further vote or action by our stockholders.

The rights of holders of Class A Common Stock are subject to, and may be adversely affected by, the rights of the holders of any shares of Preferred Stock that may be issued in the future. Our Board may authorize the issuance of Preferred Stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of Class A Common Stock. The issuance of Preferred Stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a future change in control of the Company and may adversely affect the market price of Class A Common Stock and the voting and other rights of the holders of Class A Common Stock.

Series A Preferred Stock

In fiscal year 2015, we established awards under our Equity and Long-Term Incentive Plan and certain of our executive officers received awards of our Series A Preferred Stock. In April 2015, we filed a Certificate of Designations with the Secretary of State of the State of Delaware, establishing the voting rights, powers, preferences and privileges, and the relative, participating, optional or other rights, and the qualifications, limitations or restrictions thereof, with respect to our Series A Preferred Stock, which various and several voting powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions thereof may be severally set forth in various subscription agreements relating to the issuance and sale of the Series A Preferred Stock (each, a “Series A Subscription Agreement”). Under the terms provided in the various Series A Subscription Agreements, a holder of Series A Preferred Stock may be entitled to exchange any or all vested Series A Preferred Stock prior to varying dates specified in the Series A Subscription Agreements, into, at our sole election, either cash or shares of Class A Common Stock, as calculated and subject to the limitations set forth therein.

Shares of Series A Preferred Stock are not entitled to receive any dividends and have no voting rights, except as required by law. Upon our liquidation, dissolution or winding up, each share of Series A Preferred Stock entitles the holder to receive out of our assets available for distribution to stockholders, after satisfaction of liabilities to creditors and subject to the rights of senior securities, an amount in cash per share equal the then fair market value per share of such Series A Preferred Stock as determined by an independent qualified professional appraisal firm. Such shares will not be entitled to an additional amount after the full liquidation distribution has been paid.

Series A-1 Preferred Stock

In fiscal year 2019, we granted awards of our Series A-1 Preferred Stock in connection with grants under our Elite stock investment program. In February 2019, we filed a Certificate of Designations with the Secretary of State of the State of Delaware, establishing the voting rights, powers, preferences and privileges, and the relative, participating, optional or other rights, and the qualifications, limitations or restrictions thereof, with respect to our Series A-1 Preferred Stock, which various and several voting powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions thereof is set forth in a subscription agreement relating to the issuance and sale of the Series A-1 Preferred Stock (the “Series A-1 Subscription Agreement”). Under the terms provided in the Series A-1 Subscription Agreement, a holder of Series A-1 Preferred Stock is entitled to exchange any or all vested Series A-1 Preferred Stock prior to varying dates specified in the Series A-1 Subscription Agreement, into, at our sole election, either cash or shares of Class A Common Stock, as calculated and subject to the limitations set forth therein.

Shares of Series A-1 Preferred Stock are not entitled to receive any dividends and have no voting rights, except as required by law. Upon our liquidation, dissolution or winding up, each share of Series A-1 Preferred Stock entitles the holder to receive out of our assets available for distribution to stockholders, after satisfaction of liabilities to creditors and subject to the rights of senior securities, an amount in cash per share equal to $0.10. Such shares will not be entitled to an additional amount after the full liquidation distribution has been paid.

Controlled Company Status

As of the date of this prospectus, the JAB Investors (as defined below) beneficially own approximately 60% of the outstanding shares of Class A Common Stock, which also represents approximately 60% of the voting power of our capital stock. Accordingly, we qualify as a “controlled company” under the NYSE Listed Company Manual rules (the “NYSE Rules”). As a “controlled company,” we are permitted to take advantage of exemptions from certain of the corporate governance requirements under the NYSE Rules, including the requirements that a majority of our Board consist of independent directors, that we have a nominating and corporate governance committee that is composed entirely of independent directors and that we have a compensation committee that is composed entirely of independent directors. As a result, for so long as we are a controlled company, stockholders may not have the same protections afforded to stockholders of companies that are subject to all of the corporate governance requirements under the NYSE Rules. However, the Stockholders Agreement described below contains certain obligations with respect to the independence of our Board and a committee of our Board.

Stockholders Agreement

The Company is party to a stockholders agreement, dated as of March 17, 2019 (the “Stockholders Agreement”), with JAB Holdings B.V., JAB Cosmetics B.V. and Cottage Holdco B.V. (the “JAB Investors”). Pursuant to the Stockholders Agreement, among other things:

•

during the three year period following April 30, 2019, the JAB Investors shall not, subject to certain exceptions, effect or enter into any agreement to effect any acquisition of additional shares of capital stock of the Company (including Class A Common Stock, “Company Securities”); provided that, the JAB Investors may acquire Company Securities on an established securities exchange or through privately negotiated transactions that, after giving effect to such acquisition, does not result in an increase in the JAB Investors’ and their affiliates’ collective beneficial ownership percentage of the voting power of the then issued and outstanding Company Securities to an amount greater than the percentage of the voting power of the issued and outstanding Company Securities beneficially owned by the JAB Investors, collectively, as of the consummation of the Offer, plus 9% (meaning a cap of approximately 69% for three years after April 30, 2019);


•	during the three year period following April 30, 2019, the JAB Investors shall not, subject to certain exceptions, transfer any Company Securities to any other person or group (other than an affiliate of any of the JAB Investors) that, after giving effect to such transfer, would beneficially own in excess of 20% of the voting power of the Company;

•

for so long as the Stockholders Agreement is in effect, the JAB Investors shall not effect or seek to effect, or announce any intention to effect, any “Rule 13e-3 transaction” as defined in Rule 13e-3 under the Exchange Act unless such transaction is conditioned on both (i) the affirmative approval of a special committee of our Board comprised solely of individuals who are each (1) “independent” under the requirements of Rule 10A-3 under the Exchange Act, and under the rules of the applicable securities exchange on which Company Securities are traded and (2) disinterested as it relates to the JAB Investors and their respective affiliates (any such individual, an “Independent Director”) and who are disinterested and independent under Delaware law as to the matter under consideration, duly obtained in accordance with the applicable provisions of the Company’s organizational documents, applicable law and the rules, regulations and listing standards promulgated by any securities exchange on which Company Securities are traded (“Disinterested Director Approval”) and (ii) the affirmative vote of our stockholders representing at least a majority of the voting power of the Company beneficially owned by stockholders that are not the JAB Investors or their affiliates;


•	for so long as the Stockholders Agreement is in effect, material related party transactions involving the JAB Investors or any of their affiliates and the Company will require Disinterested Director Approval; and


•	for so long as the Stockholders Agreement is in effect, the JAB Investors and the Company have agreed to take all necessary actions within their control to maintain no fewer than four Independent Directors on our Board and to cause, no later than September 30, 2019, to be elected to our Board two new Independent Directors.

The Stockholders Agreement also provides the JAB Investors with certain customary demand and shelf registration rights with respect to Company Securities and restricts the registration rights we may grant other stockholders after the date thereof. Prior to the entry into the Stockholders Agreement, we granted certain other stockholders customary demand and “piggyback” registration rights.

The Stockholders Agreement will terminate upon the earlier of the mutual consent of the parties to the Stockholders Agreement (including, with respect to the Company, Disinterested Director Approval) or such time as the JAB Investors and their affiliates cease to beneficially own 40% of the voting power of the Company capital stock on a fully diluted basis. The Stockholders Agreement may be amended by the JAB Investors and the Company after receipt of Disinterested Director

Approval. Any waiver by the Company of any condition or of any breach of any term, covenant, representation or warranty contained in the Stockholders Agreement also requires Disinterested Director Approval.

Anti-Takeover Effects of Delaware Law, Certificate of Incorporation and By-laws

The following provisions may make a change in control of our business more difficult and could delay, defer or prevent a tender offer or other takeover attempt that a stockholder might consider to be in its best interest, including takeover attempts that might result in the payment of a premium to our stockholders over the market price for their shares. These provisions also may promote the continuity of our management by making it more difficult for a person to remove or change the incumbent members of our Board.

Controlling Stockholder. As of the date of this prospectus, the JAB Investors beneficially own approximately 60% of the outstanding shares of Class A Common Stock, which also represents approximately 60% of the voting power of our capital stock. This concentrated control could have the effect of discouraging others from initiating a potential merger, takeover or other future change of control transaction that other stockholders may view as beneficial.

Delaware Law. We are subject to the provisions of Section 203 of the DGCL regulating corporate takeovers. In general, the statute prohibits a publicly-held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a period of three years after the date that the person became an interested stockholder, subject to exceptions, unless the business combination is approved by our Board in a prescribed manner or the transaction in which the person became an interested stockholder is approved by our Board and disinterested stockholders in a prescribed manner. Generally, a “business combination” includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the stockholder. Generally, an “interested stockholder” is a person who, together with affiliates and associates, owns, or within three years prior, did own, 15% or more of the corporation’s voting stock. These provisions may have the effect of delaying, deferring or preventing a change in control of our business without further action by the stockholders.

Authorized but Unissued Shares; Undesignated Preferred Stock. The authorized but unissued shares of Class A Common Stock will be available for future issuance without stockholder approval. These additional shares may be utilized for a variety of corporate purposes, including future public offerings to raise additional capital, acquisitions and employee benefit plans. In addition, our Board may authorize, without stockholder approval, the issuance of undesignated Preferred Stock with voting rights or other rights or preferences designated from time to time by our Board. The existence of authorized but unissued shares of Class A Common Stock or Preferred Stock may enable our Board to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise.

Advance Notice Requirements for Stockholder Proposals and Nominations of Directors. Our By-laws require stockholders seeking to bring business before an annual meeting of stockholders, or to nominate individuals for election as directors at an annual or special meeting of stockholders, to provide timely notice in writing, as specified therein. These provisions regulate our stockholders in bringing matters before the annual meeting of stockholders or making nominations for directors at any meetings of stockholders. These provisions may also discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the potential acquiror’s own slate of directors or otherwise attempting to obtain control of our business.

Special Meetings of Stockholders. Our Certificate of Incorporation and By-laws provide that special meetings of stockholders may be called only by our Chairman, Chief Executive Officer or our Board or by our Secretary at the request of holders of not less than a majority of the combined voting power of Class A Common Stock.

Cumulative Voting. Our Certificate of Incorporation provides that our stockholders are not permitted to cumulate votes in the election of directors.

Transfer Agent

The transfer agent and registrar for our Class A Common Stock is Computershare Trust Company, N.A.

Exhibit 10.45

FORM OF SUBSCRIPTION AGREEMENT

This Subscription Agreement (this “Agreement”), dated [ ] is by and between, Coty Inc., a Delaware corporation (the “Parent”) and [ ] (the “Subscriber”) and collectively as “parties”.

RECITALS

WHEREAS, [ ] and Subscriber are parties to that certain Employment Agreement, dated as of [ ] (the “Employment Agreement”).

WHEREAS, the Parent and the Subscriber desire to enter into this Agreement to obligate the Subscriber to acquire shares of preferred stock of the Parent (as described below) to be delivered to the Subscriber pursuant to and subject to the terms of the Coty Inc. Equity and Long-Term Incentive Plan (the “Plan”).

WHEREAS, the Parent desires to issue and sell to Subscriber, and Subscriber desires to purchase from the Parent, [ ] shares of Series A-1 Preferred Stock of the Parent (the “Shares”), with the terms and conditions substantially as set forth in that Certificate of Designations filed with the Secretary of State of the State of Delaware relating to the Shares, including the various and several voting powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions thereof set forth in Annex A hereto, for an aggregate cash payment equal to [ ] (the “Purchase Price”), subject to the terms and conditions described herein.

AGREEMENT

NOW THEREFORE, in consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be legally bound hereby, the parties agree as follows:

ARTICLE I

PURCHASE AND SALE

Section 1.1Purchase and Sale of the Shares. Upon the terms and subject to the conditions of this Agreement, at the Closing, the Parent agrees to issue and sell to the Subscriber, and the Subscriber agrees to purchase from the Parent, the Shares for an aggregate cash purchase price equal to the Purchase Price.

Section 1.2 Closing.

(a)The sale and purchase of the Shares shall take place at a closing (the “Closing”) to be held at the offices of Coty, Inc., on [ ] at 350 Fifth Avenue, New York, New York 10118, or at such other place or at such other time or on such other date as the Parent and the Subscriber mutually may agree in writing. The day on which the Closing takes place is referred to as the “Closing Date.”

(b)At the Closing, the Parent shall deliver to Computershare Trust Company (the “Transfer Agent”) an instruction letter authorizing and directing the Transfer Agent to record in the share register of the Parent book entry positions representing the Shares issued in the name of the Subscriber.

(c)At the Closing, the Subscriber shall deliver to the Parent the Purchase Price in cash.

ARTICLE II

REPRESENTATIONS AND WARRANTIES OF THE PARENT

The Parent hereby represents and warrants to the Subscribers as follows:

Section 2.1Organization and Qualification. The Parent is a corporation duly organized, validly existing and in good standing under the laws of the state of Delaware. The Parent has all requisite power, right and authority to carry on its business as now conducted.

Section 2.2Share Issuance. The Shares to be issued to the Subscriber pursuant to this Agreement, when issued and delivered in accordance with the terms of this Agreement, will be free and clear of all liens and other encumbrances, duly and validly issued and will be fully paid and non-assessable and free from preemptive rights.

Section 2.3Authority. The Parent has full corporate power and authority to execute, deliver and perform its obligations under this Agreement. This Agreement has been duly executed and delivered by the Parent and is legal, valid, binding and enforceable upon and against the Parent.

Section 2.4No Conflict; Required Filings and Consents. The execution, delivery and performance by the Parent of this Agreement and the consummation by the Parent of the transactions contemplated hereby do not and will not (a) violate any provision of the certificate of incorporation or bylaws (or similar organizational documents) of the Parent; (b) violate any federal, state or local statute, law, regulation, order, injunction or decree (“Law”); or (c) require any consent or approval of any person, including any registration or filing with, or notice to any federal, state or local governmental authority or any agency or instrumentality thereof (a “Governmental Authority”).

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF THE SUBSCRIBER

The Subscriber, severally as to itself only and not jointly as to or with anyone else, hereby represents and warrants to the Parent as follows:

Section 3.1Authority and Enforceability. The Subscriber has full power and authority to enter into this Agreement, the execution and delivery of which has been duly authorized and this Agreement constitutes a valid and legally binding obligation of the Subscriber, except as may be limited by bankruptcy, reorganization, insolvency, moratorium and similar laws of general application relating to or affecting the enforcement of rights of creditors, and except as enforceability of the obligations hereunder are subject to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or law).

Section 3.2Legends. The Subscriber understands and agrees that the certificates for the Shares, if any, shall bear substantially the following legend until such Shares shall have been registered under the Securities Act of 1933, as amended (the “Securities Act”) and effectively disposed of in accordance with a registration statement that has been declared effective, and that the Parent has no intention of registering such Shares pursuant to the Securities Act:

THE SHARES REPRESENTED BY THIS CERTIFICATE ARE RESTRICTED FROM SALE, TRANSFER, EXCHANGE OR ASSIGNMENT, EXCEPT PURSUANT TO A REGISTRATION STATEMENT EFFECTIVE UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (I) TO THE PARENT, (II) BY THE LAWS OF DESCENT AND DISTRIBUTION, OR (III) UPON RECEIPT OF A WRITTEN OPINION OF COUNSEL TO THE PARENT OR THE PARENT’S SECRETARY AND GENERAL COUNSEL.

Section 3.3No Conflict; Required Filings and Consents. The execution, delivery and performance by the Subscriber of this Agreement and the consummation by the Subscriber of the transactions contemplated hereby do not and will not (a) violate any Law, or (b) require any consent or approval of any person, including any registration or filing with, or notice to any Governmental Authority.

Section 3.4Resale; Accredited Investor. The Subscriber is acquiring the Shares solely for the Subscriber’s own beneficial account, for investment purposes, and not with a view towards, or resale in connection with, any distribution of the Shares. The Subscriber is an “accredited investor” as defined in Rule 501(a) under the Securities Act, and a sophisticated purchaser who has made its own independent investigation, review and analysis of the transactions contemplated hereby. The Subscriber has been furnished with all information (or provided access to all information) regarding the attributes of the Shares for which it is subscribing and the merits and risks of an investment in such Shares that it requested to evaluate the investment in such Shares. The Subscriber is relying solely on the representations, warranties and agreements of the Parent contained in this Agreement, and agrees that at no time was it presented with or solicited by or through any leaflet, public promotional meeting, television advertisement or any other form of general or public advertising or solicitation.

Section 3.5Equity Award. The Subscriber acknowledges and agrees that (i) the Series A-1 Preferred Stock issued to the Subscriber hereunder is in full satisfaction of the Parent’s obligation to grant the equity award to him under Section 5 of the Employment Agreement and (ii) no Stock Options (as defined in the Plan) will be issued to him pursuant to Section 5 of the Employment Agreement.

ARTICLE IV

GENERAL PROVISIONS

Section 4.1Amendment and Modification. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument in writing specifically designated as an amendment hereto, signed on behalf of each party.

Section 4.2Waiver. No failure or delay of either party in exercising any right or remedy hereunder shall operate as a waiver thereof. Any such waiver by a party shall be valid only if set forth in writing by such party.

Section 4.3Notices. All notices and other communications hereunder shall be in writing and shall be deemed duly given if delivered personally or sent by facsimile, e‑mail, overnight courier or registered or certified mail, postage prepaid, to the address set forth on the signature pages hereto opposite the party to receive such notice, or to such other address as may be designated in writing by such party.

Section 4.4Entire Agreement. This Agreement, together with the Plan, constitute the entire agreement, and supersedes all prior written agreements, arrangements and understandings and all prior and contemporaneous oral agreements, arrangements and understandings between the parties with respect to the subject matter of this Agreement. No party to this Agreement shall have any legal obligation to enter into the transactions contemplated hereby unless and until this Agreement shall have been executed and delivered by each of the parties.

Section 4.5Third-Party Beneficiaries. Nothing in this Agreement shall confer upon any person other than the parties and their respective successors and permitted assigns any right of any nature.

Section 4.6Governing Law. This Agreement and all disputes or controversies arising out of or relating to this Agreement or the transactions contemplated hereby shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without regard to the laws of any other jurisdiction that might be applied because of the conflicts of laws principles of the State of Delaware.

Section 4.7Award Subject to Plan; Administration. This Agreement is and shall be construed as an “Other Stock-Based Award” granted to Subscriber pursuant to the Plan (as such term is defined therein). The Remuneration and Nominating Committee of the Board of Directors of Coty, Inc. (the “Committee”) administers the Plan and shall administer this Agreement as an award under the Plan. The Subscriber’s rights under this Agreement are expressly subject to the terms and conditions of the Plan, including any guidelines the Committee adopts from time to time. The Subscriber hereby acknowledges receipt of a copy of the Plan.

Section 4.8Submission to Jurisdiction. Each of the parties irrevocably agrees that any legal action or proceeding arising out of or relating to this Agreement or for recognition and enforcement of any judgment in respect hereof brought by the other party or its successors or assigns may be brought and determined in any New York State or federal court sitting in the Borough of Manhattan in The City of New York (or, if such court lacks subject matter jurisdiction, in any appropriate New York State or federal court), and each of the parties hereby irrevocably submits to the exclusive jurisdiction of the aforesaid courts for itself and with respect to its property, generally and unconditionally, with regard to any such action or proceeding arising out of or relating to this Agreement and the transactions contemplated hereby (and agrees not to commence any action, suit or proceeding relating thereto except in such courts). Each of the parties further agrees to accept service of process in any manner permitted by such courts. Each of the parties hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any action or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby, (a) any claim that it is not personally subject to the jurisdiction of the above-named courts for any reason other than the failure lawfully to serve process, (b) that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) to the fullest extent permitted by law, that (i) the suit, action or proceeding in any such court is brought in an inconvenient forum, (ii) the venue of such suit, action or proceeding is improper or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such courts.

Section 4.9Assignment; Successors. This Agreement may not be assigned by either party without the prior written consent of the other party, except that the Parent may assign this Agreement to any of its Affiliates. Subject to the preceding sentence, this Agreement will be binding upon the parties and their respective successors and assigns. For the purposes of this Agreement, the term “Affiliate” shall mean any entity controlling, controlled by or under common control with the named party.

Section 4.10Severability. If any provision or portion of any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable Law, such invalidity, illegality or unenforceability shall not affect any other provision hereof.

Section 4.11Counterparts. This Agreement may be executed in counterparts, including electronic transmission and facsimile counterparts, all of which shall be considered one and the same instrument and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other party.

[The remainder of this page is intentionally left blank.]

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first written above by their respective officers thereunto duly authorized.



COTY INC. By: Name: Title:	Address for Notices: 350 Fifth Avenue New York, NY 10118 Attn: General Counsel
SUBSCRIBER By: Name: [ ]	Address for Notices: [ ]

Exhibit 10.46

2019 Incentive Options Terms and Conditions

This instrument (the “Terms and Conditions”) evidences the grant effective on the date set forth in Schedule 1 attached hereto (the “Grant Date”) of an award of a 2019 Stock Option to you (the “Participant”) by Coty Inc., a Delaware corporation (the “Company”). Any term capitalized but not defined in these Terms and Conditions will have the meaning set forth in the Company’s Equity and Long-Term Incentive Plan, as amended and restated (the “Plan”).

ARTICLE I

STOCK OPTIONS

Section 1.1Option Grant. In accordance with the terms of the Plan and subject to these Terms and Conditions, the Company hereby grants to the Participant as of the Grant Date an option (the “2019 Stock Option”) to purchase all or any part of the aggregate number of Shares set forth on Schedule 1 hereto (the “Option Shares”). This Option is a nonqualified stock option and is not intended to be an incentive stock option within the meaning of Code Section 422.

Section 1.2Exercise Price. The Exercise Price of the 2019 Stock Option will be the Fair Market Value of a share of the Company’s Class A Common Stock on the Grant Date.

Section 1.3Vesting, Exercisability and Clawback of Option. The Participant may exercise this Option only after it has become vested and exercisable in accordance with the following:


(a)	In General. The Option shall vest and become exercisable as follows, provided that the Participant remains in continuous Service through such dates:


(i)	Sixty percent (60%) of the 2019 Stock Option shall vest on the 3^rd anniversary of the Grant Date;


(ii)	Twenty percent (20%) of the 2019 Stock Option shall vest on the 4^th anniversary of the Grant Date;


(iii)	Twenty percent (20%) of the 2019 Stock Option shall vest on the 5^th anniversary of the Grant Date.

Each of the dates described in clauses (i), (ii), and (iii) is a “Vesting Date”.

(b)

Change in Control. If, within twelve months following a Change in Control, (i) the Participant is terminated by the Company or an employing Affiliate (that is not a Joint Venture) without Cause or (ii) the Participant resigns from the Company or an employing Affiliate (that is not a Joint Venture) for Good Reason, the Option shall vest and become exercisable on the date of such termination or resignation.

(c)

Joint Venture. If the Participant becomes an employee of a Joint Venture during the period in which the Option (or any portion thereof) remains subject to vesting in accordance with Section 1.3(a) above, the vesting of the Option shall be tolled beginning on the date the Participant becomes an employee of the Joint Venture and shall recommence on the date the Participant again becomes an Employee. Accordingly, the vesting schedule set forth in Section 1.3(a) above shall be extended by the number of days the Participant was an employee of the Joint Venture, but in no event shall the Option vest or become exercisable beyond the Expiration Date.


(d)	Retirement, Death, or Disability. The Option shall vest and become exercisable to the extent provided in Section 5.1 in the event of the Participant’s termination of Service by reason of Retirement, death, or Disability.

(e)

Forfeiture and Clawback. Notwithstanding any provision of these Terms and Conditions to the contrary, if all or any portion of the Participant’s Elite Stock Options are forfeited and canceled pursuant to Section 2.3(e) of the Participant’s Elite Subscription Agreement, a percentage of the 2019 Stock Option equal to the same percentage of the Participant’s Elite Stock Options that are forfeited and canceled pursuant to such Section 2.3(e) shall be immediately forfeited and canceled.

ARTICLE II

EXPIRATION

Subject to Article V, the Option will expire on the tenth anniversary of the Grant Date (the “Expiration Date”).

ARTICLE III

TRANSFERABILITY OF OPTION

Section 3.1 General. Except as provided in Section 3.2, (i) no Option granted under the Plan and these Terms and Conditions may be sold, transferred, pledged, assigned or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution, and (ii) the Option shall be exercisable during the Participant’s lifetime only by the Participant or his or her guardian or legal representative. The Committee may, in its sole discretion, require a Participant’s guardian or legal representative to supply it with the evidence the Committee deems necessary to establish the authority of the guardian or legal representative to act on behalf of the Participant.

Section 3.2 Successor Obligations. Subject to applicable law, Options may be transferred to any Successor. Such transferred Options may not be further sold, transferred, pledged, assigned or otherwise alienated by the Successor, and shall be subject in all respects to these Terms and Conditions and the Plan. For a transfer to be effective, the Successor shall promptly furnish the Company with written notice thereof and a copy of such other evidence as the Committee may deem necessary to establish the validity of the transfer and the acceptance of the Successor of the terms and conditions of the Plan.

ARTICLE IV

EXERCISE OF OPTION

Section 4.1 Notice of Exercise. After the Option has become vested, and while it remains exercisable in accordance with the terms of these Terms and Conditions, the Participant may exercise the Option in whole or in part on any Exercise Date permitted under Section 16.6 of the Plan (Securities Law Compliance) by delivering a signed, written exercise notice to the Company. The notice shall indicate the number of Shares being purchased. The Option must be exercised as to a whole number of Shares.

Section 4.2 Payment of Exercise Price. The Participant must pay the Exercise Price of the Option at the time of exercise as follows: (i) in cash or by check payable to the order of the Company; (ii) by means of a cashless exercise procedure approved by the Committee or, with respect to participants who are not Executive Officers, or its designee; or (iii) any combination of the foregoing.

Section 4.3 Withholding Obligation. The withholding obligation upon the Participant’s exercise of the Option must be satisfied by paying the amount of required withholding to the Company. If the Participant does not pay the amount of required withholding to the Company, the Company will withhold from the Shares delivered to the Participant the amount of funds required to cover any Withholding Tax at the maximum statutory rates in the applicable jurisdiction(s) incurred by reason of such exercise of the Option.

Section 4.5 Use of Shares. Shares used to satisfy the Exercise Price and/or any required withholding tax will be valued at their Fair Market Value, determined in accordance with the Plan.

Section 4.6 Condition of Transfer. The Company will issue no Shares pursuant to the Option before the Participant has paid the Exercise Price and any withholding obligation in full.

ARTICLE V

TERMINATION OF SERVICE

Upon termination of Service with the Company or an Affiliate, the Participant’s right to exercise the Option will be subject to the following rules:

Section 5.1 Retirement, Disability or Death. In the event a Participant’s Service terminates by reason of Retirement, Disability or death:

(a)

A pro-rata portion of the 2019 Stock Option that remains outstanding and unvested after application of the forfeiture provision of Section 1.3(e) shall become vested. Such pro-rata portion shall equal the portion of the 2019 Stock Option that would have become vested pursuant to Section 1.3(a) hereof at the next scheduled Vesting Date multiplied by a fraction, the numerator of which is the number of days

that have elapsed from the Grant Date or the most recent Vesting Date, as applicable, to the date of the Participant’s termination of Service and the denominator of which is the number of days between the Grant Date or the most recent Vesting Date, as applicable, and the next scheduled Vesting Date for such portion of the 2019 Stock Option.


(b)	The portion of an Option that is vested (whether by application of Section 5.1(a) above or otherwise) on the date the Participant terminates Service due to Retirement, Disability or death shall remain exercisable through the second (2^nd) anniversary of the date of the Participant’s termination of Service (but in no event beyond the Expiration Date) and shall thereafter expire.


(c)	Any unvested portion of the Option as of the date of termination (other than any portion thereof that becomes vested pursuant to Section 5.1(a)) shall be forfeited and canceled, without consideration, on the date of termination of Service.

Section 5.2 Other Termination of Service. Except as provided in Section 1.3(b) if the Participant’s Service terminates for any reason other than Retirement, Disability or death:


(a)	Any unvested portion of the Option as of the date of termination shall be forfeited and canceled on the date of termination, and

(b)

Subject to Section 5.3 below, the vested portion, if any, of the Option shall remain exercisable through (A) the date that is six months after the Participant’s termination of Service, if the six month period commences in an open trading window, or (B) if the six month period commences in a closed trading window, the date that is six months from the first day of the next open trading window. Any vested Option remaining outstanding after such date shall thereafter expire.

Section 5.3 Option Expiration. In no event may the Option be exercised after the Expiration Date.

ARTICLE VI

REPRESENTATIONS AND WARRANTIES OF THE PARTICIPANT

The Participant, severally as to itself only and not jointly as to or with anyone else, hereby represents and warrants to the Company as follows:

Section 6.1 Authority and Enforceability. The Participant has full power and authority to enter into these Terms and Conditions, the execution and delivery of which has been duly authorized and these Terms and Conditions constitutes a valid and legally binding obligation of the Participant, except as may be limited by bankruptcy, reorganization, insolvency, moratorium and similar laws of general application relating to or affecting the enforcement of rights of creditors, and except as enforceability of the obligations hereunder are subject to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or law).

Section 6.2 No Conflict; Required Filings and Consents. The execution, delivery and performance by the Participant of these Terms and Conditions and the consummation by the Participant of the transactions contemplated hereby do not and will not (a) violate any law, or (b) require any consent or approval of any person, including any registration or filing with, or notice to any governmental authority.

Section 6.3 Investment Purpose; Independent Decision. Any Shares the Participant acquires are solely for the Participant’s own beneficial account, for investment purposes, and not with a view towards, or resale in connection with, any distribution attributable to the Shares. The Participant acknowledges and agrees that the decision to acquire the Shares pursuant to these Terms and Conditions and the decisions whether, to what extent, and the method used to satisfy the Subscription Amount (as defined in the Elite Subscription Agreement), whether by borrowing or otherwise, are decisions that he or she makes and executes independently, and that neither the Company nor its agents shall be liable with respect to any action the Participant takes in connection with acquiring the Shares pursuant to these Terms and Conditions.

ARTICLE VII

GENERAL PROVISIONS

Section 7.1 Nontransferability.

(a)

Except as provided in Section 7.1(b), no 2019 Stock Option granted under the Plan may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent or distribution and all rights with respect to the 2019 Stock Option shall be available during the Participant’s lifetime only to the Participant or the Participant’s guardian or legal representative. The Committee may, in its sole discretion, require the Participant’s guardian or legal representative to supply it with evidence the Committee deems necessary to establish the authority of the guardian or legal representative to act on behalf of the Participant.

(b)

Subject to applicable law, all or a portion of the 2019 Stock Option may be transferred to a Successor. Such transferred 2019 Stock Option may not be further sold, transferred, pledged, assigned or otherwise alienated by the Successor, and shall be subject in all respects to the terms of these Terms and Conditions and the Plan. For a transfer to be effective, the Successor shall promptly furnish the Company with written notice thereof and a copy of such evidence as the Committee may deem necessary to establish the validity of the transfer and the acceptance of the Successor of the terms and conditions of the Plan.

Section 7.2 Securities Law Requirements.

(a)

If at any time the Committee determines that issuing Shares would violate applicable securities laws, the Company will not be required to issue such Shares. The Committee may declare any provision of these Terms and Conditions or action of its own null and void, if it determines the provision or action fails to comply with the short-swing trading rules. As a condition to exercise, the Company may require the Participant to make written representations it deems necessary or desirable to comply with applicable securities laws.


(b)	No Person who acquires Shares under these Terms and Conditions may sell the Shares, unless they make the offer and sale pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Securities Act”), which is current and includes the Shares to be sold, or an exemption from the registration requirements of the Securities Act.

Section 7.3 No Limitation on Rights of the Company. The grant of the 2019 Stock Option does not and will not in any way affect the right or power of the Company to make adjustments, reclassifications or changes in its capital or business structure, or to merge, consolidate, dissolve, liquidate, sell or transfer all or any part of its business or assets.

Section 7.4 Participant to Have No Rights as a Shareholder. Before the date as of which the Participant is recorded on the books of the Company as the holder of any Shares, the Participant will have no rights as a shareholder with respect to those Shares.

Section 7.5 Notice. Any notice or other communication required or permitted under these Terms and Conditions must be in writing and must be delivered personally, sent by certified, registered or express mail, or sent by overnight courier, at the sender’s expense. Notice will be deemed given when delivered personally or, if mailed, three (3) days after the date of deposit in the United States mail or, if sent by overnight courier, on the regular business day following the date sent. Notice to the Company should be sent to:

Coty Inc.

350 Fifth Avenue

New York, New York 10118

Attention: General Counsel

Notice to the Participant should be sent to the address on file with the Company. Either party may change the Person and/or address to which the other party must give notice under this Article 7 by giving such other party written notice of such change, in accordance with the procedures described above.

Section 7.6 Successors. All obligations of the Company under these Terms and Conditions will be binding on any successor to the Company, whether the existence of the successor results from a direct or indirect purchase of all or substantially all of the business of the Company, or a merger, consolidation, or otherwise.

Section 7.7 Governing Law. To the extent not preempted by federal law, these Terms and Conditions will be construed and enforced in accordance with, and governed by, the laws of the State of New York, without giving effect to its conflicts of law principles that would require the application of the law of any other jurisdiction.

Section 7.8 Plan and Terms and Conditions Not a Contract of Employment or Service. Neither the Plan nor these Terms and Conditions are a contract of employment or Service, and no terms of the Participant’s employment or Service will be affected in any way by the Plan, these Terms and Conditions or related instruments, except to the extent specifically expressed therein. Neither the Plan nor these Terms and Conditions will be construed as conferring any legal rights on the Participant to continue to be employed or remain in Service with the Company, nor will it interfere with any Company Party’s right to discharge the Participant or to deal with him or her regardless of the existence of the Plan, these Terms and Conditions or the Award.

Section 7.9 Plan Document Controls. The rights granted under these Terms and Conditions are in all respects subject to the provisions set forth in the Plan to the same extent and with the same effect as if set forth fully in these Terms and Conditions. If the terms of these Terms and Conditions conflict with the terms of the Plan document, the Plan document will control.

Section 7.10 Amendment of the Terms and Conditions. These Terms and Conditions may be amended unilaterally by the Committee to the extent provided under the Plan, or by a written instrument signed by both parties.

Section 7.11 Entire Agreement. These Terms and Conditions, together with the Plan, constitutes the entire obligation of the parties with respect to the subject matter of these Terms and Conditions and supersedes any prior written or oral expressions of intent or understanding with respect to such subject matter.

Section 7.12 Administration. The Committee administers the Plan and these Terms and Conditions. The Participant’s rights under these Terms and Conditions are expressly subject to the terms and conditions of the Plan, including any guidelines the Committee adopts from time to time. The Participant hereby acknowledges receipt of a copy of the Plan.

Section 7.13 Section 409A. The 2019 Stock Option awarded pursuant to these Terms and Conditions are intended to comply with or, in the alternative, be exempt from Section 409A. Any reference to a termination of Service shall be construed as a “separation from service” for purposes of Section 409A.

COTY INC.

By: ___________________________

Name:

Title:

Annex 2



Recipient	2019 Incentive Options	Elite Stock Options

Exhibit 21.1



	Coty Inc. Subsidiary List as of June 30, 2019


	Entity Name	Domestic Jurisdiction
	Coty Argentina S.A.	Argentina
	Coty Australia Holdings PTY Ltd.	Australia
	Coty Australia Legacy Pty. Limited	Australia
	Coty Australia PTY. Limited	Australia
	Gresham Cosmetics Pty Ltd	Australia
	HFC Prestige International Australia PTY Ltd	Australia
	Jemella Australia Pty Limited	Australia
	Revolver Distribution PTY Ltd.	Australia
	Younique Australia Pty Ltd.	Australia
	Coty Beauty Austria GmbH	Austria
	HFC Prestige Products N.V.	Belgium
	Younique Corporation	Belize
	Coty Brasil Comércio Ltda	Brazil
	Lancaster do Brasil Cosmeticos Ltda.	Brazil
	Savoy Indústria de Cosméticos S.A.	Brazil
	Younique do Brasil Participacoes Ltda.	Brazil
	StarAsia Distributions (Cambodia) Ltd.	Cambodia
	HFC Prestige International Canada, Inc.	Canada
	TJoy Holdings Co. Ltd.	Cayman Islands
	Coty Cosméticos Chile Limitada	Chile
	Coty China Holding Limited	China
	Coty Hong Kong Distribution Ltd.	China
	Coty International Trade (Shanghai) Co., Ltd.	China
	Coty Prestige Shanghai Ltd.	China
	HFC (Shanghai) Cosmetics Co., Ltd	China
	Nanjing Yanting Trade Co. Ltd.	China
	Suzhou Ganon Trading Co., Ltd.	China
	Suzhou Jiahua Biochemistry Co. Ltd	China
	HFC Prestige Service Costa Rica S.R.L.	Costa Rica
	Coty Ceska republika, s.r.o.	Czechia
	GHD Scandinavia ApS	Denmark
	HFC Prestige International Denmark ApS	Denmark
	Coty Holdings UK Limited	England and Wales
	Quest Beauty Limited	England and Wales
	HFC Prestige International Finland Oy	Finland
	Coty S.A.S.	France
	Coty France S.A.S.	France
	Else France S.A.S.	France
	Fragrance Production S.A.S.	France
	GHD France S.á r.l.	France
	HFC Prestige Holding France	France
	Coty Beauty Germany GmbH	Germany



Coty Brands Management GmbH	Germany
Coty Germany Holding GmbH	Germany
Coty Services and Logistics GmbH	Germany
Ghd Deutschland GmbH	Germany
HFC Prestige Manufacturing Cologne Germany GmbH	Germany
HFC Prestige Manufacturing Germany GmbH	Germany
HFC Prestige Products GmbH	Germany
HFC Prestige Service Germany GmbH	Germany
Sebastian Europe GmbH	Germany
Wella Grundstuecks- und Vermoegensverwalturngs GmbH & Co. KG	Germany
Zadafo Verwaltungsgesellschaft mbH	Germany
Wella Hellas MEPE	Greece
Chi Chun Industrial Co. Ltd.	Hong Kong
Coty Hong Kong Limited	Hong Kong
Coty INT Hong Kong Limited	Hong Kong
Coty Prestige Shanghai (HK) Ltd.	Hong Kong
Coty Prestige Southeast Asia (HK) Limited	Hong Kong
GHD Hong Kong Limited	Hong Kong
Ming-De Investment Co. Ltd.	Hong Kong
Super Globe Holdings Ltd.	Hong Kong
Younique Hong Kong, Limited	Hong Kong
Coty Hungary Kft.	Hungary
Coty India Beauty and Fragrance Products Private Limited	India
Wella India Private Limited	India
PT StarAsia Distributions Indonesia	Indonesia
PT. Coty Prestige Southeast Asia Indonesia	Indonesia
Coty Ireland Ltd.	Ireland
Coty UK&I Limited	Ireland
HFC Prestige Manufacturing Ireland Ltd.	Ireland
Coty Italia S.R.L.	Italy
GHD Italia S.r.l.	Italy
Younique Products Italy S.r.l	Italy
HFC Prestige Japan Godo Kaisha	Japan
OPI-Japan K.K.	Japan
Coty Korea Ltd.	Korea, Republic Of
HFC Prestige International Holding Luxembourg SARL	Luxembourg
HFC Prestige International Luxembourg SARL	Luxembourg
Coty INT Malaysia Sdn. Bhd.	Malaysia
Coty Prestige Southeast Asia (M) Sdn. Bhd.	Malaysia
Coty Beauty Mexico, S.A. de C.V.	Mexico
Coty México, S.A. de C.V.	Mexico
Galería Productora de Cosméticos, S. de R.L. de C.V.	Mexico
HFC Cosmetics S. de R.L. de C.V.	Mexico
HFC Prestige International S. de R.L. de C.V.	Mexico
YQ Products MEX S.de R.L. de C.V.	Mexico
Coty Lancaster S.A.M.	Monaco



Coty B.V.	Netherlands
Coty Global 1 B.V.	Netherlands
Coty Global 2 B.V.	Netherlands
Coty Global 3 B.V.	Netherlands
Coty Global 4 B.V.	Netherlands
Coty Global 5 B.V.	Netherlands
Coty Global Holdings B.V.	Netherlands
Coty Investments B.V.	Netherlands
HFC Prestige International Netherlands B.V.	Netherlands
HFC Prestige International Netherlands Holding B.V.	Netherlands
Lancaster B.V.	Netherlands
Younique Products B.V	Netherlands
Younique Products Cooperatief U.A.	Netherlands
HFC Prestige International New Zealand Limited	New Zealand
Jemella New Zealand Limited	New Zealand
GHD Scandinavia NUF (Norwegian Branch)	Norway
HFC Prestige International Norway AS	Norway
Coty Prestige Southeast Asia Philippines, Inc.	Philippines
Coty Eastern Europe sp. z.o.o.	Poland
HFC Prestige Service Poland Sp. z.o.o.	Poland
Wella Prestige Products Portugal S.A.	Portugal
HFC Prestige International Puerto Rico LLC	Puerto Rico
Coty Cosmetics Romania SRL	Romania
Bourjois Paris LLC	Russian Federation
LLC Capella	Russian Federation
Russwell Ltd	Russian Federation
Coty Arabia Trading Company LLC	Saudi Arabia
Coty Scot 1 LP	Scotland
Coty Scot 2 LP	Scotland
Coty Asia Pte. Ltd.	Singapore
Coty Prestige Southeast Asia Pte. Ltd.	Singapore
Coty Singapore Pte. Ltd.	Singapore
Coty Southeast Asia Pte. Limited	Singapore
HFC Prestige International Operations Switzerland SARL Singapore Branch	Singapore
HFC Prestige International Singapore Pte. Ltd.	Singapore
Coty Slovenská Republika s.r.o.	Slovakia
Coty Beauty South Africa (PTY) Ltd.	South Africa
Coty South Africa (Proprietary) Limited	South Africa
Good Hair Day South Africa (Proprietary) Limited	South Africa
Coty Beauty Spain, S.L.U.	Spain
Coty Spain S.L., Sociedad Unipersonal	Spain
GHD Spain, S A U	Spain
Younique Spain SL	Spain
HFC Prestige International Sweden AB	Sweden
Coty International S.a.r.l.	Switzerland
HFC Prestige International Holding Switzerland Sàrl	Switzerland



HFC Prestige International Operations Switzerland Sàrl	Switzerland
HFC Prestige International Switzerland Sàrl	Switzerland
So Be Cosmetics S.A.	Switzerland
Coty Prestige (Taiwan) Ltd.	Taiwan, Province Of China
StarAsia Taiwan Co., Ltd.	Taiwan, Province Of China
Coty Prestige Southeast Asia (Thailand) Company Limited	Thailand
HFC Prestige Manufacturing (Thailand) Ltd.	Thailand
HFC Prestij Satış ve Dağıtım Ltd. Şti.	Turkey
Coty Distribution Emirates L.L.C.	United Arab Emirates
Coty Middle East Fzco	United Arab Emirates
Coty Regional Trading FZE	United Arab Emirates
HFC Prestige International Operations SARL	United Arab Emirates
Beamly Ltd.	United Kingdom
Beauty International Ltd.	United Kingdom
Bourjois Limited	United Kingdom
Coty Brands Group Limited	United Kingdom
Coty Export U.K. Ltd.	United Kingdom
Coty Manufacturing UK Ltd.	United Kingdom
Coty Services U.K. Ltd.	United Kingdom
Coty U.K. Limited	United Kingdom
Coty UK&I Ltd	United Kingdom
Del Laboratories (U.K.) Limited	United Kingdom
ghd BondCo plc	United Kingdom
GHD Group Holdings Limited	United Kingdom
GHD Group Limited	United Kingdom
GHD Holdings Limited	United Kingdom
HFC Prestige Manufacturing UK Ltd	United Kingdom
HFC Prestige Products Ltd.	United Kingdom
HFC Prestige Service UK Ltd	United Kingdom
Jemella Group (Holdings) Limited	United Kingdom
Jemella Group Limited	United Kingdom
Jemella Limited	United Kingdom
Lancaster Group, Ltd.	United Kingdom
Lion/Gloria Bidco Limited	United Kingdom
Lion/Gloria Holdco Limited	United Kingdom
Lion/Gloria Midco 2 Limited	United Kingdom
Lion/Gloria Midco 3 Limited	United Kingdom
Lion/Gloria Midco Limited	United Kingdom
Lion/Gloria Topco Limited	United Kingdom
Rimmel International Ltd.	United Kingdom
GHD Professional, North America, Inc.	United States - CA
HFC Prestige Products, Inc.	United States - CT
Beamly Inc.	United States - DE
Calvin Klein Cosmetic Corporation	United States - DE
Coty Brands Management Inc.	United States - DE
Coty Holdings, Inc.	United States - DE



Coty Inc.	United States - DE
Coty International LLC	United States - DE
Coty US Holdings Inc.	United States - DE
Coty US LLC	United States - DE
DLI International Holding I LLC	United States - DE
DLI International Holding II Corp	United States - DE
Foundation Serviceco, LLC	United States - DE
Foundation, LLC	United States - DE
Galleria Co.	United States - DE
Graham Webb International, Inc.	United States - DE
HFC Prestige International U.S. LLC	United States - DE
Launch Beauty LLC	United States - DE
O P I Products, Inc.	United States - DE
Rimmel Inc.	United States - DE
The Wella Corporation	United States - DE
Noxell Corporation	United States - MD
Younique DISC Corporation	United States - UT
Younique International Holdings LLC	United States - UT
Younique, LLC	United States - UT
Coty Beauty Vietnam Company Limited	Viet Nam
Coty Argentina S.A.	Argentina
Coty Australia Holdings PTY Ltd.	Australia
Coty Australia Legacy Pty. Limited	Australia
Coty Australia PTY. Limited	Australia
Gresham Cosmetics Pty Ltd	Australia
HFC Prestige International Australia PTY Ltd	Australia
Jemella Australia Pty Limited	Australia
Revolver Distribution PTY Ltd.	Australia
Younique Australia Pty Ltd.	Australia
Coty Beauty Austria GmbH	Austria
HFC Prestige Products N.V.	Belgium
Younique Corporation	Belize
Coty Brasil Comércio Ltda	Brazil
Lancaster do Brasil Cosmeticos Ltda.	Brazil
Savoy Indústria de Cosméticos S.A.	Brazil
Younique do Brasil Participacoes Ltda.	Brazil
StarAsia Distributions (Cambodia) Ltd.	Cambodia
HFC Prestige International Canada, Inc.	Canada

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-189276 and 333-214532 on Form S-8 and Post-Effective Amendment No. 1 to Registration Statement No. 333-231352 on Form S-3 of our reports dated August 28, 2019, relating to the consolidated financial statements and financial statement schedule of Coty Inc. and subsidiaries (the “Company”), and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of the Company for the year ended June 30, 2019.

/s/ Deloitte & Touche LLP

New York, New York

August 28, 2019

Exhibit 31.1

Certification

I, Pierre Laubies, certify that:

1. I have reviewed this Annual Report on Form 10-K of Coty Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 28, 2019



	/s/ Pierre Laubies
	Pierre Laubies
	Chief Executive Officer

Exhibit 31.2

Certification

I, Pierre-André Terisse, certify that:

1. I have reviewed this Annual Report on Form 10-K of Coty Inc.;

d) Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 28, 2019



	/s/ Pierre-André Terisse
	Pierre-André Terisse
	Chief Financial Officer

Exhibit 32.1

Certification

Pursuant to Rule 13a-14(b) or

Rule 15d-14(b) and 18 U.S.C. Section 1350

(as adopted pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002)

Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), the undersigned officer of Coty Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Annual Report on Form 10-K for the year ended June 30, 2018 (the “Report”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: August 28, 2019	/s/ Pierre Laubies
	Pierre Laubies
	Chief Executive Officer

The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and for no other purpose.

Exhibit 32.2

Certification

Pursuant to Rule 13a-14(b) or

Rule 15d-14(b) and 18 U.S.C. Section 1350

(as adopted pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002)



Date: August 28, 2019	/s/ Pierre-André Terisse
	Pierre-André Terisse
	Chief Financial Officer